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Abstract 
 
This doctoral research aims to investigate the reputation building process of companies 
and to examine the applicability of western-developed theories about the uses of 
corporate reputation in a non-western context. It is the first study that synthesises three 
theories (value creation, strategic resources and corporate communication) to examine 
the strategic consequences of the uses of corporate reputation.  
 
Corporate reputation is an attribute or a set of attributes ascribed to a firm and inferred 
from the firm’s past actions. It is the belief of market participants about a firm’s 
strategic character (Weigelt and Camerer, 1988). Also, corporate reputation is the 
public’s cumulative judgement of a firm over time (Roberts and Dowling, 2002).  
 
The review of theoretical literature indicates the uses of corporate reputation by 
business organizations can be theorized along six dominant paradigmatic perspectives: 
1-public relations; 2-marketing; 3-management, 4-economic; 5-sociological; 6-finance 
and accounting. The uses of corporate reputation in these six paradigms are 
comprehensively discussed. The objective of this study is to establish the use of 
corporate reputation in the development of brand image strategy. A review of the uses 
of the concept of corporate reputation is discussed in detail in chapter 2.  
 
The review of the literature also identified a research gap by showing that scarce 
research has been conducted on how these three main functions (value creation, 
strategic resources and corporate communication) affect a company’s brand positioning 
strategy.  The following research question thus is proposed: How do (Taiwanese 
pharmaceutical) companies use their corporate reputation to develop a brand image 
strategy?   
 
The research hypotheses based on three theories (value-based theory, resource-based 
theory and integrated marketing communication theory) appear in Chapter 3.  The 
research question is constructed theoretically, and then a conceptual model, which 
begins with three antecedents of corporate reputation and simultaneously illustrates the 
outcomes of their use, are discussed.  
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The construct of the uses of corporate reputation has three dimensions: value creation, 
strategic resources and corporate communication.  Each of these three dimensions 
includes several items.  The items were proposed based on the previous researchers’ 
summaries and the qualitative interview. The researcher will then depict the proposed 
research conceptual framework and a number of hypotheses that will be further 
investigated and tested. 
 
Then the quantative study was completed by providing the data analysis and the results 
were explained.  A multi-stage procedure was involved in this research. First, data 
examination and screening to prepare for subsequent quantitative analyses and then the 
descriptive statistics were presented. Second, a reliability test was performed on 
measurement scales to ensure that they achieve an acceptable level of reliability for 
further analysis. The resulting solutions were then re-assessed using confirmatory factor 
analysis. Finally, PLS (Partial Least Squares) was used to test the hypothesized 
relationships between the research constructs as postulated in the conceptual model, and 
to assess the overall goodness-of-fit between the proposed model and the collected data 
set.  
 
The researcher then discusses the validation of the measurement model and the research 
findings. The findings are then further discussed in terms of the contribution to 
marketing theory and relevance to marketing managers. Then the items of adapted 
scales were subjected to several rounds of adjustments and were finally found to 
possess acceptable measurement properties. Reliability and construct validity tests 
indicated that all scales satisfied widely accepted criteria such as the minimum 
reliability of 0.7. The results of scale purification will be discussed. And an evaluation 
of the research hypotheses and their significance are summarized, the findings of all 
hypotheses testing will be reviewed and compared with previous research.  
 
According to the research findings, the hypotheses that value creation, as one dimension 
of corporate reputation, has a positive impact on brand segmentation, brand 
differentiation and brand positioning are all accepted. The hypotheses that strategic 
resource, as one dimension of corporate reputation, has a positive impact on brand 
segmentation and brand differentiation are rejected. However, the hypothesis that 
strategic resource, as one dimension of corporate reputation, has a positive impact on 
 viii
brand positioning is accepted. The hypotheses that corporate communication, as one 
dimension of corporate reputation, has a positive impact on brand segmentation and 
brand differentiation are both accepted. The hypothesis that corporate communication, 
as one dimension of corporate reputation, has a positive impact on brand positioning is 
partially supported. Finally, the hypothesis that the (see in Table 5.18) moderating effect 
of price policy on corporate reputation has a positive impact on brand image strategy is 
partially but negatively supported. 
 
This thesis makes a significant contribution to the study of corporate reputation of firms 
in the Taiwanese pharmaceutical industry from the robustness of the qualitative and 
quantitative data collection. 
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CHAPTER ONE: INTRODUCTION 
 
 
1.1 Introduction 
 
A well-developed corporate reputation can be used as a resource to develop a firm’s 
strategic value (Weigelt and Camerer, 1988; Roberts and Dowling, 2002).  It can be 
used as a trait or a signal to forecast the potential behaviour of a firm (Kreps and Wilson, 
1982; Shapiro, 1989) or to signify an organisation’s perceived capacity to meet their 
stakeholders’ expectations (Waddock, 2000), allowing a stakeholder to evaluate how 
key resource providers interpret a company’s initiatives and, from its past actions, to 
assess its ability to deliver value outcomes (Fombrun, 2002; Day, 1994). Therefore, an 
understanding of how to effectively signify a firm’s corporate reputation to its 
consumers is needed. However, very few studies of corporate reputation are available.   
 
This doctoral research is primarily concerned with the uses of corporate reputation, 
particularly developing a brand image strategy from it, within the pharmaceutical 
industry in Taiwan.  The research employs three theories – value creation, strategic 
resources and corporate communication – to study the effects of the uses of corporate 
reputation as well as relevant underlining mechanisms. This chapter explains the 
background of the research, provides a statement of the problem, identifies research 
objectives and questions, offers a rationale for the context, indicates expected research 
contributions, clarifies the proposed methodology, states the limitations of the research 
and outlines the structure of the thesis. 
 
 
1.2 The research background 
 
In order to have a clearer understanding about the research background, this section will 
first present the challenges facing pharmaceutical companies in Taiwan regarding the 
reputation a company can create in order to establish its corporate brand image, which 
` 
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will influence its perception by doctors when they prescribe medicines to their patients.  
Therefore, in order to have a better understanding of the brand strategy created by the 
brand manager, it is essential to find out the importance and the uses of corporate 
reputation.  In the last part of the research background, the importance of a firm’s 
reputation for companies in the pharmaceutical industry in general will be introduced.  
 
According to a report by BCC research (market research reports and technical 
publications provider) (Natale, 2008), “the global market for pharmaceuticals increased 
from $693.7 billion in 2007 to an estimated $737.6 billion by the end of 2008. It should 
reach over $1 trillion by 2013, a compound annual growth rate (CAGR) of 6.9%. The 
generic prescription drugs segment will experience the highest growth rate over the 
study period. Worth an estimated $88.7 billion in 2008, it will reach $151.4 billion by 
the end of 2013, a CAGR of 11.3%.”  (Figure 1.1) 
 
Figure 1.1: Worldwide market for pharmaceutical products, 2006–2013 (US$ Billions) 
 
Source: BCC Research (Natale, 2008:1) 
 
 
According to another report from BCC (Evers, 2009), “The global market for generic 
drugs was worth $81 billion in 2008, a figure that is expected to reach $84 billion in 
2009. In 2014, the market is expected to amount to $168.7 billion, for a compound 
annual growth rate (CAGR) of 15% in the 5-year period. Sales of U.S. generic drugs 
currently dominate the market, estimated at $33 billion in 2009 and projected to 
increase at a CAGR of 10.4% to $54 billion in 2014.”  
` 
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Based on the numbers estimated from the market report, therefore, we can forecast that 
there is a huge market space for generic medicine growth, basically in the US market. 
There are five reasons for this: (1) medical insurance requiring decreasing costs, (2) 
patent expirations of popular used medicines, (3) people living longer, (4) support from 
government policy and (5) prescription medicine changing to non-prescription 
medicines.  
  
1.2.1 Challenges for the pharmaceutical industry in Taiwan 
 
Since there are only 23 million people in Taiwan, also, generic drug manufacturers are 
too many and too small compared to their counterparts in India and China.  “The 
national health insurance system, which while doing immense good for improving the 
health of the general population, has budget provisions which discourage the use – and 
therefore the development – of newer, more costly drugs” (Silver, 2006). The new 
issued drug price policy caused the outlook of the whole industry to become bleak.  
When faced with the facts that Taiwanese pharmaceutical companies are master in 
manufacturing, no big name research-based drug or drug maker has emerged to date.  
So Taiwan’s pharmaceutical sector is facing a considerable challenge right now. Also, 
according to Silver (2006), looking in further, “exports make up only three percent of 
the total production value of the local drug manufacturing industry (2004 figures), 
which either means the industry has tremendous potential, or it’s a brutal reflection of 
the realities of the international marketplace.”  
 
 
1.2.1.1 Generic pharmaceuticals 
A very large number of generic in drug makers then arose in the Taiwan pharmaceutical 
industry under the circumstances stated above – many hundreds at last count.  Although 
many of these companies are too small to compete with giant overseas generics 
companies, they are being kept alive by their close relationships with local hospitals, in 
turn supported by the policies of the Bureau of National Health Insurance (BNHI).  
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There is a special market condition in Taiwan, according to Silver (2006:1),  
“representatives of overseas business groups in Taiwan such as the 
American Chamber of Commerce and the European Chamber of 
Commerce have long claimed that while more expensive drugs - 
particularly cancer drugs - produced by US, European and 
Japanese firms are not being paid for by the BNHI in Taiwan, 
hospital purchasing departments were buying cheaper drugs and 
being paid back by BNHI for more than what they paid.  This 
situation leads to over-prescribing. Hence drug prescribing is 
becoming a profit centre for a hospital.  This gradually led to 
prescription decisions being based on profit instead of efficacy and 
value of the drug to the patient.  It’s been estimated that over 
US$600 million is lost annually in BNHI funds due to this payment 
reimbursement mechanism.  Just where these funds get lost may 
explain how many small generics companies are still keeping their 
doors open, and why many of Taiwan’s big hospitals are doing 
very well for themselves.”   
 
Nowadays, there is a trend for Taiwanese generic manufacturers to obtain the US 
FDA’s (Food and Drug Administration) GMP (good manufacturing practice) 
certification, cGMP (current good manufacturing practice) certification, or the European 
ISO (International Organization for Standardization) certification and PIC 
(Pharmaceutical Inspection Co-operation Scheme) certification for their factories, 
because currently this industry is facing a big challenge. There are some government 
policies that may affect the industry. For example, pharmaceutical prices are now under 
the control of the National Health Institute. However, since Taiwan has proven expertise 
in engineering and manufacturing, generics is where it should be able to compete – if 
not on price then on quality, flexibility or where more precise or complicated processes 
are required to make the end product. Therefore, they all hope to market their products 
on the international market. 
 
Recently, the government threw a lifeline to the generics manufacturing sector by 
demanding self-sufficiency in certain drug supplies, such as vaccines and medical 
consumables. The policy was set from lessons learned during the 2003 SARS crisis 
when vital medical supplies ran out, and the policy reinforced by the current H5N1 
scare resulting in worldwide shortage of the antiviral Tamiflu.  The increase in 
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competition in the pharmaceutical market has been seen as the key driver of 
pharmaceutical industry marketisation across the world1.   
 
1.2.1.2 Research-based pharmaceutical companies 
 
While not exactly in the same league as Pfizer or GSK, there are a small number of 
research-based pharmaceutical companies producing innovative drugs, or at least 
modified existing drugs for new uses, such as TTY Biopharm, which is a publicly listed 
company making oncology drugs with improved disease-targeting behaviour. TTY 
Biopharm does its own research, as well as its own manufacturing. And moreover, it 
also has developed its own network of distributors islandwide.  
 
Other drug discovery companies also have good prospects in therapeutics for Asian-
prevalent diseases such as hepatitis.  While some will look towards the traditional  
 
“licensing-to-Big-Pharma” model for their big break, others will try 
to go it alone and research, manufacture and market their own 
products as TTY has done.  There are several companies in this area, 
such as TaiGen Biotechnology and PharmaEssentia. TaiGen is 
previously research leader for Oncology and Virology for over 10 
years at Hoffmann-La Roche, USA. TaiGen focuses on oncology, 
chronic inflammation and viral infection therapeutics and received 
early financing from MPM Capital to the extent of US$37 million. The 
company is also in research collaboration with TTY. PharmaEssentia 
is a drug discovery company with promising liver disease drugs in the 
pipeline.” (Silver, 2006:1) 
 
 
However, as we all agree, funding is vital and unavoidable for the long drug 
development process.  Unlike drug manufacturers in other countries, Taiwanese 
                                                        
1
 Including: North America (Allen and Shen, 1999; Dill, 2003; Kwong, 2000; Young, 2002); Europe 
(Middleton, 1996; Williams, 1997; Gibbs, 2001; Taylor, 2003; Binsardi and Ekwulugo, 2003; Jongbloed, 
2003; Mora, 1997; Czarniawska and Genell, 2002); Africa (Ivy, 2001; Maringe and Foskett, 2002; 
Maringe, 2004); Asia (Arimoto, 1997; Oplatka, 2002; Gray et al., 2003; Williams et al., 1997; Mok, 1999, 
2000); Australia (Baldwin and James, 2000); New Zealand (Ford et al., 1999); Russia (Hare and 
Lugachev, 1999). 
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companies have not tended to list their companies on foreign stock exchanges (Silver, 
2006:1). 
 
“Whilst Taiwan has its own vibrant venture capital industry, local 
funds are not yet flowing into the life sciences on their own accord.  
However, with its continued efforts to fund and promote the industry’s 
development, and to source and set up international collaboration 
opportunities, the government remains a force behind much of the 
continued growth of Taiwan’s life sciences industries, including the 
pharmaceutical sector.  When measured together with the prospects 
for the island’s burgeoning drug discovery industry, and considering 
the boost the recent government emphasis on drug self sufficiency has 
had on Taiwan’s bio-product manufacturing industry, it all adds up to 
a future optimistic for the industry than expected it to be.”  
 
 
On the other hand, product price regulation is an issue for the Taiwan pharmaceutical 
industry. The idea of drawing links within modes of consumer perceptions of price, 
advertising, product quality and values has been long appreciated by marketing scholars 
who are interested in understanding the significance of a firm’s reputation (Milgrom 
and Roberts, 1986; Zeithaml, 1988).  In the pharmaceutical industry, branding strategies 
such as advertising and academic reports mainly influence a doctor’s perception of a 
product (or brand).  However, a basic for understanding of a company also helps the 
customer make a decision.  The information a company sends about itself has an 
influential and unexpected impact on consumer perception.  The signals sent by a firm 
through its reputation, advertisements and product price are usually interpreted 
differently by their customers.  Therefore, there is a need to understand the link of how 
do managers use their corporate reputation to establish a firm’s brand image strategy 
(Schultz et al., 2000; Bickerton, 2000).   
 
The signal a product’s price gives to customers regarding their perception of a product’s 
quality has been noted by marketing scholars (Milgrom and Roberts, 1986; Fombrun 
and Shanley, 1990; Kalita et al., 2004).  Previous scholars asserted that a warranty is 
positively related to a firm’s reputation (Balachander, 2001). Previous scholars have 
asserted that a warranty is positively related to a firm’s reputation (Balachander, 2001). 
Previous literature (see Chapter 2) suggests that the firm organises its reputation 
according to three dimensions: (1) the way the firm organizes its strategic resources 
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(strategic resources), (2) the way the firm communicates with its customers (corporate 
communication) and (3) through the type of value it offers to its customers (value 
creation). This information enables brand managers to operate a better strategy for their 
products’ brand image (mainly about brand segmentation and positioning their 
products).    
 
Because each firm differs in how it becomes established and the methods it uses to 
survive, establishing the factors of the study’s focus is important.  For example, 
automobile companies try to build their own style or image to differentiate themselves 
from their competitors (Hsieh, 2002), though they tend to consider the same safety 
issues. Pharmaceutical companies try to achieve international standard requirements and 
build reputations to survive (Nakra, 2000; Bennett and Gabriel, 2001; Rose and 
Thomsen, 2004). Without a well-crafted or sound reputation, it is difficult for 
pharmaceutical companies to sustain their customers’ trust, and thereby they lose 
ground against competitors.  
 
For the above reason, pharmaceuticals are encouraged to develop a good reputation for 
their quality of product and services (Fombrun and Shanley, 1990; Berndt et al., 1997), 
for innovativeness (Prentis et al., 1988; Fombrun and Shanley, 1990; Valle and 
Gambardella, 1993; Achilladelis and Antonakis, 2001), for honest communication and 
for environmental responsibilities (Fombrun and Shanley, 1990; Byrne and Kavanagh, 
1996). In turn, these factors can also be converted subconsciously into the brand image 
of the products belonging to the company (Kim et al., 1989; Panigyrakis and Veloutsou, 
1999).  Because a firm’s corporate reputation tends to highly influence the initiation of a 
brand strategy decisions and brand scene-setting in pharmaceutical companies (Keller 
and Aaker, 1998; Nakra, 2000), the literature regarding this topic will be reviewed in 
the following paragraphs.  
 
First, in Taiwan, ‘biotechnology’ is defined as including the pharmaceutical, medical 
device and modern biotech sectors.  Besides, the API (Active Pharmaceutical Ingredient) 
manufacturing model fits well to Taiwan’s seemingly natural propensity to excel in 
engineering and precision manufacturing.  However, nowadays, Taiwanese 
pharmaceutical companies are trying to transform its business model from original 
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equipment manufacturer (OEM) model to knowledge-creation model in producing 
pharmaceutical ingredients on contract for some of the international brand and non-
brand drug companies seen in the modern biotech environment of gene identification 
and drug discovery.  Pharmaceuticals in Taiwan therefore are heading to a way towards 
to the innovation of the industry (Berndt et al., 1996; Lichtenberg, 1998) or focus on 
generic knowledge strategies (Bierly and Chakrabarti, 1996). 
 
Second, there is an encouraging use of generic medicines in several countries in recent 
years (King and Kanavos, 2002).  However, even the same constituents, produced by 
different manufacturers, may contain different quality ingredients or different excipients 
(an inactive substance used as a carrier for the active ingredients of a medication)  to 
work with the main constituents to produce medicines that perform differently (or are 
perceived to perform differently).  These differences are related to a firm’s knowledge, 
R&D and also its producing experience (Vendelo, 1998).  Moreover, a firm’s reputation 
has an impact on the brand message, and might even make or break the success of a 
brand depending on its marketing capability (Ling and Jaw, 2006).  Therefore, in this 
vein, generic medicine producers need to build their own brand on their corporate 
reputation for marketing purposes.   
 
Third, in pharmaceutical companies, apart from the research-and-development (R&D) 
cost, the marketing cost usually occupies a significant portion of the budget (Bulger, 
1999).  Moreover, a pharmaceutical company should have the ability to hire and retain 
good and experienced sales representatives (Ziegler et al., 1995).  Therefore, the 
marketing campaign or marketing strategy is another key focus for the marketing 
manager.  
 
In pharmaceuticals, good corporate reputation leads to good dealings with customers – 
from being able to raise a price to a deal solidifying the customer’s confidence in a 
purchase (Davies, 2003; Keh and Xie, 2008).  It has been discussed frequently that 
corporate reputation is the key to customer satisfaction (Gray and Balmer, 1998; Moss, 
2007).  A good marketing campaign which enables good sales probably has to build a 
brand especially upon the firm’s experience and knowledge (Bierly and Chakrabarti, 
1996; Yeoh and Roth, 1999; Powell, 2000; Nerkar and Roberts, 2004; Hung et al., 
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2005).  In addition, according to its style of leadership, a firm uses different strategies to 
market its products (Ogbonna and Harris, 2000; Harris and Ogbonna, 2001; Cable and 
Judge, 2003), such as more product-oriented or customer-oriented strategies.  
 
Based on the arguments and market situations or environment stated above, 
pharmaceuticals are inspired and encouraged to build their corporate reputation and 
apply it to the setting of its brand strategy.  A firm’s corporate reputation can be used to 
communicate its benefit to its customers or to the public, to enhance value for its 
customer, and has a strategic role that serves as an intangible asset for a firm 
(Fombrun, 1996; Roberts and Dowling, 2002).  Once brand managers create a brand 
image which is coherent with a firm’s image or reputation, the firm in turn can 
create a more flexible strategy regarding image for its products. 
 
1.2.2 Pharmaceuticals and their uses of corporate reputation  
 
For pharmaceuticals, it is vital to develop an organisation’s brand from its intangible 
assets (such as corporate reputation).  Evidence suggests that organisations with a 
consistent corporate strategy and can convey it consistently into its brand strategy are 
likely to perform better than those organisations with a less clear and inconsistent ethos 
(Schendel and Patton, 1978; Wind and Robertson, 1983; Varadarajan, 1992; Hatch and 
Schultz, 2001; Rao et al., 2004).  Nowadays, the pharmaceutical industry is becoming 
increasingly complex and subject to a number of critical influences.  This suggests that 
participant organisations need to actively consider how they are perceived by key 
stakeholders (Fill and Dimopoulou, 1999).  Recently, studies shows that customers 
focus on a firm’s corporate reputation by conveying and committing to a coherent brand 
message perception, especially for pharmaceutical companies (Wiedmann, 2002).  
Therefore, in order to deliver a clearer signal to its customers, corporate strategy in 
pharmaceuticals must focus on a thorough understanding of the brand perception, not 
only from the brand itself but also from the corporate perspective (Hoffman, 2006; 
Brammer and Pavelin, 2004).  Which means to look at a brand it is suggested to 
incorporate a firm’s corporate background and the corporate reputation in general. 
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As explained above, in a pharmaceutical context, in order to build up a firm’s reputation 
and its brand image, brand managers play an important role – the pharmaceutical brand 
is built to gain trust from professional people such as physicians and doctors 
(Panigyrakis and Veloutsou, 1999; Fugh-Berman and Ahari, 2007).  The brand strategy 
decision makers are highly influential in the representation of a pharmaceutical 
company or its brand to its customers (for example, as a result of targeting a brand as 
having upper-class customers, being well-reputed within the target andmarket and 
having top quality products) (Easingwood and Koustelos, 2000; Smith and Awopetu, 
2007; Robin, 2007). Brand orientation means that the formulation of company strategy 
is based on brands (Urde, 1994). 
 
There is a novel view from a brand practitioner, John Nosta, the vice president and 
creative director at Catalyst Communications, saying that: brand-makers seek out mind 
share while marketers seek out market share. “I call it (the brand) the personification of 
a product.  A brand is what sticks to the roof of your customer’s brain.  It’s memorable. 
And it’s what differentiates a product in the marketplace.… Branding is an exercise in 
perception.” (Laitin, 2000, p. 5) The brand “signature”, or “personality”, is based on 
sound strategic thinking.  Brand positioning is an exercise in customer perception. It 
decides the way you want the audience to perceive your product (Sujan and Bettman, 
1989), and it is the first step in successful branding (Park et al., 1986; Carpenter, 1989).  
For example, a reputation for innovation enhances credibility among customers. In 
particular, experimental studies have shown that innovation has made the acceptance of 
new product offerings more likely.  It also helps a firm to gain reputation if it makes the 
customers think that it shows concerns for the customer (Aaker and Joachimsthaler, 
2004). 
 
For the reasons above, it is crucial to take a firm’s reputation as a basis and set a brand 
strategy based on its current reputation in order for it to remain a corporate brand 
strategy consistent with the corporate image or reputation.  However, in order to ensure 
the brand strategy is in alignment with the corporate strategy, the branding strategy 
creation process must address such fundamental questions as “who are we targeting?” 
and “what is our core value?” (Belanger et al., 2002).  Therefore, in order to encourage 
` 
11 
 
a coherent brand strategy, managers should have the same perceptions of the values that 
are embedded in the corporation (Hatch and Schultz, 2003).   
 
 
1.3 Statement of the problem 
 
Corporate reputation is about a firm’s quality management of its corporate name.  A 
firm’s corporate reputation involves several aspects of a firm: its long-term investment 
value, its financial soundness, whether it makes a wise use of corporate assets, its 
quality of management, products and services, its ability to innovate, its ability to attract 
develop or keep talented people, its communication and environment responsibilities 
(Fombrun and Shanley, 1990; Fryxell and Wang, 1994; Caruana, 1997; Hammond and 
Slocum, 1996; Barnett et al., 2006).  As discussed above, in a pharmaceutical context, 
corporate reputation is likely to play the crucial role in the branding process.  However, 
very few studies on corporate branding are available.  Although, there are studies on 
corporate reputation and how a pharmaceutical company builds or extends its corporate 
brand (e.g. Keller and Aaker, 1998; Argenti et al., 2003), the studies are not specific on 
how firms use their corporate reputation to give more strategic insights to its brand.  
Dolphin’s (2004) study seems to be the most relevant study, giving a full review of how 
firms put the reputation idea into the branding process.  However, the concept of the 
uses of corporate reputation in pharmaceuticals still remains unclear as most of the 
studies regarding this issue were conducted solely from customer perspectives. 
 
One of the most important concerns is the fact that a firm’s reputation in 
pharmaceuticals is based on the strength in the organisation.  This factor raises the 
question of the applicability of the uses of corporate reputation in the pharmaceutical 
industry context.  There is the need for research that examines the effects of uses of 
corporate reputation at the firm level.  A firm can manage the impression it creates or its 
reputation by engaging in corporate social responsibility (Hooghiemstra, 2000; Bronn 
and Vrioni, 2001).  The literature suggests three kinds of the uses offer corporate 
reputation: value creation, strategic resources and corporate communication. Therefore, 
strategy variables are included within a proposed conceptual model in order to examine 
the underlying mechanisms of the link between the brand image strategy and its effect 
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from marketing and communication perspectives.  In addition, based on a review of the 
literature, most studies on the uses of corporate reputation in pharmaceuticals have been 
conducted in Western countries, such as the USA, the UK and Germany, thus, limiting 
the generalisablility of any theory. In order to bridge this gap, Taiwan, as a country in 
far eastern Asia, has therefore been selected as the setting of this study.  
 
 
1.4 Research objectives   
 
Given the importance of a firm’s reputation in pharmaceuticals, it is worthwhile 
investigating the concept further in order to harmonise with existing research. This 
doctoral study has two main research objectives.  First, the research attempts to develop 
a model to explain the effects of aspects of the uses of corporate reputation in 
pharmaceuticals on the brand image strategy of brand managers.  Second, the research 
intends to empirically test the model in a non-Western setting, which will help the 
researcher to examine the external validity of Western-developed theories (i.e. the 
applicability of these theories in other contexts).  This includes the assessment of the 
dimensionality and operationalisation of constructs, and the assessment of certain 
assumptions associated with findings reported in the existing literature (e.g. the 
connection between the uses of a firm’s reputation and its brand image strategy).   
 
In particular, this study intends to answer the following research question: from the 
manager perspective, what are the effects of the uses of corporate reputation on the 
brand image strategy?  This question can be divided into two sub-research questions.  
First, it is essential to find out what the previous studies have regarded as the main uses 
of a firm’s corporate reputation.  Therefore, the first question will be: what are the main 
uses of corporate reputation?  After this, it is important to find out the link between the 
uses of a firm’s corporate reputation and brand image strategies.  Therefore, a second 
question is proposed as: can a firm’s corporate reputation have an impact on its brand 
image strategies? Answers to the previous two questions will be sought through 
examining the previous literature regarding the uses of corporate reputation and the 
relationship between each construct.  Moreover, the above questions are mainly based 
on the construction of the theoretical literature.  These questions try to find out the 
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relationships between the dimensions of the uses of corporate reputation and brand 
image strategy. 
  
By achieving these research objectives, the researcher expects that this study will 
advance current knowledge about building a strategy for firms using their corporate 
reputation to create or match up with their brand strategy and offer practical insights to 
managers in practice.  Therefore, a set of questions are asked in this research as research 
hypotheses (see Table 1.1) in order to find out the answer for the research. 
 
Table 1.1: List of research hypotheses 
H1 Value creation as one dimension of the uses of corporate 
reputation has a positive impact on a firm’s brand 
segmentation strategy. 
H2 Value creation as one dimension of the uses of corporate 
reputation has a positive impact on a firm’s brand 
differentiation strategy. 
H3 Value creation as one dimension of the uses of corporate 
reputation has a positive impact on a firm’s brand 
positioning strategy. 
H4  Strategic resource as one dimension of the uses of 
corporate reputation has a positive impact on a firm’s 
brand segmentation strategy. 
H5  Strategic resource as one dimension of the uses of 
corporate reputation has a positive impact on a firm’s 
brand differentiation strategy. 
H6 Strategic resource as one dimension of the uses of 
corporate reputation has a positive impact on a firm’s 
brand positioning strategy. 
H7 Corporate communication as one dimension of 
the uses of corporate reputation has a positive 
impact on a firm’s brand segmentation strategy. 
H8 Corporate communication as one dimension of the uses of 
corporate reputation has a positive impact on a firm’s 
brand differentiation strategy. 
H9 Corporate communication as one dimension of the uses of 
corporate reputation has a positive impact on a firm’s 
brand positioning strategy. 
Source: Developed by the author 
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1.5 Rationale for the research 
 
The purpose of this research stems from the observation that pharmaceutical companies 
require a good reputation to survive. As Alsop (2004) argues, the CEO’s own reputation 
affects corporate reputation. However, reputation management is an ongoing job, and 
therefore companies should allocate certain managers or departments as primary 
guardians. 
 
Duncan Burke, former vice president of corporate image and reputation at 
GlaxoSmithKline, one of the world’s largest pharmaceutical companies, said: “I’m 
trying to get people to think about reputation systematically, to remind them to take it 
seriously all the time.” “Big pharmaceutical companies are seen as pariahs right now 
because of the issue of access to medicine at a reasonable price,” Mr. Burke continued. 
“So it’s especially important that there’s one person in my position to reflect on how the 
world thinks of Glaxo and how we want the world to see us.” Moreover, according to 
Alsop (2004, p. 23): 
“If they ever hope to maximize the value of their reputations, 
companies must make reputation management a fundamental part of 
the corporate culture and value system. Companies must spread the 
message of reputation management throughout the organization and 
make employees cognizant of how each and every one of them affects 
reputation on a daily basis. Reputation must be central to the 
corporate identity, not merely clever image advertising and 
manipulative public-relations ploys.”  
 
 
Moreover, a pharmaceutical company’s reputation has a large impact on its brand image. 
Therefore, this research aims to investigate how pharmaceutical managers make brand 
decisions based on corporate reputation. Prior research has addressed the issues of 
corporate communication and corporate branding in the pharmaceutical industry. A 
pharmaceutical company that develops innovative products based on a sound scientific 
approach usually enjoys a high reputation while also producing generic products (Dhir 
and Vinen, 2005; Krishna, 2006). The pharmaceutical industry faces considerable 
pressure from ethical groups. Workplace health and safety concerns are stressed more 
highly in the pharmaceutical industry than in any other industry (Brammer and 
Millington, 2005), and this industry has significant social externalities (Brammer and 
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Millington, 2005). That is, intangible assets, such as corporate reputation, tend to be 
more important for pharmaceutical companies than for other types of companies. 
 
Prior research has argued that in addition to a pharmaceutical firm’s corporate 
reputation, corporate branding and communication must be properly managed. For 
example, Moss (2001) and Hall and Jones (2007) found that pharmaceutical companies 
engage in corporate branding issues and focus their branding activities on products and 
product attributes. Moreover, to manage corporate communications efficiently, Dolphin 
and Ying (2000) suggested that a pharmaceutical company must understand the almost 
unlimited potential of branding issues and thus ensure consistency of its communication 
message to a wide range of stakeholders. 
 
Elaborating on the strategic communications of GlaxoSmithKline, former CEO Jean-
Pierre Garnier said: “Corporate communications are separate functions that work very 
closely together. But we still have one story here—one basic message.” He further 
elaborated, “At the end of the day, the communications aren’t owned by the 
communication department. You have to have good executives who can and will 
communicate” (Argenti et al., 2005, p. 88). 
 
Thus, the current research investigates the relationship between corporate reputation and 
communication and branding issues in the pharmaceutical industry and examines how 
the personnel involved manage these in a practical way.  In addition, few studies have 
theoretically investigated how firms use their corporate reputation to enhance their 
brand image strategy in terms of brand segmentation, differentiation and positioning. 
Therefore, this research explores how firms can use their corporate reputation to 
enhance their brand image strategy. 
 
 
1.6 Rationale for the context  
 
In accordance with the research objective, the researcher intends to empirically test the 
model in a non-Western setting in order to examine the external validity of Western-
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developed theories..  In order to test the external validity of Western-developed theories, 
several researchers (e.g. Boyacigiller and Adler, 1991; Peng et al., 1991) recommend 
collecting data in a non-Western country.  Therefore, Taiwan, a country in South-east 
Asia, has been selected as the setting of this study.   
 
Taiwan has been selected as the setting of this study because its oriental culture (which 
is mainly followed by Chinese culture) is clearly different from Western culture 
(Hofstede, 1984).  Taiwan can represent non-Western countries2 for several reasons.  
For example, Taiwan is different from many Western countries e.g., USA, UK, and 
other developed countries with regard to the distribution of power.  That is, Taiwan has 
higher inequality between people and organisations than those developed countries 
(Hofstede, 1984).  “Taiwan is a model for newly emerging economies. Since WWII, 
high levels of economic development have been achieved, due largely to a national 
policy of promoting manufacturing in the information technology sector.” (Filatotchev 
et al., 2005)  In addition, compared to those developed countries, Taiwanese have high 
uncertainly avoidance, implying that Taiwanese people have a higher tolerance for 
ambiguity, and less emotional resistance to change, etc.  Moreover, Taiwan has a very 
low score for individualism when compared to Western counties (Hofstede, 1984).  In 
addition, the values and norms of Taiwanese employees have a strong root in Buddhism 
and Taoism, which is different from those in Western countries which are mainly 
Christian – Catholicor Protestant (Hofstede, 1984).   
 
The Taiwanese generic medicine market is getting stronger and more solid. In the 1990s, 
Taiwan pharmaceutical companies were consistently among the top ten-ranked in the 
US market.  In the past two years, many companies have been turning to Taiwan to seek 
new technologies and to reduce costs. This indicates that Taiwan’s own pharmaceutical 
industry technology has greatly improved and is reaching international standards 
(Swinbanks and Cyranoski, 2000).  This trend in turn encourages competition in the 
Taiwanese pharmaceutical industry (Agoramoorthy and Hsu, 2007).  Companies in 
Taiwan, especially in the pharmaceutical industry therefore increasingly recognise the 
importance of the uses of a firm’s reputation.   
 
                                                        
2
 More details about the research setting are provided in Chapter 4. 
` 
17 
 
Moreover, due to the new corporate management trend in Taiwan during the last twenty 
years (Young, 1996; Wu, 2002; Solomon et al., 2003; Lien et al., 2005; Filatotchev et 
al., 2005; 2008), companies have made efforts to build their corporate reputation in 
order to attract new customers or retain old ones.  Companies increasingly recognise the 
importance of a firm’s reputation as judged by its financial or social performance and its 
uses when developing their own corporate brands.  They create various strategies for 
marketing and promoting their corporate brands, providing a good opportunity for this 
research to examine the effects of these communications on the pharmaceutical 
manager’s brand strategy decisions.   As this research is conducted in an attempt to 
investigate the effects of brand strategy with brand managers, as well as its underlining 
mechanism, the research will therefore have significant managerial implications, 
especially for pharmaceuticals in Taiwan, as well as other developing countries in Asia. 
 
 
1.7 Expected research contributions    
 
Two kinds of contributions are expected from this study: theoretical and managerial 
contributions.  Each is explained in the following section. 
 
1.7.1 Theoretical contributions 
 
This research is expected to make several theoretical contributions.  First of all, the 
findings will advance current knowledge by adding alternative insights to the uses of 
corporate reputation.  It will also add views on the uses of corporate reputation to 
possible outcomes of brand image strategy. Additionally, relevant mechanisms 
underlying the relationships between the uses of corporate reputation and the design of 
brand image strategy will be investigated in a non-Western context. That is, this 
research will illustrate how each dimension of the use of corporate reputation affects the 
design of brand image strategy in the pharmaceutical industry in Taiwan. 
 
In addition, the research will provide further understanding about the dimensionality 
and operationalsation of the studied concepts (the uses of corporate reputation, brand 
image strategy) from the perspective of pharmaceutical brand managers.   
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1.7.2 Managerial contributions 
 
As discussed earlier, the uses of corporate reputation in pharmaceuticals is based on 
imported knowledge from either the theoretical literature or the business sector.  Thus, it 
raises the question of the applicability of the uses of the corporate reputation concept in 
the context of pharmaceuticals.  By recognising the effectiveness of the uses of 
corporate reputation in pharmaceuticals in the setting of a firm’s brand image strategy 
from the brand manager’s perspective, the pharmaceutical management team can devise 
their branding and marketing plans more successfully.  That is, in order to create an 
effective brand image strategy, the manager can concentrate on particular aspects of 
ways to build the firm’s reputation (e.g. value creation, strategic resources and corporate 
communication) which are seen by the brand manager as effective tools for creating 
brand image strategy.   
 
In addition, by comparing which uses of corporate reputation dimensions (value 
creation, strategic resources and corporate communication) are more effective for 
influencing brand image strategy, the findings can be used by the managers as a 
guideline for allocating their resources effectively.  Therefore, the findings are likely to 
be a useful tool for brand managers of pharmaceutical companies to apply in situations 
where they need to make brand strategy decisions. 
 
 
1.8 Proposed methodology  
 
The researcher plans to employ a mixed-methods approach (Tashakkori and Teddlie, 
2003), with a dominant quantitative and qualitative component involving semi-
structured interviews and a pilot study to collect data for the development of 
measurement scales. 
   
For data collection, semi-structured interviews will be conducted in order to gain a 
deeper understanding about the topic, as well as to comprehend the constructs in the 
conceptual model and to generate their domains and measurement.  This will be 
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followed by a pilot study which will be conducted in order to gather data for purifying 
measurement scales.  Afterwards, sample questionnaires containing will be distributed 
to managers of Taiwanese pharmaceutical companies. Before the completed 
questionnaires are returned, the researcher will ask the respondents to point out any 
items that tend to be either ambiguous or difficult to answer. Subsequently, 
questionnaires for the main survey will be developed.  Managers or firm strategy 
decision-makers of Taiwanese pharmaceutical companies will be respondents for the 
main survey.  According to the aforementioned discussion, conducting the research in 
Taiwan will facilitate the evaluation of the external validity of theories (i.e. the 
applicability of theories in other contexts).    
 
 
1.9 Limitations of the research  
 
This study will be conducted in a single country and within a single industry setting, 
which therefore does limit the external validity (generalisability of findings).  However, 
conducting research in a single setting provides the researcher with a better control over 
market and environmental differences (Conant et al., 1990) and industry effects (Rao, 
1994).    
 
In addition, the causality of the relationships in this research cannot be proven.  
Therefore, the results should be interpreted with caution in terms of the exact direction 
of the relationships among the constructs in this research.  Since cross-sectional data 
captures the linkages among variables at a specific point in time, it may not be 
generalised to other periods of time. To understand the development of uses of the 
corporate reputation process over time, longitudinal data collection will be necessary. 
 
Furthermore, this study comprehensively examines the effect of the uses of corporate 
reputation in pharmaceutical companies on brand image strategy.  According to several 
of the variables affecting brand image strategy creation, therefore, it tends to be difficult 
to make a study providing a detailed investigation of all elements affecting the studied 
phenomena.  Therefore, it is possible that other constructs could be used. 
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1.10 Structure of the thesis  
 
The researcher plans to present this doctoral thesis in seven chapters, as follows: 
 
Chapter 1 Introduction 
 
Chapter 2 Literature review: a review of literature on the uses of corporate reputation 
as well as its effects is the focus of this chapter.  The chapter will first provide 
background by initially discussing the movement and influence of corporate reputation 
and brand image strategy management within pharmaceutical companies and then 
explaining further the concept of brand image strategy.  Previous studies on the effects 
of brand image strategy will subsequently be reviewed.  Finally, research gaps will be 
identified and discussed.   
 
Chapter 3 Conceptual framework and hypotheses: the discussion on the uses of 
corporate reputation in a pharmaceutical company from a value creation, strategic 
resources and corporate communication perspective is presented in this section.  
Furthermore, the effect of the uses of corporate reputation in the pharmaceutical 
industry on a firm’s brand image strategy application will be discussed.  Finally, 
research hypotheses will be provided after the discussion of each component of the 
framework.  Measurement scales will be presented at the end of the chapter. 
 
Chapter 4 Research methodology: the research philosophy will be briefly reviewed.  
Then, two general approaches in theory construction, qualitative and quantitative, will 
be discussed.  The research design, including the research setting and data collection 
process will be elaborated.  Finally, issues regarding data analysis will be highlighted 
and explained. 
 
Chapter 5 Data analysis and research findings: the findings from both qualitative and 
quantitative studies will be presented in this chapter. The outcomes of the scale 
development (the researcher plans to conduct a literature search, semi-structured 
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interviews and a pilot study) will be reviewed. The results of scale reliability and 
validity tests will be presented.  Then, the results of hypotheses testing will be shown.   
 
Chapter 6 Discussion: a discussion about the findings from the previous chapter will 
be presented in this chapter. The outcomes of the scale development and the results of 
hypotheses testing will be discussed respectively.   
 
Chapter 7 Conclusion: a summary of the study results will be presented. Research 
implications (theoretical, managerial, policy establishing), research limitations and 
possible future research directions will be discussed in this chapter. 
 
The literature review follows in the next chapter, Chapter 2.  
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CHAPTER TWO: LITERATURE REVIEW 
 
 
2.1 Introduction 
 
A positive corporate reputation brings multiple benefits to a firm, such as the ability to  
withstand occasional adverse publicity (Fombrun and Shanley, 1990), higher levels of 
customer purchase intention (Yoon et al., 1993), strong organisational identification 
among employees (Dutton et al., 1994), better attitudes towards the company’s 
salespeople and products on the part of industrial buyers (Brown, 1997), customer 
loyalty (Saxton, 1998), the attraction of investors (Fombrun and Shanley, 1990) and 
greater competitive advantage (Fombrun and Shanley, 1990; McMillan and Joshi, 1997).  
Based on the above findings by previous scholars, it is assumed that corporate 
reputation can increase financial performance. However, Gök and Özkaya’s (2011) 
study finds that a portfolio of highly reputated firms in an emerging economy (such as 
Turkey) earns about 10 percent less than that market’s overall portfolio annually. 
 
Fombrun and Shanley (1990) note that a good reputation can serve as a value signal in 
situations of information overload, complexity or inadequacy. Buyers frequently 
employ their perceptions of an organisation’s reputation to interpret “ambiguous 
informational signals” about it and hence to “gauge its relative merits” (p. 233).  They 
suggest that reputation represents an important cue about how a supplier’s products, 
strategies and prospects compare with those of competing enterprises (Bennett and 
Gabriel, 2001). 
 
In conformity with the objective of this thesis, which is to establish the use of corporate 
reputation in the development of brand image strategy and its effect on sales increases, 
this chapter provides a theoretical review of the uses of the concept of corporate 
reputation, and the strategic uses of corporate reputation in its relationship with brand 
image strategy.  In order to accomplish this objective, scholars’ view on the concept of 
corporate reputation on marketing, management, organisational studies, economics and 
business studies will be reviewed.  
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In the first section, there is a brief review of the definition of corporate reputation.  This 
is followed by a review of six areas of study (i.e. public relations, marketing, 
management, economics, sociological, and finance and accounting) where the uses of 
corporate reputation have been constructed as a concept.  An attempt is made to identify 
and integrate the arguments within the theoretical paradigms into a cohesive synthesis 
which shows the uses of corporate reputation.  In the second section, following the 
review of these different perspectives, the author will define the gaps in this study by 
arguing that there is a limited understanding of how corporate reputation enhances the 
development of brand image strategy in order to enhance its market share.  In the third 
section, new paradigmatic concepts emerging from this review together with the 
problem of this area of study will be highlighted and summarised. The final section 
reviews the research question of this dissertation.  
 
 
2.2 The definition of corporate reputation 
 
Several definitions purporting to explain the concept of corporate reputation have been 
offered by various authors (e.g. Bennett and Kottasz, 2000, p.224).  The majority of 
these definitions have emerged from public relations (Hutton et al., 2001), marketing 
(Herbig and Milewicz, 1995; Gray and Balmer, 1998; Weiss et al., 1999), economics 
(Shapiro, 1982, 1983), sociology (Camic, 1992) and strategic management (Weigelt and 
Camerer, 1988; Hall, 1992; Fombrun, 1996; Roberts and Dowling, 2002).  
 
One of the most cited definitions of corporate reputation was put forward by Weigelt 
and Camerer (1988) in strategic management.  They argued that corporate reputation is 
an attribute or a set of attributes ascribed to a firm and inferred from the firm’s past 
actions.  It is the belief of market participants about a firm’s strategic character (Weigelt 
and Camerer, 1988).  Similarly, another important definition which has been cited in 
many works is that presented in the work of Roberts and Dowling (2002).  They 
contend that corporate reputation is the public’s cumulative judgement of firms over 
time.  Some other researchers have discussed corporate reputation as a history of 
customer perception about the firm, such as collective beliefs that exist in the 
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organisational field about a firm’s identity and prominence (Rao, 1994; Rindova and 
Kotha, 2001), media  visibility and the business favour gained by a firm (Deephouse, 
2000).   
 
Corporate reputation was initially studied in the field of sociology with regard to an 
individual’s reputation. Topics studied included the impact of reputation on 
occupational change (e.g. Gold, 1952; Kriesberg, 1952; Wardwell and Wood, 1956) and 
the power and decision-making of individuals (e.g. Klapp, 1948; Schulze and Blumber, 
1957; Walton, 1966). 
  
In economics, corporate reputation is described as either a trait or signal (Kreps and 
Wilson, 1982; Shapiro, 1989) which can be transmitted from a company to its 
customers to give some clues about products or give an advance warning about 
retaliations if competitors make any adversarial moves (Weight and Camerer, 1988).  
 
From the strategic management perspective, corporate reputation is regarded either as a 
strategic resource or mobility barrier (Cave and Porter, 1977; Hall, 1992, 1993; Rao, 
1994; Roberts and Dowling, 2002; Carmeli and Tishler, 2004).  It is an asset that cannot 
be bought, is not easy to imitate, and cannot be substituted (Barney, 1986; Dierickx and 
Cool, 1989).   In general, it is difficult to copy interaction between a firm and its 
stakeholders (Fombrun and van Riel, 1997).  In addition, it takes some time for new 
entrants to a competitive market to acquire a reputation (Hall, 1993) to a level 
comparable to those of its rivals.  Empirical studies show that in order for a corporate 
reputation to be established, a company must consistently maintain credible transactions 
over time (Herbig and Milewicz, 1993; Herbig et al., 1994).  During the reputation- 
building process, the new entrants usually would have a difficult time in trying to attract 
customers as they are likely to be sceptical about a company’s existence as well as its 
products and services. 
 
On the other hand, sociologists do not view corporate reputation as an asset or a thing 
under possession but rather regard it as a social construction which can be built through 
the relationship between a company and its stakeholders (Perrow, 1961a; 1961b; Shrum 
and Wuthnow, 1988).  To sociologists, reputation is an indicator of legitimacy or social 
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acceptance, which reflects the fit between expectations (Galaskiewicz, 1985; Fombrun 
and van Riel, 1997).  An empirical study (Rao, 1994) demonstrates that by winning a 
certification contest in the automobile industry, a company can acquire acceptances 
from its stakeholders, justify its existence, especially for a young organisation, and build 
its reputation by accumulating more victories over time. 
 
Additionally, corporate reputation also has one of its roots in social identity theory 
(SIT).  At the individual level, SIT refers to the perception a person develops to identify 
who he/she is in terms of his/her group membership (Turner, 1984) and stems from 
several sources such as the categorisation of individuals, and the distinctiveness and 
prestige (i.e. reputation) of the group (Ashforth and Mael, 1989). It provides a partial 
answer to the question “Who am I?” (Abrams and Hogg, 1990; Hogg and McGarty, 
1990). Social identification normally leads to activities that are consistent with his/her 
core values and the support for any institutions that embody those values (Ashforth and 
Mael, 1989).  Essentially, reputation can be viewed as the estimation of how well one’s 
behaviour fits with “who” one claims to be and is captured by public opinion (Long-
Tolbert, 2000).  In other words, reputation acts as a reflection of someone’s activities 
and identity and simultaneously as a source from which a person derives his/her 
individuality. 
 
In general management, organisational theorists usually view corporate reputation from 
the same angle as that of sociologists.  The relationship between corporate reputation 
and corporate identity appears to be a never-ending story.  On the one hand, corporate 
reputation is considered a projection of both an organisation’s identity (who we are) and 
image (what we think other people think about us) (Fombrun, 1996; Davies et al., 2003).  
On the other hand, an impression formed by a stakeholder of an organisation results in 
his/her positive or negative reactions towards the organisation (Long-Tolbert 2000, 
p.34), hence enhancing the reformulation or maintenance of its identity. 
 
In addition, this circular relationship also implies that corporate reputation is collective 
and is shaped and reshaped over time.  These characteristics of corporate reputation are 
embedded in the development of definitions proposed by management scholars.  For 
example, Fombrun and Shanley (1990) had defined the term as “the outcome of a 
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competitive process in which firms signal their key characteristics to constituents to 
maximise their social statuses”.  The definition is borrowed from economics literature 
and focuses only on the evaluation of past actions (i.e. the outcome of the competitive 
process over a time horizon). 
 
Subsequently, Fombrun (1996, p.72) defined corporate reputation as “a perceptual 
representation of a company’s past actions and future perceptual representation of a 
company’s past actions and future prospects that describes the firm’s overall appeal to 
all of its key constituents when compared with other leading rivals”.  In the latter 
definition, the elements regarding the competitive process, the key characteristics of a 
company and communication with key constituents are still included but another 
element, about future expectations about a company’s activities, is added as a part of 
overall assessment of corporate reputation. 
 
Corporate reputation is also found as a signal of a firm’s actions in marketing literature 
as a signal to its customers of a firm’s actions (i.e. Fombrun and Shanley, 1990; Herbig 
et al., 1994; Acquaah, 2003).  Marketers send, seek for and interpret marketing cues to 
try to understand the beliefs, attitudes, or intentions of market participants (Herbig and 
Milewicz, 1993).  According to attitude theories such as the expectancy-value theory 
(Fishbein and Ajzen, 1975), market participants (e.g. consumer, retailer, supplier, etc.) 
make decisions by selecting the alternative which is perceived to be most promising and 
is likely to lead to the most favourable outcomes for them.  Consistent positive signals 
about a company’s products or services quality can enhance its credibility (Herbig et al., 
1994) and positively influence customers’ attitudes as well as purchase intentions (e.g. 
Campbell, 1999; Goldberg and Hartwick, 1990).  On the other hand, less positive or 
negative signals can render opposite results, especially when signals are sent out 
inconsistently (e.g. LaBarbera, 1982). 
 
Corporate reputation is also found as a combination of personalities of a company (e.g. 
Spector, 1961; Davies et al., 2003) in another stream of marketing literature.  A 
company is personified and assigned relevant personalities usually borrowed from 
psychological research.  A company can have up to seven types of human-like traits 
such as agreeableness, chicness and ruthlessness (Davies et al., 2003).  Two relevant 
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issues, however, should be noted here.  First, conceptualising reputation as trait is not 
always evaluative (Berens and van Riel, 2004).  A certain type of personality is assessed 
to be positive or negative partly based on the perceived fit between that personality and 
an observer’s personality (Huston and Levinger, 1978 cited in Berens and van Riel, 
2004).  Moreover, empirical evidence (e.g. Davies et al., 2003, 2004) has confirmed the 
complex nature of corporate reputation.  It has been shown that corporate reputation has 
multiple characteristics, each of which can be interpreted altogether or separately to 
describe a company. 
 
However, in the past, some marketing scholars used the term corporate reputation 
interchangeably with corporate image.  The definition of this concept is also varied.  For 
instance, it used to be defined as “the whole sensory perceptions and thought 
interrelationships associated with an entity by one individual” (Enis, 1967, p.51) and as 
“impressions and mental pictures about things” (Kennedy, 1977, p.152).  It can be seen 
that the mental picture of constituents is an important element in these early definitions.  
In recent years, the mental component has been less salient.  The definitions offered by 
marketing scholars and those of general management researchers have started to 
converge.  To marketing researchers, corporate reputation has become distinct from 
corporate image.  According to Balmer (1998), corporate reputation refers to the 
perception of an organisation which is built up over a period of time and which focuses 
on what it does and how it behaves.  More examples of definitions by different scholars 
are shown in Table 2.1.   
 
Table 2.1: Examples of definitions of corporate reputation  
Research Areas Definition Related References 
Economics Customer expectation and belief about a firm’s product quality. Shapiro (1982, 1983) 
Sociology A prevailing collective agreement about an actor’s attributes or 
achievement based on what the relevant public knows about the 
actor. 
Camic (1992) 
Strategic 
Management 
An attribute or a set of attributes ascribed to a firm, inferred 
from the firm’s past actions. 
Weigelt and Camerer 
(1988) 
Strategic 
Management 
Public’s cumulative judgements of firms over time. Roberts and Dowling 
(2002) 
Strategic 
Management 
Stakeholder’s knowledge and emotional reactions (e.g. affect, 
esteem, etc.) towards a firm. 
Hall (1992); Fombrun 
(1996) 
Marketing The estimation of the consistency over time of an attribute of an 
entity. 
Herbig and Milewicz 
(1995) 
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Marketing Public esteem judged by others Weiss et al. (1999) 
Marketing A value judgement about a company’s attributes that evolves 
over time as a result of consistent performance, reinforced by 
effective communication. 
Gray and Balmer 
(1998) 
Source: Adapted from Bennett and Kottasz (2000, p.224). 
 
According to Bensiali (2011), corporate reputation is based on intangible aspects of an 
organisation’s performance, culture, marketing and quality of product and service and 
takes time to spread.  
 
Furthermore, Burke (2011) argues that corporate reputation is becoming increasingly 
important. The advantages of corporate reputation are summarised (p. 5):  
“…A positive organization reputation will increasingly influence 
purchase decisions when there is little difference in price, quality 
design and product. There is even more competition, lack of 
differentiation, and pricing concerns in the service sector. Thus 
building a highly regarded corporate reputation or corporate 
brand had become even more important.” 
 
Burke (2011) moreover argued that there could be threats for a firm’s if it doesn’t pay 
attention to build its corporate reputation: 
“These include “bad behavior” by executives, unsafe or defective 
products, customer complaints, employee complaints, poor 
treatment of employees, poor handling of layoffs and/or 
termination.”(p. 19) 
 
“Interestingly, most people have a low opinion of corporations in 
general. So being admired offers an even more substantial benefit. 
In addition, there are more threats to a company’s reputation today 
than previously.”(p. 6) 
 
 
2.2.1 The uses of corporate reputation: a theoretical analysis 
 
The review of theoretical literature indicates that academic and practitioner 
contributions towards the understanding of the uses of corporate reputation by business 
organisations can be theorized along six dominant paradigmatic perspectives.  These are: 
sociological;(1) public relations; (2) marketing; (3) management, (4) economic; (5) 6-
financesociological; (6) finance and accounting.  Some ideas regarding the uses of 
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corporate reputation are drawn from a public relations perspective.  However, most of 
the arguments are suggested by the marketing, management, financial and accounting 
scholars in the broad field of management studies.  These are discussed 
comprehensively in the paragraphs that follow. 
 
2.2.1.1 The uses of corporate reputation in public relations literature 
There is a common notion that public relations academics and practitioners are the 
premier proponents of the concept of corporate reputation.  Works by Jeffries-Fox 
Associates (2000) suggests that this may be true.  Previous research has examined the 
concept of corporate social responsibility in terms of how firms can use it to 
articulate social responsibilities to various stakeholders (Lerbinger, 1965). According to 
Grunig et al. (1992), these goals can be achieved through the development of 
relationships with their publics.  Therefore, public relations fulfil its responsibility by 
promoting human welfare.  It also contributes towards the development of social 
systems that are needed to adapt to the changing needs of the environment (Cutlip et al., 
2003).  
 
Another use of corporate reputation within the public relations paradigm is that 
corporate reputation is a tool used by firms to attract the best employees, raise capital 
effectively, become a good community member, or gain and retain loyal customers.  In 
the same vein, L’Etang (2006) shows that corporate reputation helps to protect firms 
from excessive interpretations by reducing media to “secondary definers” (Chibnall, 
1977; Hall et al., 1978; McNair, 1996).  
 
2.2.1.2 The uses of corporate reputation in marketing literature 
Marketing literature also provides a variety of papers addressing the uses of corporate 
reputation.  For instance, corporate reputation is commonly used as a signal by business 
organisations to attract customers or enable customers’ trust in their company products 
or services (Herbig and Milewicz, 1993).  Marketers and business organisations use and 
deploy reputational cues that are interpreted by stakeholders, who often make a 
conscious attempt towards understanding the beliefs, attitudes, or intentions of market 
participants (Herbig and Milewicz, 1993).  A firm with a good reputation can use this as 
a tool to underpin that aspect of the market value stock price that is not directly 
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attributable to organisational assets and liabilities.  It enables firms to make higher 
profits than would be derived from the selling of its tangible assets.  The use of 
corporate reputation often occurs in the case of an acquisition (Walsh et al., 2008).  
 
A particular area in marketing, which is in the consumer behaviour literature, is that 
corporate reputation assists consumers who are constantly challenged by purchase 
decision- making.  This means that reputation provides important clues about how a 
supplier’s products, strategies and prospects compare with those of competing 
enterprises (Fombrun and Shanley, 1990).  For instance, the reputation developed by 
firms often helps customers to select an alternative which is perceived to be most 
promising and is likely to lead to the most favourable outcomes (Srivoravilai, 2006).  
Fombrun and Shanley (1990) also note that a good reputation serves as a value signal in 
situations of information overload, complexity or inadequacy. In other words, firms use 
their reputation to enable customers to gauge the merits of a product or service, 
especially when customers are faced with vague corporate or product information 
(Fombrun and Shanley, 1990).  In addition, consistent positive reputational signals 
about the quality of a company’s products or services can enhance credibility (Herbig et 
al., 1994) and positively influence customers’ attitudes as well as their purchasing 
intentions (e.g. Goldberg and Hartwick, 1990; Campbell, 1999).  For example, Nguyen 
and Leblanc (2001) claimed that in the services sector, firms increase their corporate 
reputation by influencing consumer behaviour through the use of factors such as contact 
personnel and the physical environment. These factors provide benefits promised to 
customers during service transactions. 
 
Similarly, some researchers (Day, 1994; Srivoravilai, 2006) asserted that if a company 
has strong marketing capabilities, it will signal the use of part of the firm’s capabilities 
to meet the needs of stakeholders (Acquaah, 2003).  Consequently, firms use such 
capabilities as reputational platforms that create a distinctive position about the 
company in the minds of stakeholders (Fombrun and van Riel, 2004).  
 
Devine and Halpern (2001) argued that corporate reputation plays a role in value creation for 
shareholders.  These authors contended that a firm’s corporate reputation is a signal for top-quality 
products, good working conditions and excellent service quality.  Dolphin (2004) also 
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suggested that corporate reputation is used as a value-creating tool.  Similarly, Caruana 
(1997) believed that corporate reputation is used as a means of generating good returns 
on a firm’s investment over time (Fombrun, 1996).  Bennett and Gabriel (2001) mention 
that in the event of corporate scandals, a positive reputation is usually drawn to counter 
unjustifiable attacks and negative publicity arising from stakeholders.  It is also used to 
attract investors (Fombrun and Shanley, 1990). 
 
A good corporate reputation reduced transaction costs and provides beneficial financial 
and non-financial outcomes (Caruana et al., 2004) to business organisations.  A firm 
with an established corporate reputation can use its history-based reputation to further 
or court even better reputations among customers (Fombrun and Shanly, 1990).  
 
It is commonly argued among marketing scholars that the idea of a favourable corporate 
reputation is used to develop competitive advantage (Worcester, 1986; Fombrun and 
Shanley, 1990; Maathuis, 1993; Greyser, 1996) and firm value (Fombrun and Shanley, 
1990; Gregory, 1991; Marconi, 1991; Fortune, 1995).  Moreover, the development of a 
good corporate reputation enhances organisational impact on customers’ retention 
decisions and increases customer loyalty (Saxton, 1998).  In a similar vein, Fombrun 
(1996) contended that corporate reputation is commonly drawn by business 
organisations as a form of goodwill.  This is often used to effectively position the 
business itself favourably in the minds of stakeholders as well as a means of 
differentiating themselves from competitors (Day, 1994).  Similarly, Fombrun (2002) 
proposed that corporate reputation provides signals about the future of organisations.  
Such signals provide insights into the firm’s profit-making ability as well as the firm’s 
ability to achieve well-defined organisational goals.  
 
2.2.1.3 The uses of corporate reputation in management literature 
However, similarly to marketing perspectives, in management studies, general 
management scholars argue that a favourable corporate reputation is used by firms to 
generate a competitive advantage (Caves and Porter, 1977; Wilson, 1985; McMillan and 
Joshi, 1997).  They regard corporate reputation as a strategic resource (Cave and Porter, 
1977; Hall, 1992, 1993; Rao, 1994; Roberts and Dowling, 2002; Carmeli and Tishler, 
2004) used to protect firms from new competitors in the market.  For instance, corporate 
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reputation is regarded by some researchers (Shenkar and Yuchtman-Yaar, 1997) as an 
important factor that enables business organisations to exist over a long period of time 
and it is difficult for businesses to even operate without a corporate reputation.   
 
Moreover, a good corporate reputation allows a firm not only to attract new consumers 
but also keep the existing ones.  Some consumers rely on a trustworthy corporate image 
and a company’s history-based reputation in environments where they are unaware of 
the quality or other features of a product (Shkolnikov et al., 2004).  Researchers 
(Shkolnikov et al., 2004) moreover argued that firms build up their corporate reputation 
in order to increase customer loyalty, reduce business risk and improve their bottom line.  
In modern corporations, reputation is used as a value-creating mechanism and 
stakeholders pay close attention to it.  
 
Reputation is a tool that is used to signify an organisation’s perceived capacity to meet 
their stakeholders’ expectations (Waddock, 2000).  In other words, firms use corporate 
reputation in order to give a positional advantage by using various strategies to 
differentiate themselves from competitors (Hall, 1992).  A positive corporate reputation 
will not only provide a greater competitive advantage for a firm (McMillan and Joshi, 
1997) but also accrue strong organisational identification among employees (Dutton et 
al., 1994) and better attitudes towards the company’s salespeople and products on the 
part of industrial buyers (Brown, 1997).  
 
Consequently, it is agreed by many management scholars that a successful corporate 
reputation increases a firm’s financial performance.  For instance, Roberts and Dowling 
(2002) asserted that good corporate reputations are crucial because of their potential for 
value creation, but also because of their intangible character which make replication by 
competing firms considerably more difficult.  McGuire et al. (1990) also confirm the 
expected benefits associated with good reputations, providing strong evidence that the 
customers’ perceptions of a firm quality can be a cause or result of a firm’s performance.  
Roberts and Dowling (2002) proved that a successful corporate reputation is capable of 
increasing a company’s financial performance.  They added that firms with relatively 
good reputations are better able to sustain superior profits over time.  
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In the same vein, Stanwick and Stanwick (1998) argue that building a firm’s corporate 
reputation requires the development or generation of feedback from stakeholders within 
the environment.  They use the corporate reputation measures – which are consistently 
used in many studies (i.e. McGuire et al., 1988; Fombrun and Shanley, 1990; Thomas 
and Simerly, 1994) – to measure corporate social responsibility. They found empirically 
that corporate reputation increases corporate social performance resulting in a better 
environmental performance.   
 
In light of its potential impact on financial performance, the idea of corporate reputation 
has been developed in a wider scope.  Fryxell and Wang’s (1994) crucial insight 
provides a detailed analysis of the multi-dimensionality of corporate reputation.  They 
argued that corporate reputation impacts significantly on the perceptions of shareholders 
and stakeholders.  Similarly, Smith (1994) presented some evidence supporting the 
positive influence and the use of a good corporate reputation on the development of 
organisational value.  Clardy (2005) argued that there is a synergy between a firm’s 
corporate reputation and its goodwill, since the accounting profession has rules for how 
to calculate and report goodwill in financial statements.  Based on this assertion, one 
could argue that corporate reputation is capable of being used as a means of developing 
goodwill among stakeholders (Clardy, 2005). 
 
2.2.1.4 The uses of corporate reputation in economics literature 
In economics, as with marketing and management scholars, Brammer and Pavelin (2006) 
also suggested that the multi-dimensionality of corporate reputation impacts on the 
perceptions of shareholders and stakeholders.  Thus, it is possible to see corporate 
reputation as a very important phenomenon that creates trust in the minds of consumers.  
Akerlof (1970) argued that corporate reputation is an information signal that firms often 
use to protect their accumulated capital and assets.   
 
Similarly, Punete et al. (2007) argued that good corporate reputation signals enable 
businesses to predict human behaviour in the future.  Consequently, the use of corporate 
reputation as a behaviour signal contributes towards a thorough understanding of not 
only consumers but also of a firm’s key competitors of (Kreps and Wilson, 1982; 
Milgrom and Roberts, 1982).  More importantly, the development of a good corporate 
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reputation, especially among customers, encourages the production of top-quality 
products (Nelson, 1970; Milgrom and Roberts, 1986) and services (Wilson, 1983; de 
Angelo, 1981; Dranove, 1983; Rogerson, 1983; Eichenseher and Shields, 1985; Beatty 
and Ritter, 1986).  
 
Equally, Weigelt and Camerer (1988) argued that corporate reputation is strategically 
important. It is used as either a trait or a signal (Kreps and Wilson, 1982; Shapiro, 1989) 
which can be transmitted from a company to its customers in order to give information 
about products or give an advance warning of competitor retaliation (Weigelt and 
Camerer, 1988).  They argued that it is used by stakeholders to forecast the potential 
behaviour of a firm.  Weigelt and Camerer (1988) also indicated that corporate 
reputation gives an organisation some return on its investment over time in “non-
salvageable goodwill”.  
 
Some economic scholars (Stigler, 1962; Klein and Leffler, 1981; Milgrom and Roberts, 
1986) suggested that a good corporate reputation gives an organisation a competitive 
advantage.  It is also regarded by some other economic researchers that corporate 
reputation is used, drawn and presented to stakeholders as an asset which cannot be 
bought, and thus is not easy to imitate or substitute (Dierickx and Cool, 1989).  Shapiro 
(1983) argued that a strong corporate reputation has been shown to be associated with 
reduced transaction costs, together with beneficial financial and non-financial outcomes.  
Corporate reputation is a cyclical phenomenon that signifies the character of a firm to 
competitors (Milgrom and Roberts, 1982) and customers (Rogerson, 1983).  Puente et al. 
(2007) asserted that well-regarded firms use their previous reputation to occupy 
privileged positions in the business environment, using it to attract better resources on 
more favourable terms.  Landon and Smith’s (1997) empirical work indicates that 
consumers use the established reputation of firms when making their purchase decisions.  
In another empirical study, Sabate and Puente (2003) argued that consumers take note 
of corporate reputation in their individual purchasing decisions.  This again signifies the 
usefulness of corporate reputation to firms.   
  
2.2.1.5 The uses of corporate reputation in sociology literature 
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However, in sociology, corporate reputation is regarded as a social construction that is 
used to build up the relationship between a company and its stakeholders (Perrow, 
1961a; Perrow, 1961b; Shrum and Wuthnow, 1988) rather than as an asset or possession 
as theorised under marketing (see For instance Fombrun and van Riel).  Similarly, 
Cornell and Shapiro (1987) asserted that it is possible for firms to lose accumulated 
reputation if they fail to keep stakeholders happy or satisfy their expectations.  Thus, the 
notion of corporate reputation is used as a guarantor of contracts.  Following this 
argument, reputation is used as an indicator of legitimacy or social acceptance, which 
reflects the congruence of expectations (Galaskiewicz, 1985).  
 
2.2.1.6 The uses of corporate reputation in finance and accounting literature 
Apart from these, the use of corporate reputation has also generated interest among 
finance and accounting authors.  In accounting, corporate reputation is used to generate 
goodwill amongst stakeholders (Rose and Thomsen, 2004) – and when firms have a 
reputation based on a good history of performance, it impacts positively on the 
perceptions of shareholders and stakeholders (Rose and Thomsen, 2004).  More 
importantly, it helps to increase the value of returns to shareholders and stakeholders 
(Rose and Thomsen, 2004).  Thus, it is possible to see corporate reputation as the very 
phenomenon that creates trust in the minds of stakeholders.  It contributes towards 
reduced transaction costs and provides beneficial financial and non-financial outcomes 
(Rose and Thomsen, 2004).  
 
Goodwill, which is commonly conceived among accountants as the basis of corporate 
reputation, was originally used to describe the “intrinsic value” inherent in an ongoing 
business.  Therefore, from an accounting perspective, goodwill is an intangible asset 
(Higson, 1998) which gives stakeholders extra value.  Thus, firms use their goodwill or 
reputation as plausible factors that enable a rise in sales level higher than the value of 
their net assets.  
 
According to Beatty and Ritter (1986), a favourable corporate reputation gives a firm a 
competitive advantage.  It can be used to reflect the portion of the market value of a 
business entity not directly attributable to its assets and liabilities.  Moreover, a good 
corporate reputation is also used to highlight the ability of firms to make a higher profit 
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than would be derived from selling only their tangible assets.  It also enhances the 
ability to raise loans from financial institutions, which, in turn, influences a firm’s easy 
access to financial capital (Beatty and Ritter, 1986; Garbett, 1988).  In some other 
accounting studies, a firm’s good reputation encourages employees to be devoted and 
stay longer (Markham, 1972; IOD, 1999) and it is increasingly seen as an intangible 
asset that create value in the future (DTI, 2001).  
 
However, in a world where a significant number of the most powerful economic entities 
are corporations, intangible assets like reputation are used and presented to stakeholders 
as corporate valuables (Moerman and Laan, 2006).  Moreover, as argued by Okano et al. 
(1999), goodwill or corporate reputation is often used as an experiential asset.  It is 
conceived as a phenomenon which enables firms to profit from a variety of benefits, 
such as increase in share price and positive financial performance (see Herremans et al., 
1993). 
 
2.2.2 Diversities and similarities in the theoretical conceptualisation of the use of 
corporate reputation 
 
The review of theoretical literature from various academic areas (i.e. public relations, 
marketing, management, economic, sociological, finance and accounting) indicates a 
strong overlap in the theoretical concept building of the uses of the concept of corporate 
reputation among business organisations.  As seen in the review of literature, scholars 
belonging to different areas appear to have conceptualised the uses of corporate 
reputation in similar ways.  Thus, there is very little difference between the ways that 
public relations and marketing academics have theorised the use of corporate reputation.  
Nor is there a significant divergence between the ways in which management academics 
and economics and accounting and finance academics have theorised the use of 
corporate reputation. 
 
Now because the uses of corporate reputation (as attested in the review of corporate 
reputation in the paragraphs above) are conceptually related, it becomes imperative and 
highly necessary to bring together various overlapping theories to enable us to focus on 
the discourse in this chapter.  Thus, an attempt shall be made in the following paragraph 
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to develop a synthesis that brings together all related theories concerning the use of 
corporate reputation into a holistic, cohesive and coherent synthesis in order to develop 
a useful and deeper understanding of the uses of corporate reputation. 
 
2.2.2.1 The uses of corporate reputation: a synthesis of overlaps 
Attention was drawn to the emergence of a number of conceptual overlaps in the 
literature concerning use of corporate reputation.  This paragraph makes a follow-up by 
presenting a synthesis underscoring the emergence of eleven conceptual overlaps on 
(see Table2.2, 2.2) within the literature relating to the focus of this chapter.  The 
interconnected arguments leading to these overlaps are discussed below.  Mainly, the 
uses of corporate reputation are categorized into three groups: value creation, 
influencing competitor’s actions and developing the relationship with stakeholders. 
 
Value creation 
 Corporate reputation is used as a tool for creating value in much previous research (see 
synthesis S3 in Table 2.2).  Arguments highlighted under the marketing perspective 
point to the use of corporate reputation as a value-creating tool (Dolphin, 2004) which 
has a positive influence on firm value (Fombrun and Shanley, 1990; Gregory, 1991; 
Marconi, 1991; Fortune, 1995).  A similar argument was presented under the finance 
and accounting perspective.  For instance, Moerman and Laan (2006) state that 
corporate reputation is used and presented to stakeholders as a corporate valuable 
(Okano et al., 1999) or as an intangible asset that creates value in the future (DTI, 2001).  
The same idea is supported by economics scholars (see Dierickx and Cool, 1989) who 
contend that corporate reputation is used as an asset, which cannot be bought, and thus 
is not easy to imitate or substitute. Some management scholars also hold a similar idea 
in that corporate reputation is regarded as an asset which cannot be bought, and thus is 
not easy to imitate or substitute (Barney, 1986).  Similarly, Shkolnikov et al. (2004) 
declare that corporate reputation is used as a value-creating mechanism. Corroborating, 
Smith (1994) averred that corporate reputation is commonly drawn as a tool for the 
development of organisational value.  Roberts and Dowling (2002) also say that 
corporate reputation is used to express a firm’s strategic value.  Similar arguments are 
supported by sociology scholars (see Rose and Thomsen, 2004) who declared that 
corporate reputation is used to increase the value of returns to shareholders.  
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Moreover, corporate reputation is used as a tool for promising good-quality products 
and service to customers (see S9 in Table 2.2).  Arguments presented under the 
marketing perspective point to the notion that positive reputational signals about the 
quality of a company’s products or services can enhance credibility (Herbig et al., 1994).  
Similarly, Devine and Halpern (2001) also support the idea that a firm’s corporate 
reputation is used as a promise for good brand quality and good service levels.  
Economics scholars also hold parallel ideas: a good corporate reputation encourages the 
production of top-quality products and services (Nelson, 1970; De Angelo, 1981; 
Wilson, 1983; Dranove, 1983; Rogerson, 1983; Eichenseher and Shields, 1985; 
Milgrom and Roberts, 1986; Beatty and Ritter, 1986).  
 
Furthermore, corporate reputation is used to reduce transaction costs (see S11 in Table 
2.2,).  Marketing scholars (see Caruana et al., 2004) argue that a strong corporate 
reputation is connected to reducing the generation of transaction costs.  Works within 
the economic perspective (Shapiro, 1983) also support this idea.  Shapiro (1983) argued 
that corporate reputation reduces transaction costs, yielding beneficial financial and 
non-financial outcomes.  Similarly this idea is also supported by management scholars 
(see Eberl and Schwaiger, 2005). 
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Table 2.2: Theoretical conceptualisations of the uses of corporate reputation 
 
Statements Author Syn 
Public relations perspective 
Communicate firm’s social responsibility to various stakeholders  Lerbinger (1965); Grunig et al. 
(1992) 
S1 
Attract the best employees, raise capital effectively, become a good community 
member or gain and retain loyal customers  
 DC 
Protect firms from excessive interpretations among stakeholders  L’Etang (2006); Chibnall (1977); 
Hall et al. (1978); McNair (1996) 
S3 
Used as an indicator of legitimacy or social acceptance, reflecting a congruence 
of expectations  
Fombrun and van Riel (1997) DC 
Marketing perspective 
Commonly used as a signal. Cues are interpreted by stakeholders who often 
make a conscious attempt to understand the beliefs, attitudes or intentions of 
market participants are sent use or deploy  
Herbig and Milewicz (1993) S8 
Create a distinctive position of the company in the mind of stakeholders  Fombrun and van Riel (2004) S9 
Generate good returns on a firm’s investment over time  
Gives the stakeholder a prospect about how key resource providers interpret a 
company’s initiatives and assess its ability to deliver value outcomes’ from a 
firm’s past actions (Fombrun, 2002) 
Caruana (1997); Fombrun (1996); 
Day (1994) 
S11 
Give positional advantage through strategies to differentiate itself from other 
competitors  
Day (1994) S9 
Use as a value-creating tool  Dolphin (2004) S5 
Have influence on firm  Fombrun and Shanley (1990); 
Fortune (1995); Gregory (1991); 
Marconi (1991) 
S5 
A favourable corporate reputation gives an organisation a competitive 
advantage  
Fombrun and Shanley (1990); 
Greyser (1996); Maathuis (1993); 
Worcester (1986) 
S9 
Enhance “the ability to withstand occasional adverse publicity”  Fombrun and Shanley (1990)   DC 
Counter unjustifiable attacks and negative publicity among stakeholders  Bennett and Gabriel (2001) DC 
Attract investors  Fombrun and Shanley (1990) DC 
Further or court even better reputations among customers  Fombrun and Shanly (1990) S2 
Affect corporate performance  Srivastava et al. (1997) S11 
Help customers to select the alternative which is perceived to be most 
promising and is likely to lead to the most favourable outcomes  
Srivoravilai (2006) S3 
Serve as a value signal in situations of information overload, complexity or 
inadequacy. 
Enable customers to gauge the merits of a product or service, especially when 
customers are faced by vague corporate or product information  
Fombrun and Shanley (1990) S3 
Consistent positive reputational signals about the quality of a company’s 
products or services can enhance credibility  
Herbig et al. (1994) S6 
Provide  important clues about how a supplier’s products, strategies and 
prospects compare with those of competing enterprises  
Fombrun and Shanley (1990) DC 
Involve customers to act as advocates of the company  Walsh et al. (2008) DC 
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Enhance higher levels of customer purchasing and customer loyalty 
 
Yoon et al. (1993); Saxton (1998) DC 
Positively influence customers’ attitudes as well as their purchasing intentions  
 
Campbell (1999); Goldberg and 
Hartwick (1990) 
DC 
 
Enhance the impact on customers’ retention decisions, having a huge impact on 
customer loyalty  
Nguyen and Leblanc (2001) DC 
A strong corporate reputation has been shown to be associated with reduced 
transaction costs together with beneficial financial and non-financial outcomes  
Caruana et al. (2004) S7 
Plays a role in value creation for their shareholders, promising quality, good 
working conditions and service levels which are not explicitly stated in any 
contracts, but when present, it also permit a company to sell products and/or 
services at higher prices, and purchase goods and services from suppliers at 
lower prices than competitors  
Devine and Halpern (2001) S6 
Finance & Accounting perspective 
Is  firm’s intangible asset which stakeholders believe it will give them some 
extra value  
Higson (1998) DC 
Influences  firm’s easy access to financial capital  Beatty and Ritter (1986); Garbett 
(1988) 
DC 
Encourages employees to be devoted and stay longer with a firm  IOD (1999); Markham (1972) DC 
Used as an experiencial asset  Okano et al. (1999) S5 
Used and presented to stakeholders as corporate valuables  Moerman and Laan (2006) S5 
Increasingly seen as an intangible asset that creates value in the future  DTI (2001) S5 
Enable firms to profit from a variety of benefits  Herremans et al. (1993) S5 
Give a firm competitive advantage  Beatty and Ritter (1986) S9 
Economic perspective 
Impacts on both the perceptions of shareholders and stakeholders  Brammer and Pavelin (2006) S2 
Gives an organisation a competitive advantage  Klein and Leffler (1981); Milgrom 
and Roberts (1986); Stigler (1962) 
S9 
Used as a signal to forecast the potential behaviour of a firm. Kreps and Wilson (1982); Shapiro 
(1989) 
S8 
Has an impact on financial performance  Sabate and Puente (2003); Sobol 
and Farrell (1988) 
S11 
Regarded as an asset which cannot be bought, and thus is not easy to imitate or 
substitute  
Dierickx and Cool (1989) S5 
Can be transmitted from a company to its customers in order to give 
information about products or give an advance warning of retaliation if 
competitors make any adversarial moves  
Weight and Camerer (1988) DC 
 
Signals or enables businesses to predict human behaviour in the future  Puente et al. (2007) S2 
Encourages the production of top-quality products and top services  Nelson (1970); Milgrom and 
Roberts (1986); Wilson (1983); De 
Angelo (1981); Eichenseher and 
Shields (1985); Dranove (1983); 
Rogerson (1983); Beatty and Ritter 
(1986) 
S6 
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Reduce transaction costs together with beneficial financial and non-financial 
outcomes  
Shapiro (1983) S7 
Used by consumers to make their purchasing decisions  Landon and Smith (1997); Sabate 
and Puente (2003) 
S3 
Is strategically important  Weigelt and Camerer (1988) S4 
Signifies the character of a firm to competitors and customers  Milgrom and Roberts (1982); 
Rogerson (1983) 
S4 
Occupies a privileged position in markets, and used to attract better resources 
on more favourable terms  
Puente et al. (2007) DC 
Management perspective 
Lead towards the development or generation of feedback from stakeholders 
within the environment.  
Increase corporate social performance, resulting in a better environmental 
performance  
Stanwick and Stanwick (1998) S1 
Generate a competitive advantage  Caves and Porter (1977); Wilson 
(1985); McMillan and Joshi (1997) 
S9 
Sustain superior profits over time. (Its potential for value creation.)  Roberts and Dowling (2002) DC 
Increase a firm’s financial performance  
 
Roberts and Dowling (2002) S11 
Corporate reputation and financial performance effects operate in both 
directions  
McGuire et al. (1990) S11 
Use as a means of developing goodwill amongst stakeholders  Clardy (2005) DC 
Can accrue the benefits of strong organisational identification among 
employees  
Dutton et al. (1994) DC 
Increase a firm’s financial performance  Roberts and Dowling (2002) S11 
Enhance firm performance (in a sample of pure internet firms)  Kotha et al. (2001) S11 
Improve attitudes towards the company’s salespeople and products on the part 
of industrial buyers  
Brown (1997) DC 
Give a positional advantage by using various strategies to differentiate itself 
from other competitors  
Hall (1992) S9 
Use as a value-creating mechanism  Shkolnikov et al. (2004) S5 
Used to signify an organisation’s perceived capacity to meet their stakeholders’ 
expectations  
Waddock (2000) S8 
Impacts on both the perceptions of shareholders and stakeholders  Fryxell and Wang (1994) S2 
Is regarded by some researchers an asset which cannot be bought, and thus is 
not easy to imitate or substitute  
Barney (1986) S5 
Is regarded either as a strategic resource or a mobility barrier  
Is used to protect a corporation from its new competitors  
Carmeli and Tishler (2004); Hall 
(1992; 1993); Cave and Porter 
(1977); Rao (1994); Roberts and 
Dowling (2002) 
DC 
Reduce transaction costs together with beneficial financial and non-financial 
outcomes  
Eberl and Schwaiger (2005) S7 
Provide strategic value  Roberts and Dowling (2002) S5 
Develop organisational value  Smith (1994) S5 
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Enable business organisations to exist over a long period of time  Shenkar and Yuchtman-Yaar 
(1997) 
DC 
Affect corporate performance Deephouse (1997); Brown (1997); 
Roberts and Dowling (1997) 
S11 
Attract new consumers but also keep the existing ones. 
Increase customer loyalty, reduce business risk and improve their bottom line  
Shkolnikov et al. (2004) S3 
Sociological perspective 
Is regarded as a social construction which can be built up through the 
relationship between a company and its stakeholders  
Perrow (1961a); Perrow (1961b); 
Shrum and Wuthnow (1988) 
S4 
A guarantor of contracts  Cornell and Shapiro (1987) S10 
Serves to generate goodwill among stakeholders  Rose and Thomsen (2004) DC 
Impact positively on the perceptions of shareholders and stakeholders  Rose and Thomsen (2004) DC 
Helpi increase the value of returns to shareholders and stakeholders  Rose and Thomsen (2004) S5 
Reduce  transaction costs together with beneficial financial and non-financial 
outcomes  
Rose and Thomsen (2004) DC 
Summaries of synthesis 
S1: use of corporate reputation as a means of communication 
S2: use of corporate reputation as a means of shaping the perception of shareholders and stakeholders 
S3: use of corporate reputation as a means of influencing consumer choices 
S4: use of corporate reputation as a tool for building a relationship between the firm and the customers 
S5: use of corporate reputation as a tool for creating value 
S6: use of corporate reputation as tool for promising good quality products and service to customers 
S7: use of corporate reputation to reduce transaction costs 
S8: use of corporate reputation as a signal to customers 
S9: use of corporate reputation as competitive advantage 
S10: use of corporate reputation as a strategic value or resource 
S11: use of corporate reputation as a tool for developing good financial performance 
*S: Synthesis   *DC: Divergent conceptualisation   *Dimensions of the uses of corporate reputation: a. Communication: S1,S2,S3,S4; b. 
Value creation: S5,S6,S8; c. Strategic sources: S9,S10,S11 
Source: Developed by the author  
 
 
Strategic resource: influencing competitor’s actions/strategies 
Corporate reputation is used as a strategic value or resource by some Economic scholars 
(see synthesis S6 in Table 2.2,). Some economic scholars (see Weigelt and Camerer, 
1988) have asserted that corporate reputation is a strategic resource as well as scholars 
belonging to the management perspective (Roberts and Dowling, 2002) and sociological 
scholars.  The latter claimed that corporate reputation is commonly used as a defence 
strategy to ward off competitors (Cornell and Shapiro, 1987). 
 
Moreover, corporate reputation is used as a signal to customers (see synthesis S4 in 
Table 2.2,). Marketing scholars have suggested that corporate reputation is commonly 
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used as a means of highlighting and signifying (Herbig and Milewicz, 1993) a firm’s 
beliefs, attitudes and intentions to market participants – and thus interpreted by 
stakeholders.  In a similar dimension, Fombrun (2002) contended that corporate 
reputation is often deployed by firms as a useful signal that gives stakeholders the 
needed insight into the future of a firm. It may be used as a signal that enables key 
resource providers such as banks and other financial institutions to interpret a 
company’s initiatives from its past actions and assess its ability to deliver value 
outcomes’ The use of corporate reputation as a signal-laden phenomenon has also been 
argued from an economic perspective.  Succinctly, authors within the economic 
perspective are of the view that corporate reputation can be used as a trait or signal to 
forecast the potential behaviour of a firm (see Kreps and Wilson, 1982; Shapiro, 1989). 
Management also authors also argue that corporate reputation is used on many 
occasions to signify an organisation’s perceived capacity to meet their stakeholders’ 
expectations (Waddock, 2000).  
 
Moreover, corporate reputation is used for competitive advantage (see synthesis S5 in 
Table 2.2,).  It is commonly agreed by marketing scholars that firms use corporate 
reputation to create a distinctive position in the mind of stakeholders (Fombrun and van 
Riel, 2004) in order to attain competitive advantage (Worcester, 1986; Fombrun and 
Shanley, 1990; Maathuis, 1993; Greyser, 1996).  Consequently, firms aspire to achieve 
competitive advantage by deploying strategies that will effectively differentiate them 
from competitors (Day, 1994).  A similar argument has been put forward by scholars 
belonging to accounting perspectives (see Beatty and Ritter, 1986), economic 
perspectives (see Stigler, 1962; Klein and Leffler, 1981; Milgrom and Roberts, 1986),  
and management perspectives (see Caves and Porter, 1977; Wilson, 1985; Hall, 1992; 
McMillan and Joshi, 1997).  Authors belonging to these disparate disciplines have all 
agreed that a favourable corporate reputation gives an organisation a competitive 
advantage.  
 
Corporate communication: developing the relationship with stakeholders 
Corporate reputation is commonly agreed by scholars to function as a means of 
communication.  It is argued under the public relations perspective (see Lerbinger, 1965; 
Grunig et al., 1992) that corporate reputation is used to communicate a firm’s social 
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responsibility activities to stakeholders within the business environment. Scholars 
within the management area have also been highly vocal about the positioning of 
corporate reputation as that which enhances the generation of better feedback from 
stakeholders within the business environment (see Stanwick and Stanwick, 1998).  See 
also synthesis S1 in Table 2.2. 
 
Moreover, corporate reputation is used as a means of shaping the perception of 
shareholders and stakeholders (see synthesis S2 in Table 2.2,). A review of theoretical 
literature belonging to the marketing perspective (Fombrun and Shanly, 1990) indicates 
that a firm’s previous corporate reputation can enhance its future reputation among 
customers. Management scholars (Brammer and Pavelin, 2006) suggested that a firm’s 
corporate reputation commonly shapes the opinions and perceptions of shareholders and 
stakeholders alike.  Puente et al. (2007) argues that a firm’s corporate reputation signals 
or enables businesses to predict human behaviour in future.  A similar argument was put 
forward under the management perspective (Fryxell and Wang, 1994).  These authors 
also agree that corporate reputation is often deployed to develop favourable perceptions 
of the firm among stakeholders.  
 
Furthermore, corporate reputation is used as a tool for building a relationship between 
the firm and the customers (see synthesis S10 in Table 2.2).  A review of economic 
literature (see Kreps and Wilson, 1982; Milgrom and Roberts, 1982) suggests that 
corporate reputation is used as a signal contributing towards a thorough understanding 
not only of consumers but also, more importantly, the key competitors of the firm 
(Kreps and Wilson, 1982; Milgrom and Roberts, 1982).  This inadvertently enhances 
the development of a sound relationship. Sociological scholars (see to Perrow, 1961a; 
Perrow, 1961b; Shrum and Wuthnow, 1988) agree.  They hold the view that corporate 
reputation is a device that could be drawn to build a relationship between a company 
and its stakeholders.  
 
Corporate reputation is used for influencing consumer choices (see synthesis S8 in 
Table 2.2, s). Lterature from a public relations perspective indicates that corporate 
reputation is drawn to protect firms from excessive interpretation among stakeholders 
(L’Etang, 2006; Chibnall, 1977; Hall et al., 1978; McNair, 1996).  Scholars belonging 
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to a marketing perspective also support this viewpoint.  They observe that a corporate 
reputation helps customers to select the best choice among many alternatives in the 
market (Srivoravilai, 2006) and serves as a value signal that enables customers to gauge 
the merits of a product or service especially in situations where customers are 
overloaded with information or in cases where there is inadequate information 
(Fombrun and Shanley, 1990) about a product.  Economic scholars agreed too.  They 
argued that corporate reputation is used by consumers to make purchasing decisions 
(Landon and Smith, 1997; Sabate and Puente, 2003).  Corroborating this viewpoint, 
management scholars contend that a good corporate reputation enables the generation of 
increased customer loyalty (Shkolnikov et al., 2004). 
 
2.2.2.2 Use of corporate reputation: practical implications in previous research  
Previous studies have identified several best practices in brand building that firms can 
undertake to sustain and improve their corporate reputation.  
 
In terms of practical implications, Siano et al. (2010) suggested that the use of corporate 
finance management and corporate reputation management (e.g., organization 
development management, cooperative management, risk management, crisis 
management) helps firms develop an appropriate cultural background to assist managers 
in maintaining corporate reputation. The integration of corporate finance with corporate 
communication and reputation allows firms to provide better training for managers in a 
deeper cultural environment, creating advantages for both large and small companies. A 
shared cultural background and language helps improve interactions and dialogue on 
both intra- and inter-organizational levels among managers, who must have a broad 
view of the company’s resources and its competences in resources management. 
Especially in smaller firms, skills that are broad based rather than specific help 
managers make correct management decisions. In larger companies, the common 
management principles of financial resources and corporate reputation can be 
particularly useful. 
 
Kotha et al. (2001) examined the relationship between three types of reputation-building 
activities and firms’ performance. These activities include marketing investments in 
reputation, reputation borrowing and media exposure. Kotha et al. (2001) indicated that 
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the effects of marketing-related expenditures tend to be transient, in line with doubts 
raised by sceptics about the long-term viability of a brand-building strategy on the 
Internet. The Economist (1999, p. 24) similarly noted:  
Most [Internet firms] despite today’s towering market capitalizations, 
will simply fade from view, unable to hold on to their much-vaunted 
“eye-balls,” or turn them into solid profits that build long-term 
businesses. 
 
Moreover, according to Lloyd (2007), there is a strategic approach to managing 
corporate reputation based on stakeholder segmentation. An improved understanding of 
the characteristics of stakeholder targets gives management a stronger position to build 
valuable stakeholder relationships. Lloyd’s research serves as a tool for strategy 
planning and for tracking a company’s reputation and provides a research approach for 
exploring other stakeholder segments.  
 
In their study, Shamma and Hassan (2009) classified the dimensions of corporate 
reputation into primary (products and services) and secondary (emotional appeal, vision 
and leadership, financial performance and social and environmental responsibility) 
pillars. The purpose of these pillars is to offer better guidance for managers who need to 
manage multiple facets of a company’s reputation. 
 
According to Ewing et al. (2010), many business-to-business firms are unable or 
unwilling to invest in long-term strategies designed to foster positive reputation among 
stakeholders, because their focus is centered more on short-term survival. Firms find it 
difficult to market their reputation beyond their current customers because they perceive 
a lack of understanding/interest among broader stakeholder groups. 
 
For event planning businesses, Campiranon (2005) recommended that to strengthen 
their corporate reputations, companies should build their image on reliability, credibility, 
trustworthiness and responsibility. This recommendation is based on Fombrun’s (1996) 
reputation drivers, which can be used by firms that depend heavily on their reputations 
to attract customers. 
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For the services sector, Walsh et al. (2009) suggested that to achieve a good corporate 
reputation, firms must continuously deliver customer satisfaction. That is, rather than 
focusing on the facets of corporate reputation, such as being a good employer, ensuring 
a financially sound company, and engaging in social responsibility, service companies 
should pay more attention to customer orientation and product and service quality 
because of these factors’ direct impact on customer satisfaction. Moreover, because 
customers often form their sense of a firm’s reputation by interacting with its employees, 
service firms should ensure that employees are empowered to address all customer 
needs, which in turn leads to customer satisfaction and trust.  
 
However, Walsh et al. (2009) also suggested that if the firm has a good reputation, it 
should invest in customer loyalty as well. However, when a firm has a poor reputation, 
it should attempt to increase customer satisfaction through service and further explore 
the reasons customers are dissatisfied. Moreover, when managers understand the nature 
of their firms’ reputation, they can determine whether to initiate dedicated word-of-
mouth campaigns to sustain other ongoing promotional activities or new product 
launches.  
 
Similarly, Dickinson-Delaporte et al. (2010) argued that to enhance corporate reputation, 
social marketers should orient themselves to their stakeholders and conduct ongoing 
research to identify their goals, their biases, and the cues they use to inform judgments 
about the legitimacy of the firm’s actions. As part of this strategy, firms should receive 
or allow stakeholder dialogue by developing a web forum, which can serve to 
communicate the firm’s situation and reinforce the firm’s positioning. Moreover, 
Dickinson-Delaporte et al. (2010) suggested that firms should reinforce their 
communication strategy by using multiple perceptions of the firms’ actions to craft an 
ambiguous position in the marketplace and to develop multiple messages to their 
stakeholders. Walsh et al. (2009) also suggested that newly deregulated energy suppliers 
should try to achieve a good reputation quickly because doing so can become a market-
entry barrier for competitors that might want to enter the newly opened market.  
 
On the one hand, Srivoravilai et al.’s (2011) study offers practical guidelines for 
managers in especially highly institutionalised companies (e.g., private hospitals) in 
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terms of enhancing their reputation and commitment to value through the achievement 
of organisational legitimacy and the use of impression management tactics. 
 
 
2.3 The brand and the corporate reputation   
 
According to some previous studies, a firm’s reputation is revealed to have an effect on 
the brand advertisement (Goldberg and Hartwick, 1990).  Umbrella branding plays a 
role at the corporate level (Berry et al., 1988).  Sometimes the company name is 
regarded as the brand name, particularly with service firms (Low and Blois, 2002).  
Also, a firm’s corporate identity, its corporate reputation, and the corporate brands are 
examined by Schultz et al. (2000) about the inter-relationship between the three 
constructs.   
 
On the other hand, the corporate reputation management process that Gotsi and Wilson 
(2001) proposed shows a two-step process: First, a firm must align its internal 
communication with its brand values, and second, the firm must align its human 
resource management practices with its brand values. Gotsi and Wilson (2001) also 
illustrated the essential role of employees in the corporate reputation management 
process.  Their study presents ways that organisations can encourage commitment, 
enthusiasm and consistent employee behaviour in delivering brand values (Gotsi and 
Wilson, 2001).  Similarly, Fombrun (1996) argued that what accountants call ‘goodwill’ 
is similar to what marketers term ‘brand equity’.   
 
According to Hatch and Schultz (2003, p. 1041),  
“Among the changes that businesses make as they move toward 
globalisation is a shift in marketing emphasis from product brands to 
corporate branding (e.g. Kapferer, 1992; Dowling, 1993, 2001; 
Balmer, 1995, 2001a; Aaker, 1996; Ind, 1997; Schmitt and Simonsen, 
1997; de Chernatony, 1999; Aaker and Joachimsthaler, 2000; Keller, 
2000; Knox et al., 2000; Olins, 2000; Harris and de Chernatony, 
2001; Hatch and Schultz, 2001). This is usually ascribed to the 
difficulties of maintaining credible product differentiation in the face 
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of imitation and homogenisation of products and services, and the 
fragmentation of traditional market segments that occurs as customers 
become more sophisticated and markets more complex. In an era 
when companies can no longer base their strategy on a predictable 
market or a stable preferential product range, the ground rules for 
competition have changed.  Differentiation requires positioning, not 
products, but the whole corporation. Accordingly, the values and 
emotions symbolised by the organisation become key elements of 
differentiation strategies, and the corporation itself moves centre 
stage.” 
 
Gotsi and Wilson (2001) suggested that a firm’s corporate reputation is affected by the 
actions of every business unit, department and employee that comes into contact with 
the stakeholders.  Gotsi and Wilson (2001) explore what a firm’s management actions 
are required to be if employees are to support and enhance a firm’s corporate reputation.  
How employees can be directed or encouraged to “live the brand” is an area which has 
received relatively limited coverage (Gotsi and Wilson, 2001). 
 
2.3.1 The uses of corporate reputation and brand image strategy  
 
First of all, it is summarised from the previous researchers (Gardner and Levy, 1955; 
Newman, 1957; Herzog, 1963; Levy, 1978; Bullmore, 1984; Runyon and Stewart, 1987) 
that brand image is defined as a totality of a consumer’s perceptions about a product’s 
attributes. The perceptions of a brand that are reflected in the brand associations that 
exist in the minds of consumers (Newman, 1957; Herzog, 1963).  However, a brand 
image not only reflects a perceptual phenomenon of the customers affected by the 
firm’s communication activities alone (Stern et al., 2001) but also represents the 
understanding consumers derive from the total set of brand-related activities engaged in 
by the firm (Park et al., 1986).  In other words, brand image is the collection of 
attributes and associations that consumers connect with a brand name (Biel, 1993).  
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Customer brand choice is based on emotional and intuitive feelings about brands, their 
images and meanings for consumers and how these brands satisfy consumer needs and 
seem to fit into the consumer’s relationship with his/her world (Meenaghan, 1995).  
Therefore, customer buying behaviour can be reliably predicted when while a 
distinguished a distinctive segment is formed (van Raaij and Verhallen, 1994).  
Segmentation acts as a counterpart for product differentiation and positioning (Van 
Raaij and Verhallen, 1994).  However, positioning concepts are developed, selected and 
communicated for these target segmented stakeholders (Kotler, 2003).  In this section, 
developing a brand image strategy by considering the uses of corporate reputation will 
be investigated through answers to a research question. 
 
Efforts have been made to investigate the strategic use of brand image by reviewing the 
works of the following scholars: Park et al. (1986), Debevec and Iyer (1986), Swartz 
(1983), Roth (1992) and Roth (1995).  Consumer needs represent an important factor 
influencing the selection of a particular brand concept.  Brand image strategy is first 
proposed by Park et al. (1986) in brand concept management (BCM), which is derived 
from segmenting and positioning in marketing strategies.  In practice, it is a genuine 
response for a firm to differentiate its products in order to respond to differing consumer 
needs (Samuelson, 1976).  Thereafter, companies apply different brand image strategies 
(in terms of segmentation and positioning) to satisfy and fulfil the various needs of their 
consumers (Ries and Trout, 1969; Park et al., 1986; Trout and Rivkin, 1996; Nandan, 
2005; Kotler, 2006).  For instance, segmentation is achieved by advertising, which is the 
most influential way to position a brand in a marketing campaign (Galbraith, 1967).  
When considering a well-structured and long-term marketing process plan as stated 
above, we sense that the brand image is constructed based on consumer needs, 
perceptions and its relationships with the producing company (Keller, 1993; 2000; Roth, 
1995). 
 
According to earlier literature, brand image can be examined through investigating three 
types of needs that it satisfies: functional needs, symbolic needs and experiential needs 
(Park et al., 1986; Bhat and Reddy, 1998; Roth, 1995).  First of all, “functional needs” 
are defined as those that motivate the search for products intended to solve 
consumption-related problems (e.g. solve a current problem, prevent a potential 
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problem, resolve conflict and restructure a frustrating situation; see Fennell, 1978).  A 
brand with a functional concept is defined as one designed to satisfy externally 
generated consumption needs.  Second, “symbolic needs” are defined as desires for 
products that fulfil internally generated needs for self-enhancement, role position, group 
membership or ego-identification.  Finally, the most complex type is “experiential 
needs”.  It is complex because experiential needs should not neglect the first two types 
but integrate the feelings of the customer towards to the company.  According to the 
literature, experiential needs are defined as desires for products that provide sensory 
pleasure, variety and/or cognitive stimulation.  Work on variety seeking (McAlister and 
Pessemier 1982), consumer aesthetics and experiential consumption (Holbrook and 
Hirschman, 1982; Holbrook et al., 1984) illustrate the importance of experiential needs 
in consumption.  A brand with an experiential concept is designed to fulfil these 
internally generated needs for stimulation and/or variety.  
 
 
2.4 Brand image strategy: segmentation, differentiation and 
positioning  
 
A firm’s reputation not only enhances the value of corporate image (Fombrun, 1996) 
but also has an effect on the brand advertising (Goldberg and Hartwick, 1990).  This 
issue is especially important in the generic product market because the threat of the 
brand name becoming used in a generic fashion is always present, and so a company 
must take steps to try to avoid this happening.  These decisions or strategies involve 
identifying the problem and then determining what action should be taken by the 
company (Low and Blois, 2002).  Moreover, Low and Blois (2002) argue that the issue 
of branding in industrial markets has received little attention relative to that accorded to 
it in consumer markets.  On the other hand, Berry et al. (1988) suggest that umbrella 
branding plays a role at the corporate level.  Also, sometimes the company name is 
regarded as the brand name, particularly with service firms (Low and Blois, 2002).   
 
However, according to Low and Blois (2002), reaching the appropriate decision 
regarding a company’s response to the use of its brand name in a generic manner is 
` 
52 
 
difficult.  Inevitably, there are a number of assumptions and “guesstimates” that have to 
be made.  Low and Blois (2002, p. 391) argued further:  
“[E]ven a large firm, which might have the resources to carry out a 
thorough assessment of the costs associated with each policy and the 
likelihood of their being successful, will still have to reach a decision 
on the basis of a high degree of uncertainty.  For a small firm with 
limited resources, the decision will necessarily be based almost 
entirely on managerial judgement for the cost of even the simple 
market survey may be too great for it to be undertaken.”   
 
Therefore, in the consumer markets, on either the product or brand level, the author 
assumes the branding strategy is related to the corporate strategy or corporate decisions.  
Based on the arguments above, the management of corporate reputation not only 
regenerates a brand (Gotsi and Wilson, 2001), a firm’s reputation also has an impact on 
its brand image indirectly (Biel, 1993; Christensen and Askegaard, 2001).   
 
It is commonly agreed by both academic scholars and practitioners that a brand image 
(the perception by customers) becomes strongly related to a brand’s segmentation and 
positioning strategy while the initial brand concept is being formed (e.g. Leisen, 2001; 
Haley, 1968; Shank and Langmeyer, 1994; Hsieh, 2002).  Therefore, a firm’s brand 
manager creates brand strategies targeting their products to a particular group of 
customers, but needing to effectively operate for each of the firm’s business units.   
 
For example, Anderson and Jolson (1980) showed that the wording in advertising 
influences product-market segmentation.  Thus, it is important to understand the 
strategy orientation when a brand makes a coherent advertising decision to match the 
corporate strategy.  Moreover, as Dawar and Parker (1994) suggested, marketers use 
retailer reputation to signal product quality. Different quality level perceived by 
consumers from the degree of signal use should differ significantly in segmentating a 
product across countries. Therefore, marketers should determine whether to segment or 
adapt the marketing mix depending on the specific culture. 
 
Although corporate reputation can enhance a firm’s brand segmentation strategy, Brown 
et al. (1989) noted that for marketing effectiveness, firms should develop strategies for 
markets, not products.  Brown et al. suggested that market selection comes first, even 
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when a product geared for that market already exists, and that reputation is one of the 
factors that firms can use to distinguish the different market segments.  
 
Similarly, in service firms, Walsh et al. (2006) noted that when determining which and 
how many segments to target, firms should focus on only one group—namely 
customers—and attempt to use their corporate reputation to distinguish the markets 
further. Walsh et al. conducted a hierarchical cluster analysis with a sample of more 
than 500 consumers and discovered three groups of consumers that have specific 
reputation-related attitudes towards the firms they rated. These attitudes include 
‘reputation admirers’, ‘reputation ambivalents’ and ‘reputation criticals’, which firms 
can use to tailor their segment-specific marketing mixes.  
 
Moreover, the brand has a strong relationship with its product.  From the beginning, 
when the brand concept is proposed, there is a never-ending discussion regarding a 
brand and the product (e.g. Gardner and Levy, 1955).  A consistent product quality 
perceived by the customer can strongly affect a firm’s reputation.  Therefore, product 
quality has been seen as an important factor by previous scholars (e.g. Steenkamp, 1989) 
that have a huge impact on the perception of consumers.  In discussing the relationship 
between perceived quality and brand image, Zeithaml (1988) argues that “extrinsic cues 
are product related, but not part of the physical product itself.  By definition, they are 
external to the product, and changing them does not change the physical product. Price, 
brand name, level of advertising, and warranty are examples of extrinsic cues to quality” 
(p.6).  However, when the extrinsic cues of a product are changed, the physical product 
is not changed (Kirmani and Zeithaml, 1993).  
 
On the other hand, Kirmani and Zeithaml (1993) cite the effects of concrete attributes 
on perceived quality. Also Aaker and Biel (1993) assert that brand image includes 
perceptions of quality, value and attitude, as well as brand associations and feelings.  It 
is more multidimensional than perceived quality and, consequently, has a higher level 
of abstraction. A large amount of literature regarding the impact of intrinsic and 
extrinsic cues on perceived quality exists.  According to Kirmani and Zeithaml (1993), 
the perceived quality is formed by advertising.  The advertising, on a concrete level and 
a lower level, is categorized by the customer’s different perceptual level of abstractions. 
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Midlevel perceptual abstractions are defined as covering such things as style and 
performance.  The increasing level of abstraction is consistent with other 
conceptualizations of a product’s attributes (e.g. Olson and Reynolds, 1983; Geistfeld et 
al., 1997) known as “means–end chains”. Kirmani and Zeithaml (1993, p. 147) say that 
“the intrinsic cues refer to concrete, physical properties of the product (i.e. lower level 
specific brand beliefs).  These intrinsic attributes cannot be changed without altering the 
nature of the product itself and are consumed as the product is consumed (Olson and 
Jacoby, 1972; Olson, 1977; 1978)”. 
 
However, in Kirmani and Zeithaml’s (1993) study, there are inter-reactions within the 
three constructs of advertising, perceived quality and brand image. The extrinsic cues in 
Kirmani and Zeithaml’s (1993) categorization of the perceived quality belong to a 
firm’s branding strategy decisions.  This is strongly related to the brand manager’s 
decisions regarding a corporate product and the brand image they want to build.  
Therefore, The statement above suggests that a firm’s corporate reputation also belongs 
to a product’s abstraction attributes, and the reputation of a firm is related to a firm’s 
brand image.  
 
A product’s intrinsic and extrinsic cues also have some impact on price and the target 
groups.  It is difficult for the branding team to directly convey a product’s quality to 
potential customers, but sometimes setting a high price can convey this.  This is because 
concrete intrinsic attributes differ widely across products, as do the attributes consumers 
use to infer quality.  Pincus and Waters (1975) verified intrinsic cues as well as the price 
of ballpoint pens and found that intrinsic cues accounted for most of the variance in 
product quality ratings.  Kirmani and Zeithaml (1993) investigated the different product 
attributes and their advertisement effects on a product’s image perception.  For example, 
the attributes that signal quality in fruit juice (colour, presence of pulp) are the concrete 
attributes, indicating that higher-level abstract dimensions of quality can be generalised 
to categories of products (Zeithaml, 1988).   
 
On the other hand, Garvin (1987) proposed that product quality can be captured in eight 
dimensions: performance, features, reliability, conformance, durability, serviceability, 
aesthetics, and perceived quality (i.e. image).  Moreover, in describing the way 
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consumers compare non-comparable alternatives. Johnson (1984) posited that 
consumers represent the attributes in memory at abstract levels.  Similarly, Olson (1978) 
discussed “descriptive beliefs”, which involve a restatement of the original information 
into more abstract terms (e.g. “accelerates from 0 to 60 mph in 5 seconds” generates the 
belief “high performance”).  Olson (1978) suggested that consumers may use 
informational cues (e.g. intrinsic and extrinsic cues) to develop descriptive beliefs about 
products.  These beliefs, in turn, could affect evaluation and choice.  
 
Parasuraman et al. (1985) found consistent dimensions of perceived quality across 
seven service industries.  These dimensions include: (a) reliability, (b) responsiveness, 
(c) assurance, (d) empathy and (e) tangibles.  This study tried to measure dimensions of 
quality.  However, in another study, Brucks and Zeithaml (1991) contend on the basis of 
exploratory research that six abstract dimensions could be generalised across categories 
of durable goods: (a) ease of use, (b) functionality, (c) performance, (d) durability, (d) 
serviceability and (f) prestige.  For instance, in the product category of beer, Jacoby et al. 
(1971) found that both brand name and actual composition characteristics were more 
important determinants of product quality perceptions than price.   
 
On the other hand, these abstract dimensions of quality also indicated the price that can 
be requested from consumers.  Price was important in judging the style dimension.  For 
example, Valenzie and Andrews (1971) found that actual tasting of margarine samples 
had a stronger influence on taste perceptions (a quality dimension) than the price.  Etgar 
and Malhotra (1981) varied both intrinsic (sole, colour, upper) and extrinsic (place of 
purchase, price) attributes of running shoes and revealed that both types of cues were 
important in determining product quality.  Respondents in these studies used different 
extrinsic and intrinsic cues for different dimensions of quality (e.g. comfort, durability 
and style).  
 
Extrinsic cues other than price also affect quality perceptions.  As mentioned earlier, 
brand name, product warranties (Bearden and Shimp, 1982; Boulding and Kirmani, 
1991) and advertising costs (Kirmani and Wright, 1989; Kirmani, 1990) have also been 
considered and documented as a signal of quality.  For example, a brand name can 
represent a cluster of intrinsic attributes.  However, intrinsic and extrinsic attributes can 
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affect each other. Intrinsic cues (such as size of a stereo speaker) can lead to an 
inference about price (an extrinsic attribute) of the speakers.  Conversely, the price of a 
product can lead the consumer to a lower level belief about the concrete aspects of the 
product.  A £5 price for a candy bar, for instance, would likely signal ‘large size’.  
 
Extrinsic cues can affect each other as well.  For instance, advertisement expenditures 
can affect the perceived price of the product (Kirmani, 1990), and a high warranty on a 
product is likely to lead to the inference that the product carries a high price, despite the 
importance of extrinsic cues in forming quality cue.  However, when advertisement 
content was informative (i.e. comfort or durability of an athletic shoe), subjects relied 
on advertising expenditures as a quality cue.  However, when ad content was 
informative (i.e. showed a photo of a shoe) about a quality dimension (style), subjects 
did not rely on advertising expenditures as a quality cue.  Boulding and Kirmani (1991) 
found that an extrinsic cue in an ad (i.e. information about product warranty) affected 
durability perceptions although the advertisement was informative about intrinsic 
product cues. 
 
Several studies have linked the notion of differentiation to a firm’s corporate reputation. 
Ghose et al. (2006) suggested that several dimensions of reputation, including problem 
response, customer service, packaging, delivery and product-specific comments, present 
the principle points that customers look for when buying from a given seller. These 
dimensions not only provide a basis on which a seller can improve but also help the 
seller differentiate itself from the competition.  
 
In addition, according to Brammer and Pavelin (2006), corporate reputation can be 
augmented by activities that also are closely related to the vertical differentiation of 
products, such as technological advancement and the cultivation of a strong brand 
image. However, a good corporate reputation can also help differentiate the brand (Fan, 
2005). Aitchison’s (1999) Emotional Selling Proposition provides brand advertisers 
with a powerful tool to manipulate consumers’ emotions to achieve brand 
differentiation. According to traditional knowledge, the crucial goal of branding is to 
situate a favourable position in the minds of consumers, one that is distinct from 
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competitors (Ries and Trout, 1982). This target can easily be achieved when a firm 
builds its own reputation.  
 
Furthermore, Gotsi and Wilson (2001) argued that organisations are increasingly 
recognising customers as their most important assets for building a favourable corporate 
reputation. Through respondent interviews of the importance of employees in corporate 
reputation management, Gotsi and Wilson emphasised that employees, as one factor to 
enhance a firm’s corporate reputation, can help differentiate an organisation from its 
rivals because consumers evaluate the corporate reputation behind the brand and 
products presented to them.  
 
 
2.5 The development and conceptualization of the research problem 
and gap  
 
The review of theoretical literature (above) has led to the development of an analytical 
framework which presents a cohesive insight into the uses of corporate reputation.  
Importantly, the review of works from a variety of perspectives (i.e. public relations, 
marketing, management, economic, sociological, finance and accounting), together with 
the development of the eleven syntheses (see Table 2.2,) indicate that work on corporate 
reputation has focused principally on a number of issues.  These include the use of 
corporate reputation and corporate social and financial performance (Sobol and Farrell, 
1988; McGuire et al., 1990; Herremans et al., 1993; Fombrun, 1996; Deephouse, 1997; 
Brown, 1997; Roberts and Dowling, 1997; Roberts; Caruana, 1997; Srivastava et al., 
1997; Kotha et al., 2001; and Dowling, 2002; Sabate and Puente, 2003) and the use of 
corporate reputation and its relationship with company value and asset (Barney, 1986; 
Dierickx and Cool, 1989; Fombrun and Shanley, 1990; Gregory, 1991; Marconi, 1991; 
Smith, 1994; Fortune, 1995; Okano et al., 1999; Shkolnikov et al., 2004; Moerman and 
Laan, 2006).  Others include the use of corporate reputation and competitive advantage 
(Worcester, 1986; Fombrun and Shanley, 1990; Maathuis, 1993; Greyser, 1996; 
Fombrun and van Riel, 2004), the use of corporate strategy (Cornell and Shapiro, 1987; 
Weigelt and Camerer, 1988) and the use of corporate reputation and communication 
(Lerbinger, 1965; Grunig et al., 1992).  There are also a number of works that mention 
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the use of corporate reputation in customer purchase decision-making (Chibnall, 1977; 
Hall et al., 1978; McNair, 1996; Fombrun and Shanley, 1990; Landon and Smith, 1997; 
Sabate and Puente, 2003; L’Etang, 2006).  
 
However, it appears that there is limited work highlighting the relationship between the 
uses of corporate reputation on the one hand and the development of brand image 
strategy and corporate reputation on the other.  In fact, some of the works of Okano et 
al., 1999; Michell et al., 2001; Davies and Chun, 2002) that have attempted to address 
the relationship between these constructs appear to have done so without any sound 
empirical evidence explicating the relationship between these constructs.  
 
This problem, which has been developed from the review of conceptual literature, will 
be the core focus of this thesis.  Based on this assertion therefore, the question that will 
be addressed throughout this thesis shall be: how do (Taiwanese pharmaceutical) 
companies use their corporate reputations to develop their brand segmentation and 
positioning strategy?   This question, which is constructed as the key focus of this study, 
will be addressed conceptually in chapter three.  
 
 
2.6 Summary 
 
This chapter reviewed existing literature as it concerns the uses of corporate reputation. 
In addressing the course of this objective, an outline (see public relations, marketing, 
management, economic, sociological, finance and accounting) highlighting the various 
perspectives on the uses of corporate reputation was developed.  Thus a framework of 
synthesis, highlighting eleven overlaps or integrants running through the public 
relations, marketing, management, economic, sociological, finance and accounting 
perspectives on the uses of corporate reputation was developed.   
 
Moreover, previous studies regarding the corporate reputation and the brand are 
reviewed.  Links between a firm’s reputation and its brand strategy are revealed from 
previous studies.  Consequently, the review of these theoretical perspectives encouraged 
the development and conceptualisation of a research problem highlighting the gap in 
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literature together with the research question (RQ) of this study: how do (Taiwanese 
pharmaceutical) companies use their corporate reputation to develop brand image 
strategy?  The development of this question sets the scene for this research.   
 
The next stage of this study will be to examine how the question stated above can be 
answered conceptually and empirically in the following chapters.  Consequently, the 
objective of the next chapter will be to (in a broader sense) develop a conceptual 
framework that attempts to offer an answer or answers to the theoretical question being 
investigated in this study.  
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CHAPTER THREE: CONCEPTUAL FRAMEWORK  
AND THE DEVELOPMENT OF HYPOTHESES 
 
 
3.1 Introduction 
 
The previous chapters reviewed existing works on the uses of corporate reputation from 
six different perspectives (i.e. public relations,-marketing, management, economic, 
sociological, finance and accounting) under which the use of corporate reputation has 
been conceptualised.  Although there were differences between the disciplines, three 
main uses emerged: value creation, strategic resources and corporate communication.  
The literature review also identified a research gap by showing that there has been little 
research about how these three main functions (value creation, strategic resources and 
corporate communication) impact on a company’s brand positioning strategy.  
Therefore, the research question (RQ) is: how do (Taiwanese pharmaceutical) 
companies use their corporate reputation to develop a brand image strategy?   
 
The aim of this chapter is to explain the research hypothesis.  First, the research 
question will be constructed theoretically, and then a conceptual model, which begins 
with three antecedents for the uses of corporate reputation and illustrates simultaneously 
the outcomes of the uses of corporate reputation, will be created.  
 
Here the main construct is the uses of corporate reputation. This construct has three 
dimensions: value creation, strategic resources and corporate communication.  Each of 
these three dimensions includes several items.  First, the uses of corporate reputation as 
a value-creation tool include promising good quality products and service to customers, 
reducing transaction costs and sending signals to its customers.  Second, the uses of a 
firm’s corporate reputation as a strategic resource include use as a competitive 
advantage, as a strategic value or resource and developing good financial performance.  
Third, the uses of corporate reputation as a communication tool include shaping the 
perception of shareholders and stakeholders, influencing consumer choices and building 
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a relationship between the firm and its customers.  The following section will depict the 
proposed research conceptual framework and a number of hypotheses that will be 
further investigated and tested. 
 
 
3.2 Research framework and hypotheses development 
 
In order to guide this study, the key constructs need to be explained.  Based on the 
conclusion of the reviewed literature and research question, three antecedents (see Table 
3.1) pertaining to value creation, influencing competitor’s actions and a development 
the relationship with its stakeholders are hypothesised to be related to brand image 
strategy.  Brand image strategy in the research model is utilised as an output of the uses 
of corporate reputation. 
Table 3.1: Twelve antecedents pertaining to three dimensions of the uses 
of corporate reputation 
Value creation: creating value  
promising good quality products and service to customers 
reduce transaction costs  
is used as a signal to customers 
Strategic resources: influencing competitor’s actions/strategies 
using as a competitive advantage 
is used as a strategic value or resource  
develop good financial performance 
Communication: developing the relationship with its stakeholders 
shaping the perception of shareholders and stakeholders 
influence consumer choices 
build a relationship between the firm and the customers  
Source: Summarized by the author  
 
In this research a framework (Figure 3.1.), which is based primarily on the three 
syntheses of the uses of corporate reputation, is examined.  As described in the literature 
review, this framework has been developed by summarizing and synthesising the works 
of a number of scholars (such as Fombrun and Shanley, 1990; Sabate and Puente, 2003; 
Shkolnikov et al., 2004; L’Etang, 2006) who have previously studied the uses of 
corporate reputation.  The various uses of corporate reputation identified by the scholars 
(shown in Figure 3.1) were grouped into three categories.  This synthesis of the uses of 
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corporate reputation has been chosen because its importance is supported by 
contemporary theoretical developments.  In the following chapter, explanations of the 
relationship between the constructs will be presented.  
 
Figure 3.1: Research conceptual framework 
 
Resource: Developed by the author 
 
 
3.3 The uses of corporate reputation 
 
The aim of this research is to find out the uses of corporate reputation in the strategic 
branding decision.  This section explains the dimensions of the uses of corporate 
reputation separately.   
 
From the review of the literature, three dimensions of the uses of corporate reputation 
may be summarised as value creation, strategic resources and corporate communication.  
These dimensions of corporate reputation will help the firm to develop its brand strategy 
dimensions. These dimensions will be discussed in the following section. 
 
  
3.4 Consequences of the uses of corporate reputation 
 
From the review of literature, scholars belonging to the marketing perspective declared 
that a good corporate reputation generates good returns on a firm’s investment over time 
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(Fombrun, 1996; Caruana, 1997) and affects corporate performance (Srivastava et al., 
1997).  Caruana (1997) suggested that the concept of corporate reputation and 
improving its measurement have had beneficial consequences for firms. It has also been 
noticed  that it has positive impacts on factors such as  a customer’s purchase intentions 
(Yoon et al., 1993), the attitude of buyers to salespersons and products (Brown, 1995) 
and the perceived quality of products and services (Rao, 1994).  
 
An important study regarding the implications of corporate reputation was carried out 
by Caruana (1997); a summary of the studies on the consequences of corporate 
reputation is presented in Table 3.2. 
 
Table 3.2: Consequences of corporate reputation  
Consequence of corporate reputation  Author  
intention to purchase a service  Yoon et al., 1993 
the attitude of buyers to salespersons and 
products  
Brown, 1995  
the perceived quality and deterring 
competitor entry when a tough stance is 
adopted  
Weigelt and Camerer, 1988 
contributing to performance differences 
between firms  
Rao, 1994 
attracting investors, lowering cost of capital 
and enhancing competitive ability of firms  
Fombrum and Shanley, 
1990  
financial performance  Hall , 1993; Eberl and 
Schwaiger, 2005  
enabling strong organisation identification 
by employees and “inter-organisational 
cooperation or citizenship” behaviour  
Dutton et al., 1994  
Source: Template provided by Caruana (1997), developed by the 
author. 
 
Corporate reputation can help to deter competitors from entering markets (Weigelt and 
Camerer, 1988) and contribute to performance differences between firms (Rao, 1994).  
Therefore, increased understanding of corporate reputation helps to attract investors, 
lower the cost of capital and enhance the competitive performance of firms (Fombrum 
and Shanley, 1990). The reasons above imply that a firm’s reputation can help to 
improve the level of organisational identification of employees with a firm and enhance 
‘inter-organisational cooperation or citizenship behaviour’ (Dutton et al., 1994).   
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According to Table 3.2, a firm’s financial performance is affected by corporate 
reputation (Caruana, 1997). Several accounting scholars also affirm that a firm’s 
corporate reputation enables firms to profit from a variety of benefits (Herremans et al., 
1993).  Scholars within the economic perspective observed that a firm’s corporate 
reputation has an impact on financial performance (Sobol and Farrell, 1988; Sabate and 
Puente, 2003).  Sharing similar thoughts, some management scholars indicate that a 
good corporate reputation is used by firms to enhance corporate performance 
(Deephouse, 1997; Brown, 1997; Roberts and Dowling, 1997) as well as financial 
performance (McGuire et al., 1990; Kotha et al., 2001; Roberts and Dowling, 2002).  
 
For example, concerned with elucidating the effect of corporate reputation on financial 
performance, Eberl and Schwaiger (2005) concluded that two kinds of phenomena— 
cognitive and affective—constitute corporate reputation.  On this basis, they argued that 
corporate reputation is an attitudinal construct that exists and operates in the minds of 
the general public.  Thus, they argue that it is vital for reputation management to focus 
on communication with the relevant stakeholder groups rather than those internal to the 
company.  In other words, although external agents view financially successful 
companies favourably, they also tend to be risk averse. That is, companies with a good 
reputation gain more trust from the external agents or their direct customers, thus 
leading to more business or better performance. 
 
Based on the efforts of previous scholars on the uses of corporate reputation in different 
perspectives, good uses of a firm’s corporate reputation will certainly lead to a good 
financial performance.  This proven causal relationship shows the huge impact of a 
corporate reputation on a firm’s brand image strategy, which can also be seen as an 
outcome of building a good corporate reputation.   
 
3.4.1 The uses of corporate reputation and brand image strategy  
 
As discussed in chapter 2, there is a strong causal relationship between a firm’s image 
and its brand image. Much literature has been concerned with investigating whether 
corporate reputation has an inevitable impact on brand image because it can influence 
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the perception of customers.  Therefore, in this section, we are going to investigate the 
impact of not corporate reputation on brand image strategy-setting among brand 
manager decision makers. The relationship between corporate reputation and a firm’s 
brand image has not been comprehensively defined in previous literature.  Nevertheless, 
when considering the three dimensions of the uses of corporate reputation mentioned 
above, brand managers’ views will be important in brand image strategy decisions.  In 
this section, the brand image strategy-setting (when brand managers lay out their 
strategies) will be investigated in connection with the uses of corporate reputation.  
 
Based on the previous conceptualization of the use of corporate reputation, the more 
significant three schools of thought emerged involving these uses of corporate 
reputation: value creation, strategic resources and corporate communication.  Following 
the argument of brand image strategy above, it is important to discuss how the three 
dimensions of the uses of corporate reputation have an impact on brand managers’ 
strategy-setting. The next section, will review earlier literature examining the 
relationship uses between each use of corporate reputation and the setting of brand 
image strategy by brand managers.  
 
3.4.1.1 Value creation: value creation and brand image strategy  
The value provided by a firm to a customer is always judged during the customer 
purchasing process.  Therefore, the value creation ability of a firm is deeply related to 
the its relationship with its customers and influences the perception of its customers.  In 
essence, the resource-based theory (Grant, 1991; Peteraf, 1993; Barney and Zajac, 1994; 
Conner and Prahalad, 1996) provides a general way for a firm to find its core value.  
The resource-based theory suggested that a firm tries to achieve superior returns by 
exploiting internal resources and capabilities.  Corporate reputation is commonly used 
by a firm as a strategic resource (Roberts and Dowling, 2002) or as a tool for the 
development of organisational value (Smith, 1994).  Since corporate reputation cannot 
be and bought and is not easy to imitate or substitute, it is therefore regarded as an asset 
of a firm (Dierickx and Cool, 1989; Barney, 1986).  
 
In finance and accounting disciplines, for stakeholders, corporate reputation is presented 
and seen as a corporate valuable (Okano et al., 1999; Moerman and Laan, 2006) or used 
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as an intangible asset that can create value in the future (Dierickx and Cool, 1989; DTI, 
2001; Dolphin, 2004; Shkolnikov et al., 2004).  Therefore, it is used to increase the 
value of returns to shareholders (Rose and Thomsen, 2004) and to have a positive 
influence on firm value (Fombrun and Shanley, 1990; Gregory, 1991; Marconi, 1991; 
Fortune, 1995).  
 
In addition, according to some other researchers (e.g. Herbig et al., 1994; Devine and 
Halpern, 2001), corporate reputation is used as a tool for promising good quality 
products and service to customers in marketing.  A firm’s corporate reputation is used 
as a promise for good brand quality and good service levels (Devine and Halpern, 2001) 
since positive reputational signals about the quality of a company’s products or services 
can enhance credibility (Herbig et al., 1994).  Therefore, it is agreed by economic 
scholars that a good corporate reputation encourages a firm to produce top-quality 
products and services (Nelson, 1970; de Angelo, 1981; Wilson, 1983; Rogerson, 1983; 
Dranove, 1983; Eichenseher and Shields, 1985; Milgrom and Roberts, 1986; Beatty and 
Ritter, 1986).  
 
Marketing scholars argued that a strong corporate reputation enhances the generation of 
transaction costs (Caruana et al., 2004).  In the same vein, Shapiro (1983) and Eberl and 
Schwaiger (2005) also agreed that corporate reputation reduces transaction costs 
together with beneficial financial and non-financial outcomes.  
 
A review of the value-based theory will be conducted in order to better understand the 
intentions and mind-interaction in consumers when they are trying to evaluate the 
benefits that can be derived from the brand or the product.  Moreover, and consequently, 
by reviewing a customer value-based theory of the firm, it is easier for researchers to 
understand a firm’s marketing strategy (Slater, 1997).  Such a focus is understandable 
for marketing strategy nowadays because market forces predominantly drive strategic 
decision-making (Cravens, 1998).  
 
Schwartz and Bilsky (1987) claim that values are cognitive representations of universal 
human requirements: biological needs, social interactional requirements and social 
institutional demands on the individual.  Subsequently, some scholars – Parasuraman 
` 
67 
 
(1997) and Woodruff (1997) – proposed that a thorough understanding is needed to 
clarify the complexities of customer value perceptions, the processes for customer value 
monitoring and the processes for leveraging the firm knowledge.  These help to validate 
the strategy the managers follow by creating, developing, and delivering value to the 
customers (Piercy, 1998; Flint, 2004). 
 
Following from the above, human values have been increasingly used as a basis for 
market segmentation (Kamakura and Novak, 1992).  Similarly, Flint (2004) also argues 
that customer valued-based strategy resides in segmentation, branding, positioning, 
integrated marketing communication, professional selling, advertising, pricing, product 
development, and distribution/logistics strategies.  
 
From the arguments above, the value system has been used by marketers to explain 
phenomena such as consumer behaviour (Henry, 1976; Vinson and Munson, 1976; Pitts 
and Woodside, 1983) as well as strategic marketing (Flint, 2004).  As has been stressed, 
that creating a value-based strategy relating to customers gains a reputation for a firm, 
we confirmed that a firm with a good corporate reputation as an intangible asset can 
also benefit the firm by reducing transaction costs, indirectly creating a value for the 
firm. 
 
Given the focus of this study on the relationship between value creation and branding 
strategy, it is also proposed that: 
 
H1: Value creation as a dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand segmentation strategy. 
 
H2: Value creation as a dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand differentiation strategy. 
 
H3: Value creation as a dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand positioning strategy. 
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3.4.1.2 Strategic resource: influencing a competitor’s actions/strategies and brand 
image strategy 
Strong financial performance generally signals an effective corporate strategy.  It helps 
a firm to establish or maintain a good reputation (Roberts and Dowling, 2002; Sabate 
and Puente, 2003).  This confirms the notion that corporate reputation is an undervalued 
strategic asset (Smythe et al., 1992) because it gives the stakeholders an idea about a 
firm’s financial stability background and shows which direction the firm is heading to.  
In comparison with other more tangible assets, it is rarely the subject of investment 
(Weigelt and Camerer, 1988). 
 
In sociology, corporate reputation is commonly used as a defence strategy to ward off 
competitors (Cornell and Shapiro, 1987).  Thus, it is argued in economics that corporate 
reputation is found to be a strategic resource (Weigelt and Camerer, 1988). In addition, 
Roberts and Dowling (2002) contended from a management perspective that corporate 
reputation, as used among business organisations, has a strategic value. These 
arguments above are based on the fact that corporate reputation is not easy to build nor 
easy to replicate (Barney, 1986; Dierickx and Cool, 1989).  It takes some time for new 
entrants to a competitive market to develop a reputation that is comparable with those 
competing in the market before it (Hall, 1993). 
 
Therefore, corporate reputation may well result in gaining a competitive advantage for 
an organisation.  According to the literature, it is commonly agreed within marketing, 
accounting, economics and management scholars that firms deploy strategies by using 
their corporate reputation to effectively differentiate them from competitors (Stigler, 
1962; Caves and Porter, 1977; Klein and Leffler, 1981; Wilson, 1985; Beatty and Ritter, 
1986; Milgrom and Roberts, 1986; Hall, 1992; Day, 1994; McMillan and Joshi, 1997) 
and to create a distinctive position in the mind of stakeholders (Fombrun and van Riel, 
2004) in order to attain competitive advantage (Worcester, 1986; Fombrun and Shanley, 
1990; Maathuis, 1993; Greyser, 1996).  
 
Corporate reputation is seen by economic and management scholars (Kreps and Wilson, 
1982; Shapiro, 1989) and as a signal-laden phenomenon that can be used to forecast the 
potential behaviour of a firm and also by management scholars (Waddock, 2000).  
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In Milewicz and Herbig’s (1994) study, they evaluated  brand extension by building a 
brand extension reputation model.  The model represents consumer cognitive processes, 
showing that corporate reputation is commonly used to highlight and signify (Herbig 
and Milewicz, 1993) a firm’s beliefs, attitudes and intentions to market participants  and 
that is often deployed by marketers as a useful signal that gives stakeholders the needed 
insight into the future of a firm (Fombrun, 2002).  
 
For example, for banks and other financial institutions, the expression of corporate 
reputation is used as a signal that enables key resource providers to interpret a 
company’s initiatives and assess its ability to deliver value outcomes from the firm’s 
past actions.  Therefore, in management studies, corporate reputation is used on many 
occasions to signify an organisation’s perceived capacity to meet their stakeholders’ 
expectations (Waddock, 2000).  
 
In this part, we start to review the resource-based view (RBV) of a firm.  This view has 
been extensively summarised in contemporary strategy literature (Wernerfelt, 1984, 
1995; Grant, 2010; Mahoney, 1995).  
 
A definition and classification scheme of resources has been suggested. Barney (1991) 
defined resources as a bundle of assets, capabilities, organisational processes, firm 
attributes, information and knowledge.  These resources can be broadly categorized as 
tangible and intangible and consist of financial, physical, legal, human, organisational, 
relational, technological and informational assets, skills and competencies.  
 
Resource-based scholars suggested that certain assets (tangible or intangible) with 
certain characteristics will lead to sustainable competitive advantage (Hooley et al., 
1998).  Resource-based theorists suggest that for a strategy to be sustainable it needs to 
be embedded in the firm’s resources and capabilities.  For example, Grant (2010) argues 
that as rates of change in the external environment increase firms have to increasingly 
base their long term strategies on internal resources and capabilities rather than focus on 
external market forces.  Several years later, it was also proposed by Varadarajan and 
Jayachandran (1999) that organisational issues (e.g. corporate reputation) are relevant to 
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marketing strategy such as branding, competitive behaviour, positioning, and 
segmentation, and have an impact on quality management, marketing and business 
strategy (e.g. market orientation), and outcomes of marketing strategy (e.g. market share, 
customer satisfaction).  Based on the above statements, we suggest that corporate 
reputation can be used as a strategic resource that helps to make a brand image strategy. 
 
As mentioned earlier, the terms “capabilities” and “competencies” are used 
interchangeably as in most of the strategy literature (e.g. Prahalad and Hamel, 1990; 
Day, 1994; Hooley et al., 1998). Hooley et al. (1998), (see Figure 3.2 ) proposes a 
typology of resources, briefly explained below, focusing on marketing assets and 
capabilities and relating these to competitive positioning alternatives.  Two aspects of a 
firm’s resources are presented: “organisational assets” and “company capabilities”. 
 
According to Hooley et al. (1998), a basic distinction has been made between assets and 
capabilities (Penrose, 1959; Mahoney, 1995; Kamoche, 1996).  “This distinction was 
perhaps most clearly articulated by Day (1994), who suggested that assets are the 
resource endowments the business has accumulated (e.g. investments in scale, plant, 
location and brand equity) while capabilities are the glue that binds these assets together 
and enables them to be deployed advantageously.  The latter are complex bundles of 
skills and collective learning, exercised through organisational processes, which ensure 
superior coordination of functional activities.  In what follows we take resources to 
contain both assets and capabilities”. 
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Figure 3.2: Typology of organisation resources    
    Resource     
          
          
 Assets     Capabilities  
          
 Tangible Intangible    Individual Group Corporate 
 
Physical 
 
Land 
-  Strategic Orientation, 
dominant 
logic 
Customer care Customer 
orientation 
Market 
orientation 
Financial Cash in hand Credit 
worthness 
 Learning Individual 
learning 
Group 
learning 
Organisational 
learning 
Operations Plant & 
machines 
Procedures & 
systems 
 Organizing/ 
Managing 
Self-
management 
Interpersonal 
skills 
Portoflio 
management 
Human The people Their 
abilities 
 Functional Outside-In External focus Marketing Marketing 
sensing 
Marketing Customer 
database 
Brands & 
reputation 
 Inside – out Internal focus operations Resource 
utilization 
Legal Copyrights & 
patents 
Reputation in  
litigation 
 Spanning Coordinating 
skills 
New product 
development 
Innovation 
Systems Database & 
MIS 
Knowledge 
& DSS 
 Operational Task skills Individual 
tasks 
Group tasks Planning 
processes 
Other ? ?  Other ? ? ? 
(Items in italics are only examples and are not intended to be exhaustive) 
Source: Hooley et al. (1998) 
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Therefore, from the review of the previous studies – which establishedthat the 
resource-based theory (and market orientation) – corporate reputation has been 
regarded by many researchers as a strategic resource for a firm (Wernerfelt, 1984), 
which explains the rent- earning capability of resources (see Amit and Schoemaker, 
1993).  This dynamic capabilities approach examines how resources and capabilities 
are developed in a firm context (Mahoney, 1995) and will also be developed into a 
competitive positioning strategy (Hooley et al., 1998).  Hooley et al. (1998) reconcile 
the market orientation and resource-based view by developing a positioning strategy 
concept.  
 
As stated above (see Hooley et al., 1998), two main approaches to resources have 
developed.  However, previous researchers investigated the strength of corporate 
reputation used as a strategic resource of a firm. In this research, however, we propose 
to view simply corporate reputation as one of the intangible assets. 
 
Given the focus of the study on the relationship between the strategic resource role of 
corporate reputation and brand image strategy, it is also proposed that: 
 
H4: Strategic resource as a dimension of the corporate reputation has 
a positive impact on a firm’s brand segmentation strategy. 
 
H5: Strategic resource as a dimension of the corporate reputation has 
a positive impact on a firm’s brand differentiation strategy. 
 
H6: Strategic resource as a dimension of the corporate reputation has 
a positive impact on a firm’s brand positioning strategy. 
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3.4.1.3 Corporate communication: developing the relationship with its 
stakeholders and brand image strategy 
Corporate communication is regarded by researchers as a very important tool, directly 
influencing consumer perception and creating competitive advantage for a company 
(Gray and Balmer, 1998).   In an analysis of corporate communication, recognition 
must be given to the idea that the information related to corporate reputation is used to 
communicate a firm’s social responsibility activities to stakeholders within the 
business environment (Lerbinger, 1965; Grunig et al., 1992).  For instance, although a 
medicine brand may have excellent medical performance; the manufacturer may use 
other forms of its firm’s reputation to transmit a different image to their brands.  For 
example, a representation of an experience with this pharmaceutical corporation is 
‘safe’ or trustable (e.g. “It was very reliable and could be trusted when I prescribed 
the medicine to my patient)”.  
 
The underlying reputation dimensions correspond to a strategic resource, which is 
used to integrate the mass communication and being used under the resource-based 
environment (Deephouse, 2000).  Also, the corporate reputation can be positioned to 
the specific target group that enhances the generation of better feedback from 
stakeholders within the business environment (Stanwick and Stanwick, 1998).  
 
According to an analogous school of thought (Fombrun and Shanley, 1990; 
Shkolnikov et al., 2004), corporate reputation is developed on the basis of consumer 
perception.  Therefore, marketers portray corporate reputation as a benefit for the 
customers because when they feel more secure about a firm’s ability they will buy 
more.   
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Moreover, a firm’s reputation can influence customer choice.  Fombrun and Shanley 
(1990) argued that corporate reputation serves as a value signal that enables customers 
to gauge the merits of a product or service, especially in situations where customers 
are overloaded with information or in cases where there is inadequate information 
about a product.  Similarly, Srivoravilai (2006) observe that a corporate reputation 
helps customers to select the best choice among many alternatives in the market. 
Landon and Smith (1997) and Sabate and Puente (2003) also confirmed that corporate 
reputation is used by consumers to make purchasing decisions.  Corroborating this 
point of view, it is suggested by Shkolnikov et al. (2004) that a good corporate 
reputation enables the generation of increased customer loyalty. 
 
The review of literature in public relations indicated that corporate reputation is 
devised to protect firms from excessive interpretation  by stakeholders (Chibnall, 
1977; Hall et al., 1978; McNair, 1996; L’Etang, 2006).  
 
Furthermore, a company’s corporate reputation builds a relationship between the firm 
and its customers.  Firms are keen to employ their corporate reputation to enhance the 
development of a sound relationship with their customers (see Perrow, 1961a; Perrow, 
1961b; Shrum and Wuthnow, 1988).  This is based on the fact that corporate 
reputation is frequently used as a signal contributing towards a thorough 
understanding of not just consumers but, more importantly, the key competitors of the 
firm (Kreps and Wilson, 1982; Milgrom and Roberts, 1982).  For this reason, 
corporate reputation is a device that can be devised to build a relationship between a 
company and its stakeholders. 
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The last dimension to be considered relates to corporate communication. Earlier 
literature also indicated that the relationship between a firm’s communications with 
its customers has an impact on brand image strategy-setting.  Some researchers 
(Birkigt and Stader, 1986; Gray and Balmer, 1997) have noted that communication 
plays an important role in the branding process. Fombrun and Rindova (1998), in their 
study on reputation management strategies of leading US/UK companies, concluded 
that communication benefits result from the variety of issues about itself that a firm 
reveals through its communications. It is also put forward by Fombrun and Rindova 
(1998) that communications make a firm transparent, and enabling shareholders to 
appreciate the firm’s operations better. This argument suggests that communication 
can play a pivotal role in corporate brand management. 
 
Several researchers have suggested that a firm’s communications have a direct impact 
on setting the scene for segmenting and positioning a firm’s product, either in direct 
marketing (e.g. Peltier and Schribrowsky, 1997) or in service sectors (e.g. Zineldi, 
1996).  To be more specific, a firm’s use of communication in any form (e.g. package 
design, logo design, distribution channel and salesperson) creates a platform to make 
their consumers understand more about themselves and their products (or services), 
making it easier for brand managers to target their branding strategy to a clearly 
defined or segmented market groups. 
 
However, according to communication literature, communication can be categorised 
into two streams of thought.  Similar to Peltier and Schribrowsky (1997), Nandan 
(2005) also indicated that marketing communications and brand management 
influences brand image and enhances brand equity (Nandan, 2005).  Moreover, Flint 
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(2004) asserted that it is also necessary to gain considerable understanding of its 
competitors through customer relationships if a firm focuses mostly on its customers.  
Then it is easier for a firm to understand their customers’ needs, communicate with 
them and set a brand aiming at and focusing on at specific segments in the market 
(Dickson and Ginter, 1987).  
 
Another stream of corporate communication thought can be found in consumer 
behaviour research.  Scholars belonging to this group argued that marketing 
communication (e.g. multi-attribute attitude models, self-image congruence models) 
is a function of situational factors such as product utilitarianism and product value-
value-expressiveness which expressiveness that is employed by managers to set their 
positioning strategy (Johar and Sirgy, 1989).  Accrding to van Raaij and Verhallen 
(1994), a firm differentiates its product to position its brand in a specific market by 
using different designs or campaigns to communicate with its customers.  Similarly, 
Schultz (1998) argued that brands are central to this integrated marketing 
communication.  Keller (1993) points out that customer-based brand equity emanates 
from consumer familiarity and strong, favourable associations with thea brand.  Keller 
(1993) further argued that marketing communication represents the voice of a brand. 
Through marketing communication, companies can establish a dialogue with 
consumers concerning their product offerings (1993). 
 
Additionally, Madhavaram et al. (2005) suggested that an effective use of IMC 
(Integrated marketing communication) will result in a situation whereby a consumer-
held brand image will be congruent with the strategist’s intended brand identity.  This 
is because that by clearly and consistently communicating the brand identity to other 
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brand stewards, the brand strategist can ensure a more synergistic and effective IMC 
(for an IMC construct conceptual framework see Figure 3.3).  Therefore, for 
practitioners, according to Madhavaram et al., IMC has become an integral part of 
brand strategy that requires extensive brand development activities within the firm 
before beginning any external brand communications efforts. In addition, Vargo and 
Lusch (2004) argued that marketing is evolving toward a dynamic and evolutionary 
process based on a service-centred view.  In keeping with this evolution, they 
suggested that brand management should be used for initiating and maintaining a 
continuing dialogue with the customers. 
 
Figure 3.3: IMC construct conceptual framework 
 
Source: Madhavaram (2004) 
 
Based on Madhavaram et al.’s (2005) theory that a firm can use communication to 
enhance its brand image strategy, they argued that a when a firm has a clear and 
accurate understanding of the brand identity, it is able to develop a better IMC 
Brand 
identity- 
orientated 
Top 
management 
supports 
Internal 
market 
IMC synergy  
Constructs 
 
 Interactivity 
IMC  
Effectiveness 
Brand equity 
 Awareness 
 Image 
Brand identity Brand equity contact 
Note IMC = integrated marketing communication 
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programme to communicate their brand identity more clearly and accurately.  And 
they might finally get feedback from customers, the prospects and the general public 
regarding brand awareness and image. Feedback from other entities in the 
environment, including competitors, will enable the brand owner to adjust its brand 
image strategy, and/or its IMC strategy.  Therefore, they suggested that a firm should 
put more effort into communicating with to their customers to generate brand-related 
market information from the environment.  
 
Discussing communication, the two most common approaches used in marketing 
communication to influence consumer choice are categorized as: Brand Image 
Strategy (Ogilvy, 1963) and the Unique Selling Proposition (USP) strategy (Reeves, 
1961).  To summarise those previous researchers’ thinking stated above, Johar and 
Sirgy (1989) asserted that the IMC based on brand image strategy – which is 
essentially used to position a company’s brand in the market possess a dual nature of 
both rational and emotional elements.  These elements are based on the use of self-
image congruence models and the use of multi-attribute attitude models in brand 
positioning. Image strategy involves the building of a “personality” for the product or 
creating an image of the product user (Ogilvy, 1963). USP strategy, on the other hand, 
involves informing consumers of one or more key benefits that are perceived to be 
highly functional. Both of these theories are developed into a construct of brand 
positioning (Johar and Sirgy, 1989; Hooley et al., 2004). 
 
Given the focus of the study on the uses of corporate reputation,  and that shaping the 
perception of shareholders and stakeholders plays a role of communication in a 
company’s branding strategy, it is proposed that: 
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H7: Corporate communication as a dimension of corporate reputation 
has a positive impact on a firm’s brand segmentation strategy. 
 
H8: Corporate communication as a dimension of corporate reputation 
has a positive impact on a firm’s brand differentiation strategy. 
 
H9: Corporate communication as a dimension of corporate reputation 
has a positive impact on a firm’s brand positioning strategy. 
 
 
3.4.2 The application of a firm’s corporate reputation signals to brand image 
strategy 
 
From the review of literature on the uses of corporate reputation, although corporate 
reputation has not been defined as a business function, a proper definition of this 
concept will require a fusion between aspects of human resource management, 
marketing, business strategy and corporate communications (Gray and Balmer, 1998; 
Hooghiemstra, 2000).  In Weigelt and Camerer’s (1988) review of the theory and 
applications of the uses of corporate reputation on corporate strategy, they identified a 
corporate reputation as a set of attributes ascribed to a firm, inferred from the firm’s 
past actions, while strong financial performance generally signals an effective 
corporate strategy.  Therefore, a corporate reputation helps a brand to create customer 
satisfaction, thus resulting in a higher level of financial performance for the firm 
(Weigelt and Camerer, 1988).  However, on the other way around, some researchers 
(Roberts and Dowling, 2002; Sabate and Puente, 2003) suggested that a firm’s good 
financial performance helps a firm to establish or maintain a good reputation. 
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In order to understand the relationship between corporate reputation and brand image, 
it is important to understand the context in which corporate branding operates (Hatch 
et al., 1998; Bickerton, 2000).  An UOVP (Unique Organization Value Proposition) 
model was proposed by Knox and Maklan (1998) with the aim of positioning and 
branding an organisation.  This branding process consists of four “higher marketing 
mix variables”: reputation; product and service performance; product brand and 
customer portfolio; and networks.  With these four components, the organisational or 
corporate brand is created and the means by which this brand is differentiated from its 
competitors.  In this way, corporate reputation helps managers to lay out a brand 
image strategy. 
 
One year later, following Knox and Maklan’s (1998) study, Knox (1999) proposed 
another model called “the organisation brand monitor” after proposing the UOVP 
model for the organisation branding concept.  This identified the existing brand and 
mapped out the desired brand for the firm in the future.  In this model, reputation is 
used as a factor to monitor the development of an organisation.  Based on the 
organisation brand monitor concept, it implies the existence of a causal link between a 
firm’s corporate reputation and its brand image. 
  
According to many corporate reputation scholars, a corporate reputation scale (Fryxell 
and Wang, 1994) is extensively used in practice as a positioning instrument to 
maintain or modify customer behaviour.  For example, Nguyen and Leblanc (2001) 
studied the relationship between corporate reputation and customer loyalty in the 
service sector.  A review of the literature reveals that it is a widely shared belief that a 
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firm’s corporate reputation has a large impact on customer loyalty (Nguyen and 
Leblanc, 2001).  This implies the effect of corporate reputation on customer retention 
indecisions in the service sector, since the service loyalty in itself represents the 
customer’s rejection of competitive offerings aimed at changing buying habits and 
constitutes one of the most reliable overall indicators of the service firm’s success.  
Their study gave the managers a thorough understanding of these relationships which 
contribute to establishing the distinction between image and reputation and help 
management use them more effectively in their communication strategy, thereby 
enhancing the firm’s positioning strategy.  In essence, they suggested that the 
managers to use corporate reputation as a tool to help them devise a positioning 
strategy for their products. 
 
3.4.3 Price regulation 
 
According to previous researchers, price policy has become an important issue for the 
pharmaceutical industry world-wide (Huttin, 1992; Dickson and Redwood, 1998; 
Scherer, 2004; de Wolf et al., 2005). In most of the advanced countries (e.g. the UK, 
Germany, Canada, the USA and Japan) in the world, the price of medicines is an 
important issue and may be affected by government policy.  
 
However, previous literature (Myers and Reynolds, 1967; Lee, 2008) also has 
suggested that a product’s price influences a customer’s brand perception. Marketing 
studies also show that price can have an impact on customers’ evaluations of a brand 
(Larkin, 2010). However, the more a customer is loyal to a particular brand, the lower 
is his or her price elasticity of the demand functions (Starr and Rubinson, 1978).    
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According to Aaker (1996, p. 17), when firms increase price to contribute to their 
profitability, they must ensure that customers have a positive perception of their 
brands’ quality. That is, “branded products enjoy higher prices than the generic 
products, resulting in higher market valuation of firm assets, even if the production 
technology is somewhat similar” (Larkin, 2010, p. 16). Larkin (2010) suggested that 
firms can measure consumers’ preferences through their views of a brand. The more a 
consumer prefers a brand, the more he or she is willing to pay for and the more 
quantity he or she is will to purchase of the brand. Thus, Larkin (2010, p. 31) 
maintains that “firms with strong brands have loyal consumers with high subjective 
value for the firm’s products and who are willing to pay more and stick with the 
product despite higher prices or price cuts by competitors.”  
 
It was mentioned by Anis and Wen (1998, p. 21) that “patent holding pharmaceutical 
firms are modeled as price-discriminating international monopolies. In an unregulated 
world market, firms set monopoly prices in each national market. Three types of 
regulatory rules: (i) ‘reasonable’ relationship rule, (ii) international price comparison 
rule, and, (iii) therapeutic class comparison rule, are examined. While price regulation 
may lead to lower introductory prices for new drugs, the price of existing drugs may 
increase. Domestic price regulation may increase foreign prices. Canadian data 
supported the model's predictions. Policy makers should anticipate these responses 
that affect the entire vector of drug prices and not just those subject to specific 
regulations.” And some other articles (Zweifel and Crivelli, 1996; Danzon and 
Furukaw, 2003; Danzon and Furakawa, 2008) addressed on the similar issue in 
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different countries such as Canada, France, Germany, Italy, Japan, Mexico, the United 
Kingdom and the United States.  
 
However, the literature doesn’t indicate strong support for price regulation as a factor 
in the relationship between the uses of corporate reputation and brand image strategy. 
This moderating effect of price regulation will be discussed in more detail in the 
qualitative result in the next chapter.  
 
 
3.5 Hypothesis developing 
 
In the following section, based on the previous literature and arguments, a hypothesis 
table (Table 3.3) is developed which established the relationship between each 
constructs. This table bares an intension to explain the proposed framework in this 
study.  
 
Table 3.3: List of research hypotheses 
H1 Value creation as one dimension of the uses of corporate reputation has 
a positive impact on a firm’s brand segmentation strategy. 
H2 Value creation as one dimension of the uses of corporate reputation has 
a positive impact on a firm’s brand differentiation strategy. 
H3 Value creation as one dimension of the uses of corporate reputation has 
a positive impact on a firm’s brand positioning strategy. 
H4  Strategic resource as one dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand segmentation strategy. 
H5  Strategic resource as one dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand differentiation strategy. 
H6 Strategic resource as one dimension of the uses of corporate reputation 
has a positive impact on a firm’s brand positioning strategy. 
H7 Corporate communication as one dimension of the uses of 
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corporate reputation has a positive impact on a firm’s brand 
segmentation strategy. 
H8 Corporate communication as one dimension of the uses of corporate 
reputation has a positive impact on a firm’s brand differentiation 
strategy. 
H9 Corporate communication as one dimension of the uses of corporate 
reputation has a positive impact on a firm’s brand positioning strategy. 
Source: Developed by the author 
 
 
3.6 Conclusion 
 
This chapter provides a detailed investigation of earlier literature on corporate 
reputation, identifying three dimensions of antecedents in the use of corporate 
reputation as: value creation, influencing competitor’s actions and developing a 
relationship with its stakeholders.  The study also highlights the impact of corporate 
reputation on a firm’s brand image strategy as a consequence.  Explanations of the 
hypotheses on brand image strategy which are affected by the uses of corporate 
reputation are proposed.  Hypotheses demonstrated the different relationships between 
the study constructs in the integrative framework provided.  
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CHAPTER FOUR: METHODOLOGY 
 
 
4.1. Introduction 
 
The previous chapter detailed the conceptual framework and the hypotheses.  The 
purpose of this chapter is to justify and outline the methodology used to empirically 
test the proposed conceptual model, and to answer the research questions of the study.  
Following the introduction, this chapter is mainly divided into four sections.  The first 
section provides a description of the research design in the current study justifying the 
choice of both qualitative and quantitative methodologies.  The second section of this 
two-phase study illustrates the qualitative study and its objectives.  The third section 
highlights the development of the questionnaire to be used in the data collection phase.  
The pilot study, sampling procedures and the main survey will also be discussed in 
this section as will data analysis techniques.  
 
 
4.2. Research strategy 
 
First of all, the researcher began by highlighting the nature of her research objectives 
in order to identify the research approach to be used in this thesis.  This study aims to 
explain the significance and importance of the uses of corporate reputation for 
managers. The study also aims to explain the impact of value creation, influencing 
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competitors’ actions and developing the relationship with its stakeholders (which are 
the uses of corporate reputation) and the consequences of the uses of corporate 
reputation for brand managers when laying out brand image strategy.  Those factors 
have been derived from extant literature and theories from related fields of study (i.e. 
corporate reputation, branding, communication and marketing strategy literature).  
Hence, the research problem of this thesis has been built on what is already known 
from previous studies.  As a consequence, a theoretical framework has been 
developed as a start for the current study.  This framework presents variables that are 
claimed to be important in either fostering or discouraging the uses of corporate 
reputation in setting brand image strategy in the pharmaceutical industry.  In order to 
achieve the research objectives, the researcher has taken into consideration the fact 
that it is important to choose a research method based on her objectives and her 
research questions. The following paragraphs attempt to illustrate and justify the 
research methods used in this study. 
 
In general, two approaches (i.e. deductive and inductive) are always applied by 
researchers to build and test the built theory. In a deductive approach, the researcher 
begins with an abstract, logical relationship among concepts, then moves towards 
concrete empirical evidence. In the inductive approach, the researcher begins with 
detailed observations of the world and moves towards more abstract generalisations 
and ideas (Neuman, 2003). In practice, most researchers use both approaches at 
various points in their studies. This research employs a deductive approach to 
research the theoretical relationship.  This implies that the research is built on theories 
that already exist in the domain that is being researched (Bryman and Bell, 2007).  
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Hypotheses are developed from those relevant theories and will be tested after data 
collection and analysis phases.  
 
Based on Crotty (1998), in designing a research proposal, we should consider four 
questions, which are: (1) “what epistemology – theory of knowledge embedded in the 
theoretical perspective – informs the research (e.g. objectivism, subjectivism, etc)? (2) 
What theoretical perspective – philosophical stance – lies behind the methodology in 
questions (e.g. positivism and post-positivism, interpretivism, critical theory, etc.)? (3) 
What methodology – strategy or plan of action that links methods to outcomes – 
governs our choice and use of methods (e.g. experimental research, survey research, 
ethnography, etc.)? (4) What methods – techniques and procedures – do we propose 
to use (e.g. questionnaire, interview… etc.)?”  Based on Crotty’s model, Creswell 
(2009) addressed three elements of inquiry (i.e. knowledge claim, strategies of inquiry 
and methods) that pertain to the design of the research.  With respect to the current 
study, the researcher will follow Creswell’s (2003) model in order to illustrate the 
research design.  Figure 4.1 shows that how these elements merge together to outline 
the approach of the research and, in turn, translate into processes in the design of the 
research. 
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Figure 4.1: Knowledge claims, strategies of inquiry and methods leading to 
approaches and the design processes. 
 
Source: Adapted from Creswell (2003, p.5) 
 
According to Creswell (2009) the first step when designing a research is to evaluate 
the knowledge claims brought to the study.  “Knowledge claim means that researchers 
start a project with certain assumptions about how they will learn and what they will 
learn during their enquiry.  These claims might be called paradigms (Mertens, 1998; 
Lincoln and Guba, 2000); philosophical assumptions, epistemologies and ontologies 
(Crotty, 1998); or broadly conceived research methodologies (Neuman, 2000). 
Philosophically, researchers make claims about what is knowledge (ontology), how 
we know it (epistemology), what values go into it (axiology), how we write about it 
(rhetoric), and the process for studying it (methodology)” (Creswell, 1994) (Creswell, 
2009, p.6).  Four sets of assumptions are suggested by Creswell (2009) concerning the 
knowledge claims: postpositivism, constructivism, advocacy/participatory and 
pragmatism.  However, most ongoing social research is based on two major 
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approaches – positivism and interpretivism.  Positivism is the oldest and most widely 
used approach.  It is broadly defined as the approach of natural sciences.  However, 
interpretive researchers claim that the goal of social research is to develop and 
understand social life and discover how people construct meaning in natural settings 
in contrast to e positivism (Neuman, 2003). It is argued by Neuman (2003) that 
ordinary people use common sense to guide their daily living, so one must first grasp 
common sense. 
 
Qualitative research allows researchers to formulate explanations of the subjects 
under study and to give representations of these explanations in order to add to a body 
of knowledge (Wright 2008).  However, in the real life, neither common sense nor 
scientific law has perfect answers.  Therefore, social researchers developed 
triangulation by using qualitative and quantitative methods to provide a view from a 
number of perspectives rather than from only one perspective to look at a concept, 
some phenomenaor circumstances.  Hence, Neuman (2003) proposes four types of 
triangulation.  First comes the measurement triangulation, which means using more 
than one measure for the same phenomena.  Second is triangulation of the observer, in 
which the data are collected by a variety of observers to give a more complete picture 
of the setting.  The third one is triangulation of theory, which is when the researcher 
uses multiple theoretical perspectives in the planning stage of the research.  The last 
one is triangulation of methods, which means conducting qualitative and quantitative 
approaches of research. 
 
The current study will employ the fourth type of triangulation or the “mixed methods 
approach” (Tashakkori and Teddlie, 2003).  It is an approach in social sciences which 
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employs collecting data by both forms of research styles (i.e. qualitative and 
quantitative concurrently or sequentially) (Creswell, 2009).  Adopting this approach 
also means that data will be integrated, related or mixed at some stage or research.  
The reasons for combining the two methods are various and differ from one 
researcher to another.  For example, Bryman (2006) classified two schemes for 
justifying the combination of quantitative and qualitative research based on a content 
analysis of 232 social science articles in which the two methods were combined (see 
Table 4.1).  
 
Table 4.1: The reasons for combining the qualitative and quantitative methods 
Scheme one 
Triangulation Convergence, corroboration, correspondence or results from different 
methods. In coding triangulation, the emphasis was placed on 
seeking corroboration between quantitative and qualitative data. 
Complementarity Seeks elaboration, enhancement, illustration, clarification of the 
results from one method with the results from another (Greene et. al, 
1989, p. 259) 
Development Seeks to use the results from method to help develop or inform the 
other method, were development is broadly construed to include 
sampling and implementation, as well as measurement decisions 
(Greene et al., 1989, p. 259) 
Initiation Seeks the discovery of paradox and contradiction, new perspective of 
frameworks, the recasting of questions or results from one method 
with questions or results from the other method (Greene et al., 1989, 
p. 259) 
Expansion Seeks to extend the breadth and range of enquiry by using different 
methods for different inquiry components (Greene et al., 1989, p. 
259) 
Scheme two 
Triangulation or greater 
validity 
Refers to the traditional view that quantitative and qualitative 
research might be combined to triangulate findings in order that they 
may be mutually corroborated. If the term was used as a synonym for 
integrating quantitative and qualitative research, it was not coded as 
triangulation. 
Offset  Refers to the suggestion that the research methods associated with 
both quantitative and qualitative research have their own strength 
weaknesses so that combining them allows the researcher to offset 
their weaknesses to draw on the strength of both. 
Completeness Refers to the notion that the researcher can bring together a more 
comprehensive account of the area of enquiry in which he or she is 
interested if both quantitative and qualitative are employed. 
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Process  Quantitative research provides an account of structures in social life 
but qualitative research provides sense of process. 
Different research 
questions 
This is an argument that quantitative and qualitative research can be 
each answered in different research questions. 
Explanation One is used to help explain findings generated by the others. 
Unexpected results Refers to the suggestion that quantitative and qualitative research can 
be fruitfully combined when one generates surprising results that can 
be understood by employing the other. 
Instrument development Refers to contexts in which qualitative research is employed to 
develop questionnaire and scale items- for example, so that better 
wording or more comprehensive closed answers can be generated. 
Sampling Refers to situations in which one approach is used to facilitate the 
sampling of respondents or cases 
Credibility Refers to suggestions that employing both approaches enhances the 
integrity of findings 
Context  Refers to cases in which the combination is rationalized in terms of 
qualitative research providing contextual understanding coupled with 
either generalizable, externally valid findings or broad relationships 
among variables uncovered through a survey. 
Illustration  Refers to the use of qualitative data to illustrate quantitative findings, 
often referred to as putting ‘meats on the bones’ of dry quantitative 
findings. 
Utility or improving the 
usefulness of findings 
Refers to a suggestion which is more likely to be prominent among 
articles with an applied focus, that combining the two approaches 
will be more useful to practitioners and others. 
Confirm and discover This entails using qualitative data generate hypotheses and using 
quantitative research to test them within a single project. 
Diversity of views This includes two slightly different rationales – namely, combining 
researchers’ and participants’ perspective through quantitative and 
qualitative research respectively, and uncovering relationships 
between variables through quantitative research while also revealing 
meanings among research participants through qualitative research. 
Enhancement or building 
upon 
quantitative/qualitative 
findings 
This entails a reference to making more of or augmenting either 
quantitative or qualitative findings by gathering data using a 
qualitative or quantitative research approach. 
Other/unclear  
Not stated  
Source: Adpted from Bryman (2006) 
 
Many influential researchers in the social and behavioural sciences present different 
paradigms, commonly called ‘pragmatism’ (Tashakkori and Teddlie, 1998).  However, 
the major concern for most of the pragmatism forms is the problem itself instead of 
the problem-solving methods or the solution that is used (Patton, 2002).  Therefore 
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the researchers use all the approaches necessary to understand the problem (Creswell, 
2009).  The merit of this method is the fact that a qualitative study will excel at telling 
the story, understanding complex social phenomena and assist the researcher in 
developing themes from the respondents’ point of view, while quantitative research 
will summarise a large amount of data for generalisation purposes. 
 
After determining to use mixed methods for this research, it is necessary to consider 
the strategy of inquiry that will be used (Creswell, 2009).  Three strategies have been 
illustrated in Creswell (2009) for mixed methods: sequential, concurrent and 
transformative procedures.  In sequential procedures, which is the strategy used in the 
current study, researchers may start with a qualitative method for exploratory 
purposes and then move towards a quantitative method using a large sample. Hence, 
the qualitative data collection techniques of this study will be conducted prior to the 
main quantitative survey to increase the validity of the research (Deshpande, 1983). 
Alternatively, researchers could begin with a quantitative method to test the theory, 
followed by a qualitative method to add depth of understanding.  
 
Finally, the major element in the research approach is to find specific methods of data 
collection and analysis. As mentioned earlier, this study will commence with a 
qualitative research phase in order to (1) gain deeper understanding of the topic, (2) 
refine and revise the preliminary research model and hypotheses and (3) purify 
measures for the questionnaire (Churchill, 1979).  In this phase, a qualitative method 
will be adopted, using content analysis of managers’ opinions about their decisions 
regarding brand image strategy for the pharmaceutical industry  This method was 
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previously adopted by several researchers (e.g. Deephouse, 2000; Bickerton, 2000; 
Bromley, 2001) to reach similar research objectives for corporate reputation studies.  
 
 
4.3 Research design 
 
4.3.1 The first phase – qualitative data collection 
 
Qualitative research is more suitable when there is a need for unfolding what 
surrounds a phenomenon (Carson et al., 2001). van Maanen (1979) defines qualitative 
methods as “an array of interpretative techniques which seek to describe, decode, 
translate and otherwise come to terms with the meaning, not the frequency, of certain 
more or less naturally occurring phenomena in the social world” (p. 520). 
 
A considerable number of studies have used qualitative methods to gain insights into 
the phenomena being investigated (e.g. Arnould and Price, 1993; Clesi et al., 1993; 
Thompson, 1997).  Therefore the researcher proposes to conduct exploratory research 
in the first phase to e gain insights into the studied phenomenon (Zikmund, 2003).  
The choice of exploratory research design for this first phase of the study was 
influenced by the nature of the research objectives.  With respect to the construct of 
the uses of corporate reputation, the researcher is looking for a better understanding of 
strategy, corporate communication and value creations between the firm and their 
customers before undertaking the quantitative research in the second phase.  
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The semi-structure interview was conducted as follows: First, a list of questions was 
designed on the basis of the reviewed literature and the research question, along with 
several open-ended questions (see Table 4.2). Second, a research framework was 
designed and provided to the interviewees. Third, the interviewees answered the semi-
structure interview questionnaire to gain a better perspective on the relationship 
between the hypotheses and related issues.  
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Table 4.2:  Research question, hypotheses, and qualitative questions 
RQ: How do (Taiwanese pharmaceutical) companies use their corporate reputation to develop brand image strategy?   
*RQ: Research question 
Hypotheses Supporting 
Literature 
Qualitative Questions 
H1:  A firm’s corporate 
reputation, which is used to 
create value, has a positive 
impact on a firm’s brand 
segmentation strategy. 
Ludlow (1997); 
Kaplan and Norton 
(2000); Pires and 
Aisbett (2003); 
Ulaga (2001); Priem 
(2007); Payne 
(2002); Kamakura 
and Novak (1992)  
 
Can you suggest the characteristics of value creation which tend to encourage the 
setting of brand segmentation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand segmentation strategy, what value creation characteristics (of 
the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
H2:  A firm’s corporate 
reputation, which is used to 
create value, has a positive 
impact on a firm’s brand 
differentiation strategy. 
Can you suggest the characteristics of value creation which tend to encourage the 
setting of brand differentiation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand differentiation strategy, what value creation characteristics (of 
the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
H3: A firm’s corporate 
reputation, which is used to 
create value, has a positive 
impact on a firm’s brand 
positioning strategy. 
Can you suggest the characteristics of value creation which tend to encourage the 
setting of brand positioning strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand positioning strategy, what value creation characteristics (of the 
uses of corporate reputation) would you put more attention to or would like to invest 
more? And why? 
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H4:  A firm’s corporate 
reputation, which is used as a 
strategic resource, has a positive 
impact on a firm’s brand 
segmentation strategy. 
 Birger Wernerfelt 
(1984) 
Can you suggest the characteristics of strategic resource which tend to encourage the 
setting of brand segmentation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand segmentation strategy, what strategic resource characteristics 
(of the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
H5: A firm’s corporate 
reputation, which is used as a 
strategic resource, has a positive 
impact on a firm’s brand 
differentiation strategy. 
Can you suggest the characteristics of strategic resource which tend to encourage the 
setting of brand differentiation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand differentiation strategy, what strategic resource 
characteristics (of the uses of corporate reputation) would you put more attention to 
or would like to invest more? And why? 
H6: A firm’s corporate 
reputation, which is used as a 
strategic resource, has a positive 
impact on a firm’s brand 
positioning strategy. 
Can you suggest the characteristics of strategic resource which tend to encourage the 
setting of brand positioning strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand positioning strategy, what strategic resource characteristics 
(of the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
H7:  A firm’s corporate 
reputation, which is used to 
communicate with its 
stakeholders, has a positive 
impact on a firm’s brand 
segmentation strategy. 
Reeves, 1961; 
Ogilvy, 1963;   
Dickson and Ginter, 
1987; Johar and 
Sirgy, 1989; Sirgy, 
1989;   Peltier and 
Schribrowsky, 1997; 
Vargo and Lusch, 
Can you suggest the characteristics of corporate communication which tend to 
encourage the setting of brand segmentation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in 
the firm to create brand segmentation strategy, what communication characteristics 
(of the uses of corporate reputation) would you put more attention to or would like to 
invest more? And why? 
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H8: A firm’s corporate 
reputation, which is used to 
communicate with its 
stakeholders, has a positive 
impact on a firm’s brand 
differentiation strategy. 
2004;    Flint, 2004; 
Hooley et al., 2004; 
Madhavaram et al., 
2005; Nandan, 2005 
 
Can you suggest the characteristics of corporate communication which tend to encourage the 
setting of brand segmentation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in the firm to 
create brand segmentation strategy, what communication characteristics (of the uses of 
corporate reputation) would you put more attention to or would like to invest more? And why? 
H9: A firm’s corporate 
reputation, which is used to 
communicate with its 
stakeholders, has a positive 
impact on a firm’s brand 
positioning strategy. 
Can you suggest the characteristics of corporate communication which tend to encourage the 
setting of brand segmentation strategy? And why?   
You, as a brand manager, who is responsible for controlling the quality of a brand in the firm to 
create brand segmentation strategy, what communication characteristics (of the uses of 
corporate reputation) would you put more attention to or would like to invest more? And why? 
Source: Develop by the author 
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4.3.2 Research setting: country and industry 
Having chosen a specific country for study, companies in a single industry were 
chosen as the setting for this research.  Certain considerations led to this choice.  
According to Baker (1994, p.109) and Bernard (2000, p.66), the selection of the 
research setting is an important part of any successful research project. Considerations 
about where to conduct research pose limitations on propositions generated from a 
theoretical model.  They set a boundary for generalisability. Moreover, an appropriate 
research setting can facilitate a researcher in effectively taking note of social 
phenomena, examining proposed theories and confidently drawing conclusions about 
empirical tests (Eisenhardt, 1989; Doktor et al., 1991).  
 
The review of literature shows that the majority of previous studies about the uses of 
corporate reputation have been completed in Western countries (the USA, the UK, 
Germany, Australia, Japan, Germany and the Netherlands, etc.) and concentrate less 
on investigating the topic in other regions (e.g. Asia, Africa, or South America), 
which have therefore limited any generalisability of theory (Boyacigiller and Adler, 
1991; Peng et al., 1991; Trompenaars and Hampden-Turner, 1998).  In order to bridge 
this gap, Taiwan, one of the most dynamic business environment countries in Asia, 
was selected as the setting of this study for several reasons. 
 
First, Taiwan is culturally similar to its Asian neighbours (e.g. China) and clearly 
different from Western countries (Hofstede, 1980; McGill, 1995), where most of the 
corporate reputation studies have been carried out. According to Hofstede (1980, 
pp.165–222), Taiwan is different from the USA, UK, and other developed countries 
on both uncertainty avoidance and individualism aspects.  Taiwan obtained a 
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relatively low score for uncertainty avoidance (i.e. has a higher tolerance for 
ambiguity, less emotional resistance to change, etc.) and a very low score for 
individualism (i.e. group decisions are considered better than individual decisions, 
employees have strong emotional dependence on company, etc.).  Moreover, the 
values and norms of Taiwanese consumers have strong roots in Chinese folk 
religion – which integrates Buddhist elements alongside a basically Taoist base 
(Taiwan’s major religion adopted by more than 90 per cent of its population) (Taiwan 
Yearbook, 2006; CIA world factbook).  An important element in the philosophy of 
Buddhism, the “anatta” or “no-self”, helps differentiate Taiwanese consumers from 
those in Western countries who mainly are Catholic or Protestant (Wattanasuwan and 
Elliot, 1999). It is also stated in Child and Tsai (2005) that Taiwan has developed to a 
stage where the key stakeholders are very knowledgeable.  Moreover, Taiwan is one 
of the fastest-growing economies of the newly industrialized countries.  Much of its 
growth has come from multinational companies. 
 
Second, Taiwan is also home to the regional headquarters of many multinational 
companies in Asia.  It also has a language and cultural advantage, helping 
multinational companies to carry out their ownership advantage, internal 
nationalisation advantage and location-specific advantage when they try to invest in 
Chinese market.  Therefore, it is possible for multinational companies to use Taiwan 
as a platform for developing their business in Chinese or other Asian markets.  
Moreover, Taiwanese foreign exchange reserves consist of USD$266 billion and there 
is a high percentage of experienced workers and researchers in Taiwan.  
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Third, Taiwan has a high credit rating internationally. Taiwan has a stable and 
dynamic business environment (Economist Information Unit; EIU, 2006).  According 
to the international credit rating company Standard and Poor, Taiwan’s sovereign 
credit was rated at level of AA, which is better than other Asia countries (i.e. Japan – 
AA; China – BBB; South Korea – A-; Malaysia – BBB+).  The above statements 
suggest that Taiwan has good financial stability.  Moreover, in 2006, Taiwan is 
ranked as number three in Asia and number six in the world for its overall business 
environment, as reported by the Business Environment Risk Intelligence (BERI) 
when evaluating the risks attached to an investment environment. This is just next to 
Switzerland, Singapore, Holland, Norway and Japan.  Here are some comments from 
two different company general managers in Taiwan: 
 
“By contrast to China, the Taiwan authorities adopt a much more 
uniform and universalistic approach to managing environmental 
issues. The institutional constraints in Taiwan are stringent and less 
open to negotiation. This reflects the fact that Taiwan has been 
under western (especially American) influence for a longer period 
of time and also that it is wealthy enough to address the cost of 
dealing with environmental problems. The tough enforcement of 
environmental regulations has in fact encouraged some enterprises 
to relocate, often to China and Southeast Asian countries.” [General 
Manager1, Taiwan] 
 
“As a long experience in international business competition and 
influences, Taiwanese enterprise is going towards to international 
market. It has developed an operational model about production 
and selling as follows: it used to stress on the production for 
exporting, emphasising on the strategy of light, thin, short, and 
small as bearing a strategy to sell high volume with low profit 
margin.  Nowadays, it became a combination supply chain 
production which possesses a more accurate, more profitability and 
vertical division of labour supply chain associate production.  
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Moreover, it enforce the high adding value on the product and 
brand marketing strategy, therefore it has successfully enter the 
international market.  
 
It is pointed out in the data of Taiwanese ministry of economic 
affairs that in the international business, Taiwanese small and 
middle businesses have developed a tight relationship with the 
international big company and forms an international marketing 
network.  The Taiwanese business competitive advantage is based 
on that the business can become a first supplier in the international 
market. Moreover, they develop the ability to gain the profit base on 
not only the first-line supplier but also possess the ability of 
invention in advance.  Apart from this, the relationship between 
Taiwanese businesses and international brand becomes a closely 
related strategy union which maybe is a result of the effort on R&D 
that Taiwanese businesses worked on.  Moreover, according to 
Fortune previous years statistics, multinational corporation from 
the developing countries are increasing and becoming a new power, 
which become a parallel situation with the multinational 
corporations from Europe, American, and Japan (Taiwan Yearbook 
2006; CIA - The World Factbook)” [General Manager2, Taiwan].   
 
Following the selection of Taiwan, companies in a single industry were chosen as the 
setting for this research.  Certain considerations led to this choice.   First, the single-
industry design provided the researcher with a better control over market and 
environmental anomalies (Conant et al., 1990) and industry effects (Rao, 1994).  It is 
because a single industry would be more focused on a particular manufacturing 
procedure, ways of marketing their goods and keeping their customer relationships. 
Second, it was desirable to study a setting in which: (1) the three dimensions of the 
uses of corporate reputation could be explained and clearly measured; (2) corporate 
reputation played an important role in the general operations and the survival of 
businesses; (3) previous research had identified the presence of various types of 
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strategic use of a firm’s intangible assets, communication and value creation activities, 
and (4) reliable and adequate data were available for the purification of measurement 
scales and hypothesis testing.   
 
Given the requirements above, the pharmaceutical industry was chosen because 
reputation building is particularly important for it:  since medicines are considered 
vital for human life, corporate reputation thus plays an important role in the general 
operations and the survival of business.  Furthermore, a pharmaceutical firm can use 
its reputation to signal its customers about its new technology, the standards they 
require or just to build trust within its customers.  As a result they might get a higher 
price for their products.  The managers in this industry make mainly strategic 
decisions on the use of a firm’s intangible assets, its corporate communication and 
value-creation activities.  
 
 
4.4 Scale Development and Validation 
 
The scale development procedure included four major steps (see Figure 4.2). The first 
step involved specifying operational definitions and dimensions of focal constructs to 
help the subsequent generation of items hypothesised refer to each dimension. The 
use of different definitions and dimensions constrains comparison and collection of 
the findings (Churchill, 1979). A literature search helped achieve this step. Existing 
scales and related domains were reviewed, and items from various marketing and 
management journals (e.g, Corporate Reputation Review, Journal of Marketing, and 
Academy of Management Journal) were adopted. 
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Figure 4.2: Steps in measurement scales development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The second step involved creating additional measurement items using semi-
structured interviews with experts. The expert interviews included showing the 
conceptual framework to respondents and asking questions about the measurement 
items of each construct. Examples of questions included “What do you think are 
important aspects to the uses of corporate reputaiton, and why?” and “What items on 
this page do you think are not relevant to value creation, and why?” The face validity 
and content validity were also examined in this step (Netemeyer et al., 2003, p. 16).  
 
The third step involved subjecting the items generated in the previous phase to a pilot 
test as an item-trimming procedure (DeVellis, 2003). Questionnaires containing all 
potential items were distributed through a web-survey system to the managers in the 
2) Measurement Items 
Generation 
1) Specifying 
Definition and Domain 
3) Purifying 
Measurement Items 
4) Validating 
Measurement Scales 
Techniques Employed 
• Literature Search including the 
review of existing related scales 
• Literature Search 
• Experience Survey  
        (Interview with experts) 
• Coefficient Alpha 
• Item-to-total correlation 
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sample companies in the Taiwanese pharmaceutical industry. From their experiences 
with their companies, respondents rated items on the scale from 1 (“disagree”) to 5 
(“agree”). I translated items extracted from English-based journals and dialogues with 
English-speaking experts in the previous two steps into Mandarin Chinese, and an 
expert in the English language back-translated them into English (Brislin, 1970). 
Before the final questionnaires were completed, respondents were randomly asked to 
point out any item that was either ambiguous or difficult to answer (Kohli et al., 1993). 
 
Subsequently, coefficient alphas and item-to-total correlations were computed to 
check for the reliability of measurement scales (Churchill, 1979; DeVellis, 2003). A 
set of questionnaires along with purified items from this step was edited and prepared 
for the main survey (Lagas, 2000; Long-Tolbert, 2000; Algesheimer et al., 2005). 
 
In the fourth step, following the main survey, purified measurement scales were sent 
to confirmatory factor analysis (CFA) as a method to confirm the scales. This 
procedure was employed to examine scale properties, such as reliability, and construct 
validity (convergent and discriminant validity). The tests based on the data from the 
main survey were performed in the PLS software. A further discussion about the CFA 
technique appears in section 4.5.1, and the results of the literature search, qualitative 
studies, and the pre-test also are presented. 
 
4.4.1 Literature search and existing measurement scales 
 
The main objectives of conducting literature search and qualitative studies are to 
identify the domains of measurement scales and generate items for each of them. 
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Domains of constructs were derived from existing related concepts and scales in 
various academic journals (see complete list in Appendix 1).  In general, there are 
various developed measurement scales, all of which are a Likert type with marketing 
capabilities and operating performance. The researcher identified three domains for 
the construct of the uses of corporate reputation (value creation, strategic resources 
and corporate communication), and three domains for the construct of brand image 
strategy (brand segmentation, brand differentiation and brand positioning).  
According to past articles (e.g., Ashforth and Gibbs, 1990; Wayne and Ferris, 1990; 
Suchman, 1995; Foreman and Whetten, 2002), the domains of all concepts can be 
classified in many different ways. While not comprehensive, the domains of 
constructs in this research were identified and integrated so as to be as concise as 
possible. Examples of domains, including their corresponding items, are exhibited in 
Table 4.3. 
 
The uses of a corporate reputation construct were found to be named and 
operationalised differently in the existing literature. The majority of articles focused 
on specific forms of support such as value creation (e.g. Milgrom and Roberts, 1986; 
Beatty and Ritter, 1986; Wong and Saunders, 1993; Herbig et al., 1994; Devine and 
Halpern, 2001; Eberl and Schwaiger, 2005), strategic resources (e.g. Barney, 1986; 
Cornell and Shapiro, 1987; Weigelt and Camerer, 1988; Dierickx and Cool, 1989; 
Roberts and Dowling, 2002), and corporate communication (e.g. Lerbinger, 1965; 
Grunig et al., 1992; Gray and Balmer, 1998).  
 
Wong and Saunders (1993) researched value creation, which has been classified into 
four categories: (function/instrumental value, experiential/hedonic value, 
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symbolic/expressive value, cost/sacrifice value). These items of value creation, 
developed fully by Wong and Saunders (1993) were taken by the researcher for 
examination.   
 
Strategic resources have been also found to be named differently in existing literature: 
namely competitive advantage, capability to influence competitors’ actions, strategies 
or decision making. The researcher developed items for strategic resources based on 
competitive advantage scales/items (Wong and Saunders, 1993), such as efficient 
sales and marketing, advanced R&D, early market entry and large cash resources. 
 
The construct of corporate communication has been poorly addressed in existing 
literature.  However, it has been addressed collectively (e.g., Lerbinger, 1965; Grunig 
et al., 1992; Gray and Balmer, 1998) with a similarity of terms, such as: corporate 
reputation as used to communicate a firm’s social responsibility activities to 
stakeholders within the business environment (Lerbinger, 1965; Grunig et al., 1992). 
The corporate reputation is also used as a means of shaping the perception of 
shareholders and stakeholders (Fombrun and Shanly, 1990), used as a tool for 
building a relationship between the firm and the customers (Perrow, 1961a; Perrow, 
1961b; Kreps and Wilson, 1982; Milgrom and Roberts, 1982; Shrum and Wuthnow, 
1988), used as a means of influencing consumer choices (Chibnall, 1977; Hall et al., 
1978; Fombrun and Shanley, 1990; McNair, 1996; Landon and Smith, 1997; Sabate 
and Puente, 2003; Shkolnikov et al., 2004; L’Etang, 2006; Srivoravilai, 2006), and 
court better reputations among customers (Fryxell and Wang, 1994; Brammer and 
Pavelin, 2006; Puente et al., 2007). 
   
` 
107 
 
In contrast, previous research has examined the three constructs of brand image 
strategy under the names brand segmentation (Dickson and Ginter, 1987), brand 
differentiation (Dickson and Ginter, 1987), and brand positioning (Wong and 
Saunders, 1993).  Dickson and Ginter (1987) indentify the domains of the brand 
segmentation construct and brand differentiation.  Brand segmentation and brand 
differentiation are constructed with items adopted from Dickson and Ginter (1987), 
and brand positioning items are constructed with items adopted from Wong and 
Saunders (1993). The construct items appear in Table 4.3. 
 
Table 4.3: The domains and items of constructs in extent literature  
Construct Examples of Domains and Items Major 
References 
Value 
creation (25) 
Function/Instrumental Value (7) 
 Our firm’s corporate reputation promises good quality 
products and service to customers. 
 Our firm competes by creating useful products. 
 Our firm competes by creating the correct product attributes 
for its targeted customers. 
 Our firm competes by appropriate performances. 
 Our firm competes by appropriate outcomes. 
 Our firm’s value-chain activity is consistent with functional 
value creation. 
 Our firm’s resource allocation is consistent with functional 
value creation. 
 
Experiential/Hedonic Value (6) 
 Our firm competes by appealing to the senses. 
 Our firm competes by creating appropriate emotions (fun, 
pleasure, excitement, relaxation, etc.) 
 Our firm competes by facilitating social relationships (bonds, 
attachments, and togetherness). 
 Our firm competes by creating epistemic value (knowledge, 
novelty, fantasy). 
 Our firm’s value-chain activity is consistent with experiential 
value creation. 
 Our firm’s resource allocation is consistent with experiential 
value creation. 
 
Symbolic/Expressive Value (5) 
 Our firm competes by enhancing its customers’ self-identity. 
 Our firm competes by enhancing its customers’ self-concept. 
 Our firm competes by enhancing its customers’ self-worth. 
 Our firm competes by creating personal meaning. 
 Our firm competes by facilitating self-expression. 
Wong and 
Saunders (1993) 
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Cost/Sacrifice Value (7) 
 The corporate reputation of our firm helps to reduce 
transaction costs. 
 Our firm competes by offering economic value (low prices, 
value in use, life costs). 
 Our firm competes by simplifying the purchasing process for 
its consumers (ease of use, ease of doing business, simplicity, 
availability, accessibility). 
 Our firm compete by enabling ease of use of its products 
(time, effort, energy). 
 Our firm compete by minimizing customer risk (personal, 
technological, strategic).  
 Our firm’s value-chain activity is consistent with symbolic 
value creation. 
 Our firm’s resource allocation is consistent with symbolic 
value creation. 
Wong and 
Saunders (1993) 
Strategic 
value or 
resource (5) 
 
 In our organization, corporate reputation serves as a 
competitive advantage. 
 Our firm’s corporate reputation sends a strong signal to its 
customers. 
 Our firm’s corporate reputation implies efficient sales and 
marketing. 
 Our firm’s corporate reputation implies its advanced R&D. 
 Our firm’s corporate reputation implies that we are able to 
enter markets early. 
Wong and 
Saunders (1993) 
Corporate 
communicati
on (3) 
 Our firm’s corporate reputation shapes the perceptions of 
shareholders and other stakeholders. 
 Our firm’s corporate reputation builds a relationship between 
the firm and its customers. 
 Our firm’s corporate reputation influences consumer choices. 
 
Segment 
development 
(5) 
 Our corporate brand strategy has one particular form of 
demand function modification. 
 Our corporate brand strategy requires product differentiation. 
 Our corporate brand strategy requires changes in point 
distribution location. 
 Our corporate brand strategy requires changes in importance 
attached to a non-physical product. 
 Our corporate brand strategy requires changes in importance 
attached to a physical product. 
Dickson and 
Ginter (1987) 
Product 
Differentiati
on (7) 
 How our corporate brand is perceived varies according to 
whether consumers have experienced our products. 
 How our corporate brand is perceived varies by word of 
mouth. 
 How our corporate brand is perceived varies by promotion. 
 Our corporate brand is actually created differently by product 
characteristics. 
 Our corporate branding maybe directed at different market 
segments. 
 Our corporate brand may utilize physical product 
characteristics. 
 Our corporate brand may utilize non-physical product 
characteristics. 
Dickson and 
Ginter (1987) 
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4.4.2 Generation of Measurement Items   
 
Following the literature search, semi-structured interviews with experts were 
conducted. Following Miles and Huberman (1994, pp.10–11), the researcher extracted 
items from interview data by using data reduction and display functions in Nvivo 7 
software. A coding scheme was designed based on literature and transcripts. Data 
were grouped according to relevant codes. Items were subsequently drawn from each 
group and compared with those obtained from literature (see Table 4.3). The profile 
of interviewees and details about interviews are presented in Table 4.4 as follows: 
 
Table 4.4: The list of respondents and their titles 
Intervie
wee 
The 
Respondent 
The Organisation Duration 
(minutes) 
Interview 
Date 
1 Vice Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company A) 
90 November, 
2009 
2 
 
Sales Manager A Japanese original medicine company 
Taiwan branch (company B) 
120 November, 
2009 
3 Chairman A Taiwanese local pharmaceutical 
manufacturing company (company C) 
60 November, 
2009 
4 Manager 
(Management) 
A Taiwanese local pharmaceutical 
manufacturing company (company D) 
90 November, 
2009 
Competitive 
position (8) 
 Our firm’s corporate brand positioning strategy signifies high 
quality to its customers.  
 Our firm’s corporate brand positioning strategy signifies 
better product performance to its customers. 
 Our firm’s corporate brand positioning strategy is to achieve 
a higher frequency of advertising. 
 Our firm’s corporate brand positioning strategy involves a 
long distribution chain.  
 Our firm’s corporate brand positioning strategy is to provide 
a much better service to its customers.   
 Our firm’s corporate brand positioning strategy tries to fulfil 
the basic needs of our customers. 
 Our firm’s corporate brand positioning strategy tries to fulfil 
the basic needs of our customers. 
 Our firm’s corporate brand positioning strategy tries to target 
upmarket audiences. 
Wong and 
Saunders (1993) 
Source: Adapted from previous literature as stated 
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5 Chief Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company E) 
90 November, 
2009 
6 
 
Chief Executive 
Officer 
A Taiwanese local pharmaceutical 
manufacturing company (company F) 
90 November, 
2009 
7 
 
Chief Executive 
Officer 
 
A commercial agent selling European 
imported raw material medicine and 
local generic medicine (company G) 
120 November, 
2009 
8 Marketing 
Department 
Manager 
The largest Taiwanese local 
pharmaceutical manufacturing company 
(company H) 
90 November, 
2009 
9 Sales Manager A Japanese original medicine company 
Taiwan branch (company I) 
90 November, 
2009 
10 
 
Chairman A B2B marketing company selling 
European imported medicine and local 
generic medicine (company J) 
90 November, 
2009 
11 Sales Manager 
 
A leading American original medicine 
company Taiwan branch (company K) 
90 November, 
2009 
12 
 
Chairman 
 
A commercial agent selling European 
imported raw material medicine and 
local generic medicine (company L) 
50 November, 
2009 
13 
 
Sales Manager A Japanese original medicine company 
Taiwan branch (company M) 
60 November, 
2009 
14 
 
Sales Manager A Taiwanese local pharmaceutical 
manufacturing company (company N) 
60 November, 
2009 
Resource: Developed by the researcher 
 
The second step of Churchill’s (1979) paradigm is to generate sample items which 
capture the domain as specified.  It includs generating additional measurement items 
by using, for example, literature searches, experience surveys, exploratory research, 
critical incidents and focus groups (Churchill, 1979).  The researcher plans to employ 
a combination of literature search and exploratory research which will include semi-
structured interviews with the pharmaceutical company managers.  The items 
representing the construct and their sub-components have been regenerated for the 
initial item pool from the marketing literature (see Table 4.2).  However, the issues 
which are expected to emerge from the exploratory research will be integrated for 
generating the items.  
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In this study, each construct is a multi-item scale.  Churchill (1979, p. 66) suggests 
that single items usually have considerable “uniqueness or specificity in that each 
item seems to have only a low correlation with the attribute being measured and tends 
to relate to other attributes as well.”  In addition, single items also have considerable 
measurement error; they produce “unreliable responses in the sense that the same 
scale position is unlikely to be check in successive administrations of an instrument” 
(Churchill, 1979, p. 66).         
 
The initial measurement for the dimensions of the uses of corporate reputation is 
mainly based on the work by Wong and Saunders (1993).  This study covered the 
relationship between business orientation and performance. Their results are based on 
structured interviews conducted with 90 chief executives of companies all operating 
in the United Kingdom.  Data was gathered on the business orientations and broad 
strategy directions of the firms using a battery of 45 items based on Kotler (1991) and 
O’Shaughnessy (1984) examining the following seven dimensions: (1) strategic 
objectives, (2) strategic focus, (3) target markets, (4) competitive targets, (5) 
differential advantage, (6) marketing mix emphasis and (7) current competitive 
position.  Moreover, organisational traits were measured with the McKinsey 7-S 
framework as the basis for the following six dimensions: 5) (1) strategy, (2) structure, 
(3) systems, (4) style and (5) staff (Wong and Saunders, 1993). The items regarding 
corporate communications originate from van Riel (2000).  Items of the other 
construct about brand image strategy are adapted from original items in the studies by 
Park et al. (1986), Dickson and Ginter (1987), Roth (1995) and Hsieh (2001).  More 
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details about the domains and items of constructs in existing literature can be found in 
Table 4.3. 
 
According to Carson et al. (2001), when there is the need to clarify circumstances that 
surround a phenomenon, conducting qualitative research tends to be suitable.  Several 
studies on the uses of corporate reputation (e.g. Clayman, 1987; Weigelt and Camerer, 
1988; McGuire et al., 1990; Shefrin and Statman, 1995, 1997; Nanda et al., 1996; 
Antunovich and Laster, 1998; Groenland, 2002; Schwaiger, 2004) use qualitative 
methods to gain insight into the investigated phenomena.  The researcher, therefore, 
plans to conduct exploratory research for the first phase to gain insights into the 
studied phenomenon.   
 
The objective of this study is to investigate the effects of the uses of corporate 
reputation on brand image strategy in the pharmaceutical industry from the 
managerial perspective.  Therefore, this research was conducted through in-depth 
interviews with managers in the pharmaceutical industry in Taiwan.  Fourteen brand 
managers from pharmaceutical companies in Taiwan were used as respondents.  The 
respondents were selected because they have experience in implementing brand 
segmentation and positioning strategies in their pharmaceutical company. They were 
able to provide information about how their firms’ current situations affect corporate 
strategy. 
  
The 14 interviewees were selected from companies within the Taiwanese 
pharmaceutical industry. The following section provides a brief introduction of each 
interviewee. The interviewed manager from company A is a vice executive officer 
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with more than 20 years’ experience in big pharmaceutical companies in Europe (e.g., 
Germany, Holland). The manager in company B is now a sales manager in the 
Japanese original company with more than 20 years’ prior experience working at 
Pfizer in Taiwan as a sales director and marketing manager. The interviewee from 
company C is the chairman of the company, which is a local pharmaceutical company 
with high-quality supply-chain management. The company, which has sought 
international cooperation and has been approved by the Pharmaceutical Inspection 
Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/S) 
international standard, is the first Taiwanese company to sell medicine into the 
European market. The interviewee from company D, the largest local pharmaceutical 
company in Taiwan, is the speaker of the company who has served in that capacity 
for more than 30 years. Company D is well known for its effort in building corporate 
social responsibility and in providing feedback to the local area and society with 
social services.  
 
The interviewee in company E is the CEO of the company. Company E is a local 
Taiwanese pharmaceutical company with 40 years’ experience in pharmaceutical 
manufacturing and selling. The interviewee from company F is also the company’s 
CEO. Company F is a medium-sized pharmaceutical company with more than 80 
years of pharmaceutical experience and is well known for its high-quality products. 
The interviewee from Company G is the CEO of the company. Company G’s main 
practice is distributing imported and locally produced medicine to hospitals, both 
regular and teaching. The interviewee from company H is the marketing department 
manager. Company H is the largest Taiwanese local pharmaceutical manufacturing 
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company that produces its own patent medicine as well as generic medicine; the 
company holds the leading position in the Taiwanese pharmaceutical market.  
 
The interviewee from company I, which is a local branch of a Japanese original 
medicine company situated in Taiwan for more than 40 years, is a sales manager. 
Company I hosts international conferences and seminars and is well connected with 
research in academia and practice. The interviewee from company J is the chairman 
of the company. Company J’s business is mainly importing European original 
medicine and health care products, such as vitamins, ointment and hand cream. The 
interviewee from company K, which is a branch of a leading U.S. original medicine 
company in Taiwan, is a sales manager. The original company is among the largest 
pharmaceutical companies in the world and is advanced in R&D and sales. It was the 
first foreign company to be approved to build a factory in Taiwan. The interviewee 
from company L is also the company’s chairman. Company L’s business area is 
mainly importing medicinal material, turning the material into medicine and then 
selling the medicine to hospitals. Interviewee from company M, which is a branch of 
a Japanese original medicine company in Taiwan, is a sales manager. The core value 
of company M is its R&D; it has invented many patent medicines over several 
decades, though it specialises in diabetics and cardiovascular patent medicines. The 
interviewee from company N, which is a local Taiwanese pharmaceutical 
manufacturing company, is a sales manager. The firm mainly focuses on injection 
medicine products. The background information of each interviewee and the company 
to which he or she belongs appears in Table 4.5. 
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Table 4.5: Qualitative interviewee and belonged company background information 
 
No. 
 
Title of the 
interviewee 
 
Company name 
 
Business type 
Number 
of 
employee 
Company 
size: Capital 
or Turnover 
1 Vice 
Executive 
Officer 
Taiwan Biotech co. Ltd. - 
A Taiwanese local 
pharmaceutical 
manufacturing company 
(company A) 
Producing western medicine, medical 
medicine, medical supplies product, 
healthy food, import and export trading, 
offer medical information service and 
health care service. 
700 Capital:  
US$33,000,00
0  
2 Sales 
Manager 
FUJISAWA TAIWAN 
CO., LTD. - A Japanese 
original medicine 
company: Taiwan branch 
(company B) 
Producing antibiotics powder, injection, 
capsule and pills.  
NA Capital: 
US$12,000,00
0 
3 Chairman Gentle Pharma - A 
Taiwanese local 
pharmaceutical 
manufacturing company 
(company C) 
The biggest producing company of 
Taiwanese antibiotics. 
80 Capital: 
US$5,000,000 
4 Management 
Manager  
Yung Shin Phar. IND. 
Co., Ltd - A Taiwanese 
local pharmaceutical 
manufacturing company 
(company D) 
Producing human medicine, animal 
medicine, facial skincare, healthy food, 
API (Active Pharmaceutical 
Ingredients), Refined Chemicals, and 
medical supplies products 
 
1100  Capital: 
US$84,579,00
0 
5 Chief 
Executive 
Officer 
Swiss Pharmaceutical Co 
Ltd. - A Taiwanese local 
pharmaceutical 
manufacturing company 
(company E) 
Producing, processing and selling 
western medicine and raw material, 
animal medicine, Chinese medicine, 
agricultural pesticides. Trading medicial 
supplies products.  
 
190 Capital: 
US$5,200,000 
6 Chief 
Executive 
Officer 
Ying Yuan 
Pharmaceutical co., Ltd - 
A Taiwanese local 
pharmaceutical 
manufacturing company 
(company F) 
R&D and selling NHI medicine, human 
medicine, animal medicine.  
160 Capital: 
US$2,700,000 
7 Chief 
Executive 
Officer 
 
Wide Pharmaceutical - A 
commercial agent selling 
European imported raw 
material medicine and 
local generic medicine 
(company G) 
Exclusive distribute local pharmaceutical 
products and serve as a general agent of 
European medicine products 
25 Turnover: 
US$2,500,000 
 
8 Marketing 
Department 
Manager 
CCPC - The largest 
Taiwanese local 
pharmaceutical 
manufacturing company 
(company H) 
R&D and Generation of labor on 
medicine and medical products. Serve as 
medical brand agent and channel 
marketing and provide home care 
service.  
1000  Capital: 
US$100,000,0
00 
9 Sales 
Manager 
Tanabe Pharmaceuticals 
Taiwan, Ltd. - A 
Japanese original 
medicine company: 
Taiwan branch (company 
I) 
Producing and selling NHI medical and 
medicine products, and healthy food. 
And sell as a consignee for any kind of 
healthy food.  
170 Capital: 
US$3,000,000 
10 Chairman Weal-Chance Trading 
Co. Ltd. - A business-to-
business marketing 
Serve as a wholesaler of western and 
Chinese medicine. Quoted price, bid and 
sell local and foreign products. Act as an 
NA Capital: 
US$250,000 
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In conducting the interviews, questions based on the measurement items of each 
construct were asked.  For example, for the uses of corporate reputation construct, 
questions such as: “What do you think are the uses of corporate reputation 
dimensions?” and “Why?” were employed. More details about the questions can be 
found in Appendix 2.  Appendix 2 shows how the qualitative questions are related to 
the research questions and the research hypotheses.  It should be noted that content 
and face validity 3are also examined in this step (Netemeyer et al., 2003). In this step, 
                                                        
3
 The definition of several types of validity will be provided later in the last section of this chapter.  
company selling 
European imported 
medicine and local 
generic medicine 
(company J) 
agent, import and export healthy food, 
customics, raw material medicine 
products and toy.  
11 Sales 
Manager 
 
Pfizer (Taiwan) Co. Ltd. 
- A leading U.S. original 
medicine company: 
Taiwan branch (company 
K) 
R&D and producing all kinds of western 
medicine products. 
400 Capital: 
US$9,100,000 
12 Chairman 
 
Yang De 
Pharmaceutical Co Ltd. - 
A commercial agent 
selling European 
imported raw material 
medicine and local 
generic medicine 
(company L) 
Exclusive distribute local pharmaceutical 
products and serve as a general agent of 
European medicine products 
10 Turnover: 
US$1,000,000 
 
13 Sales 
Manager 
Takeda Pharmaceuticals 
Taiwan, Ltd. - A 
Japanese original 
medicine company: 
Taiwan branch (company 
M) 
Producing and selling medine and food 
additives. Import foreign mother 
company and related enterprise products; 
buy raw material, finished products, and 
semi-finished products to provide forign 
Mother Company and related enterprises. 
Import and export animal medicine, 
forage and forage additives. Import, 
export and sell environmental sanitation 
medicine.  
NA Capital: 
US$3,000,000 
14 Sales 
Manager 
Nang Kuang 
Pharmaceutical Co. Ltd. - 
A Taiwanese local 
pharmaceutical 
manufacturing company 
(company N) 
Producing western medicine 
product,  especial ly medicial drop 
and inject ion products.  
300 Capital: 
US$21,000,00
0  
Note: NA = not available. The company identification information is for the examiners only and will be 
deleted from the published thesis. 
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a diagram (see Figure 3.1) representing the conceptual framework and a table of items 
(see Table 4.2) were shown to the respondents.  The respondents were asked if they 
agreed with the list of existing items, or whether they could suggest additional items.  
 
The information from the interviews was integrated with the items regenerated from 
the literature.  The questionnaire statements for these items were constructed by the 
researcher.  Afterwards, the first draft of the quantitative questionnaire was designed. 
 
In general, the respondents agreed with the existing items shown during the 
interviews; nobody suggested that any of the constructs be deleted. Rather, a few 
additional items were suggested for insertion into relevant scales. Three major issues, 
which were raised by the interviewees, are going to be stated one by one in the 
following section. 
  
 
4.5 Pilot Test 
 
4.5.1 Measurement Scales of Corporate Background Variables 
 
Measurement Scales of four corporate background variables known to affect 
corporate reputation were adapted from existing literature and subjected to tests as 
explained below. 
 
Corporate history  A measurement scale for corporate history was developed 
according to Balmer and Greyser (2006). The scale ranges from “less than 10 years” 
` 
118 
 
to “more than 81 years” of history. Since this data is an objective indicator, reliability 
and validity tests were not needed. 
 
Operating performance  Operating performance can be measured in different ways. 
In this study, since the researcher could not acquire financial figures of all private 
companies, subjective performance indicators were used instead in hypotheses testing 
as recommended by Dess and Robinson Jr. (1984) and Covin and Slevin (1989). 
Turnover was the item used to measure this construct. 
 
Corporate characteristics  A measurement scale for corporate characteristics in this 
study was adapted from the qualitative interview. The scale has “manufacturing + 
sales (America original)”, “manufacturing + sales (European original)”, 
“manufacturing + sales (Asia [e.g. Japan, South Korea, India] original)”, “Dealer for 
America original company products”, “Dealer for European original company 
products”, “Dealer for Asia original company products”, “Local (Taiwan) 
manufacturer + sales”. Respondents were asked to pick which one their business 
belongs to. Since this data is an objective indicator, reliability and validity tests were 
not needed. 
 
Firm size  Size has been operationalised in various ways in the literature. In this study, 
number of staff was used as an indicator of size. Note that a monetary indicator such 
as total assets was not employed because of the limited availability of data. Since this 
data is an objective indicator, reliability and validity tests were not undertaken. 
 
 
` 
119 
 
4.5.2 Sampling 
 
Since it is not possible to collect data from all brand managers, the researcher 
employed a sampling method to initiate a sample of pharmaceutical managers.  
Sampling techniques can be divided into the two broad categories of probability and 
non-probability samples (Churchill, 1996).  In survey research, a probability sampling 
method is generally more appropriate than a non-probability one because “the 
resulting sample is likely to provide a representative cross-section of the whole” 
(Denscombe, 2002, p. 12). Moreover, researchers can make an unambiguous 
statement about “the accuracy and validity of the finding from the survey by 
referencing to the degree of error and/or bias which may be present in it as measured 
by well understood statistical methods” (Baker, 2002, p. 106).  In a probability 
sample, “each member of the population has a known, nonzero chance of being 
included in the sample.  The chance of each member of the population being included 
in the sample may not be equal, but everyone has probability of inclusion” (Churchill, 
1996, p. 479).  Conversely, with non-probability samples, “there is no way of 
estimating the probability that any population element will be included in the sample” 
(Churchill, 1996, p. 479).    
 
However, because of data protection, it is likely that the pharmaceutical companies 
may not allow the researcher to access the staff database.  In this case, the research 
could neither identify nor enumerate sampling units.  Therefore, a probability-based 
sampling could not be conducted.  However, when a probability-based sampling 
cannot be conducted due to some limitations, a non-probability sampling technique is 
considered to be an appropriate choice although the generalisability of statistical 
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results can be relatively limited (Baker, 2002; Denscombe, 2002).  Examples of non-
probability based sampling techniques include convenience samples, judgement 
samples and quota samples (Churchill, 1996).   
 
This study will use a judgement sample as a non-probability-based sampling 
technique.  The key feature of this judgement is that population elements are 
purposely selected because it is believed that they are representative of the population 
of interest, and they are expected to serve the research propose (Churchill, 1996).  
With a judgement sample, the researcher is not interested in sampling a cross-section 
of opinion but rather in sampling those who can offer some perspective on the 
research question (Churchill, 1996).  Therefore, the researcher plans to distribute a 
questionnaire to pharmaceutical managers because they tend to be familiar with brand 
strategy decision making within the pharmaceutical industry.        
 
4.5.3 Pretest Scale Items 
 
Table 4.6: Pre-test Data Profile 
Details about Questionnaires and Respondents 
No. of Distributed Questionnaires 20 sets 
No. of Returned Questionnaires 16 sets (80 % response rate) 
Pharmaceutical managers and above 100 % of total respondents 
 
Corporate history between 11 to 30 years 81.25% 
Corporate history between 30 to 50 years 18.75% 
  
Size more than 100 staff (include) 25 % 
Size less than 100 staff (exclude) 75 % 
 
Local company (manufacturing + sales ) 43.75 % 
Original company or dealers of European or 
American pharmaceuticals 
56.25 % 
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Turnover over 150 million TW dollars 43.75 %  
Turnover less than 150 million TW dollars 56.25 % 
*(1 British pound = 1.45 US dollar = 50 TW dollars) 
Source: Developed by the author 
 
Participants were recruited from managers in the Taiwanese pharmaceutical industry. 
Eighty per cent of distributed questionnaires (n=16) were returned online to the 
researcher. 
 
All respondents held the position of manager or above. The majority of the companies 
(81.25 per cent) the respondents have a 31–50-year corporate history. The majority of 
the companies (75per cent) have fewer than 100 staff. More than half (56.25 per cent) 
are original companies or dealers of European or American pharmaceuticals, and 
more than half (56.25 per cent) of the companies have less than 150 million TW 
dollars turnover. Respondents were also randomly asked to indicate their opinion on 
the clarity and comprehensibility of questionnaire items (Bearden et al., 2001; Kohli 
et al., 1993). 
 
4.5.4 Measurement Purification  
 
The third step of Churchill’s (1979) paradigm involves reliability and validity 4testing 
for the scale items because it is very important to ensure that the data which 
researchers plan to collect is meaningful and accurate.  Therefore, the researcher plans 
to use expert judgement (managers or so-called practitioners) and the application of 
the first draft of the questionnaire to a sample of individuals – i.e. a pilot study 
                                                        
4
 See Section 4.6, for more details about the assessment of reliability and validity. 
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(Churchill, 1979) in order to complete this step.  Thus, the questionnaire containing 
the items obtained from the existing literature and the qualitative study will be 
distributed to respondents after the evaluation of the managers.      
 
A pilot study will be conducted (de Vellis, 2003) followed by the pool of items 
generated in the previous phase.  After the evaluation of the managers, the 
questionnaires which contain all potential items will be distributed to group of up to 
16 managers in companies within the Taiwanese pharmaceutical industry.  Examples 
from the literature suggest that pre-test sample sizes of up to 100 respondents are 
appropriate (e.g., Diamantopoulos et al., 1994).  However, because of the small total 
number of people in the target group, the pilot study sample is small as well. In this 
research, 20 sets of questionnaires were distributed in the pre-quantative-study and 16 
were collected (80% response rate). 
 
Based on the respondents’ experience within the pharmaceutical industry, they will be 
asked to rate items on a scale from “1” (Strongly disagree) to “5” (Strongly agree).  
Items extracted from English journals in the two steps above will be translated into 
Taiwanese by the researcher and translated back into English by a qualified translator 
in English language (Brislin, 1970).  In addition, the researcher plans to randomly ask 
the respondents to point out any item that is either ambiguous or difficult to answer 
(Kohli et al., 1993).  The data will then be subjected to a further purification process.  
This will involve reliability analysis and exploratory factor analysis (EFA).     
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4.5.5 Reliability Analysis 
 
In line with Melewar (2001, p. 38), before the main survey is conducted, it is vital that 
“the measures used are developed and investigated for their reliability”.  According to 
de Vellis (1991, p. 24) scale reliability is “the proportion of variance attributable to 
the true score of the latent variable”.  Based on the literature, the types of scale 
reliability include: (1) internal consistency reliability, which is concerned with “the 
homogeneity of the items comprising a scale” (de Vellis, 1991, p. 25; Churchill, 
1979); 2) the test-retest reliability, which is concerned with “the stability of item 
responses over time” (Nunnally, 1967,  p. 206); and (3) the alternative-form of 
reliability, which refers to “the extent to which two different statements can be used to 
measure the same construct at two different times” (Netemeyer et al., 2003, p. 46).  
However, to be consistent with several authors (e.g. Churchill, 1979; de Vellis, 1991; 
Melewar and Saunders, 1999; Melewar; 2001), the research refers to the scale 
reliability as internal consistency reliability.  Internal consistency implies that items 
are highly inter-correlated (de Vellis, 1991; Melewar, 2001).   High inter-item 
correlation infers that items of scale share a common core and measure the same thing 
(de Vellis, 1991; Melewar, 2001; Netemeyer et al., 2003).   
 
In order to assess the internal consistency, several researchers (e.g. Churchill, 1979; 
de Vellis, 1991; Melewar, 2001) recommend measuring the coefficient alphas 
(Cronbach, 1951).  The coefficient α is widely used as a measure of reliability (de 
Vellis, 1991).  The research will, therefore, assess the internal consistency of a set of 
items by measuring their coefficient alphas (Churchill, 1979).  Internal consistency is 
typically equated with Cronbach’s (1951) coefficient α.  Theoretically, the coefficient 
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α is concerned with “the degree of interrelatedness among a set of items designed to 
measure a single construct” (Netemeyer et al., 2003, p. 49).  The coefficient α 
(Cronbach, 1951) can be defined as: 
 
The coefficient alpha (α) = N. / [ + (N-1). ] 
 
Where:   N = the number of items in the scale 
 = the average variance  
 = the average of all correlation among items in the scale 
 
The coefficient alphas will be computed as a means of checking the reliability of 
measurement scales (Churchill, 1979; Melewar, 2001; de Vellis, 2003).   According to 
Melewar (2001, p. 39), “A low coefficient α indicates the sample of items performs 
poorly in capturing the construct”.  Based on a standard of reliability, it suggests that 
the values of α equal to or above 0.70 indicate that the items are reliable (Nunnally, 
1967; Nunnally and Bernstein, 1994; Melewar, 2001; de Vaus, 2002).  Hair et al. 
(2006) assert that a coefficient α which is greater than 0.70 is highly satisfactory for 
most research purposes. 
 
4.5.6 Pre-test 
 
The purpose of the pre-test was to determine whether the survey questions were 
contradictory or inappropriate before commencing formal research. The pre-test 
process helped us to find out issues with the survey questions and to fix these issues. 
Most importantly, it was to test the reliability and validity of the survey questionnaire. 
According to Punck (1998:100), when the reliability of a questionnaire or a measure 
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is pretty low, the difference between respondents is not a real difference but a faked 
difference. Therefore, if a survey questionnaire that is used for collection of research 
data is not stable, reliable and precise; the data collected will be questioned.  The pre-
test questionnaire was reviewed by industry professionals and scholars, and issued to 
the research target respondents, the managers of the pharmaceutical industry in 
Taiwan, in March 2010. Because of a lack of respondents, we collected only 16 
copies of the valid pre-test questionnaires, which were completed in detail by our 
respondents.  None of these questionnaires were invalid5.  
 
4.5.6.1 Validity Analysis 
Validity of one measurement tool (or technique) refers to the preciseness and 
accuracy of measurement results. In other words, validity asks to what degree the 
expected targets are actually measured by the designated scale or questionnaire. 
Validity of one measurement can be tested in three aspects. “Content Validity6” 
focuses on the extent to which a measure represents all facets of a given situation. 
“Criterion-related validity7” is used to demonstrate the accuracy of a measure or 
                                                        
5
 One of the pretest samples was considered as invalid because one question in it was left unanswered. 
Moving averages and the median method were not used to substitute the unanswered item. 
6
 Content Validity refers to the extent to which a measure represents all facets of a given situation.  
Those who want to evaluate content validity need to be highly aware of target subjects of one 
measurement, and to analysis measurement resulting systematically and logically. Validity content 
focuses on breadth, coverage, and of content, coverage and richness to serve as the main basis for 
external inference (Chiu, 2005; Lin, 2006, p.198). 
7
 Criterion-related validity is a measure of how well one variable or set of variables predicts an 
outcome based on information from other variables. The key point for the measure is to select valid 
criteria to reflect the validity of the score outcome. The criterion not only has to reflect the 
characteristic and personality of an independent measure, but also has to be accepted by the public and 
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procedure by comparing it with another measure or procedure which has been 
demonstrated to be valid. “Construct Validity8” refers to the degree to which a 
theoretical definition matches an experimentally determined definition. However, it 
was not possible to obtain construct validity by statistical analysis9, because only 16 
samples were available for the pre-test.  
 
The measurement was amended based on theoretical foundations demonstrated by 
experts and scholars (Dickson and Ginter, 1987; Wong and Saunders, 1993). Some 
items’ “factor loading” values which were below 0.5 and “Corrected Item-total 
Correlation” value below 0.3 were deleted, thus resulting in a better Cronbach’s 
Alpha (α) value (See the next section: Validity Analysis and Project Analysis for an 
explanation in detail). This measure can still be trusted for its content validity on the 
based on theoretical grounds. 
 
                                                                                                                                                               
general researchers as an index to specifically reflect a particular characteristic of the measurement 
information. (An index, 2005; Lin, 2006, p.198). 
8
 Construct validity refers to the degree to which the theoretical constructs can be measured. Construct 
validity includes convergent validity and discriminant validity. Convergent validity is the degree to 
which an operation is similar to (converges on) other operations that it theoretically should also be 
similar to. And similarities are highly expected between these two operations. Discriminant validity 
describes the degree to which the operationalisation is not similar to (diverges from) other 
operationalisations that it theoretically should not be similar to. Similarity between two operations is 
not wanted in this case (Lin, 2006:199). 
9
 A factor analysis model is needed for the development of construct validity. A prerequisite to running 
a factor analysis model is to consider the correlation between the sample size and the number of survey 
questions. Normally, the sample size has to be three to five times larger than the number of survey 
questions. However, the research includes too many survey questions and thus it is not going to be easy 
to develop construct validity using a factor analysis model (Chen et al., 2003). 
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Although it is impossible to ensure the validity of the questionnaire by factor analysis, 
appropriate questions for the questionnaire can still be determined by project analysis 
and reliability analysis. Project analysis and reliability analysis of the questionnaire 
design were as follows: 
 
4.5.6.2 Validity Analysis and Project Analysis 
Project analysis of individual items in the questionnaire 
A “consistency test” was used in this study to analyse factors, and factor analysis was 
used to decide the final version of questionnaire. (see Table 4.6 for a project analysis 
of the scale of Value Creation; Table 4.7 for a project analysis of the scale of Strategic 
Value or Resources; Table 4.8 for a project analysis of the scale of Corporate 
Communication; Table 4.9 for a project analysis of the scale of Brand Positioning; 
Table 4.10 for a project analysis of the scale of Product Differentiation; Table 4.11 for 
a project analysis of the scale of Product Segmentation; Table 4.12 for a project 
analysis of the scale of Medicine Price). Consistency of questions in the 
questionnaires was tested by “Cronbach’s α”, and according to the principle of 
Cronbach’s α, the question (or item) with the highest Cronbach’s α values, on an 
indicated dimension, were deleted. This was to ensure that all the questions in the 
questionnaire consistently asked about the target characteristics. 
 
The appropriateness of the questions was examined by modifying the correlation 
coefficient between individual questions and overall scores. Questions (Q1, Q20 from 
the value creation construct; Q6 from the corporate communication construct; Q7 
from the brand positioning construct; Q6 from the brand differentiation construct; Q1, 
` 
128 
 
Q7 from the brand segmentation construct) were deleted because they had a Corrected 
Item-total Correlation value lower than 0.3 in their correlation coefficients. 
 
Confirmatory factor analysis (CFA), based on PLS (Partial Least Square), was used to 
estimate the value of standardised factor loading. The value of standardised factor 
loading was used as the criterion to test homogeneous consistency of Questions (Q1, 
Q4, Q20, Q23 from the value creation construct; Q6, Q7 from the corporate 
communication construct; Q3, Q7 from the brand positioning construct; Q6 from the 
brand differentiation construct; Q1, Q7 from the brand segmentation construct; Q5 
from the medicine price construct) were deleted because they had a standardised 
factor loading value lower than 0.5. 
 
Reliability analysis of questionnaires 
Project analysis is used to examine the reliability of individual questions in the 
questionnaire, and reliability analysis is used to estimate the reliability and stability of 
the questionnaire. The coefficient of internal consistency10 of statistics, obtained from 
the pre-test samples, has been examined by reliability analysis. The analysis results 
indicated that the value of Cronbach’s α, in individual cases, were all higher than 0.7. 
Based on this, the questionnaire was proved to be highly reliable. 
 
                                                        
10
 Coefficient of internal consistency includes the alternate forms of reliability, split-half reliability, 
Kuder-Richardson reliability (KR20). They all refer to the internal homogeneity, consistency, and 
stability of the measuring instrument. α coefficient is now the most accepted criterion for judging  
reliability (Chiu, 2005). 
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(1) Project analysis and reliability analysis of the scale of “value creation” for the 
purpose of measuring the uses of corporate reputation.  
 
Table 4.7: Value creation items and reliability analysis 
Questionnaire Questions  Factor 
Loading 
Corrected 
Item-Total 
Correlation 
Cronbach’s 
α if Item 
Deleted 
Cron-
bach’s α 
1. Our firm’s corporate reputation promises 
good quality products and service to 
customers. 
0.197 0.179 0.955 0.954 
2. The corporate reputation of our firm helps 
to reduce transaction costs. 
0.849 0.799 0.951 
3. Our firm competes by creating useful 
products. 
0.758 0.713 0.951 
4. Our firm competes by creating the correct 
product attributes for its targeted 
customers. 
0.496 0.431 0.954 
5. Our firm competes by providing good 
financial performances. 
0.852 0.807 0.951 
6. Our firm competes by providing product 
with appropriate outcomes. 
0.902 0.884 0.950 
7. Our firm’s value-chain activity is consistent 
with functional value creation. 
0.538 0.537 0.953 
8. Our firm’s resource allocation is consistent 
with functional value creation. 
0.629 0.610 0.952 
9. Our firm’s products compete by appealing 
to the senses. 
0.918 0.903 0.949 
10. Our firm competes by creating appropriate 
emotions (e.g. fun, pleasure, excitement, 
relaxation, etc.) 
0.924 0.913 0.948 
11. Our firm competes by facilitating social 
relationships (e.g. bonds, attachments and 
togetherness). 
0.809 0.790 0.950 
12. Our firm competes by creating epistemic 
value (e.g. knowledge and novelty). 
0.923 0.909 0.948 
13. Our firm’s value-chain activity is 
consistent with experiential value creation 
(e.g. happiness, affection and excitement...). 
0.743 0.687 0.951 
14. Our firm’s resource allocation is consistent 
with experiential value creation. 
0.778 0.729 0.951  
15. Our firm competes by enhancing its 
customers’ self-identity. 
0.769 0.767 0.951 
16. Our firm competes by enhancing its 
customers’ self-concept (or self-image). 
0.836 0.823 0.950 
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17. Our firm competes by enhancing its 
customers’ self-worth. 
0.664 0.616 0.952 
18. Our firm competes by facilitating self-
expression. 
0.802 0.795 0.950 
19. Our firm competes by offering economic 
value (low prices, value in use, life costs). 
0.745 0.693 0.952 
20. Our firm competes by simplifying the 
purchasing process for its consumers (ease of 
use, ease of doing business, simplicity, and 
availability of purchasing, accessibility). 
0.338 0.299 0.957 
21. Our firm competes by enabling ease of use 
of its products (time, effort, energy). 
0.725 0.666 0.952 
22. Our firm competes by minimising customer 
risk (personal, technological, strategic). 
0.522 0.498 0.954 
23. Our firm’s value-chain activity is consistent 
with symbolic value creation. 
0.500 0.496 0.954 
24. Our firm’s resource allocation is consistent 
with symbolic value creation. 
0.623 0.618 0.952 
 
(2) Project analysis and reliability analysis of the scale of “strategic resources” in the purpose 
of measuring the uses of corporate reputation 
 
Table 4.8: Strategic resources items and reliability analysis 
Questionnaire Questions Factor 
Loading 
Corrected 
Item-Total 
Correlation 
Cron-
bach’s α if 
Item 
Deleted 
Cron-
bach’s α 
1. In our organization, corporate reputation 
serves as a competitive advantage. 
0.928  0.884  0.935  0.939 
2. Our firm’s corporate reputation sends a 
strong signal to its customers. 
0.532  0.541  0.939  
3. Our firm’s corporate reputation implies 
efficient sales and marketing. 
0.609  0.619  0.937  
4. Our firm’s corporate reputation implies it 
has advanced R&D. 
0.578  0.558  0.940  
5. Our firm’s corporate reputation implies 
that we are able to enter markets early. 
0.932  0.877  0.929  
6. Our firm’s corporate reputation gains the 
firm more opportunity for strategic alliance 
or business cooperation. 
0.689  0.697  0.935  
7. Our firm’s corporate reputation is 
enhancing the prices by validating them in 
published clinical reports. 
0.675  0.605  0.937  
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8. Our firm’s corporate reputation enables 
the firm to enter the market more easily. 
0.814  0.742  0.933  
9. Our firm’s corporate reputation gains 
more customers for the firm. 
0.933  0.918  0.928  
10. Our firm’s corporate reputation makes 
the marketing system work more efficiently. 
0.926  0.867  0.929  
11. Our firm’s corporate reputation makes it 
easier for us to find a downstream reseller. 
0.843  0.785  0.932  
12. Our firm’s corporate reputation can 
enhance our firm’s sales force. 
0.698  0.637  0.937  
13. Our firm’s corporate reputation helps the 
new product to enter the market. 
0.822  0.738  0.933  
14. Our firm’s corporate reputation helps the 
strategic link with complementary products. 
0.778  0.702  0.935  
 
(3) Project analysis and reliability analysis of the scale of “corporate communication” for the 
purpose of measuring the uses of corporate reputation 
 
Table 4.9: Corporate communication items and reliability analysis 
Questionnaire Questions  Factor 
Loading 
 Corrected 
Item-Total 
Correlation 
Cronbach’
s α if Item 
Deleted 
Cronbach
’s α 
1. Our firm’s corporate reputation shapes 
the perceptions of shareholders and other 
stakeholders. 
0.624  0.599  0.821  0.842 
2. Our firm’s corporate reputation builds a 
relationship between the firm and its 
customers. 
0.770  0.657  0.817  
3. Our firm’s corporate reputation 
influences consumer choices. 
0.880  0.866  0.797  
4. Our firm’s corporate reputation is based 
on the experience of the sales people. 
0.793  0.642  0.817  
5. Our firm’s corporate reputation is based 
on the sales ability of the sales people. 
0.772  0.647  0.816  
6. Our firm’s corporate reputation is based 
on the firm's awareness of social 
responsibility. 
0.278  0.252  0.862  
7. Our firm’s corporate reputation can be 
used for all types of negotiations with our 
customers, competitors or the government. 
0.387  0.326  0.857  
8. Our firm’s corporate reputation helps 
internal communication (the 
communication between our firm and our 
staffs). 
0.899  0.732  0.809  
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9. Our firm’s corporate reputation helps 
external communication (the 
communication between our firm and our 
customers). 
0.802  0.629  0.830  
 
(4) Project analysis and reliability analysis of the scale of “brand positioning” for the purpose 
of measuring brand image strategy 
 
Table 4.10: Brand positioning items and reliability analysis 
Questionnaire Questions Factor 
Loading 
Corrected 
Item-Total 
Correlation 
Cronbach’s 
α if Item 
Deleted 
Cronba
ch’s α 
1. Our firm’s corporate brand positioning 
strategy signifies high quality to its 
customers. 
0.796  0.557  0.719  0.744 
2. Our firm’s corporate brand positioning 
strategy signifies better product 
performance for its customers. 
0.820  0.562  0.721  
3. Our firm’s corporate brand positioning 
strategy is to achieve a higher frequency of 
advertising. 
0.468  0.406  0.733  
4. Our firm’s corporate brand positioning 
strategy involves a long distribution chain. 
0.842  0.790  0.613  
5. Our firm’s corporate brand positioning 
strategy is to provide a much better service 
to its customers. 
0.680  0.407  0.730  
6. Our firm’s corporate brand positioning 
strategy tries to fulfil the basic needs of our 
customers. 
0.632  0.597  0.678  
7. Our firm’s corporate brand positioning 
strategy tries to target upmarket audiences. 
0.483  0.299 0.766  
 
(5) Project analysis and reliability analysis of the scale of “product differentiation” for the 
purpose of measuring brand image strategy  
 
Table 4.11: Brand differentiation items and reliability analysis 
Questionnaire Questions Factor 
Loading 
Corrected 
Item-Total 
Correlation 
Cronbach’
s α if Item 
Deleted 
Cronbac
h’s α 
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1. Our corporate brand is perceived 
differently according to whether consumers 
have experienced our products. 
0.820  0.667  0.728  0.772 
2. Our corporate brand is perceived 
differently by word of mouth. 
0.818  0.660  0.743  
3. Our corporate brand is perceived 
differently by promotion. 
0.722  0.529  0.744  
4. Our corporate brand is actually created 
differently by product characteristics. 
0.652  0.531  0.739  
5. Our corporate branding may be directed at 
different market segments. 
0.858  0.793  0.708  
6. Our corporate brand may utilize physical 
product characteristics. 
0.095  0.026  0.824  
7. Our corporate brand may utilise non-
physical product characteristics. 
0.618  0.475  0.757  
8. Our firm’s corporate brand positioning 
strategy is based on advanced R&D which 
leads the needs of the targeted market. 
0.749  0.657  0.721 
 
(6) Project analysis and reliability analysis of the scale of “product segmentation” for the 
purpose of measuring brand image strategy  
 
Table 4.12: Brand segmentation items and reliability analysis 
Questionnaire Questions Factor 
Loading 
Corrected 
Item-Total 
Correlation 
Cronbach’
s α if Item 
Deleted 
Cronbac
h’s α 
1. Our corporate brand strategy has one 
particular form of demand function 
modification. 
0.396  0.255  0.753  0.747 
2. Our corporate brand strategy requires 
product differentiation. 
0.807  0.603  0.700  
3. Our corporate brand strategy requires 
changes in point distribution location. 
0.840  0.660  0.662  
4. Our corporate brand strategy requires 
changes in importance attached to a non-
physical product. 
0.855  0.667  0.668  
5. Our corporate brand strategy requires 
changes in importance attached to a physical 
product. 
0.695  0.402  0.729  
6. Our corporate brand strategy is decided by 
the needs of the customers to decide the 
product differentiation. 
0.564  0.553  0.696  
7. Our corporate brand strategy is based on 
different channels of distribution. 
0.205  0.219  0.778 
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(7) Project analysis and reliability analysis of the scale of “medication price” for the purpose 
of measuring medication price 
 
Table 4.13: Medicine price construct and reliability analysis 
 
Questionnaire Questions 
Factor 
Loadin
g 
Corrected 
Item-Total 
Correlation 
Cronbach’s 
α if Item 
Deleted 
Cronba
ch’s α 
1. A medicine with a higher price shows a higher 
quality of product to its customers. 
0.7896 0.581 0.814 0.829 
2. A medicine with a higher price shows a better 
image of the company it belongs to. 
0.7879 0.648 0.801 
3. A medicine with a higher price usually 
captures the value that is generated in the 
product. 
0.5422 0.565 0.812 
4. Our firm customises price by value that is 
perceived by our customers. 
0.5219 0.444 0.822 
5. Our firm customises price by distinguishing 
customers who pursue high values and customers 
with strict budgets. 
0.4377 0.534 0.812 
6. Our firm customises price by offering coupons, 
regional prices, limited consumption or 
negotiatory prices to a specific group of 
customers. 
0.7374 0.444 0.829 
7. Our firm customises price according to the 
characteristics of the customers. 
0.7926 0.670 0.794 
8. Our firms customise price according to the 
trading characteristics. 
0.5919 0.689 0.792 
9. Our firm pays considerable attention to 
effective publicity and communication while 
operating bulk buying/discounts. 
0.7896 0.404 0.824 
 
 
4.6 Main Survey 
 
4.6.1 Targeted Respondents and Collection Procedure 
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Following the development of the measurement scales, a main questionnaire survey 
was conducted with pharmaceutical companies in Taiwan.  In this section, the target 
respondents and the data collection procedure in this research will be discussed. 
 
4.6.1.1 Targeted respondents 
The targeted participants of the main survey were managers (marketing managers, 
sales managers, general managers and business executives) from the pharmaceutical 
industry in Taiwan.  The pharmaceutical companies were chosen because it was 
argued in the previous literature that a firm’s corporate reputation has a huge impact 
on its financial performance (Sobol and Farrell, 1988; Deephouse, 1997; Brown, 1997; 
Roberts and Dowling, 1997; Caruana, 1997; Sabate and Puente, 2003).  However, in 
the relationship between a firm’s reputation and its performance, there are some 
issues regarding how each strategist sets and generates their segmentation and 
positioning strategies.  Therefore, the respondents for this study needed to have 
experience in setting brand strategies which related to several strategies of corporate 
reputation. Such experience was held by the Taiwanese respondents in this study. The 
respondents were asked questions regarding the effects of the uses of corporate 
reputation on brand image strategy setting.   
 
4.6.1.2 Data collection procedure  
The researcher started the procedure by contacting a relevant professional association 
to ask for its support and more information about the Taiwanese pharmaceutical 
companies.  The Taiwanese BNHI (Bureau of National Health Insurance) provides a 
list of contacts of its association members.  The researcher contacted all the 
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pharmaceutical companies in the Taiwanese pharmaceutical industry in the database 
to inform them about this research project and to confirm their current addresses. 
 
Since it is not possible to collect data from all managers, the researcher employed a 
sampling method to initiate a sample of pharmaceutical managers.  However, because 
of data protection, it is likely that the pharmaceutical companies may not allow the 
researcher to access the staff database.  In this case, the research could neither 
identify nor enumerate sampling units.  Therefore, a probability-based sampling could 
not be conducted.  However, when a probability-based sampling cannot be conducted 
due to some limitations, a non-probability sampling technique is considered to be an 
appropriate choice although the generalisability of statistical results can be relatively 
limited (Baker, 2002; Denscombe, 2002).  
 
In this study, a judgement sample as a non-probability-based sampling technique was 
used.  The researcher plans to distribute a questionnaire to pharmaceutical managers 
because they tend to be familiar with brand strategy decision making within the 
pharmaceutical industry.        
 
It is noted that this sampling method may be biased toward the respondents (brand 
managers) because they may evaluate managers’ strategic decisions on the adoption 
of the uses of corporate reputation based on a firm’s strategic use of its intangible 
assets rather than as a consequence of a firm’s operation.  However, the chosen group 
of brand managers were desirable for this study because it was the group that could 
estimate the effects of the uses of corporate reputation in pharmaceuticals on brand 
` 
137 
 
image strategy.  Moreover, it was one of the most accessible groups of respondents, 
which could help to facilitate the survey process. 
 
The 61 probability selected samples (of the 200 overall targeted respondents) were 
collected from an online survey and are anonymous. Appendix 5 presents the targeted 
respondents and their company background information (i.e., firm history, firm size, 
position of the respondent in the company, and service the company provide). 
 
4.6.1.3 Sample size 
The researcher used confirmatory factor analysis (CFA) for finalising the scales (de 
Vellis, 1991).  A minimal sample size for CFA is usually recommended to be more 
than the number of covariances in the input data matrix (Netemeyer et al., 2003; Hair 
et al., 2006).  The researcher plans to use PLS (Partial Least Squares, one of the 
structural equation modelling software) to perform CFA.  However, an empirical ratio 
of at least five observations per parameter has also been proposed (Bollen, 1989; 
Joreskog and Sorbom, 1989).  Floyd and Widaman (1995) assert that a sample size of 
around five to ten observations per parameter is likely to be sufficient.  Based on the 
discussion above, the sample size in this study will be approximately 60. 
 
Therefore, PLS was chosen because of small sample size of this research. However, 
as identified 173 companies, the target respondents are managers in Taiwanese 
pharmaceutical industry, and the whole population of the target respondents is around 
200. Therefore, this small sample size was considered and tested by suitable software 
designed for a small number of respondents, namely PLS.  
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Table 4.14 illustrates the study’s overall domain, including corresponding items. 
Table 4.14: Details about questionnaires and respondents 
Number of distributed questionnaires to managers 200 sets  
Number of questionnaires received from managers 61 sets (30% response rate) 
Usable questionnaires 61 sets 
  
Corporate history  less than 30 years 65% 
Corporate history more than 30 years 35% 
  
Size more than 100 employees (include) 65.57 % 
Size less than 100 employees (exclude) 34.43 % 
  
Local company (manufacturing + sales ) 43.37 % 
Original company or dealers in European pharmaceuticals 15.66 % 
Original company or dealers in American pharmaceuticals 18.07 % 
Original company or dealers in Asian pharmaceuticals 22.89 % 
  
Turnover over 16.67 million US dollars 25% 
Turnover between 1.67 and 16.67 million US dollars 52% 
Turnover below 1.67 million US dollars 23% 
*(1 British pound = 1.45 US dollars = 50 TWDollars) 
 
The quantitative questionnaires were collected through an online questionnaire 
website. At the beginning of the questionnaire, respondents specified the background 
information of their firm, including company history, company size, and the service 
each company provided. Of the 61 respondent companies, 14 (23%) had company 
turnovers below US$1.67 million, 15 (25%) had company turnovers over US$16.67 
million, and 32 (52%) had company turnover between US$1.67 million and US$1.67 
million. In addition, in all companies, staff numbers were fewer than 3,000 people. 
Therefore, 75% of the surveyed companies were categorised as small to medium-
sized enterprises (which is the main component of the Taiwanese business 
environment). Moreover, 66% of surveyed companies had fewer than 100 people, 21 
(34%) had more than 100 people, and 7 (11%) had an even number of 300 staff 
members.  
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4.6.2 Data analysis techniques  
 
Following the main survey, confirmatory factor analysis (CFA) was performed on the 
main survey data. The following sections will discuss the data analysis techniques 
which the researcher plans to apply to this study.     
 
4.6.2.1 Confirmatory factor analysis (CFA)  
Following the main survey, purified measurement scales were to be subjected to 
confirmatory factor analysis (CFA) as a method to finalise the scales (de Vellis, 
1991). CFA was performed on the main survey data (Gerbing and Anderson, 1988; 
Diamantopoulos and Siguaw, 2000; Hair et al., 2006).  According to de Vellis (1991), 
CFA is used to confirm that the number of latent variables underlying the items 
corresponds to the number that the researcher expects.  Moreover, “if the factor 
analysis ‘discovers’ precisely the item groupings that [researchers] intended when 
creating the items, [the researchers] will have strong confirmation of their initial 
hypothesis concerning how the items should relate to one another” (de Vellis, 1991, p. 
109).    
 
In this study, CFA was used for testing whether the pre-specified relationship 
predicted by the theory is presented in the data (Huang, 2001; Hair et al., 2006).  Like 
EFA, CFA can be used to reduce the number of items (Netemeyer at al., 1996).  
However, the researcher employed CFA after EFA had been performed on the data 
obtained from the pilot study.  This is because EFA can provide insight about the 
potential dimensionality by revealing items that load poorly on an intended factor or 
load highly on more than one factor, whereas CFA can assess both the quality of a 
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factor solution and the specific parameters which constitute a model (Kelloway, 
1998).  Generally, CFA is used as an assessment of construct validity 11to ensure that 
the theoretical meaning of a construct is empirically captured by its indicators 
(Steenkamp and van Trijp, 1991).  This basis is very important for theory testing and 
development (Steenkamp and van Trijp, 1991).   
 
Following recommendations by Anderson and Gerbing (1982, 1988), the researcher 
conducted model-testing in two stages. The first stage was the development of a 
measurement model.  This was to confirm the relationships between the construct and 
its indicators.  The second stage involved the testing of the model to show the causal 
relationships between the latent constructs (Anderson and Gerbing, 1982; 
Diamantopoulos and Siguaw, 2000).   
 
Testing the measurement model was assisted by CFA (Diamantopoulos and Siguaw, 
2000).   When the measurement model was estimated using CFA, the fundamental 
dimensions which affect the validity of a construct were assessed (Anderson and 
Gergin, 1988).  The dimensions of construct validation include: unidimensionality of 
a construct; reliability; convergent validity; discriminant validity; and nomological 
validity 12 13(Peter, 1981; Anderson and Gergin, 1988, Steenkamp and Trijp, 1991). 
The research used PLS, structural equation modelling software, to perform CFA. 
 
4.6.2.2 Model testing 
                                                        
11
 More details about an assessment of construct validity will be provided later in section 4.6.2.3.  
12
 The definition of several types of validity will be provided later in section 4.6.2.3. 
13
 More details about the assessment of validity can be found in Section 4.6.2.3. 
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Anderson and Gerbing (1988, p.416) state that “after a measurement model has been 
estimated, a researcher should assess how well the specified model accounted for the 
data with one or more overall goodness-of-fit indices”.  In order to test how well a 
measurement model fits a set of observations, researchers are recommended to assess 
the model’s overall fit. The aim of a model’s overall fit is to confirm that consistency 
of a theoretical model and confirm that the estimated model is based on the observed 
values (Diamantopoulos and Siguaw, 2000; Hair et al., 2006). The model’s overall fit 
is evaluated on the basis of both incremental and absolute goodness of fit measures.  
Although, there are many statistics developed to test the overall fit of a model 
(Joreskog and Sorbom, 1989), none of them alone can provide an absolute assurance 
of model fit.  Each measure can be superior to the others under different conditions 
such as “sample size, estimation procedure, model complexity, violation of 
underlying assumptions of multivariate normality and variable independence” 
(Diamantopoulos and Siguaw, 2000, p.83).     
 
The goodness-of-fit measures indicate the extent to which the sample covariances are 
reproduced by the observed covariance or correlation matrix (Hair et al., 2006). The 
researcher used all the indices to select the best latent variable for the model as 
suggested by modification indices and fit indices (Gerbing and Anderson, 1988; 
Kohli et al., 1993).  The final variable that has the appropriate indices was selected.  
Then, the average value of each item was used to represent the latent variables.  
Afterwards, the latent variables were used in the hypotheses.  Composite score (i.e. 
summated score), which is the average of value of each item, was used to represent 
the latent variables used in the hypotheses testing (Netemayer et al., 2003; Hair et al., 
2006). 
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4.6.2.3 The assessment of reliability and validity 
According to the research processes of this study, after the content and the relevance 
of the multi-item scales had been refined on the basis of qualitative and quantitative 
data gathered from the exploratory research and the pilot study, the scale was 
validated on the basis of the quantitative data obtained from the main survey.  
Following the main survey, confirmatory factor analysis (CFA) was performed on the 
main survey data, followed by the model testing (Gerbing and Anderson, 1988; Hair 
et al., 2006; Diamantopoulos and Siguaw, 2000).  Based on the research design, the 
assessment of reliability and validity during these processes is discussed in this 
section. 
 
Several marketing researchers (e.g. Jacoby, 1978; Churchill, 1979; Peter, 1979; 1981; 
Zaichkowsky, 1985; Lichtenstein et al., 1990; Kotabe, 1990; Melewar; 2001) 
emphasised the need for attention to be paid to investigating the validity and 
reliability of measures used.  Validity refers to “the degree to which instruments truly 
measure the constructs which they are intended to measure” (Peter, 1979, p.6), 
whereas according to Peter (1979, p. 6), reliability is a necessary condition for validity 
as it ensures that “measures are free from error and therefore yield consistent results”.  
In order to assess reliability, coefficient α is the basic statistic for determining the 
reliability of a measure (Churchill, 1979).    
 
As discussed earlier (See Section 4.5.5), this research assessed the reliability (internal 
consistency reliability) by measuring the coefficient alphas as well as item-to-total 
correlations.  The coefficient α is widely used as a measure of reliability (de Vellis, 
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1991).  A coefficient α check was initially applied to quantitative data gathered from 
the pilot study.  Theoretically, the coefficient α is concerned with “the degree of 
interrelatedness among a set of items designed to measure a single construct” 
(Netemeyer et al., 2003, p. 49).  The coefficient alphas were computed as a mean to 
check for the reliability of the measurement scales (Churchill, 1979; de Vellis, 2003).  
Based on a standard of reliability, values of α equal to or above 0.70 indicate 
reliability (Nunnally, 1967; Nunnally and Bernstein, 1994; de Vaus, 2002; Hair et al. 
(2006).  While an item-to-total correlation was above 0.35, the question needed to be 
corrected (Saxe and Weitz, 1982).   
 
In addition, to finalise a measurement scale, it is very important that measurement 
scale validity also be investigated.  Scale validity refers to the extent to which an 
operational measure truly reflects the concept being investigated or the extent to 
which the latent construct is the underlying cause of item co-variation (de Vellis, 
2003; Peter, 1981).  In line with existing  research (e.g. Peter and Churchill, 1986; 
Melewar and Karaosmanoglu, 2006), the types of validity which will be evaluated in 
this study are: (1) content validity; (2) face validity; (3) convergent validity; (4) 
discriminant validity; (5) nomological validity; and (6) ecological validity (see Table 
4.15). 
 
Table 4.15: Types of validity assessment in this study 
Types Definitions 
Content validity refers to the extent by which the elements of measurement scales are 
relevant to, and representative of, the targeted construct for a particular 
assessment purpose 
Face validity refers to an assessment of how adequately items of a scale measure the 
construct of interest 
Convergent validity refers to the extent to which independent measures of the same construct 
converge or are highly correlated 
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Discriminant validity refers to the extent to which measures diverge from other 
operationalisations from which the construct is conceptually distinct 
Nomological validity refers to the examination of the hypothesised relationships between 
constructs and the empirical link between indicators and their underlining 
dimensions 
Ecological validity refers to the degree to which the behaviour observed in a study reflect the 
behaviour that actually occurs in natural settings (Denscombe, 2002).   
Source: Based on the literature (e.g. Peter, 1981; Peter and Churchill, 1986; 
Denscombe, 2002; Morgan et al., 2004; Homburg and Furst, 2005; Netemeyer et al., 
2005) 
 
In this research, content validity and face validity of scale were examined in the 
second step of the scale’s development procedure (Figure 4.2).  Content validity 
evaluates the overall validity of the measures used in the data collection instrument 
(Peter and Churchill, 1986).  It is used to assess the extent by which the elements of 
measurement scales are relevant to and representative of the targeted construct for a 
particular assessment purpose.  Face validity is used to assess the extent by which 
items on a scale adequately measure the construct of interest.  In order to assess 
content validity and face validity, the list of domains and examples of scale items 
were shown to the interviewees.  Respondents were asked to give opinions on 
whether they agree with the lists and provide specific reasons, if any.   
 
Convergent and discriminant validity were assessed after the confirmatory factor 
analysis had been performed (Anderson and Gerbing, 1988).  In other words, the 
convergent and discriminant validity were assessed when testing the measurement 
model.  Convergent validity refers to the extent by which the latent variable correlates 
to indicators pre-specified to measure the same latent variable (Peter and Churchill, 
1986; Anderson and Gerbing, 1988; Steenkamp and van Trijp, 1991).  It can be 
assessed by examining whether the factor loadings of items (i.e. pattern coefficient) in 
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their respective constructs are large14  and statistically significant 15  (Anderson and 
Gerbing, 1988; Joreskog and Sorbom, 1996).   
 
The presence of discriminant validity is indicated when the correlation between two 
constructs is significantly lower than 1.00 (Anderson and Gerbing, 1988).  According 
to (Joreskog and Sorbom, 1996, p. 416), discriminant validity is assessed for each pair 
of constructs at a time “by constraining the estimated correlation parameter between 
them to unity (1.0) and then performing a chi-square difference test on the values 
obtained for the constrained and unconstrained models”.  A significantly lower chi-
square value for the model in which the correlations between latent variables are not 
constrained to unity indicates that those latent variables are not perfectly correlated 
and that discriminant validity is achieved (Bagozzi and Phillips, 1982)          
 
Convergent and discriminant validity are subtypes of construct validity.   A validity 
of a construct is an essential condition for further theory testing and development 
(Carmines and Zeller, 1979; Steenkamp and van Trijp, 1991).  Construct validity 
(Cronbach and Meehl, 1955 cited in de Vellis, 1991, p.47) is concerned with the 
theoretical relationship of one variable to other variables.  Validity of a construct 
implies the degree to which the construct is empirically captured by its indicators 
(Steenkamp and van Trijp, 1991).  According to several authors (e.g. Peter, 1981; 
Gerbing and Anderson, 1988; Steenkamp and van Trijp, 1991), apart from the 
convergent validity and the discriminant validity, in order to claim that a construct is 
                                                        
14
 Factor loading which is equal to or greater than 0.6 is considered the minimum level at which 
convergent validity could be suggested(Bagozzi and Yi, 1998) 
15
 Any factor loading whose corresponding t-value is greater than 1.96 for 95% confidence level will be 
considered statistically significant. 
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valid the following criteria should also be assessed: unidimensionality of a construct; 
reliability and nomological validity.   
 
When the measurement model is estimated using CFA (Chau, 1997; Diamantopoulos 
and Siguaw, 2000; Huang, 2001), the unidimensionality of a construct, reliability and 
nomological validity can be also assessed.  The researcher used EFA (after the pilot 
study) and CFA (after the main survey) for testing the unidimensionality of a scale.  
According to Anderson and Gerbing (1988), the unidimensionality of a construct 
should be achieved initially before any attempt at further theory testing (Anderson 
and Gerbing, 1988) because it implies that the multiple indicators of a construct are 
internally consistent and externally distinct from other measures.   CFA ensures that a 
construct is unidimensional, so that it is composed of a set of logical (theoretical) 
indicators (Gerbing and Anderson, 1988; Steenkamp and van Trijp, 1991; Hair et al., 
2006).  It permits the computation of the criteria for assessing convergent validity, 
discriminate validity, as well as nomological validity.  
 
As discussed earlier, given acceptable convergent and discriminate validity, CFA as a 
test of structural model then constitutes a confirmatory assessment of nomological 
validity (Anderson and Gerbing, 1988).  Nomological validity refers to the 
examination of the hypothesised relationships between constructs and the empirical 
link between indicators and their underlining dimensions (Peter, 1981; Peter and 
Churchill, 1986).  In short, it concerns the overall fit of a model.  Lagas (2000) and 
Steenkamp and van Trijp (1991) suggest the utilisation of goodness-of-fit indices in 
order to assess nomological validity.         
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In addition, ecological validity is considered in this study.  Melewar and 
Karaosmanoglu (2006, p. 847) state that “any theoretical or conceptual argument 
needs to be tested in actual application” (also See Allen and Janiszewski, 1989).  A 
study which does not represent the actual procedure of a real-life situation is seen as 
being low in ecological validity, whereas a study which can be generalised beyond the 
setting in which the study was carried out is seen as high in ecological validity 
(Brewer, 2000).  Ecological validity is the degree to which the behaviour observed in 
a study reflects the behaviour that actually occurs in natural settings (Denscombe, 
2002).  It refers to how well findings from a study are linked to the social 
environment in which they occurred (Denscombe, 2002).  For a study to have 
ecological validity, the methods and setting of the study must approximate the real-
life situation that is under investigation (Brewer, 2000).  Ecological validity is closely 
related to external validity, which states the limits of generalisation that 
operationalisation imposes (Payne and Payne, 2004).  However, a study that has 
ecological validity may not have external validity because they are independent 
(Brewer, 2000; Shadish et al., 2002).  Nevertheless, improving the ecological validity 
of a study typically improves the external validity (Brewer, 2000; Shadish et al., 
2002). 
 
The aim of this research is to develop a better understanding of branding strategy 
decisions in pharmaceutical companies through examining three dimensions of the 
uses of corporate reputations and for the manager to put these into their strategy 
decision considerations. The researcher has reviewed the existing literature on the 
uses of the corporate reputation concept and the effects of brand image strategy.  
Following this, the researcher has proposed a conceptual model of the uses of 
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corporate reputation in pharmaceutical companies based on the literature.  The 
researcher plans to empirically examine how the effects of the uses of corporate 
reputation are in practice, in comparison to its theoretically defined effects.  By 
examining the brand managers’ views, the researcher will demonstrate how each 
dimension of the uses of corporate reputation and its effects have been explained and 
perceived in practice from the pharmaceutical brand manager’s perspective.  In line 
with Melewar and Karaosmanoglu (2006), the researcher believes that this approach 
will enable the researcher to operationalise the proposed conceptual framework by 
examining it in an “ecologically valid environment” (Smith et al., 1998, p. 64) rather 
than at a theoretical level.  The findings of this study are linked to the real-life social 
environment in which they occurred, which means this study has ecological validity 
(Denscombe, 2002). 
 
 
4.7 Hypothesis Testing 
 
After testing the scale for reliably and validity, the hypothesised relationships will be 
assessed.  PLS (Partial Least Squares) will be used at the expense of structural 
equation modelling (SEM), even though SEM is appropriate for simultaneously 
testing structural relationships among latent variables.  
 
The researcher plans to employ PLS, in order to test the research hypotheses. The 
researcher will use a regression model to test the model, which consists of three 
independent variables: value creation, strategic resources and corporate 
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communication; one moderator variable (medicine price); and three dependent 
variables (brand segmentation, brand differentiation and brand positioning).   
 
As suggested by Baron and Kenny (1986), in order to test for moderating effects, the 
first step of hypothesis testing is to find the significant level for the relationships 
between the independent variables and the dependent variable.  The second step is 
then to find the significant level for the relationships between the moderator variables 
and the dependent variable.  Subsequently, the moderator hypotheses are supported if 
the interactions between moderator variables and independent variables are 
significant. 
 
 
4.8 Summary 
 
In summary, this chapter has discussed the research design of the study and the detail 
of each stage has been presented.  A mixed-method, with a quantitative basis, is 
employed in this study.  In order to develop measurement scales for constructs in the 
model, the procedures for developing measurement suggested by Churchill (1979) are 
mainly employed.   
 
The research design incorporates information from three stages of data collection.  
First, the qualitative research (exploratory research) will be conducted – these are the 
in-depth interviews.  This phase is expected to provide more insights into the subject 
of interest, and to support the design of the research instrument.  Then, the first draft 
of the qualitative questionnaire (see Appendix 3) will be designed based on the items 
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generated from interviews and existing literature.  After that, a pilot study will be 
conducted in order to purify the measurement. Subsequently, questionnaires 
containing purified items from this step will be edited and prepared for the main 
survey.  The results from the survey will then be used to test the hypotheses.  
 
This research attempts to examine the relationship between firms’ use of corporate 
reputation and their brand image strategy. During the decision-making process, firms’ 
use three types of activities related to corporate reputation—namely value creation, 
strategic resources and corporate communication—to help inform their brand image 
strategy. Therefore, in line with the quantitative research presented previously, this 
study hypothesises that the three types of corporate reputation positively influence 
three types of brand image strategy (brand segmentation, brand differentiation and 
brand positioning). Table 4.16 provides a list of the summarised hypotheses and the 
research framework. 
 
Table 4.16: Summary hypotheses and research framework 
H1 Value creation, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand segmentation strategy. 
H2 Value creation, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand differentiation strategy. 
H3 Value creation, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand positioning strategy. 
H4  Strategic resource, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand segmentation strategy. 
H5  Strategic resource, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand differentiation strategy. 
H6 Strategic resource, as one dimension of the uses of corporate reputation, has a positive 
impact on a firm’s brand positioning strategy. 
H7 Corporate communication, as one dimension of the uses of corporate 
reputation, has a positive impact on a firm’s brand segmentation strategy. 
H8 Corporate communication, as one dimension of the uses of corporate reputation, has a 
positive impact on a firm’s brand differentiation strategy. 
H9 Corporate communication, as one dimension of the uses of corporate reputation, has a 
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positive impact on a firm’s brand positioning strategy. 
H10 Medicine price moderate the relationship between the uses of corporate reputaiton and 
brand image strategy. 
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CHAPTER FIVE: DATA ANALYSIS AND  
RESEARCH FINDINGS  
 
 
5.1 Introduction 
 
Firstly, this chapter presents the qualitative result. Content analysis was used to 
analyse the 14 interview findings. Secondly, this chapter provides an explanation of 
how the quantative study was completed by explaining the data analysis and results. It 
details the process of the data collection and the results. As discussed in Chapter 4, 
this involved a multi-stage procedure. The data examination and the screening to 
prepare for subsequent quantitative analyses are presented first, followed by the 
descriptive statistics. A reliability test was performed on the measurement scales to 
ensure that they achieve an acceptable level of reliability for further analysis. The 
resulting solutions were then re-assessed using confirmatory factor analysis. Finally, 
PLS (Partial Least Squares) was used to test the hypothesized relationships between 
the research constructs as postulated in the conceptual model, and to assess the overall 
goodness-of-fit between the proposed model and the collected data set. Conclusions 
are drawn in the last section. 
 
 
5.2 Qualitative Interview Findings 
 
5.2.1 Interviews about the Uses of Corporate Reputation        
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5.2.1.1 Interview results on value creation  
The experts generally clearly believe that value creation is important. Experts 
discussed the importance of the ability to create value for the uses of corporate 
reputation in pharmaceutical companies as follows: 
 
“We can discuss the value of brand from two different aspects. 
Brand value could be considered as a brand reputation that people 
recognize. Employees’ commitment toward this company, in fact, is 
actually the strength to support a brand value from inside out. By 
saying employees’ commitment, I mean that workers and their 
family members must be proud of this company. One company can 
make a brand name more famous by stretching its tentacles to 
different industries. Take our company as an example; our company 
might want to invest in [the] real estate industry. By expanding a 
company’s size like this, it is possible that this company will 
eventually become a conglomerate. I have gone too far. What I 
really want to say is that a company with a good reputation will 
always attempt to expand its size.” [Manager in company #F] 
 
 
“What we value the most is the remedial effect of the medicine. It is 
fair to say that medication from original pharmaceutical companies 
is usually more expensive. Lots of people believe that an expensive 
drug guarantees its effects. However, I focus more on the efficacy of 
the medication. Our company is now one of the biggest 
pharmaceutical companies in Taiwan, and manufactures drugs with 
better quality. Good quality of medicine and affordable price are the 
two most important factors for a pharmaceutical company to 
promote its products. A pharmaceutical company needs to firstly 
make one product affordable for customers. Besides, it needs to 
provide medication with good quality to its customers.”  [Manager 
in company #A] 
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Additionally, the value created by the firm helps a firm to establish their 
marketing plan. The following comment of an interviewee reflects these points: 
 
“A: A pharmacist could persuade a customer to buy one product by 
saying this product is manufactured by a famous pharmaceutical 
company. A pharmacist who says this is not standing on the 
patient’s side. An original or big pharmaceutical company tends to 
convince customers by its company image and value of performance. 
The medication which comes from a big, famous company is always 
more expensive than medication produced by pharmaceutical 
companies in Taiwan. For doctors and patients, what really matters 
about a medicine is its remedial effects, not its country of origin. 
That is, medicine produced by a local company can be as good as 
one manufacture overseas. International pharmaceutical companies 
spend lots of money on building company images compared with 
pharmaceutical companies in Taiwan. Our company focuses on 
more than that. The reputation of our company in markets 
represents the image of our company. Marketing is the next step for 
the biggest pharmaceutical companies.” [Manager in company #A] 
 
 
Another conclusion to be drawn is that, several different aspects of value can be 
created for the customers based on different customer characteristics. The following 
statement illustrates this:  
 
“B: I suppose that four aspects are all included. But different 
companies may emphasize disproportionately on these aspects. The 
sales language has been recognized in medication industry since the 
1970s and 1980s. When saying ‘value creation’, each company will 
always refer to the same aspects with only differing emphasis on 
each aspect. When talking about company reputation, headquarters 
will focus on general practice. It could take a lot of effort for one 
company to take care of general practice. It costs a large proportion 
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of operating expense. Our company has a control over the variety of 
products, since we owned some ancient prescriptions. Procurement 
departments in hospitals will check this company’s website when 
having trouble on medicine purchase. This could demonstrate the 
superior reputation that our company has established in the past 
eighty years.” [Manager in company #F] 
 
 
However, they had different opinions about which type of value creation is the most 
important. The most commonly given answer, functional value created by their firm, 
is the most popular strategy in the pharmaceutical company. The following statement 
illustrates this: 
 
“The offshore pharmaceutical companies, compared with local 
pharmaceutical companies in Taiwan, give less focus on the value of 
medical efficacy. The offshore pharmaceutical companies, instead, 
may focus more on customers’ thoughts toward their products. 
Their marketing strategy emphasizes the value of experience and 
happiness. That is, they put users as the first priority. In most 
situations, the sale of one medicine relies heavily on doctors’ 
recommendations for a product. This is because doctors are those 
who really contact with patients directly. By convincing patients to 
buy medicine, doctors need to prove the medicine is effective. 
Doctors can introduce the efficacy and some weaknesses of one 
medical product and speak about the benefits and effects that this 
medical product can bring to the patients. It is not necessary to 
mention the value of the company or product as people are all 
familiar with the power of a famous brand name. Pharmaceutical 
companies in Taiwan could improve the image of their products by 
connecting the company to socially-economically disadvantaged 
groups or charity institutes. For example, there are several charity 
groups that provide financial and emotional support for patients 
with cancer. In my opinion, I suppose the efficacy is the most 
important element for a good medicine.” [Manager in company #I] 
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On the other hand, experiential value creation is an important aspect in forming the 
corporate reputation of Taiwanese pharmaceutical companies. The following 
statement illustrates this: 
 
“A: This step [the experiential value creation], in my opinion, is the 
value of experience and happiness to our company, and it will 
definitely affect the value creation. One thing happened to me which 
could be an example that explains what I just said. I attended my 
50th primary school reunion one Saturday, and I talked to my 
teacher on that day. I passed my name card to my teacher to 
introduce the business I am in and the company I am running. He 
said, I knew this company had reputation for its great ointment. This 
is to prove its technical strategy using empirical evidence works 
very well to create its good company image in its ointment having a 
good curative effect. The ointment works very well. Of course this is 
maybe you can say that this is how functionality works on this 
strategy.” [Manager in company #F] 
 
 
5.2.1.2 Interview results on strategic resources 
The research undertaken has revealed that a firm with a good reputation has some 
strategic advantages. It is agreed by the experts that the use of corporate reputation as 
a strategic resource is important. A good corporate reputation attracts good 
salespeople, helps a company to launch its new products into the market, helps a firm 
to merge with other smaller pharmaceutical producers or to expand the market,  to co-
operate with and add more sales channels to the company and aids in raising funds. 
The following statements illustrate this: 
 
“It’s all about products. Reputation is something that a company 
must emphasize. According to my past experience, a successful 
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marketing requires a good integration between production 
department and sales department. A group of strong salesman could 
be a crucial part for our company to promote our products 
successfully. Characteristics of a good salesman have changed over 
time. A person, who speaks articulately, has good social skills and 
loves drinking used to be considered as a good sales person. 
However, the quality that makes an individual a top sales person is 
totally different from it used to be. This is because the way of 
business negotiation has changed. I can assure you that you’ve 
found the right sales person and he is doing great in this position.” 
[Manager in company #E] 
 
 
“In my opinion, a company with a good reputation is more likely to 
succeed in introducing the market to their new product. From sales 
department’s point of view, product launch can easily impress the 
market if the product is from a reputable company. The good first 
impression of a product may come from customers’ expectations. 
Once a company’s reputation is established, the value of the brand 
will definitely benefit the stated four strategic resources…. The 
potential meaning of using the corporate reputation as a strategic 
resource could be expanded in breadth and depth beyond its literal 
meaning. From the salesman’s point of view, new products are more 
likely to be popular when we promote our product on a regular time 
frame and a good company image or reputation.” [Manager in 
company #F] 
 
 
“I suppose that good company reputation can boost product sales 
and push products into markets more quickly. A firm’s reputation 
can affect other substantial elements of marketing strategy, 
including human resources, retailers and product price.” [Manager 
in company #I]   
 
 
“Our company owns a few subsidiaries. It was established in 1945 
as a pharmaceutical company. Recently the company decided to use 
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the pharmaceutical product equipments to produce health 
supplement food with medication standard and high quality. Along 
with the reputable medicine product for a long history, it is easier 
for the health supplement food to launch into the market. Now the 
health supplement food produced is expected to be on the shelves of 
Carrefour.” [Manager in company #A] 
 
 
“A company needs to raise a huge amount of funds to expand its 
size. To be frankly, funds are the single most important element for 
a company to expand. A company with a good reputation may 
consider seeking for assistance from financial institutes.” [Manager 
in company #A] 
 
 
Additionally, a good corporate reputation can effectively enhance sales and marketing, 
and also enable a new product’s entry to the market. It makes the firm easier to sell 
products to its customers. The following statement from a Japanese company Taiwan 
branch’s sales manager illustrates this: 
 
“The marketing strategy of a company must be effective and feasible. 
A big company can use its reputation to promote its products in 
markets. A big company with good reputation can always control 
the markets. A big company can take advantage from availability of 
huge amount of funds, professionals in the company and a big group 
of customers. A small company without good reputation can find it 
difficult to promote its products in markets.” [Manager in company 
#B] 
 
 
Moreover, a good corporate reputation also makes it easier for the firm to sell 
products to distributors. 
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“A company can use customer loyalty as a part of a marketing 
strategy. I can rely on the reputation of my company. My company 
is attractive to distributors because of its good reputation. In other 
words, distributors will be more confident and interested to do 
business with a company with a good reputation. My company can 
also benefit from the human resource in distributors. There are a lot 
of top salesmen in retail shops. My company can promote its 
products successfully by just offering salesmen commission on the 
products they sell. Thus, it is significant to co-operate with a 
powerful retailer in the first place. And I will then make my products 
more popular and more attractive to the market by presenting a 
good reputation and good image of my company.” [Manager in 
company #B] 
 
 
5.2.1.3 Interview results on corporate communication 
The research undertaken has revealed that a firm’s corporate reputation encourages 
greater commitment from employees and internal communication within the company. 
The following statement illustrates this: 
 
“I have spent my most valued 30 years in this company. There must 
be a reason for me to stay for such a long time. And this reason is 
the commitment to this company. I was proud to say Taiwan Biotech 
Co. in each time I am asked the company I work for. I am not proud 
of my company because of the easy money I earned. I am proud of 
company because I stay in a good company.” [Manager in company 
#A] 
 
 
Moreover, a firm’s corporate reputation can not only be used to communicate with its 
stakeholders but also builds the relationship between the firm and its customers. That 
is, the corporate reputation also builds external communication with the customer. An 
example was given by one of the experts talking about how a firm with a good 
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corporate reputation can influence its customers and also make customers have a 
better perception of the company and its FABs (Features, Advantages and Benefits): 
 
“Employees’ commitments toward the company and good 
communication between company and customers are the most 
important factors for a successful company. The sale of products 
relies heavily on good communications between company and 
customers.” [Manager in company #A] 
  
 
“Most pharmaceutical companies can produce medicine with 
similar effects to METAPOLITAN, which is used to treat diabetic 
patients in endocrinology and metabolism departments. One doctor 
could meet several salesmen from five or six different companies to 
promote the medicine for diabetic patients. What really affects 
doctors’ decisions on choosing the medicine is the reputation of the 
pharmaceutical company. Company reputation can come from 
customers’ trust in products of this company, and customers trust is 
established on the quality service that a company provides.” 
[Manager in company #A] 
 
“The ways we use to communicate with consumers includes building 
a relationship between company and consumers. A well-reputed 
company gains more trust from the customers. This helps to 
strengthen the relationship between the company and the customers. 
If you have a strong relationship with customers, you will have more 
resources to market your products and achieve your sales target.  
 
The next step is to send the message to customers. The 
pharmaceutical company will promote its products and 
communicate with customers using a professional medical 
conference, an academic research result presentation or a seminar 
on product introduction when launching a new product. No matter 
just for product promotion or launching a new product, you can still 
send a message to customers. These communication methods can be 
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used in different circumstances and markets.” [Manager in company 
#H] 
 
 
One way that a good corporate reputation can tighten the relationship between the 
company and its customer is stated below:  
 
“For a company with a good reputation, it is able to attract loyal 
customers to participation into your marketing events. However, 
this will not work for a small company. A well-known company with 
a good name has great fundamentals and a strong relationship to 
interact with customers using an indirect communication and 
marketing method, such as a professional medical conference. In a 
medical conference, there will be professionals and scholars invited 
to make a presentation on academic topics. This is placement 
marketing for promoting the product indirectly. Also, customers will 
receive messages from an academic research result presentation 
delivered by respected international scholars as an indirect 
communication method.” [Manager in company #H] 
 
 
However, some time is needed for a customer to recognize a firm as a “well-reputed” 
firm: 
 
“A company with a good reputation can always influence customers’ 
decisions. But it could take a lot of effort for the company to 
establish its reputation. The establishment of company reputation 
could require 10 or 20 years of hard work.” [Manager in company 
#B] 
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Furthermore, some firms sell their stock in the market. By advertising a company’s 
core values, a firm can enhance its market price. The following statement illustrates 
this: 
 
“TTY BioPharm can be used to illustrate this idea. The stock price 
per share of this company has increased from 50–60 dollars to more 
than 100 dollars, and hit its peak. This pharmaceutical company 
specialises in producing anti-cancer medication and protein biotech. 
According to the director, the commercial advertisement of this 
company keeps emphasizing their hard work on studying the 
treatment for cancer. The findings of their study on cancer are 
already a breakthrough, although the discovered treatment is not 
promised to be also effective on the human body. However, once the 
treatment, which was introduced in the commercial, is proved to be 
effective for patients with cancer, the company will get enormous 
success. In order to show their findings in the study of cancer, one 
of this company’s factories was opened for customers and visitors 
last Friday. The market share of this company is big. This resulted 
from their efforts on promoting their findings related to the cancer 
study. This improved the image of the company, and lots of share 
holders and investors will feel more confident about the future of 
this company. Shareholders with this company may get a $2 
dividend for a $200 share from this company. But they may get $2 
dividend for a $20 share from another company. Will TTY 
BioPharm still be attractive for the investors? Yes, it will. Some 
findings of the company’s study are at the forefront. The financial 
report of this company has been revealed publicly, and this report 
has passed more positive messages to the customers. There could be 
more and more people investing in this company because of this. 
Market share of this company in cancer treatment is big.  
 
Communication is a bridge between the company and our customers. 
This bridge it meant to strengthen the communication between the 
company and our customers. In short, the reputation of our 
company is established on the trusts from all customers in the past 
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80 years. These customers could be a powerful resource for us. To 
utilise the resource, our company needs to understand marketing 
strategies that different customers used. Some medicine retailers 
like to create a homey atmosphere for customers, while some 
distributors want to show a professional image and trophies to their 
consumers. The idea of making our products sweet came from 
retailers’ suggestions. Salespeople need to find out different 
strategies to do business with different retailers on a daily basis. 
There could be plenty of marketing strategies that salespeople can 
use. Our products can only differentiate market segments. Rhodiola 
with three stars could be an example for a market segment. The 
medical product has some features which are different from other 
products’.” [Manager in company #F] 
 
 
From the above, we know that the communication with customers is 
important; moreover, the respondent stated that: 
 
“Our firm’s corporate reputation with a good manufacturing 
history, a reputable product experience, helps the communication 
with our customers.” [Manager in company #F] 
 
 
5.2.2 Interviews about Brand Image Strategy        
              
5.2.2.1 Interview results on brand segmentation 
As was argued in the literature review, segment development is important in 
implementing a firm’s brand image strategy. However, segmentation is based on 
differentiating the needs of the customer. Similar factors of target segments of 
customers enable managers to implement a strategy, but there are different ways of 
implementing segmentation within one organisation. According to the manager in 
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company F: 
 
A: “I prefer using diseases for market segmentation. I mean that 
diseases are used for identification of niche products. For example, 
every patient with cancer will visit an oncology department. This is 
a good example of using disease for market segmentation because it 
uses differences between products to introduce a new product. Also, 
we can use price to create market segmentation such as with OTC 
products. Furthermore, we can use the national health insurance 
system to identify niche products for prescription drugs. Moreover, 
age or sex, male and female, is also a good way to identify niche 
products. For example, our company has Viagra products for 
impotence symptoms. We can thus use price or sex to identify our 
niche products. Therefore, you can apply these niche products as 
yours and we can also produce these drugs for different sexes and 
ages. For instance, we are making drugs for alopecia. Not many 
companies are doing these drugs for those who are worried about 
getting bald. It won’t be difficult to identify niche products as long 
as you think about many different factors, not just only one factor.” 
[Manager in company #F] 
 
 
However, it is customer oriented/based to implement segmentation strategy, 
according to several interviewees: 
 
“They are all customers. The only difference is they present 
different types of customers. We have to manage these customers 
based on their characteristics and use these different characteristics 
for market segmentation.” [Manager in company #B] 
 
 
B: “The product itself can be used for market segmentation. 
However, that is not the only factor for market segmentation. We 
can also use customers as a good factor for market segmentation. 
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There are many factors to choose from for market segmentation, 
including sales and service.” [Manager in company #F] 
 
 
Moreover, some companies use different channels of distribution to implement 
segmentation strategy, such as hospitals, clinics and pharmacies. The following 
statement illustrates this:  
 
“Market segmentation can be done via pointing out the difference 
between its [this company’s] product and other competitors’ 
products. It is difficult to find complementary medicines for other 
competitors’ products…. We could probably talk about evidence to 
prove the product’s advantage. For example, our strategy is to focus 
on medicines for CV and cardiology. Why do we only choose these 
two products given so many different kinds of products to choose 
from? The reason is to focus on our distribution channels. The large 
corporations have their own hospital channels to promote their 
products. That is how they can produce the best outcome via proper 
allocation of their staffs and use of the existing resources. Take Tung 
Yang as a good example for market segmentation, they did their own 
research on anti-cancer drugs. This helps them to strengthen their 
company name for consumers and industry peers, especially on 
anti-cancer drugs. They thus control the distribution channel and 
social networks. That is how they achieved market segmentation.”  
[Manager in company #I]   
 
 
However, the product manager in company F thinks it is unnecessary to 
implement segmentation in the beginning when you launch a new product: 
 
“When you make a strategy, you have to know your position in a 
market. If you spend too much time in positioning your products in 
the market, there will be more than 20 manufacturers already 
making the same products. If you just start the market segmentation 
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strategy, you will have no market for your product. Then you can 
only rely on customers for market segmentation. Customers will 
decide whether your product is in a leading role or a supporting 
role. If your product just plays a supporting role, it will rely on your 
customers for deciding your market place. Those contracted 
products mostly play a supporting role. If a medication product 
plays a leading role, it must be able to cure diseases. For example, 
if you can manufacture hypertension drugs, you can become hugely 
successful in the industry. That is impossible. It is because 
customers have different kinds of hypertension drugs to choose from. 
Therefore, you have to promote this product in a different way. After 
spending much time, you realise this product can help patients 
against stroke. That will be the feature for us to promote this 
product. This will be a useful product. You have to keep promoting 
the feature because the hypertension drugs are already too many in 
the market.  
 
I want to summarize the point. Now we know the market positioning 
strategy for the product and the niche to promote the product. We 
will know how to position the product in the market. We then use the 
market position for market segmentation. Then we can think about 
where the customer is and how the customer will respond to the 
product.… That is what I say about using customers to position your 
product for market segmentation.” [Manager in company #F] 
 
 
Other interviewees suggested that there are many other factors, such as whether there 
is a focus on R&D, that decide the type of segmentation. The following statement 
illustrates this: 
 
“Tung Yang is a good example of this. Tung Yang is a very unique 
company. It is never a follower. It is the first pharmaceutical 
company which successfully manufactured anti-cancer drugs. Its 
anti-cancer drug is just as successful as Panadol.… However, it 
continues to focus on this niche product because it has no choice but 
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continues to work on promoting this product. After three to five 
years, it provides clinical reports regarding new knowledge about 
cancer, and builds a strong relationship with clinics. Its products 
become accepted by these clinics. It then makes very good money…. 
Its total operating profit is about $500 million. This proves its 
success with anti-cancer drugs. It has now started to make other 
medications. However, it is still famous for its anti-cancer drug. It is 
now in the top 50 small to medium enterprises in Taiwan. It has 
successfully built its brand name.” [Manager in company #E] 
 
 
Besides R&D, different channels of distribution can be the basis of brand 
segmentation. The following statement illustrates this:  
 
B: “The distribution channel for these products will be hospitals 
since the price of our products is relatively high. Hospitals normally 
can accept products with a higher price range. However, these 
products won’t be popular for clinics given that the doctor in a 
clinic is the boss. They care about medication costs. Therefore, they 
probably won’t use the medicine from an original manufacturer 
given the price is too high for them.” [Manager in company #E] 
 
5.2.2.2 Interview results on brand differentiation 
As it was argued in the literature review, to enable a good brand image strategy, brand 
differentiation has to be applied as well. However, achieving brand differentiation is 
very difficult in this particular industry. There is a standard procedure (bioequivalence 
and bioavailability, as explained in the following paragraph) that has to be followed 
during production in the pharmaceutical industry. Thus in the end it is not possible to 
distinguish between original and generic products. The following statement illustrates 
this: 
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“It looks like it is simple to start a business in the pharmaceutical 
industry. The entry barrier will be whether you can successfully 
make a product or whether you can copy the successful business 
model and products from the original manufacturer. The key point is 
to make exactly the same product as the original manufacturer. 
 
… If the difference does not exceed a certain level, you conclude 
that there is no significant difference between these two products 
but you still cannot claim these two products are exactly the same. It 
is said that there will be no significant difference and the 
manufacturing procedure for BE (bioequivalence) and BA 
(bioavailability) testing is almost the same.” [Manager in company 
#E] 
 
 
Even if it is hard to implement brand differentiation strategy in this industry, there are 
two ways of implementing brand differentiation strategy: product oriented and 
customer based. First, the product packaging can make the company image; this can 
be behind the logic of brand image strategy making. The following statement 
illustrates this: 
 
“There are so many things to be done to differentiate your drug 
products, including dosage, product features, packaging, drug in 
tablet or liquid form, flavours, clinical evidence and approval 
certificate by Health Department etc. We can apply and combine 
these products features and the use of end users to differentiate our 
brand.”  [Manager in company #F] 
 
 
“The product package represents a company’s image. It is not 
limited to real packaging. A nice looking package of course can 
attract consumers to buy your products. You don’t want your 
consumers to complain to doctors about how uncomfortable they 
are after taking the drug and the package doesn’t look right, 
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including packaging colour fading or cracking. This is all about a 
company’s image. You can also put a photo of charity events funded 
by your company such as a running event for cancer patients. You 
can find many charity events or organisations overseas.” [Manager 
in company #A] 
 
 
A common way of differentiation for pharmaceutical products is to make them into 
different forms of a medical product, such as liquid, tablets or capsules. Different 
forms of the medicine enable different brand image strategies to be applied. The 
following statement illustrates this:  
 
“No one will care about brand differentiation if your drugs and 
other competitors’ drugs are both within legal limits. However, 
there are definitely differences between your products and others. 
The only job is just you have to know what the difference is and how 
you can show the brand differentiation to your consumers. For 
example, if you feel like making a drug as a tablet, capsule or film 
coating and if is not easy to get the drug to a certain feature, you 
then turn to make the drug in liquid form, such as syrup or 
injections. However, a drug in liquid form is normally unstable. 
That is what you can use to promote your drug, just like using a 
slogan ‘our product as a tablet is better and stable’.” [Manager in 
company #E] 
 
 
In addition to packaging, some creative R&D combine two ingredients into one tablet 
to enable the consumer to use the medical product more easily – thereby creating a 
differentiation:  
 
“I don’t know whether you have noticed that few of the modern drug 
products contain only one ingredient. Most of the modern drug 
products tend to combine two ingredients called a ‘combo’. Take 
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hypertension drugs as an example. Actually a diuretic can be used 
to cure hypertension. How do we combine a hypertension drug and 
a diuretic to make a good hypertension drug? What proportions of 
these two ingredients will perfectly combine to work better in curing 
hypertension patients? This will rely on our directors’ professional 
opinions because some of our directors are doctors with actual 
experiences of curing hypertension patients. With actual experience 
from our directors, sales people, customers, and pharmacists, we 
can identify the market trends.… Therefore we are the original 
company. Our competitors can only import similar products from 
overseas.” [Manager in company #A] 
 
 
Second, categorising customers can have an impact on the entire production and 
marketing scheme. The following statement illustrates this: 
 
“I will differentiate my products for the end users, doctor and 
pharmacist. No matter whether we differentiate our products for the 
end users or any other ways, we all want the same result, which is to 
influence the customers’ behaviour. I will tend to promote sales to 
the end users and strengthen our aftersales service to achieve this.” 
[Manager in company #F] 
 
 
There are different ways to implement customer-based brand differentiation: 
 
“The price of TWD $75 for three days applies to every clinic and 
every patient (a current medicine policy in Taiwan). How can we 
promote more sales under this kind of condition? Because 
consumers want more of these products after they get used to these 
products. That is how we become successful. That is why Ying-Jie 
continues to focus on making eye drops. 
 
We have another way to win the battle, which is signing contracts. 
We are very flexible in signing sales contracts. That will make our 
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sales people easily get the sales contract signed by our customers. 
Our salesman can flexibly change the contract and tailor the 
contract based on their sales volume.…” [Manager in company #F] 
 
 
Some other ways of implementing a customer-based differentiation strategy, by using 
low prices, spread by word of mouth and using opinion leaders to lead consumer 
thinking, give quick results for brand differentiation. The following statement 
illustrates this: 
 
“The best and most direct method to differentiate your brand name 
is to create the product value by a cheaper price. Then your 
customers can accept your products easily and quickly given that 
they recognize the differentiation in your product. They will help to 
promote your product as a cheap and good product via word of 
mouth. Consumers nowadays want a good value product and that 
really works on them…. 
 
That is so-called endorsement by opinion leader. Where shall we go 
to sell the drug products to consumers? We can differentiate our 
product via hiring an opinion leader in the medical industry to 
endorse our products with their own good experiences and 
treatment results.… It is a great advantage for products to be able 
to sell in 7–11 stores. Then your distribution channel will not be 
limited to pharmacies. If the products can only be sold in a 
pharmacy, we can only use the end user, such as a doctor, to help us 
to differentiate the product. I use the power of word of mouth among 
consumers to promote our products. When it comes to drug products, 
word of mouth marketing is pretty basic. That is how we 
differentiate our products.” [Manager in company #I] 
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5.2.2.3 Interview results on brand positioning 
As was argued in the literature review, one of the most important factors in 
implementing positioning strategy is price. A good example is a business scheme by 
which the medicine produced in Taiwan is targeted at high-income customers in 
mainland China: 
 
“The high-end market is attractive for pharmaceutical companies. 
The maternity medicine Ann Bao, which stabilizes physical 
conditions when a woman is pregnant, is now popular in the high-
end market in mainland China. Ann Bao is sold at a high price in 
mainland China, both needle shots and tablets of this medicine are 
available for customers.” [Manager in company #A] 
 
 
Some companies position their product as a premium product because they have a 
very good corporate image or appear frequently in commercials. This kind of 
positioning strategy is based on the corporate image. The following statement 
illustrates this: 
 
“A company with a good reputation can also promote their products 
more easily by improving company image and by connecting itself 
to the distributors. For example, we usually advertise in the medical 
journals or show up at the medical conferences to enhance our 
reputation. A debut conference and a product commercial are often 
used to boost customers’ confidence in a new medical product and 
to position well this product. Thus it also builds an unseen 
positioning strategy within customers’ minds.” [Manager in 
company #B] 
 
 
` 
173 
 
Another way to position their product at the high-end market is to use ingredients 
from a certain country. For example, products from the USA, Europe or Taiwan can 
be positioned for the high-end market and sold for a high price. The following 
statement illustrates this: 
 
“Pharmaceutical companies in Taiwan are very likely to succeed in 
product positioning…. We prefer ingredients for medicine 
production from Europe and India, and we would rather not use 
ingredients from China. People can find out the differences between 
ingredients from different regions when testing these ingredients. 
The medical ingredients from China may survive testing on effects, 
but these ingredients always fail impurity tests.” [Manager in 
company #A] 
 
 
Some companies implement their positioning strategy by basing it on medical 
effectiveness. This positioning strategy is based on customer needs: 
 
“A company needs to take all aspects, such as efficacy of the 
medicine, of one medication into consideration before doing product 
positioning. Anti-wrinkle products with good effects on skin could 
be an example for product positioning. Medication with good 
efficacy will be recognised as a high-end product, even if producing 
expense of this medication is not high.” [Manager in company #B] 
 
 
However, some companies which are more manufacturer-oriented would rather 
position their products as good quality by focusing on customer relationships. A 
statement from one manager illustrates this: 
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“I’d rather do business with small firms. A company is more likely 
to make the profit from the business with small firms, and this sort 
of business allows the company to make bigger profit from the 
products they have sold.… 
 
The quality and efficacy of medical products have been improved a 
lot in recent years. The retailers and distributors are also strong on 
promoting medical products. And a pharmaceutical company can 
rely on good post-sales service. Pharmaceutical companies are 
doing well in almost everything.” [Manager in company #E] 
 
 
“A good post-sale service is required after the value of one product 
is recognized by customers. A good post-sale service is to strengthen 
customer’s faith in the product value and to influence doctors’ 
prescriptions. This is to enlarge the market share of a single 
product.” [Manager in company # I] 
 
 
Company F positions the company to sell different types of medical products, which 
suit three different types of customer need. The following statement illustrates this: 
“Pharmaceutical companies always want to produce the most 
evolutional drug one step ahead others. However, it could be really 
difficult to really get there. In real situations, pharmaceutical 
companies produce medicines, which have been introduced by other 
companies, after patents of these medicines have expired. TTY 
BioPharm is poised to introduce its newest medicine. The efficacy of 
this medicine remains unrevealed.  
 
Similar customer groups are targeted by different companies. 
Product positioning of three affiliations, including Ying Yung, Ying 
Jie and Ying Ann, could be an example for this. Ying Yung 
concentrates on ordinary medical products, such as medicine for 
headache relief, cold and flu. They also have flu syrup, needle shots 
and ointments. People are suggested to check up with Ying Yung, if 
they can’t find what they want in the market. Therefore Ying Yung is 
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targeting to very popular stores like Carrefour. Ying Jie, on the 
other hand, only focuses on one product called “idrop”. This 
company’s 50 per cent profit comes from the sale of idrop. Its 
position is on particular one kind of product….” [Manager in 
company #F] 
 
 
5.2.3 Interviews about Medicine Price 
 
In all of the interviews, price turns out to be a major issue in the Taiwanese 
pharmaceutical industry. Currently Taiwanese pharmaceutical companies are at the 
stage of producing generic products and not able to invest a lot of money in inventing 
new products. Therefore price is a critical factor. However, it is agreed by most of the 
consumers that a medicine with a higher price suggests a better quality of product and 
a better company image. 
 
“I suppose that good company reputation can boost product sales 
and push products into markets more quickly. A good corporate 
image can affect other substantial elements of marketing strategy, 
including human resources, retailers, and product price. Inevitably, 
a product with a higher price sometimes shows its better function or 
produces a better company image.” [Manager in company #I]   
 
 
A medicine with a higher price usually captures the value that is generated in the 
product. 
 
“When a new product in a new area comes on the market, as for my 
experience, if you use the brand value to make a price-oriented 
segmentation, 90 per cent of the time it will be success.” [Manager 
in company #B]   
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“I think the symbolic or expressive value is important. For example, 
some companies give the customers an impression of high class 
because the company’s products are located in the market as a 
pioneer product. This means the company has good ability with 
R&D, therefore, the product is considered to be good quality and 
requires a higher price.” [Manager in company #B]   
 
“Actually it [price] is the value that is perceived in the consumer’s 
mind. A medicine with a higher price, and if its marketing campaign 
runs well, gives the customer an impression that it has more 
effectiveness and maybe other combined functions or added value.” 
[Manager in company #G]   
 
 
Price can also be a useful factor for creating segmentation. The following statement 
illustrates this: 
 
“My company’s reputation will be bad if we have a different 
segmentation with the Chinese firms which have the product with an 
average or poor quality. This will also impact on the price, which 
has the so-called price segmentation as well.” [Manager in 
company #D]   
 
 
“The product price will be a very crucial factor when it comes to 
market segmentation.… That is the reason I want to point it out here 
regarding the adoption of price for market segmentation. It is used 
to create a new market and expand your business. We used to say 
that you have to use the best medication for liver or kidney diseases. 
That will create economic value or benefit for us. The benefit from 
these medications can strengthen our competitiveness compared to 
other competitors. Otherwise, you won’t be able to make money 
under the national health insurance system or under the civil service 
insurance and labour insurance system…. However, even if you 
lower your price, you can still earn more money if you achieve more 
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sales.… Thus, I will adopt pricing strategy and price my product 
higher to achieve the purpose of market segmentation.” [Manager in 
company #A] 
 
 
Some companies also customize price by distinguishing between customers who 
pursue high values and customers with strict budgets. 
 
“There are two kinds of hospital customers. Because products with 
higher prices could put pressure on profits, some hospitals could 
lose money because of this. One kind is pursuing high values added 
to the medical product. They would like to give a good price and get 
the service and use high-level products. The other kind of hospital 
customers makes strict budgets and put pressure to cut medicine 
prices so they are very low, so that these hospitals can have profit 
margins.” [Manager in company #G] 
 
From the interview, what the respondent said supported the idea that having a higher-
priced product usually signals a better quality or higher level of products. Therefore, 
the qualitative result indirectly indicates that the medicine price moderates the 
relationship of the uses of corporate reputation and a firm’s brand image strategy.  
  
5.2.4 Qualitative analysis conclusion 
 
From the analysis of the qualitative data, it may be concluded that experts suggested 
new items for each construct. The interviewees suggested adding eight new items to 
the strategic resource construct, which are: (1) gains more opportunities for strategic 
alliances or business cooperation; (2) enhances prices by validating medicines in 
published clinical reports; (3) makes market entry easier; (4) gains more customers for 
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the firm; (5) makes the marketing system work more efficiently; (6) makes it easier 
for the firm to find a downstream reseller; (7) enhances the firm’s sales force; (8) 
develops strategic links with complementary products.  
 
Six items were suggested as additions to the previous corporate communication 
construct: (1) the experience of the sales people; (2) the sales ability of the sales 
people; (3) the firm’s awareness of social responsibility; (4) using all types of 
negotiations with customers, competitors or the government; (5) helps internal 
communication; (6) helps external communication.  One additional item was 
recommended for the brand differentiation construct: advanced R&D leads the needs 
of the target market. And two items were suggested for the brand segmentation 
construct: to be based on customer needs, and to be based on different channels of 
distribution.  
 
Finally, a whole new construct is suggested to act as a link between the relationship of 
the uses of corporate reputation and brand image strategy: namely, medicine price.  
 
This exploratory qualitative study provided a richness of data forming the basis for 
developing the quantitative study. The study provided a better understanding of the 
research question. (RQ [research question] - How do Taiwanese pharmaceutical 
companies use their corporate reputation to develop brand image strategy?). The 
qualitative research of the interviews gave the researcher more knowledge about how 
corporate reputation is used in practice and how the brand strategies operate 
practically. 
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The findings of this exploratory qualitative study generally confirmed the research 
model. None of the original items were to be deleted. However, some items were 
suggested as additions, as stated above. And the findings also confirmed the research 
hypotheses with the exception of a moderating construct of “price”. The following 
framework (see Figure 5.1) is the outcome of the literature search and is supported by 
the qualitative study. One hypothesis regarding the way price moderates the 
relationship between the uses of corporate reputation and brand image strategy was 
added. 
 
Figure 5.1: Revised conceptual framework 
 
Srouce: Developed by the researcher 
 
 
5.3 Main Study: Measurement Scales Validation and Hypothesis 
Testing 
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5.3.1 Descriptive statistical analysis  
 
With regard to the company histories, there are three in the “less than 10 years” 
category, accounting for 4.92%, 36 in the “11–30 years”, accounting for 59.02%, 16 
in the “31–50 years” category, accounting for 26.23%, five in the “51–80 years” 
category, accounting for 8.20%, and one in the “more than 81 years” category,  
accounting for 1.64%. For the details, please see Table 5.1. 
 
Table 5.1: Descriptive analysis table of company statistics  
Variable Category of information  No. of 
samples 
Percentage 
(%) 
Cumulative 
percentage (%) 
Firm history 
(1) less than 10 years 3 4.92 4.92
(2) 10–30 years 36 59.02 63.93
(3) 30–50 years 16 26.23 90.16
(4) 50–80 years 5 8.20 98.36
(5) Over 80 years 1 1.64 100.00
Sales turnover 
(1) < 1 million pounds 14 22.95 22.95
(2) 1 million to 2.99 million sterling 
pounds (£) 
17 27.87 50.82
(3) 3 million to 9.99 million sterling 
pounds (£) 
15 24.59 75.41
(4) Over 10 million sterling pounds 
(£) 
15 24.59 100.00
 How many 
people work for 
your company? 
(1) Fewer than 50 people 25 40.98 40.98
(2) 51–100 people 15 24.59 65.57
(3) 101300 people 14 22.95 88.52
(4) More than 300 people 7 11.48 100.00
Which (1) Sales department 20 32.79 32.79
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department do 
you belong to? 
(2) Marketing department 15 24.59 57.38
(3) Management department 26 42.62 100.00
Which position 
do you hold in 
your company? 
(1) Board chairman 3 4.92 4.92
(2) General manager 10 16.39 21.31
(3) Department manager 48 78.69 100.00
How many years 
have you worked 
in this company?  
(1) Less than 1 year 4 6.56 6.56
(2) 2–3 years 8 13.11 19.67
(3) 4–10 years 21 34.43 54.10
(4) 11–20 years 15 24.59 78.69
(5) More than 20 years 13 21.31 100.00
Firm character 
(multiple choice) 
(1) A foreign-owned company 
(American company) 
1  
(2) A foreign–owned company 
(European company) 
0  
(3) A foreign–owned company 
(Asian company) 
2  
(4) A trader company (American 
company) 
7  
(5) A trader company (European 
company) 
9  
(6) A trader company (Asian 
company) 
22  
(7) Local company 38  
Source: Developed by the researcher 
 
After the pilot study, in the questionnaire, we assigned each item a code name making 
it easier for us to observe the correlation of each item with the construct. Regarding 
the codes for each item, please refer to Table 5.2.  
 
Table 5.2: Measurement items of the theoretical constructs and their codes 
Construct Items wording Items 
codes 
Value creation 
 
 
 
The corporate reputation of our firm helps to reduce transaction 
costs.  
VC1 
Our firm competes by creating useful products.  VC2 
Our firm competes by providing good financial performances.  VC3 
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Value creation 
 
Our firm competes by providing products with appropriate outcomes.  VC4 
Our firm’s value-chain activity is consistent with functional value 
creation.  
VC5 
Our firm’s resource allocation is consistent with functional value 
creation.  
VC6 
Our firm’s products compete by appealing to the senses.  VC7 
Our firm competes by creating appropriate emotions (e.g. fun, 
pleasure, excitement, relaxation, etc.)  
VC8 
Our firm competes by facilitating social relationships (e.g. bonds, 
attachments and togetherness).  
VC9 
Our firm competes by creating epistemic value (e.g. knowledge and 
novelty).  
VC10 
Our firm’s value-chain activity is consistent with experiential value 
creation (e.g. happiness, affection and excitement...).  
VC11 
Our firm’s resource allocation is consistent with experiential value 
creation.  
VC12 
Our firm competes by enhancing its customers’ self-identity.  VC13 
Our firm competes by enhancing its customers’ self-concept (or self-
image).  
VC14 
Our firm competes by enhancing its customers’ self-worth.  VC15 
Our firm competes by facilitating self-expression.  VC16 
Our firm competes by offering economic value (low prices, value in 
use, life costs).  
VC17 
Our firm competes by enabling ease of use of its products (time, 
effort, energy).  
VC18 
Our firm competes by minimizing customer risk (personal, 
technological, strategic).  
VC19 
Our firm’s resource allocation is consistent with symbolic value 
creation. 
VC20 
Strategic resources In our organization, corporate reputation serves as a competitive 
advantage.  
SR1 
Our firm’s corporate reputation sends a strong signal to its 
customers.  
SR2 
Our firm’s corporate reputation implies efficient sales and marketing.  SR3 
Our firm’s corporate reputation implies it has advanced R&D.  SR4 
Our firm’s corporate reputation implies that we are able to enter 
markets early.  
SR5 
Our firm’s corporate reputation gains the firm more opportunity for 
strategic alliance or business cooperation.  
SR6 
Our firm’s corporate reputation is enhancing the prices charged by 
validating them in published clinical reports.  
SR7 
Our firm’s corporate reputation enables the firm to enter the market 
more easily.  
SR8 
Our firm’s corporate reputation gains more customers for the firm.  SR9 
Our firm’s corporate reputation makes the marketing system work 
more efficiently.  
SR10 
Our firm’s corporate reputation makes it easier for us to find a 
downstream reseller.  
SR11 
Our firm’s corporate reputation can enhance our firm’s sales force.  SR12 
Our firm’s corporate reputation helps new products to enter the 
market.  
SR13 
Our firm’s corporate reputation helps the strategic link with 
complementary products.  
SR14 
Corporate 
communication 
Our firm’s corporate reputation shapes the perceptions of 
shareholders and other stakeholders.  
CC1 
Our firm’s corporate reputation builds a relationship between the 
firm and its customers.  
CC2 
Our firm’s corporate reputation influences consumer choices.  CC3 
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Our firm’s corporate reputation is based on the experience of the 
sales staff.  
CC4 
Our firm’s corporate reputation is based on the sales ability of the 
sales staff.  
CC5 
Our firm’s corporate reputation helps internal communication (the 
communication between our firm and our staff).  
CC6 
Our firm’s corporate reputation helps external communication (the 
communication between our firm and our customers).  
CC7 
Brand positioning Our firm’s corporate brand positioning strategy signifies high quality 
to its customers.  
BP1 
Our firm’s corporate brand positioning strategy signifies better 
product performance for our customers.  
BP2 
Our firm’s corporate brand positioning strategy involves a long 
distribution chain.  
BP3 
Our firm’s corporate brand positioning strategy is to provide a much 
better service to our customers.  
BP4 
Our firm’s corporate brand positioning strategy tries to fulfil the 
basic needs of our customers.  
BP5 
Brand 
differentiation 
Our corporate brand is perceived differently according to whether 
consumers have experienced our products.  
BD1 
Our corporate brand is perceived differently by word of mouth.  BD2 
Our corporate brand is perceived differently by promotion. BD3 
Our corporate brand is actually created differently by product 
characteristics.  
BD4 
Our corporate branding may be directed at different market 
segments.  
BD5 
Our corporate brand may utilize physical product characteristics. BD6 
Our corporate brand may utilize non-physical product characteristics.  BD7 
Brand 
segmentation 
Our corporate brand strategy requires product differentiation.  BS1 
Our corporate brand strategy requires changes in point distribution 
location.  
BS2 
Our corporate brand strategy requires changes in importance attached 
to a non-physical product.  
BS3 
Our corporate brand strategy requires changes in importance attached 
to a physical product.  
BS4 
Our corporate brand strategy is decided by the needs of the 
customers when determining product differentiation.  
BS5 
Medicine price A medicine with a higher price shows a higher quality of product to 
our customers.  
PP1 
A medicine with a higher price shows a better image of the company 
it belongs to.  
PP2 
A medicine with a higher price usually captures the value that is 
generated in the product.  
PP3 
Our firm customizes price by value that is perceived by our 
customers.  
PP4 
Our firm customizes price by distinguishing between customers who 
pursue high values and customers with strict budgets. 
PP5 
Our firm customizes price by offering coupons, regional prices, 
limited consumption or negotiatory prices to a specific group of 
customers.  
PP6 
Our firm customizes price according to the characteristics of the 
customers.  
PP7 
Our firm customizes price according to the trading characteristics.  PP8 
Our firm pays considerable attention to effective publicity and 
communication while operating bulk buying/discounts.  
PP9 
Resource: Developed by the researcher 
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5.3.2 Descriptive statistical analysis of measurement items  
 
5.3.2.1 Value creation scales  
In terms of “value creation,” the mean values of the respective measurement items are 
between 3.590 and 4.508; the average score of the dimension is 3.943. The dimension 
with the highest score (4.508) was “Our firm competes by minimizing customer risk”. 
Other dimensions which were scored higher than the average were “Our firm 
competes by enabling ease of use of its products”, “Our firm’s value-chain activity is 
consistent with experiential value creation”, “The corporate reputation of our firm 
helps to reduce transaction costs”, “Our firm competes by creating useful products”, 
“Our firm competes by enhancing its customers’ self-worth”, “Our firm’s resource 
allocation is consistent with experiential value creation”, “Our firm’s resource 
allocation is consistent with functional value creation”, “Our firm’s value-chain 
activity is consistent with functional value creation”, “Our firm competes by 
providing product with appropriate outcomes”, “Our firm competes by providing 
good financial performances”, and “Our firm competes by minimizing customer risk”. 
  
The dimension with the lowest score (3.590) was “Our firm competes by facilitating 
self-expression”. Other dimensions which scored lower than the average were “Our 
firm competes by enhancing its customers’ self-identity”, “Our firm competes by 
enhancing its customers’ self-concept or self-image”, “Our firm competes by offering 
economic value”, “Our firm’s resource allocation is consistent with symbolic value 
creation”, “Our firm competes by creating appropriate emotions”, “Our firm competes 
by facilitating social relationships”, “Our firm’s products compete by appealing to the 
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senses”, “Our firm competes by creating epistemic value” and “Our firm competes by 
facilitating self-expression”. The above data is compiled in Table 5.3.  
 
Table 5.3: Descriptive statistical analysis of the value creation scales 
Item  Item 
code 
Mean of 
dimension Mean 
Std 
deviation Ranking 
  3.943    
1. The corporate reputation of our firm helps to 
reduce transaction costs.  
VC1  3.951 .921 9 
2. Our firm competes by creating useful products.  VC2  3.984 1.162 8 
3. Our firm competes by providing good financial 
performances.  
VC3  
4.393 .759 2 
4. Our firm competes by providing product with 
appropriate outcomes.  
VC4  4.311 .765 3 
5. Our firm’s value-chain activity is consistent with 
functional value creation.  
VC5  4.066 .750 4 
6. Our firm’s resource allocation is consistent with 
functional value creation.  
VC6  
4.049 .784 5 
7. Our firm’s products compete by appealing to the 
senses.  
VC7  3.623 1.267 18 
8. Our firm competes by creating appropriate 
emotions (e.g. fun, pleasure, excitement, 
relaxation, etc.)  
VC8  
3.738 1.182 16 
9. Our firm competes by facilitating social 
relationships (e.g. bonds, attachments and 
togetherness).  
VC9  
3.656 1.209 17 
10. Our firm competes by creating epistemic value 
(e.g. knowledge and novelty).  
VC10  3.623 1.098 19 
11. Our firm’s value-chain activity is consistent with 
experiential value creation (e.g. happiness, 
affection and excitement...).  
VC11  
3.951 .939 10 
12. Our firm’s resource allocation is consistent with 
experiential value creation.  
VC12  4.016 .866 6 
13. Our firm competes by enhancing its customers’ 
self-identity.  
VC13  3.885 1.127 12 
14. Our firm competes by enhancing its customers’ 
self-concept (or self-image).  
VC14  3.885 1.185 13 
15. Our firm competes by enhancing its customers’ 
self-worth.  
VC15  4.000 1.155 7 
16. Our firm competes by facilitating self-expression.  VC16  3.590 1.202 20 
17. Our firm competes by offering economic value 
(low prices, value in use, life costs).  
VC17  3.885 1.142 14 
18. Our firm competes by enabling ease of use of its 
products (time, effort, energy).  
VC18  3.951 .990 11 
19. Our firm competes by minimizing customer risk 
(personal, technological, strategic).  
VC19  4.508 .722 1 
20. Our firm’s resource allocation is consistent with 
symbolic value creation.  
VC20  3.787 1.002 15 
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5.3.2.2 Strategic resource scales  
In terms of “strategic resources”, the mean values for the respective measurement 
items are between 3.525 and 4.426, and the mean dimension is 4.103. The dimension 
with the highest score (4.426) was “Our firm’s corporate reputation gains the firm 
more opportunity for strategic alliance or business cooperation”. Other dimensions 
which were scored higher than the average were “Our firm’s corporate reputation 
implies that we are able to enter markets early”, “Our firm’s corporate reputation 
helps the strategic link with complementary products”, “Our firm’s corporate 
reputation implies efficient sales and marketing”, “Our firm’s corporate reputation 
enables the firm to enter the market more easily”, “Our firm’s corporate reputation 
helps a new product to enter the market”, “Our firm’s corporate reputation gains more 
customers for the firm”, “Our firm’s corporate reputation makes the marketing system 
work more efficiently”, “In our organization, corporate reputation serves as a 
competitive advantage”, “Our firm’s corporate reputation sends a strong signal to its 
customers”, “‘Our firm’s corporate reputation makes it easier for us to find a 
downstream reseller”, and “Our firm’s corporate reputation gains the firm more 
opportunity for strategic alliance or business cooperation” are higher than the mean 
dimension. The dimension with the lowest score (3.525) was “Our firm’s corporate 
reputation implies it has advanced R&D”. Other dimensions which were scored lower 
than the average were “Our firm’s corporate reputation can enhance our firm’s sales 
force”, “Our firm’s corporate reputation is enhancing our prices by validating them in 
published clinical reports” and “Our firm’s corporate reputation implies it has 
advanced R&D”. The above data is compiled in Table 5.4. 
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Table 5.4: Descriptive statistical analysis of strategic values and resource scales 
Item 
Item 
code Mean of dimension Mean 
Std 
devia-
tion 
Rank-
ing 
  4.103    
1. In our organization, corporate reputation 
serves as a competitive advantage. 
SR1 
 4.262 .893 4 
2. Our firm’s corporate reputation sends a 
strong signal to its customers. 
SR2 
 4.279 .915 3 
3. Our firm’s corporate reputation implies 
efficient sales and marketing. 
SR3 
 4.148 .813 9 
4. Our firm’s corporate reputation implies 
it has advanced R&D. 
SR4 
 3.525 1.246 14 
5. Our firm’s corporate reputation implies 
that we are able to enter markets early. 
SR5 
 4.115 .950 11 
6. Our firm’s corporate reputation gains 
the firm more opportunity for strategic 
alliance or business cooperation. 
SR6 
 4.426 .805 1 
7. Our firm’s corporate reputation is 
enhancing our prices by validating them in 
published clinical reports. 
SR7 
 3.590 1.174 13 
8. Our firm’s corporate reputation enables 
the firm to enter the market more easily. 
SR8 
 4.164 .969 8 
9. Our firm’s corporate reputation gains 
more customers for the firm. 
SR9 
 4.213 .897 6 
10. Our firm’s corporate reputation makes 
the marketing system work more 
efficiently. 
SR10 
 4.213 .859 5 
11. Our firm’s corporate reputation makes 
it easier for us to find a downstream 
resaler. 
SR11 
 4.328 .908 2 
12. Our firm’s corporate reputation can 
enhance our firm’s sales force. 
SR12 
 3.852 1.06 2 12 
13. Our firm’s corporate reputation helps a 
new product to enter the market. 
SR13 
 4.180 .958 7 
14. Our firm’s corporate reputation helps 
the strategic link with complementary 
products. 
SR14 
 4.148 1.078 10 
 
5.3.2.3 Corporate communication scales  
In terms of “corporate communication,” the mean values of the respective 
measurement items are between 3.213 and 4.344. The mean of dimension is 3.977. 
The dimension with the highest score (4.344) was “Our firm’s corporate reputation 
builds a relationship between the firm and its customers”. Other dimensions which 
were scored higher than the average were “Our firm’s corporate reputation 
influences consumer choices”, “Our firm’s corporate reputation shapes the 
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perceptions of shareholders and other stakeholders”, “Our firm’s corporate 
reputation helps external communication”, and “Our firm’s corporate reputation 
builds a relationship between the firm and its customers”. The dimension with the 
lowest score (3.213) was “Our firm’s corporate reputation is based on the 
experience of the sales staff”. Other dimensions which scored lower than the average 
were “Our firm’s corporate reputation is based on the sales ability of the sales 
staff”, “Our firm’s corporate reputation helps internal communication” and 
“Our firm’s corporate reputation is based on the experience of the sales staff.” 
The above data is compiled in Table 5.5. 
 
 
Table 5.5: Descriptive statistical analysis of corporate communication scales  
Item Item 
code 
Mean of 
dimension Mean 
Std. 
deviation Ranking 
  3.977    
1. Our firm’s corporate reputation shapes the 
perceptions of shareholders and other 
stakeholders. 
CC1 
 4.180 .806 3 
2. Our firm’s corporate reputation builds a 
relationship between the firm and its customers. 
CC2 
 4.344 .750 1 
3. Our firm’s corporate reputation influences 
consumer choices. 
CC3 
 4.148 1.014 4 
4. Our firm’s corporate reputation is based on the 
experience of the sales staff. 
CC4 
 3.213 1.185 7 
5. Our firm’s corporate reputation is based on the 
sales ability of the sales staff. 
CC5 
 3.869 .885 5 
6. Our firm’s corporate reputation helps internal 
communication (the communication between our 
firm and our staff). 
CC6 
 3.820 1.133 6 
7. Our firm’s corporate reputation helps external 
communication (the communication between our 
firm and our customers). 
CC7 
 4.262 .728 2 
 
 
5.3.2.4 Brand positioning scales  
In terms of “brand positioning,” the mean values of the respective measurement items 
are between 3.852 and 4.443. The mean of dimension is 3.977. The dimension with 
the highest score (4.443) was “Our firm’s corporate brand positioning strategy 
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signifies better product performance for its customers”. Other dimensions which 
scored higher than the average were “Our firm’s corporate brand positioning strategy 
is to provide a much better service to its customers”, “Our firm’s corporate brand 
positioning strategy signifies high quality to its customers’, and ‘Our firm’s corporate 
brand positioning strategy signifies better product performance for its customers”. 
The dimension with the lowest score (3.852) was “Our firm’s corporate brand 
positioning strategy involves a long distribution chain”. Another dimension which 
scored lower than the average was “Our firm’s corporate brand positioning strategy 
tries to fulfil the basic needs of our customers” and “Our firm’s corporate brand 
positioning strategy involves a long distribution chain.” The above data is compiled in 
Table 5.6. 
 
Table 5.6: Descriptive statistical analysis of brand positioning scales 
Item 
Item 
code Mean of dimension Mean 
Std. 
deviati
on 
Rankin
g 
  4.220    
1. Our firm’s corporate brand positioning 
strategy signifies high quality to its customers. 
BP1 
 4.410 .783 2 
2. Our firm’s corporate brand positioning 
strategy signifies better product performance for 
its customers. 
BP2 
 4.443 .696 1 
3. Our firm’s corporate brand positioning 
strategy involves a long distribution chain. 
BP3 
 3.852 1.167 5 
4. Our firm’s corporate brand positioning 
strategy is to provide a much better service to its 
customers. 
BP4 
 4.246 .907 3 
5. Our firm’s corporate brand positioning 
strategy tries to fulfil the basic needs of our 
customers. 
BP5 
 4.148 .963 4 
 
5.3.2.5 Brand differentiation scales  
In terms of “product differentiation,” the mean values of the respective 
measurement items are between “3.361 and 4.098. The mean of dimension is 3.827. 
The dimension with the highest score (4.098) was “Our corporate brand is perceived 
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differently according to whether consumers have experienced our products”. Other 
dimensions which scored higher than the average were “Our corporate brand is 
perceived differently by word of mouth”, “Our corporate branding may be directed 
at different market segments”, ‘Our firm’s corporate brand positioning strategy is 
based on advanced R&D which meets the needs of the targeted market” and “Our 
corporate brand is perceived differently according to whether consumers have 
experienced our products.” The dimension with the lowest score (3.361) was “Our 
corporate brand is perceived differently by promotion”. Other dimensions which 
scored lower than the average were “Our corporate brand may utilize non-physical 
product characteristics”, “Our corporate brand is actually created differently by 
product characteristics”, and “Our corporate brand is perceived differently by 
promotion.” The above data is compiled in Table 5.7. 
 
 
Table 5.7: Descriptive statistical analysis of brand differentiation scales 
Item 
Item 
code Mean of dimension Mean 
Std. 
deviati
on 
Rankin
g 
  3.827    
1. Our corporate brand is perceived 
differently according to whether consumers 
have experienced our products. 
BD1 
 4.098 .851 1 
2. Our corporate brand is perceived 
differently by word of mouth. 
BD2 
 3.869 1.056 4 
3. Our corporate brand is perceived 
differently by promotion. 
BD3 
 3.361 1.330 7 
4. Our corporate brand is actually created 
differently by product characteristics. 
BD4 
 3.639 1.126 6 
5. Our corporate branding may be directed at 
different market segments. 
BD5 
 4.066 .946 3 
6. Our corporate brand may utilize non-
physical product characteristics. 
BD6 
 3.689 1.177 5 
7. Our firm’s corporate brand positioning 
strategy is based on advanced R&D which 
meets the needs of the targeted market. 
BD7 
 4.066 .998 2 
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5.3.2.6 Brand segmentation scales 
In terms of “brand segmentation,” the mean values of the respective measurement 
items are between 3.426 and 3.902. The mean of dimension is 3.643. The dimension 
with the highest score (3.902) was “Our corporate brand strategy requires product 
differentiation”. Another dimension which scored higher than the average was 
“Our corporate brand strategy requires changes in importance attached to a physical 
product” and “Our corporate brand strategy requires product differentiation.” The 
dimension with the lowest score (3.426) was “Our corporate brand strategy requires 
changes in importance attached to a non-physical product”. Other dimensions which 
scored lower than the average were “Our corporate brand strategy is decided by the 
needs of the customers when determining product differentiation” and “Our 
corporate brand strategy requires changes in point distribution location” and “Our 
corporate brand strategy requires changes in importance attached to a nonphysical 
product.” The above data is compiled in Table 5.8. 
 
 
Table 5.8: Descriptive statistical analysis of brand segmentation scales 
Item Item 
code 
Mean of 
dimension Mean 
Std. 
deviation Ranking 
  3.643    
1. Our corporate brand strategy requires 
product differentiation. 
BS1 
 3.902 .995 1 
2. Our corporate brand strategy requires 
changes in point distribution location. 
BS2 
 3.508 1.233 4 
3. Our corporate brand strategy requires 
changes in importance attached to a non-
physical product. 
BS3 
 3.426 1.117 5 
4. Our corporate brand strategy requires 
changes in importance attached to a physical 
product. 
BS4 
 3.869 1.008 2 
5. Our corporate brand strategy is decided by 
the needs of the customers when 
determining product differentiation. 
BS5 
 3.508 1.337 3 
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5.3.2.7 Medicine price scales 
In terms of “medicine price,” the mean values of the respective measurement items 
are between 3.230 and 3.803. The mean of dimension is 3.446. The dimension with 
the highest score (3.803) was “Our firm pays considerable attention to effective 
publicity and communication while operating bulk buying/discounts”. Other 
dimensions which scored higher than the average were “Our firms customize price 
according to the trading characteristics”, “A medicine with a higher price shows a 
better image of the company it belongs to”, “A medicine with a higher price 
usually captures the value that is generated in the product”, and “Our firm pays 
considerable attention to effective publicity and communication while operating bulk 
buying/discounts.” The dimension with the lowest score (3.230) was “Our firm 
customizes price by value that is perceived by our customers”. Other dimensions 
which were scored lower than the average were “A medicine with a higher price 
shows a higher quality of product to its customers”, “Our firm customizes price 
according to the characteristics of the customers”, “Our firm customizes price by 
offering coupons, regional prices, limited consumption or negotiatory prices to a 
specific group of customers”, “Our firm customizes price by distinguishing 
between customers who pursue high values and customers with strict budgets” and 
“Our firm customizes price by value that is perceived by our customers.” The 
above data is compiled in Table 5.9. 
 
 
Table 5.9: Descriptive statistical analysis of medicine price scales 
               Item 
Item 
code Mean of dimension Mean 
Std. 
deviat
ion 
Ranking 
  3.446    
1. A medicine with a higher price shows 
a higher quality of product to its 
customers.  
PP1 
 3.410 1.243 5 
2. A medicine with a higher price shows a 
better image of the company it belongs to. 
PP2 
 3.508 1.299 3 
3. A medicine with a higher price usually PP3  3.721 1.127 2 
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captures the value that is generated in the 
product.  
4. Our firm customizes price by value that 
is perceived by our customers. 
PP4 
 3.230 1.383 9 
5. Our firm customizes price by 
distinguishing between customers who 
pursue high values and customers with 
strict budgets. 
PP5 
 3.262 1.303 8 
6. Our firm customizes price by offering 
coupons, regional prices, limited 
consumption or negotiatory prices to a 
specific group of customers. 
PP6 
 3.295 1.321 7 
7. Our firm customizes price according to 
the characteristics of the customers. 
PP7 
 3.295 1.229 6 
8. Our firms customize price according to 
the trading characteristics. 
PP8 
 3.492 1.120 4 
9. Our firm pays considerable attention to 
effective publicity and communication 
while operating bulk buying/discounts. 
PP9 
 3.803 1.166 1 
 
 
5.4 Confirmatory factor analysis (CFA) (questionnaire reliability and 
validity analysis/measurement model analysis) 
 
The validity and reliability of the questionnaire in this research were tested through 
confirmatory factor analysis (CFA) and Cronbach’s coefficient as described below. 
This section is divided into two parts: the validity analysis and the reliability analysis. 
 
5.4.1 Validity analysis  
 
In this study, the confirmatory factor analysis has been adopted to test the suitability 
of the respective dimension measurement models in order to determine whether the 
dimensions have enough convergent validity and discriminant validity. The 
convergent validity and discriminant validity are analysed as follows. 
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 5.4.1.1 Convergent validity analysis 
In this study, evaluations were based on the convergent validity analysis criteria 
suggested by Anderson and Gerbing (1988), the confirmatory factor analysis (CFA) 
criteria proposed by Bagozzi and Yi (1988) and the goodness of fit (GoF) proposed by 
Gefen, Straub and Boudreau (2000). The three evaluation criteria are: (1) the factor 
loadings of all indicators have reached significance; (2) the Composite Reliability 
(CR) of the dimensions is higher than 0.7; (3) the average variance extracted (AVE) is 
higher than 0.5. Data analysis of the items in the dimensions was then conducted 
using PLS1.04. 
 
Value creation scales  
In the measurement model of “value creation scales”, the Cronbach Alpha is 0.938, 
and the factor loadings of the respective measurement indicators have reached 
significance; the Composite Reliability (CR) and the Average Variance Extracted 
(AVE) are 0.945 and 0.469 respectively, indicating the CR and AVE are both higher 
than 0.7 and 0.4. Therefore, the data analysis shows that the convergent validity of 
“value creation” is within the acceptance range. This data is compiled in Table 5.10. 
 
Table 5.10: Confirmatory factor analysis of value creation 
Variable 
 Estimated MLE 
parameter 
Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor 
loading 
(λx) 
Measure-
ment error 
(δ) 
   0.945 0.469 
1. The corporate reputation of our firm helps to reduce 
transaction costs.  0.590  0.652    
2. Our firm competes by creating useful products.  0.462  0.786    
3. Our firm competes by providing good financial 
performances.  0.644  0.585    
4. Our firm competes by providing products with 
appropriate outcomes.  0.607  0.631    
5. Our firm’s value-chain activity is consistent with 0.548  0.700    
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Table 5.10: Confirmatory factor analysis of value creation 
Variable 
 Estimated MLE 
parameter 
Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor 
loading 
(λx) 
Measure-
ment error 
(δ) 
functional value creation.  
6. Our firm’s resource allocation is consistent with 
functional value creation.  0.623  0.612    
7. Our firm’s products compete by appealing to the 
senses.  
0.783  0.387    
8. Our firm competes by creating appropriate emotions 
(e.g. fun, pleasure, excitement, relaxation, etc.)  0.675  0.545    
9. Our firm competes by facilitating social relationships 
(e.g. bonds, attachments and togetherness).  0.693  0.520    
10. Our firm competes by creating epistemic value (e.g. 
knowledge and novelty).  0.652  0.575    
11. Our firm’s value-chain activity is consistent with 
experiential value creation (e.g. happiness, affection and 
excitement...).  
0.743  0.449    
12. Our firm’s resource allocation is consistent with 
experiential value creation.  0.714  0.491    
13. Our firm competes by enhancing its customers’ self-
identity.  0.858  0.263    
14. Our firm competes by enhancing its customers’ self-
concept (or self-image).  0.865  0.252    
15. Our firm competes by enhancing its customers’ self-
worth.  0.893  0.202    
16. Our firm competes by facilitating self-expression.  0.791  0.375    
17. Our firm competes by offering economic value (low 
prices, value in use, life costs).  0.656  0.569    
18. Our firm competes by enabling ease of use of its 
products (time, effort, energy).  0.593  0.648    
19. Our firm competes by minimizing customer risk 
(personal, technological, strategic).  0.436  0.810    
20. Our firm’s resource allocation is consistent with 
symbolic value creation.  0.651  0.576    
Cronbach Alpha =0.938; the factor loading is a standardized value, indicating p<0.001 
 
Strategic value and resources scales 
In the measurement model of “value creation and resources scales,” the Cronbach 
Alpha is 0.955, and the factor loadings of the respective measurement indicators have 
reached significance; the Composite Reliability (CR) and Average Variance Extracted 
(AVE) are 0.964 and 0.662 respectively, indicating the CR and AVE are both higher 
than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of 
“strategic value and resources scales” is within the acceptance range. This data is 
compiled in Table 5.11. 
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Table 5.11: Confirmatory factor analysis of strategic value and resources scales 
Variable 
Estimated MLE parameter  Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.964 0.662 
1. In our organization, corporate reputation 
serves as a competitive advantage. 0.793  0.371    
2. Our firm’s corporate reputation sends a 
strong signal to its customers. 0.895  0.200    
3. Our firm’s corporate reputation implies 
efficient sales and marketing. 0.788  0.380    
4. Our firm’s corporate reputation implies it 
has advanced R&D. 0.668  0.554    
5. Our firm’s corporate reputation implies 
that we are able to enter markets early. 0.892  0.204    
6. Our firm’s corporate reputation gains the 
firm more opportunity for strategic alliance 
or business cooperation. 
0.813  0.339    
7. Our firm’s corporate reputation is 
enhancing prices by validating them in 
published clinical reports. 
0.692  0.521    
8. Our firm’s corporate reputation enables 
the firm to enter the market more easily. 0.935  0.127    
9. Our firm’s corporate reputation gains 
more customers for the firm. 0.830  0.312    
10. Our firm’s corporate reputation makes 
the marketing system work more efficiently. 0.904  0.183    
11. Our firm’s corporate reputation makes it 
easier for us to find a downstream resaler. 0.838  0.299    
12. Our firm’s corporate reputation can 
enhance our firm’s sales force. 0.588  0.655    
13. Our firm’s corporate reputation helps a 
new product to enter the market. 0.916  0.161    
14. Our firm’s corporate reputation helps the 
strategic link with complementary products. 0.756  0.428    
Cronbach Alpha =0.955; the factor loading is a standardized value, indicating p<0.001 
 
Corporate communication scales 
In the measurement model of “corporate communication scales,” the Cronbach 
Alpha is 0.840, and the factor loadings of the respective measurement indicators have 
reached significance; the Composite Reliability (CR) and Average Variance Extracted 
(AVE) are 0.892 and 0.547 respectively, indicating the CR and AVE are both higher 
than 0.7 and 0.5. Therefore, the data analysis shows that the convergent validity of 
“corporate communication” is within the acceptance range. This data is compiled 
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in Table 5.12. 
 
 
Table 5.12: Confirmatory factor analysis of corporate communication scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.892 0.547 
1. Our firm’s corporate reputation shapes the 
perceptions of shareholders and other 
stakeholders. 
0.816  0.335    
2. Our firm’s corporate reputation builds a 
relationship between the firm and its 
customers. 
0.827  0.316    
3. Our firm’s corporate reputation influences 
consumer choices. 0.637  0.594    
4. Our firm’s corporate reputation is based 
on the experience of the sales staff. 0.545  0.703    
5. Our firm’s corporate reputation is based 
on the sales ability of the sales staff. 0.741  0.451    
6. Our firm’s corporate reputation helps 
internal communication (the communication 
between our firm and our staff). 
0.767  0.412    
7. Our firm’s corporate reputation helps 
external communication (the communication 
between our firm and our customers). 
0.798  0.364    
Cronbach Alpha =0.840; the factor loading is a standardized value, indicating p<0.001 
 
Brand positioning scales 
In the measurement model of “brand positioning scales,” the Cronbach Alpha is 
0.851, and the factor loadings of the respective measurement indicators have reached 
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE) 
are 0.902 and 0.650 respectively, indicating the CR and AVE are both higher than 0.7 
and 0.5. Therefore, the data analysis shows that the convergent validity of “brand 
positioning” is within the acceptance range. This data is compiled in Table 5.13. 
 
Table 5.13: Confirmatory factor analysis of brand positioning scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
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Table 5.13: Confirmatory factor analysis of brand positioning scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.902 0.650 
1. Our firm’s corporate brand positioning 
strategy signifies high quality to its 
customers. 
0.751  0.437    
2. Our firm’s corporate brand positioning 
strategy signifies better product performance 
for its customers. 
0.866  0.250    
3. Our firm’s corporate brand positioning 
strategy involves a long distribution chain. 0.816  0.335    
4. Our firm’s corporate brand positioning 
strategy is to provide a much better service 
to its customers. 
0.878  0.230    
5. Our firm’s corporate brand positioning 
strategy tries to fulfil the basic needs of our 
customers. 
0.707  0.500    
Cronbach Alpha =0.851; the factor loading is a standardized value, indicating p<0.001 
 
Brand differentiation scales  
In the measurement model of “brand differentiation scales,” the Cronbach Alpha is 
0.874, and the factor loadings of the respective measurement indicators have reached 
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE) 
are 0.909 and 0.590 respectively, indicating the CR and AVE are both higher than 0.7 
and 0.5. Therefore, the data analysis shows that the convergent validity of “product 
differentiation” is within the acceptance range. This data is compiled in Table 5.14. 
 
Table 5.14: Confirmatory factor analysis of brand differentiation scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.909 0.590 
1. Our corporate brand is perceived 
differently according to whether consumers 
have experienced our products. 
0.813  0.340    
2. Our corporate brand is perceived 
differently by word of mouth. 0.752  0.434    
3. Our corporate brand is perceived 
differently by promotion. 0.679  0.539    
4. Our corporate brand is actually created 0.852  0.275    
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Table 5.14: Confirmatory factor analysis of brand differentiation scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
differently by product characteristics. 
5. Our corporate branding may be directed at 
different market segments. 0.779  0.393    
6. Our corporate brand may utilize non-
physical product characteristics. 0.664  0.559    
7. Our firm’s corporate brand positioning 
strategy is based on advanced R&D which 
meets the needs of the targeted market. 
0.818  0.331    
Cronbach Alpha =0.874; the factor loading is a standardized value, indicating p<0.001 
 
Brand segmentation scales 
In the measurement model of “brand segmentation scales,” the Cronbach Alpha is 
0.896, and the factor loadings of the respective measurement indicators have reached 
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE) 
are 0.927 and 0.717 respectively, indicating the CR and AVE are both higher than 0.7 
and 0.5. Therefore, the data analysis shows that the convergent validity of “product 
segmentation” is within the acceptance range. This data is compiled in Table 5.15. 
 
Table 5.15: Confirmatory factor analysis of product segmentation scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.927 0.717 
1. Our corporate brand strategy requires 
product differentiation. 0.836  0.300    
2. Our corporate brand strategy requires 
changes in point distribution location. 0.909  0.174    
3. Our corporate brand strategy requires 
changes in importance attached to a non-
physical product. 
0.879  0.227    
4. Our corporate brand strategy requires 
changes in importance attached to a physical 
product. 
0.816  0.334    
5. Our corporate brand strategy is decided by 
the needs of the customers when 
determining product differentiation. 
0.788  0.378    
Cronbach Alpha =0.896; the factor loading is a standardized value, indicating p<0.001 
` 
200 
 
 
Medicine price scales  
In the measurement model of “medicine price scales,” the Cronbach Alpha is 0.906, 
and the factor loadings of the respective measurement indicators have reached 
significance; the Composite Reliability (CR) and Average Variance Extracted (AVE) 
are 0.924 and 0.577 respectively, indicating the CR and AVE are both higher than 0.7 
and 0.5. Therefore, the data analysis shows that the convergent validity of “medicine 
price scales” is within the acceptance range. This data is compiled in Table 5.16. 
 
Table 5.16: Confirmatory factor analysis of medicine price scales 
Variable 
Estimated MLE parameter Compo
-site 
Relia-
bility 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Factor loading 
(λx) 
Measure-
ment error 
(δ) 
   0.924 0.577 
1. A medicine with a higher price shows a 
higher quality of product to its 
customers.  
0.724  0.476    
2. A medicine with a higher price shows a 
better image of the company it belongs to. 0.660  0.565    
3. A medicine with a higher price usually 
captures the value that is generated in the 
product.  
0.654  0.573    
4. Our firm customizes price by value that is 
perceived by our customers. 0.728  0.471    
5. Our firm customizes price by 
distinguishing between customers who 
pursue high values and customers with strict 
budgets.  
0.851  0.275    
6. Our firm customizes price by offering 
coupons, regional prices, limited 
consumption or negotiatory prices to a 
specific group of customers. 
0.794  0.370    
7. Our firm customizes price according to 
the characteristics of the customers. 0.878  0.228    
8. Our firms customize price according to 
the trading characteristics. 0.824  0.320    
9. Our firm pays considerable attention to 
effective publicity and communication while 
operating bulk buying/discounts. 
0.685  0.531    
Cronbach Alpha =0.906; the factor loading is a standardized value, indicating p<0.001 
 
5.4.1.2 Discriminant validity analysis 
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The study was conducted in line with the two criteria of discriminant validity 
proposed by Gask and Nevin (1985): (1) the correlational coefficient between the two 
dimensions is less than 1; (2) the correlational coefficients of the two dimensions are 
smaller than the individual Cronbach’s reliability coefficients, indicating the two 
dimensions possess discriminant validity. In addition, following Fornell and Larcker 
(1981), a third criterion for determining the discriminant validity has been proposed: 
(3) the correlational coefficients of the two dimensions are smaller than the square 
root of AVE, indicating that the two dimensions possess discriminant validity. In this 
study, SPSS 15.0 and PLS 1.04 were used to analyse the correlational coefficient 
matrixes of the measurement variables. The analysis data results as shown in Table 
5.16 are consistent with the three discriminant validity criteria mentioned above, 
indicating good discriminant validity.  
 
5.4.2 Reliability analysis  
 
The study was conducted in accordance with the internal consistency of the 
Cronbach’s coefficient questionnaire (as shown in Table 5.16) proposed by Bagozzi 
and Yi (1988). In terms of the respective scales, the items were examined to determine 
whether or not the item-total correlations of the respective items are higher than 0.5. 
The Cronbach’s coefficient of the “value creation” dimension is greater than 0.5, 
indicating that the “value creation” scales possess good reliability and internal 
consistency. The Cronbach’s coefficient of the “strategic resources” is 0.955, and the 
item-total correlations are all greater than 0.5, indicating that the “strategic resources” 
scales possess good reliability and internal consistency. The Cronbach’s coefficient of 
the “corporate communication” dimension is 0.840, and the item-total correlations are 
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all greater than 0.5, indicating that the “corporate communication” scales possess 
good reliability and internal consistency. The Cronbach’s coefficient of the “brand 
segmentation” dimension is 0.896, and the item-total correlations are all greater than 
0.5, indicating that the“brand segmentation” scales possess good reliability and 
internal consistency. The Cronbach’s coefficient of the “brand differentiation” 
dimension is 0.874, and the item-total correlations are all greater than 0.5, indicating 
that the “brand segmentation” scales possess good reliability and internal consistency. 
The Cronbach’s coefficient of the “brand positioning” dimension is 0.851, and the 
item-total correlations are all greater than 0.5, indicating the “brand segmentation” 
scales possess good reliability and internal consistency. The Cronbach’s coefficient of 
the “medicine price” dimension is 0.906, and the item-total correlations are all greater 
than 0.5, indicating that the “medicine price” scales possess good reliability and 
internal consistency. This data is compiled in Table 5.17.       
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        Table 5.17: Table of discriminant validity analysis and correlational coefficients of variables 
Dimension  Value 
creation 
Strategic 
resources 
Corporate 
communication  
Brand 
segmentation 
Brand 
differentiation 
Brand 
positioning 
Medicine 
price 
CR AVE 
Composite 
Reliability 
(CR) 
Average 
Variance 
Extracted 
(AVE) 
Value creation .777       0.945 0.469 
Strategic 
resources 
.829 .871      
0.964 0.662 
Corporate 
communication 
.751 .745 .818     
0.892 0.547 
Brand 
segmentation 
.730 .755 .805 .895    
0.927 0.717 
Brand 
differentiation 
.796 .790 .825 .947 .839   
0.909 0.590 
Brand 
positioning 
.826 .847 .762 .830 .867 .866  
0.902 0.650 
Product price .546 .586 .484 .636 .579 .527 .836 0.924 0.577 
Mean          
Variance          
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Cornbach’s α 0.938 0.955 0.840 0.896 0.874 0.851 0.906   
        The diagonal value is the square root of AVE; CR represents Composite Reliability; AVE represents Average Variance Extracted; the lower triangle is   
        Pearson correlation. 
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5.5 Structural Equation Modelling Analysis  
 
To further validate the relationship between each dimension based on the conceptual 
framework mentioned in this study, structural equation modelling analysis was 
conducted to understand the relationship of the modelling as a whole. The overall 
structural equation modelling combines the factor analysis and path analysis of 
traditional statistics. In addition, the simultaneous equation in econometrics was 
included to simultaneously process the relationship of a series of dependent variables, 
which is suitable for the discussion of the causal relationship of the overall modelling in 
this study. Therefore, in order to further examine the relationship between each 
dimension mentioned in the theoretical framework in this section, all the samples 
underwent structural equation modelling analysis to verify the conceptual framework 
mentioned in this study and to understand the relationship between each dimension. 
 
With regard to the analysis procedures of the structural equation modelling, in this study 
the two-stage structural equation modelling analysis proposed by Anderson and Gerbing 
(1988) and Williams and Hazer (1986) was conducted: (1) the first stage targets the 
respective research dimensions and items to conduct confirmatory factor analysis and 
Cronbach’s coefficient analysis. Moreover, through analysis of convergent validity, 
discriminant validity and reliability, a stable measurement model was developed; (2) the 
second stage focuses on the reduction of multiple measurement items into a few 
measurement indicators in which the structural model was used to verify the hypotheses 
in this study. The advantage of the two-stage analysis is that the measurement model 
and structural model were differentiated. If the reason for the test results not reaching 
significance cannot be ascertained, the analysis can still help researchers to clarify 
questions related to the measurement model or the dimensions. The stage 1 analysis can 
be found in 5.3 of this chapter, so it will not be explained further in this section. In this 
section, the stage 2 to 4 analyses are included. 
 
5.5.1 Development of the Overall Modelling  
 
Section 5.3 of this chapter shows that the measurement models of the respective 
dimensions are stable. In addition, the convergent validity, discriminant validity and 
reliability have all reached acceptable standards. Since the variables in the research 
framework are within a single dimension, the single dimension was adopted during the 
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verification. Therefore, in terms of the measurement models of “value creation”, 
“strategic resource”, “corporate communication”, “brand differentiation”, “brand 
segmentation”, “brand positioning” and “medicine price”, the scores of the 
measurement items in the respective dimensions served as the measurement indicators 
to measure the theoretical model. In this study, there are 61 samples for analysis using 
the PLS package software. At the same time, the correlational coefficient matrixes of 
the respective measurement variables are as shown in Table 5.18. The measurement 
variables that are correlated have reached significance, indicating the structural equation 
modelling analysis is suitable. 
 
5.5.2 Hypothesis Validation and Result Analysis  
 
As the PLS gives emphasis to the capabilities of the formative indicators and reflective 
indicators, while the concomitant variable estimation methods for the different indicator 
samples vary, the measurement values of the Goodness of Fit (GoF) have not been 
provided. The explanatory power of the model is represented by R square, which 
indicates an ability of the cause indicators to explain the potential variables. The size of 
the load value determines the strength of the respective indicators in affecting the 
dimensions, and the path coefficients are standardized estimation values in which their 
significance can be determined by the p-value obtained from the Bootstrapping analysis. 
The structural modelling analysis results in this study are as follows: in the structural 
model, the forecast variables are “value creation”, “strategic resources” and “corporate 
communication”, which were used to predict the dependent variables including “brand 
segmentation”, “brand differentiation” and “brand positioning”. In terms of the 
regression model, with “brand segmentation” as a dependent variable, the standardized 
value for “value creation” is 0.232 (t-value=1.537), the standardized value of “strategic 
resources” is 0.164 (t-value=1.521), the standardized value of “corporate 
communication” is 0.517 (t-value=3.679) and the model’s explanatory power R is 0.723. 
In terms of the regression model, with “brand differentiation” as a dependent variable, 
the standardized value of “value creation” is 0.334 (t-value=2.459), the standardized 
value of “strategic resources” is 0.143 (t-value=1.256), the standardized value of 
“corporate communication” is 0.477 (t-value=3.878) and the model’s explanatory power 
R is 0.783. In terms of the regression model, with “brand positioning” as a dependent 
variable, the standardized value of “value creation” is 0.327 (t-value=2.595), the 
standardized value of “strategic resources” is 0.363 (t-value=1.996), the standardized 
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value of “corporate communication” is 0.278 (t-value=2.643) and the model’s 
explanatory power R is 0.808. A model with path values and t-values is shown in Figure 
5.2. 
 
Figure 5.2: Path values (structural path relationships) and t-value (significance of 
structural path based on t-value) in brackets 
 
 
In this study, with “medicine price” as the regulatory variable, the effect of the uses of 
corporate reputation on brand image strategy was explored. The analysis results have 
found that the standardized estimate value of the uses of corporate reputation is 0.736 (t-
value=11.444), the standardized estimate value of medicine price is 0.211 (t-
value=3.223), the standardized estimate value of the regulatory effect variables between 
the uses of corporate reputation and brand image strategy is -0.177 (t-value=-3.068), 
while the explanatory power R of the model is 0.845. The result findings show that 
medicine price has a negative moderating effect on the uses of corporate reputation in 
“brand image strategy” (Please refer to Figure 5.2). In other words, the more recognized 
medicine price is, the less helpful its role will be in having an effect on the the uses of 
corporate reputation in brand image strategy. The negative effect of medicine price on 
brand image strategy will interfere with the positive effect of the uses of corporate 
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reputation in brand image strategy. A model of the moderating effect between the 
relationship of the uses of corporate reputation and brand image strategy is shown in 
Figure 5.3. 
 
Figure. 5.3: Moderating effect between the relationship of the uses of corporate 
reputation and brand image strategy 
 
Table 5.18: Table of standardized path coefficients and hypothesis validation of the 
research model 
Hypothesis Path Correlation between dimensions Path 
coefficient 
t-value Test results 
H1 β1 Value creation  Brand segmentation 
(VCBS) 
0.232 1.537 Rejected 
H2 β4 Value creation  Brand differentiation 
(VCBD) 
0.334* 2.459 Accepted 
H3 β7 Value creation  Brand positioning 
(VCBP) 
0.327* 2.595 Accepted 
H4 β2 Strategic resources  Brand 
segmentation (SRBS) 
0.164 1.521 Rejected 
H5 β5 Strategic resources  Brand 
differentiation (SRBD) 
0.143 1.256 Rejected 
H6 β8 Strategic resources  Brand positioning 
(SRBP) 
0.363* 1.996 Accepted 
H7 β3 Corporate communication  Brand 
segmentation (CCBS) 
0.517* 3.679 Accepted 
H8 β6 Corporate communication  Brand 
differentiation (CCBD) 
0.477* 3.878 Accepted 
H9 β9 Corporate communication  Brand 
positioning (CCBP) 
0.278* 2.643 Accepted 
H10 β10 Moderating effects of medicine 
priceBrand image  
-0.177* -3.0768 Accepted 
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According to the results, we assume that there were some issues as follows. First, the 
comparatively small sample size with some of the constructs having too many items (i.e. 
there are 20 items in the value creation construct). To reduce the number of items, some 
items, based on factor loading below 0.7, are deleted. Only those items which have with 
higher loadings are retained.  Second, there is a lack of discriminant validity in the 
analysis. For the above reason, the model was run again with the constructs of the 
deleted items. 
 
5.5.3 Second Round Analysis 
 
5.5.3.1 Direct effects 
Based on Henseler et al. (2009), some items with a factor loading (absolute standardized 
outer loading) below 0.7 (≈ √0.5) were deleted. Thus, VC1, VC2, VC3, VC4, VC5, 
VC6, VC7, VC8, VC9, VC10, VC11, VC12, VC17, VC18, VC19, VC20 were deleted 
from the value creation construct and VC13, VC14, VC15, VC16 were retained. SR1, 
SR3, SR4, SR6, SR7, SR9, SR12, SR14 were deleted from the strategic resource 
construct and SR2, SR5, SR8, SR10, SR11, SR13 retained. CC3, CC4, CC5 and CC6 
were deleted from the corporate communication construct and CC1, CC2, CC7 were 
retained. BP1, BP5 were deleted from the brand positioning construct and BP2, BP3, 
BP4 three items are retained. BD3, BD6 were deleted from the brand differentiation 
construct and BD1, BD2, BD4, BD5, BD7 retained. Finally, BS4 and BS5 were deleted 
from the brand segmentation construct and BS1, BS2, BS3 were retained. PP4, PP5, 
PP6, PP8, and PP9 were deleted from the medicine price construct and PP1, PP2, PP3 
and PP7 were retained. 
 
According to Henseler et al. (2009), “cross-loadings offer another check for 
discriminant validity. If an indicator has a higher correlation with another latent variable 
than with its respective latent variable, the appropriateness of the model should be 
reconsidered.” Therefore, the cross loading was checked, as is shown in Table 5.19. For 
example, the BDBD cross loadings should be higher than the loadings of BD with 
other constructs. The same rule can be applied to other constructs. 
 
According to Henseler et al. (2009), “the essential criterion for this (structural model) 
assessment is the coefficient of determination (R square) of the endogenous latent 
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variables. Chin (1998) describes R square values of 0.67, 0.33, and 0.19 in PLS path 
models as substaintial, moderate, and weak, respectively.” Therefore, in this second 
round of analysis, it is shown that the R square values of BD, BP and BS are 0.6536, 
0.7508 and 0.6633 respectively. The average value of R square is 0.689233, which, 
according to Chin’s (1998) description, is “substaintial”. 
 
Table 5.19: Cross loadings table 
     BD BP BS CC SR VC 
 BD1 0.8398 0.7371 0.6806 0.6962 0.6436 0.5485 
 BD2 0.7754 0.5751 0.6353 0.6175 0.5148 0.4777 
 BD4 0.8453 0.6452 0.8024 0.6121 0.6124 0.5654 
 BD5 0.7874 0.7022 0.7176 0.4854 0.6316 0.5174 
 BD7 0.8746 0.6061 0.6755 0.6936 0.6124 0.4573 
 BP2 0.7799 0.8253 0.6694 0.7127 0.6508 0.5374 
 BP3 0.6379 0.8761 0.7545 0.5403 0.6909 0.752 
 BP4 0.6777 0.9298 0.6583 0.6512 0.8129 0.6622 
 BS1 0.8082 0.7014 0.8661 0.6285 0.6471 0.5475 
 BS2 0.7574 0.748 0.9439 0.6284 0.6268 0.7192 
 BS3 0.7657 0.7085 0.9218 0.6196 0.5706 0.7144 
 CC1 0.652 0.6034 0.5939 0.8946 0.6747 0.4117 
 CC2 0.6762 0.6313 0.6288 0.9187 0.7164 0.439 
 CC7 0.6752 0.6678 0.5892 0.8328 0.6974 0.5109 
SR10 0.61 0.7354 0.5461 0.7115 0.9324 0.6187 
SR11 0.5676 0.7095 0.5671 0.6542 0.8606 0.6149 
SR13 0.6642 0.7592 0.6704 0.6775 0.9286 0.6755 
 SR2 0.689 0.8096 0.6051 0.6921 0.9097 0.7096 
 SR5 0.7555 0.7197 0.6604 0.7954 0.8887 0.5912 
 SR8 0.6906 0.7489 0.6115 0.7789 0.944 0.5679 
VC13 0.5457 0.7068 0.6519 0.4473 0.6406 0.9355 
VC14 0.5586 0.6729 0.6675 0.4996 0.6347 0.9418 
VC15 0.6192 0.7958 0.7173 0.5187 0.7024 0.9566 
VC16 0.5797 0.565 0.6669 0.441 0.5802 0.8725 
 
 
 
The construct level discriminant validity is computed using the Fornell-Larcker 
criterion (1981), where the square root of the latent variables shared variance (i.e. AVE) 
of each variable is higher than the other variables’ correlation (See the row and coloum 
in the Table). Even though the inter-construct correlation was very high between the 
latent constructs (e.g., BSBD = 0.81 or 81%), the criterion of discriminant validity is 
still satisfied (i.e. BD= 0.83 or 83%). 
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Table 5.20: Inter-construct correlation 
   BD BP BS CC SR VC 
BD 0.83*                                         
BP 0.79 0.88                                 
BS 0.81 0.79 0.91                         
CC 0.76 0.72 0.69 0.88                 
SR 0.73 0.82 0.67 0.79 0.91         
VC 0.62 0.74 0.73 0.52 0.69 0.93 
* is square root of AVE replaced by diagonal value 1.  
 
 
According to Henseler et al. (2009), to access the structural model, the average variance 
extracted (AVE) and R square should be checked as well. Also, the “R square values of 
0.67, 0.33, or 0.19 for endogenous latent variables in the inner path model are described 
as substaintial, moderate, or weak” (Chin, 1998, p. 323) The AVE value and R square 
are shown in Table 5.21.   
 
Moreover, according to Henseler et al. (2009), “the PLS goodness-of-fit proposal by 
Tenenhaus et al. (2005) is the geometric mean of the average communalities (outer 
measurement model) and the average R square of endogenous latent variables, and is 
normed between 0 and 1, where a higher value represents better path model estimations.” 
In this research, the result of the second round of data analysis shows that the GoF value 
is 73%, which is more than 50% of value. 
 
Table 5.21: Over view of model  
   AVE Composite 
Reliability 
R-Square Cronbachs 
Alpha 
Communality Redundancy AVE-
square 
BD 0.6812 0.9142 0.6536 0.8824 0.6812 0.3438 0.83 
BP 0.771 0.9097 0.7508 0.8503 0.771 0.2057 0.88 
BS 0.8303 0.9361 0.6633 0.8974 0.8303 0.3463 0.91 
CC 0.7793 0.9136          0.8573 0.7793            0.88 
SR 0.8301 0.967          0.9589 0.8301            0.91 
VC 0.8596 0.9607          0.9452 0.8596            0.93 
GoF= 0.738793 
 
 
According to Henseler et al. (2009), in order to assess the structural model, the path 
coefficient should be checked. Therefore, the path coefficients of each construct are 
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shown in Table 5.22.  The p-value is calculated by using a two-tailed student t-test; as is 
shown in the table, H2, H5 and H9 are not acceptible.  
 
Table 5.22: Path coefficient table 
Hypo
thesis 
         Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T-Statistics 
(|O/STERR
|) 
p-value Test results 
H1 VC -> BS  0.5351  0.521 0.1197 0.1197 4.4686 0.000*** Accepted 
H2 VC -> BD  0.2526  0.2428 0.1147 0.1147 2.2015 0.029** Accepted  
H3 VC -> BP  0.3495  0.3588 0.0993 0.0993 3.5205 0.001*** Accepted 
H4 SR -> BS -0.0576 -0.0632 0.1865 0.1865 0.3086 0.758 Rejected 
H5 SR -> BD  0.1607  0.1885 0.2144 0.2144 0.7495 0.454 Rejected 
H6 SR -> BP  0.4069  0.423 0.1436 0.1436 2.8342 0.005** Accepted 
H7 CC -> BS  0.4547  0.4783 0.2198 0.2198 2.0687 0.040* Accepted 
H8 CC -> BD  0.5004  0.4918 0.1604 0.1604 3.1191 0.002** Accepted 
H9 CC -> BP  0.2181  0.2047 0.1127 0.1127 1.9352 0.054 Rejected 
 
 
5.5.3.2 Moderating effects 
The second model analysis tested the moderating role on each hypothesis. In Table 5.23 
(path coefficient of moderating effects), the moderating effects of medicine price (PP) 
on each construct of the uses of corporate reputation (VC, SR and CC) on each 
construct of brand image strategy (BP, BD and BS) are shown, and none of the 
moderating effects are supported. However, the medicine price is supported as a 
predictor of BS, which shared 26% of variance (beta value or standard estimation) and 
its t-value was 2.7803. A model with path values and t-values is shown in Figure 5.4. 
 
 
Table 5.23: Path coefficient value of moderating effects  
              Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|) 
Test results 
CC * PP -> BP -0.216 -0.099 0.1554 0.1554 1.3903 Rejected 
CC * PP -> BD 0.1658 -0.0225 0.1876 0.1876 0.8838 Rejected 
CC * PP -> BS 0.1817 0.1042 0.1677 0.1677 1.0835 Rejected 
SR * PP -> BP -0.0692 -0.1219 0.1473 0.1473 0.4699 Rejected 
SR * PP -> BD 0.0787 0.199 0.2213 0.2213 0.3556 Rejected 
SR * PP -> BS -0.1506 -0.0874 0.1804 0.1804 0.835 Rejected 
VC * PP -> BP -0.051 -0.0369 0.1416 0.1416 0.3603 Rejected 
VC * PP -> BD -0.3136 -0.0767 0.2066 0.2066 1.5176 Rejected 
VC * PP -> BS -0.2312 -0.1696 0.1937 0.1937 1.1933 Rejected 
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Figure 5.4: Path values (structural path relationships) and t-value (significance of 
straturactural path based on t-value) in brackets ( path supported; - -> path 
unsupported) 
 
* t-values greater than 1.96 were significant. 
Source: Developed for the current study 
 
5.5.4 Third-Round Analysis 
 
In this section, several items from the first- and second-round analyses were deleted to 
refine the model by reducing cross-loadings, which consequently increased the 
discriminant validity of the model (Fornell and Larcker, 1981; Henseler et al., 2009). 
For example, BD2 (loading=0.77) was deleted because of the cross-loading with BS and 
CC (0.63 and 0.61, respectively) (see Table 5.19); BD5 was deleted because of the 
cross-loading with BP, BS and SR; SR5 was deleted because of the cross-loading with 
BD, BP and CC; SR11 was deleted because of the cross-loading with BP; and VC16 
was deleted because of the cross-loading with BS. 
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Table 5.20 and Table 5.26 show the effect of the deletion of the cross-loadings. As 
Table 5.20 shows, the square root of the average variance extracted (AVE) was close to 
the inter-construct correlation (e.g., 0.81 between BD and BS), which has a lower 
discriminant validity between the constructs; Table 5.26 reveals that the difference was 
higher than the square root of AVE and inter-construct correlations and thus satisfies the 
criterion of discriminant validity (Fornell and Larcker, 1981). 
 
In order to increase the discriminant validity, three highest loading items for each 
construct were kept to run the third round analysis. Other items were deleted. Therefore, 
BD1, BD4 and BD7 were retained for the brand differentiation construct; BP2, BP3 and 
BP4 were retained for the brand positioning contruct; BS1, BS2 and BS3 were retained 
for the brand segmentation construct; CC1, CC2 and CC7 were retained for the 
corporate communication construct; PP1, PP2 and PP3 were retained for the medicine 
price construct and SR8, SR10 and SR13 were retained for the strategic resource 
construct. And finally, VC13, VC14 and VC15 were retained for the value creation 
construct. And in order to simplify the model, paths that are not supported in the last 
round of analysis were deleted. A new path of the relationship of PP and BS was added 
from the last round of analysis. A model with path values and t-values is shown in 
Figure 5.5. 
 
Table 5.24: Outer loadings 
          BD      BP      BS      CC      PP      SR      VC 
 BD1 0.8371                                                 
 BD4 0.8687                                                 
 BD7 0.9058                                                 
 BP2         0.8227                                         
 BP3         0.8779                                         
 BP4         0.9303                                         
 BS1                 0.8705                                 
 BS2                 0.9434                                 
 BS3                 0.9185                                 
 CC1                         0.8956                         
 CC2                         0.921                         
 CC7                         0.8295                         
 PP1                                 0.9288                 
 PP2                                 0.9494                 
 PP3                                 0.9408                 
SR10                                         0.9487         
SR13                                         0.9397         
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 SR8                                         0.9578         
VC13                                                 0.9489 
VC14                                                 0.9454 
VC15                                                 0.9736 
 
 
Table 5.25: Cross loadings 
          BD      BP      BS      CC      PP      SR      VC 
 BD1 0.8371 0.7353 0.6808 0.6955 0.5525 0.5905 0.5362 
 BD4 0.8687 0.6453 0.8032 0.6123 0.3552 0.571 0.5277 
 BD7 0.9058 0.6047 0.677 0.6943 0.4447 0.5776 0.4477 
 BP2 0.7913 0.8227 0.671 0.7133 0.5203 0.588 0.5465 
 BP3 0.6105 0.8779 0.7536 0.539 0.4227 0.6644 0.769 
 BP4 0.6252 0.9303 0.6589 0.65 0.4878 0.812 0.6815 
 BS1 0.7841 0.7008 0.8705 0.6289 0.5594 0.634 0.5221 
 BS2 0.7352 0.7483 0.9434 0.6281 0.5621 0.5962 0.7109 
 BS3 0.7431 0.7089 0.9185 0.6192 0.4812 0.5373 0.6961 
 CC1 0.658 0.6028 0.5947 0.8956 0.4383 0.6555 0.4141 
 CC2 0.7252 0.6295 0.6297 0.921 0.2704 0.6737 0.4344 
 CC7 0.6493 0.6674 0.5889 0.8295 0.432 0.6849 0.5037 
 PP1 0.3823 0.4556 0.4957 0.3632 0.9288 0.3666 0.5086 
 PP2 0.5492 0.5731 0.5835 0.4161 0.9494 0.5538 0.6572 
 PP3 0.5255 0.4874 0.5637 0.4244 0.9408 0.5455 0.4758 
SR10 0.5805 0.7357 0.5474 0.7107 0.5327 0.9487 0.6169 
SR13 0.6494 0.7598 0.6717 0.6771 0.4761 0.9397 0.6866 
 SR8 0.6662 0.749 0.613 0.7784 0.4888 0.9578 0.568 
VC13 0.5403 0.7074 0.6512 0.4468 0.5746 0.6047 0.9489 
VC14 0.5357 0.6739 0.6644 0.4989 0.5048 0.6061 0.9454 
VC15 0.5826 0.7965 0.7165 0.5175 0.5952 0.6724 0.9736 
 
Table 5.26: Fornell-Larcker criterion: square inter-construct correlation 
        BD      BP      BS      CC      PP      SR      VC 
BD 0.7586                                                 
BP 0.580796 0.771                                         
BS 0.681285 0.62331 0.8304                                 
CC 0.5909 0.515237 0.469773 0.7795                         
PP 0.27238 0.29214 0.342459 0.183698 0.8831                 
SR 0.444356 0.622205 0.41538 0.578969 0.276571 0.9001         
VC 0.335357 0.580035 0.503532 0.261019 0.342342 0.432832 0.914 
 
 
Table 5.27: Overview model 
       AVE Composite 
Reliability 
R Square Cronbachs 
Alpha 
Communality Redundancy 
  
BD 0.7586 0.904 0.6379 0.8404 0.7586 0.4329 
BP 0.771 0.9097 0.7565 0.8503 0.771 0.2428 
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BS 0.8304 0.9362 0.6648 0.8974 0.8304 0.3254 
CC 0.7795 0.9137          0.8573 0.7795            
PP 0.8831 0.9577          0.9339 0.8831            
SR 0.9001 0.9643          0.9445 0.9001            
VC 0.914 0.9696          0.9529 0.914            
 
Table 5.28: Path coefficient 
 
Hypot
hesis 
Path Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|) 
Test result 
H8 CC -> BD 0.6398 0.6545 0.0871 0.0871 7.3456  Accepted 
H9 CC -> BP 0.2691 0.2729 0.1168 0.1168 2.3032 Partially 
supported 
H7 CC -> BS 0.4056 0.4328 0.151 0.151 2.6864  Accepted 
H6 SR -> BP 0.3056 0.3128 0.154 0.154 1.9851 Accepted 
H2 VC -> BD 0.2522 0.2478 0.1035 0.1035 2.4369 Accepted 
H3 VC -> BP 0.4231 0.4108 0.1 0.1 4.2321 Accepted 
H1 VC -> BS 0.3979 0.3832 0.1553 0.1553 2.5614 Mainly supported 
 
Figure 5.5: Path values (structural path relationships) and t-value (significance of 
straturactural path based on t-value) in brackets ( path fully supported; - -> path 
partially supported) 
 
* t-values greater than 1.96 were significant. 
Source: Developed for the current study 
 
As a condition of that we took the supported path from the second round. The result of 
the third round analysis is that, apart from the fact that the paths of the relationship of 
PP and BS and the relationship of VC and BS are not supported, other paths are 
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supported. Therefore, we conclude that paths of PP and BS and VC and BS are partially 
supported.  
 
5.5.5 Fourth Round Analysis 
 
According to Barclay et al. (1995), a rule of thumb for robust PLS path modelling 
estimations, the sample size in the inner path model should be larger than “ten times the 
largest number of structural paths directed at a particular construct” (Henseler et al., 
2009). Therefore, because of the small number of respondents, based on the previous 
model of analysis, we tried to simplify the model by separating one model into three 
simpler models for the fourth round of analysis. A model with path values and t-values 
is shown in Figure 5.6, Figure 5.7 and Figure 5.8. 
 
 
Table 5.29: Outer loadings 
          BP      SR      VC 
 BP2 0.8101     
 BP3 0.885     
 BP4 0.9336     
SR10   0.9487   
SR13   0.9398   
 SR8   0.9577   
VC13     0.9494 
VC14     0.9441 
VC15     0.9742 
 
 
Table 5.30: Cross loadings 
          BP      SR      VC 
 BP2 0.8101 0.588 0.5476 
 BP3 0.885 0.6644 0.7695 
 BP4 0.9336 0.812 0.6821 
SR10 0.7381 0.9487 0.6175 
SR13 0.7623 0.9398 0.6869 
 SR8 0.7501 0.9577 0.5681 
VC13 0.7091 0.6047 0.9494 
VC14 0.6779 0.6062 0.9441 
VC15 0.7992 0.6725 0.9742 
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Table 5.31: Fornell-Larcker criterion: 
square inter-construct correlation 
        BP      SR      VC 
BP 0.7704     
SR 0.625523 0.9001   
VC 0.585837 0.433491 0.9139 
 
 
Table 5.32: Overview model 
       
AVE 
Composite 
Reliability 
R Square Cronbachs 
Alpha 
Communality Redundancy 
BP 0.7704 0.9094 0.7312 0.8503 0.7704 0.4177 
SR 0.9001 0.9643   0.9445 0.9001   
VC 0.9139 0.9696   0.9529 0.9139   
 
 
Table 5.33: Path coefficient 
 
Hypot
hesis  
    Path      Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|) 
Test 
result 
H6 SR -> BP 0.5065 0.5148 0.0935 0.0935 5.419 Accepted 
H3 VC -> BP 0.4319 0.4243 0.0967 0.0967 4.4664 Accepted 
 
 
Figure 5.6: Path values (structural path relationships) and t-value (significance of 
straturactural path based on t-value) in brackets ( path fully supported; - -> path half-
supported) 
 
* t-values greater than 1.96 were significant. 
Source: Developed for the current study 
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Table 5.34: Outer loadings 
          BD      CC      VC 
 BD1 0.8368                 
 BD4 0.8689                 
 BD7 0.906                 
 CC1         0.8978         
 CC2         0.9247         
 CC7         0.8232         
VC13                 0.949 
VC14                 0.9459 
VC15                 0.973 
 
Table 5.35: Corss loadings 
          BD      CC      VC 
 BD1 0.8368 0.6941 0.5358 
 BD4 0.8689 0.6125 0.5275 
 BD7 0.906 0.6955 0.4478 
 CC1 0.658 0.8978 0.4141 
 CC2 0.7252 0.9247 0.4344 
 CC7 0.6492 0.8232 0.5032 
VC13 0.5402 0.4456 0.949 
VC14 0.5357 0.4977 0.9459 
VC15 0.5825 0.5153 0.973 
 
Table 5.36: Fornell-Larcker criterion: 
sqare inter-construct correlation 
        BD      CC      VC 
BD 0.7586                 
CC 0.590746 0.7797         
VC 0.335009 0.259183 0.914 
 
Table 5.37: Overview model 
       AVE Composite 
Reliability 
R Square Cronbachs 
Alpha 
Communality Redundancy 
BD 0.7586 0.904 0.6382 0.8404 0.7586 0.4329 
CC 0.7797 0.9137          0.8573 0.7797            
VC 0.914 0.9696          0.9529 0.914            
 
Table 5.38: Path coefficient 
 
Hypot
hesis 
Path Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|) 
 Test result 
H8 CC -> BD 0.6398 0.6524 0.0889 0.0889 7.1961  Accepted 
H2 VC -> BD 0.2531 0.2453 0.106 0.106 2.3879  Accepted 
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Figure 5.7: Path values (structural path relationships) and t-value (significance of 
straturactural path based on t-value) in brackets ( path fully supported) 
 
* t-values greater than 1.96 were significant. 
Source: Developed for the current study 
 
Table 5.39: Outer loadings 
          BS      CC      PP      VC 
 BS1 0.8704                         
 BS2 0.9434                         
 BS3 0.9185                         
 CC1         0.898                 
 CC2         0.9222                 
 CC7         0.8258                 
 PP1                 0.9288         
 PP2                 0.9494         
 PP3                 0.9408         
VC13                         0.9481 
VC14                         0.9467 
VC15                         0.9731 
 
Table 5.40: Cross loadings 
          BS      CC      PP      VC 
 BS1 0.8704 0.6291 0.5594 0.5211 
 BS2 0.9434 0.6277 0.5621 0.7108 
 BS3 0.9185 0.6186 0.4812 0.6968 
 CC1 0.5947 0.898 0.4383 0.4147 
 CC2 0.6296 0.9222 0.2704 0.4345 
 CC7 0.5889 0.8258 0.432 0.5034 
 PP1 0.4957 0.363 0.9288 0.5086 
 PP2 0.5834 0.4153 0.9494 0.6563 
 PP3 0.5637 0.424 0.9408 0.4752 
VC13 0.6512 0.4458 0.5746 0.9481 
VC14 0.6644 0.4984 0.5048 0.9467 
VC15 0.7165 0.5163 0.5952 0.9731 
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Table 5.41: Fornell-Larcker criterion: sqare 
inter-construct correlation 
        BS      CC      PP      VC 
BS 0.8304                         
CC 0.469362 0.7796                 
PP 0.342459 0.18327 0.8831         
VC 0.503248 0.260202 0.34164 0.914 
 
Table 5.42: Overview model 
       AVE Composite 
Reliability 
R Square Cronbachs 
Alpha 
Communality Redundancy 
BS 0.8304 0.9362 0.6649 0.8974 0.8304 0.3252 
CC 0.7796 0.9137          0.8573 0.7796            
PP 0.8831 0.9577          0.9339 0.8831            
VC 0.914 0.9696          0.9529 0.914            
 
Table 5.43: Path coefficient 
 
Hypot
hesis 
Path Original 
Sample 
(O) 
Sample 
Mean 
(M) 
Standard 
Deviation 
(STDEV) 
Standard 
Error 
(STERR) 
T Statistics 
(|O/STERR|
) 
Test 
result  
H7 CC -> BS 0.4055 0.4354 0.1465 0.1465 2.7682 Accepted 
H1 VC -> BS 0.398 0.3799 0.1466 0.1466 2.7146 Accepted 
 
 
Figure 5.8: Path values (structural path relationships) and t-value (significance of 
straturactural path based on t-value) in brackets ( path fully supported; - -> path 
partially supported) 
 
 
* t-values greater than 1.96 were significant. 
Source: Developed for the current study 
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The tests in rounds 2, 3 and 4 are accepted, and therefore H1 is supported. For H2, the 
tests in rounds 1, 2, 3 and 4 are accepted, and therefore H2 is supported. For H3, the 
tests in rounds 1, 2, 3 and 4 are accepted, and therefore H3 is supported. H4 is rejected, 
because the tests in rounds 1, 2 and 3 are all rejected. H5 is rejected, because the tests in 
rounds 1 and 2 are rejected. For H6, the tests in rounds 1, 2, 3 and 4 are accepted, and 
therefore H6 is supported. For H7, the tests in rounds 1, 2, 3 and 4 are accepted, and 
therefore H7 is supported. For H8, the tests in rounds 1, 2, 3 and 4 are accepted, and 
therefore H8 is supported. H9 is partially supported; the tests in rounds 1 and 3 are 
accepted, but in round 2, the test is rejected. H10 is partially supported; the test in round 
1 is accepted, but in round 2 the moderating effects are all rejected separately. A 
summary of the hypotheses appears in Table 5.44 and Table 5.45, and a diagram of the 
final results is depicted in Figure 5.9. 
 
Table 5.44: Table of standardized path coefficients and hypothesis validation of the 
research model (numbers based on fourth round analysis) 
Hypoth
esis 
Path Correlation between dimensions Path 
coefficient 
t-value Test results 
H1 β1 Value creation  Brand segmentation 
(VCBS) 
0.398 2.715 Accepted 
H2 β4 Value creation  Brand differentiation 
(VCBD) 
0.253 2.388 Accepted 
H3 β7 Value creation  Brand positioning 
(VCBP) 
0.432 4.466 Accepted 
H4 β2 Strategic resources  Brand segmentation 
(SRBS) 
- - Rejected 
H5 β5 Strategic resources  Brand 
differentiation (SRBD) 
- - Rejected 
H6 β8 Strategic resources  Brand positioning 
(SRBP) 
0.507 5.419 Accepted 
H7 β3 Corporate communication  Brand 
segmentation (CCBS) 
0.406 2.768 Accepted 
H8 β6 Corporate communication  Brand 
differentiation (CCBD) 
0.640 7.196 Accepted 
H9 β9 Corporate communication  Brand 
positioning (CCBP) 
- - Partially 
supported 
H10 β10 Moderating effects of medicine 
priceBrand image  
- - Partially 
supported 
 
 
Table 5.45: Table of hypothesis about the relationship test results 
Hypoth
esis 
Hypothesis Test results 
H1 A firm’s corporate reputation, which is used to create value, 
has a positive impact on a firm’s brand segmentation 
strategy. 
Accepted 
H2 A firm’s corporate reputation, which is used to create value, 
has a positive impact on a firm’s brand differentiation 
strategy. 
Accepted 
H3 A firm’s corporate reputation, which is used to create value, 
has a positive impact on a firm’s brand positioning strategy. 
Accepted 
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H4 A firm’s corporate reputation, which is used as a strategic 
resource, has a positive impact on a firm’s brand 
segmentation strategy. 
Rejected 
H5 A firm’s corporate reputation, which is used as a strategic 
resource, has a positive impact on a firm’s brand 
differentiation strategy. 
Rejected 
H6 A firm’s corporate reputation, which is used as a strategic 
resource, has a positive impact on a firm’s brand positioning 
strategy. 
Accepted 
H7 A firm’s corporate reputation, which is used to communicate 
with its stakeholders, has a positive impact on a firm’s brand 
segmentation strategy. 
Accepted 
H8 A firm’s corporate reputation, which is used to communicate 
with its stakeholders, has a positive impact on a firm’s brand 
differentiation strategy. 
Accepted 
H9 A firm’s corporate reputation, which is used to communicate 
with its stakeholders, has a positive impact on a firm’s brand 
positioning strategy. 
Partially 
supported 
H10 Medicine price moderate the relationship between the uses 
of corporate repoutaiton and brand image strategy. 
Partially 
supported 
Resource: Developed by the author for the current research 
 
Figure 5.9: Final results diagram 
 
 
 
5.6 Results of Testing the Hypotheses 
 
The results are presented in four stages. It is because of the items were firstly, at the 
second round, deleted on the basis of the outer loading that is below 0.7. At the third 
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round analysis the three highest loadings items of each construct were selected as the 
measurements of each construct. At the fourth round the unsupported correlations were 
deleted on the basis of Henseler et al.’s (2009) suggestion of the analysed sample size. 
In total, ten hypotheses were tested (see Table 5.22). The implications of these results 
are further discussed in Chapter 6. 
 
H1: Value creation and brand segmentation (VCBS) 
As shown earlier, hypothesis H1 explained the relationship between the exogenous 
variable (Value Creation) and endogenous variable (Brand Segmentation). As outlined 
in Table 5.44, the hypothesized relationship was found to be significant (t-value = 
4.468). Thus, this hypothesis was supported. 
 
H2: Value creation and brand differentiation (VCBD) 
As shown earlier, hypothesis H4 explained the relationship between the exogenous 
variable (Value Creation) and endogenous variable (Brand Differentiation). As outlined 
in Table 5.22, the hypothesized relationship was found to be significant (t-value = 
2.201). Thus, this hypothesis was supported. 
 
H3: Value creation and brand positioning (VCBP) 
As shown earlier, hypothesis H7 explained the relationship between the exogenous 
variable (Value Creation) and endogenous variable (Brand Positioning). As outlined in 
Table 5.22, the hypothesized relationship was found to be significant (t-value = 3.520). 
Thus, this hypothesis was supported. 
 
H4: Strategic resources and brand segmentation (SRBS) 
As shown earlier, hypothesis H2 explained the relationship between the exogenous 
variable (Strategic Resources) and endogenous variable (Brand Segmentation). As 
outlined in Table 5.22 and Table 5.44, the hypothesized relationship was found to be 
insignificant (t-value = 0.758) in the second round. Thus, this hypothesis was rejected. 
 
H5: Strategic resources and brand differentiation (SRBD) 
As shown earlier, hypothesis H5 explained the relationship between the exogenous 
variable (Strategic Resources) and endogenous variable (Brand Differentiation). As 
outlined in Table 5.22, the hypothesized relationship was found to be insignificant (t-
value = 1.256) in the second round but insignificant in the second round (t-value = 
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0.454). Thus, this hypothesis was not supported. 
 
H6: Strategic resources and brand positioning (SRBP) 
As shown earlier, hypothesis H8 explained the relationship between the exogenous 
variable (Strategic Resources) and endogenous variable (Brand Positioning). As 
outlined in Table 5.22, the hypothesized relationship was found to be significant (t-
value = 2.834). Thus, this hypothesis was supported. 
 
H7: Corporate communication and brand segmentation (CCBS) 
As shown earlier, hypothesis H3 explained the relationship between the exogenous 
variable (Corporate Communication) and endogenous variable (Brand Segmentation). 
As outlined in Table 5.22, the hypothesized relationship was found to be significant (t-
value = 2.068). Thus, this hypothesis was supported. 
 
H8: Corporate communication and brand differentiation (CCBD) 
As shown earlier, hypothesis H6 explained the relationship between the exogenous 
variable (Corporate Communication) and endogenous variable (Brand Differentiation). 
As outlined in Table 5.22, the hypothesized relationship was found to be significant (t-
value = 3.119). Thus, this hypothesis was supported. 
 
H9: Corporate communication and brand positioning (CCBP) 
As shown earlier, hypothesis H9 explained the relationship between the exogenous 
variable (Corporate Communication) and endogenous variable (Brand Positioning). As 
outlined in Table 5.22, the hypothesized relationship was found to be insignificant (t-
value = 1.935) in the second round but significant (t-value = 2.303) in the third round. 
Thus, this hypothesis was partially supported. 
 
H10: Moderating effect of medicine price and brand image 
As shown earlier, hypothesis H10 explained the moderating effect of the relationship 
between the uses of corporate reputation and brand image strategy. The hypothesized 
relationship was found to be significant (t-value = -3.077) in the first round analysis. 
However, in testing the moderating effect on each relationship respectively, as outlined 
in Table 5.23, none of the moderating effects tested as significant. Thus, this hypothesis 
was partially supported. 
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5.7 Summary 
 
This chapter reported the results of the data analysis for the quantitative phase of this 
thesis. Following this, the demographic characteristics of this sample are described. The 
two-step procedure of Anderson and Gerbing (1988), which required measurement 
models to be estimated before the structural analysis, was followed. The items for the 
exogenous constructs were derived from the literature and the qualitative interview. 
After running the reliability test, it was decided to delete 12 items from six constructs, 
as they were highly cross-loaded on other factors that could not be theoretically justified, 
had low communalities or low reliability. And in the second round analysis, 39 items 
with a factor loading below 0.7 were deleted (Henseler et al., 2009).  
 
The second part of data analysis is the use of SEM, which was conducted in two stages: 
the measurement model and the structural model. In the first stage, the fit for the 
measurement model was assessed by using a CFA. At this point, the assessment of all 
indicators was highly loaded on their specified factors and the overall goodness-of-fit 
indices suggested acceptance of the model. Each construct was then tested for reliability 
and validity. 
 
Cronbach’s alpha, composite reliability and average variance extracted (AVE) were 
higher than the required values. Accordingly, all constructs were reliable. In addition, 
convergent, discriminant and nomological validity for each construct were confirmed. 
 
The next stage, the assessment of the structural model, has also been undertaken. The 
structural model results showed that out of ten hypotheses, six pathways were 
significant. The structural model indicated that three variables (value creation, strategic 
value and corporate communication) had a different level of impact on three constructs 
of brand image strategy. Thus the model provides a strong test of the hypothesized 
relationships between the constructs of interest. We have completed GoF indices 
suggested by Tenenhaus et al. (2005) and it was 0.738. 
 
The moderating effect of medicine price on the impact of the three dimensions of the 
uses of corporate reputation on the three dimensions of brand image strategy was tested. 
The results showed that the medicine price construct has a negative effect in moderating 
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the impact of the uses of corporate reputation on brand image strategy. Therefore, the 
hypothesized moderating effect of medicine price on the relationship between the uses 
of corporate reputation and brand image strategy was confirmed. However, in the 
second round of analysis, the moderating role of medicine price was tested for the 
relationship of each construct in the uses of corporate reputation and each construct in 
brand image strategy. The results show that none of the moderating effects was 
significant, but that the medicine price is significant as a predictor for the brand 
segmentation construct.   
 
The next chapter discusses the above results in detail in order to answer the research 
questions outlined in Chapter 1. Further, it draws the implications for both practice and 
theory, discusses the limitations of this thesis, describes the directions for further 
research and identifies the final conclusions. 
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CHAPTER SIX: RESULTS AND DISCUSSION 
 
 
6.1 Introduction  
 
The purpose of this thesis was to investigate the role of the uses of corporate reputation 
in building brand image strategy and the results of this study were presented in the 
previous chapter. In this chapter we will discuss the validation of the measurement 
model and the research findings in more detail. The findings are ‘fleshed out’ in greater 
depth by incorporating qualitative findings where appropriate. The findings are then 
further discussed in terms of the contribution to marketing theory and relevance to 
marketing managers. In the previous chapter, the items of adapted scales were subjected 
to several rounds of adjustments and were finally found to possess acceptable 
measurement properties. Reliability and construct validity tests indicated that all scales 
satisfied widely accepted criteria such as the minimum reliability of 0.7. 
 
The structure of this chapter is as follows. First, the results of scale purification will be 
discussed. Second, an evaluation of the research hypotheses and their significance are 
summarized and the findings of all hypotheses testing will be reviewed and compared 
with previous research.  
 
 
6.2 Overview of Study 
 
This research project examined the concept of the uses of corporate reputation and its 
dimensions. The study involves factors of the uses of corporate reputation that are most 
likely to have a significant influence on brand image strategy within the context of the 
Taiwanese pharmaceutical industry. The topic is important because in recent decades, it 
is difficult but important for a firm’s product to compete in the market and distinguish 
itself from competitors (Dennis et al., 2002; Lili, 2010; Cheng et al., 2010). The uses of 
corporate reputation were claimed to affect managers’ decisions when applying a firm’s 
brand image strategy (Hatch et al., 1998; Bickerton, 2000; Cretu and Brodie, 2007). As 
a consequence, interest in the uses of corporate reputation has increased at an 
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astonishing rate (see Chapter 2).  However, so far, very limited empirical research has 
been carried out in this area to capture the true meaning of the concept (Gale, 1994; 
Cravens et al., 2003). Furthermore, a few companies properly adopted the uses of 
corporate reputation, but most companies failed to do so because the literature lacks an 
integrative theoretical framework to address this research problem (Balmer, 2001a). 
 
A multi-method approach was adopted to investigate this research problem. A 
sequential approach consisting of qualitative research, which acts as the foundation for 
the quantitative study, was implemented. The qualitative findings generally showed that 
three dimensions of the uses of corporate reputation (i.e. value creation, strategic 
resources and corporate communication) are applicable to managers’ brand image 
strategy implementation for the Taiwanese pharmaceutical industry. The findings were 
consistent with other studies on brand image strategy (Urde, 2003; Knox and Bickerton, 
2003; Foreman and Argenti, 2005). A qualitative method was used, in conjunction with 
quantative methods, to investigate a domain of the uses of corporate reputation that has 
received little attention to date (Cable and Graham, 2000; Srivoravilai, 2006). 
 
A questionnaire was developed on the basis of the reviewed literature and the 
qualitative study to quantify, supplement and complement the first stage. The 
theoretical model was then operationalised in this stage. 
 
As mentioned earlier, in Chapter 4, items generated from both literature review and 
qualitative studies were subjected to qualitative and quantitative refinements. Next, the 
developed scales were tested using statistical data reduction techniques, i.e. 
confirmatory factor analysis (CFA) in the main survey. 
 
The quantitative data was analysed by using PLS 1.04. Additionally, the constructs of 
interest showed a high degree of reliability, convergent and discriminant validity. A 
number of statistically significant pathways were confirmed between the uses of 
corporate reputation and brand image strategy constructs, with satisfactory fit indices 
for both the measurement and structural model. Finally, the overall structural model 
was evaluated and a discussion of these findings is described in the next section. 
 
A conceptual model was developed that showed the impact of the uses of corporate 
reputation that influenced brand image strategy as a consequence. The model was then 
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tested using a sample of Taiwanese pharmaceutical managers. The results of the tests 
demonstrate strong support for the model. Specifically, the measurement model is 
assessed in the main study using the particular samples of Taiwanese pharmaceutical 
managers. The confirmatory factor analysis (CFA) showed that the model received a 
significant fit to the data, following the principles recommended by Anderson and 
Gerbing (1988), Tabachnick and Fidell (2001) and Hair et al (2006). 
 
In testing the hypothesized model, the results presented in Table 5.44 indicated that the 
hypotheses H1, H2, H3, H6, H7 and H8 were supported. The standardized estimate for 
these hypotheses were all significant (= 0.398, 0.406, 0.253, 0.640, 0.432, 0.507, 
respectively).The hypotheses H9 and H10 were partially supported. The hypothesis H4 
and H5 were rejected because it was not statistically significant. The following section 
evaluates the conceptual model by first summarizing the supporting evidence for the 
hypotheses.  
 
 
6.3 Measurement Scale Purification 
 
The first issue to be discussed is the operationalisation and validation of concepts in this 
study. As mentioned in Chapter 4, the researcher developed measurement scales by 
extracting items from existing literature scales and qualitative interviews. Face and 
content validity were also examined by academic experts and interviewees. 
Additionally, the developed measurement scales were subjected to data reduction in 
CFA and several statistical tests (e.g. convergent and discriminant validity test, 
composite reliability test, etc.). 
 
Overall, the finalized scales were found to have satisfactory validity and reliability and 
were subsequently used in the hypotheses testing. In addition, some issues can be 
observed as follows. First, the operationalisation of constructs was shown to depend on 
research settings (e.g. country, culture, industry, etc.) For instance, when the 
pharmaceutical managers were asked to explain how the brand image strategy is applied, 
more emphasis was placed on sales experiences. This resembles the findings of studies 
such as Flynn (2000), Kargar (2005) and Aura (2010). 
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Another example is the applicability of measurement items to items of the strategic 
resources tactics with a firm’s corporate reputation. A respondent suggested that the 
uses of a firm’s reputation would “gain the firm more opportunity for strategic alliance 
or business cooperation”. Based on the Taiwan market environment, this argument 
would be appropriate only for huge generic pharmaceutical companies. This is mainly 
due to the differences in the corporate strength and a tricky combination of each 
company’s different core values.    
 
Second, the dimensionality of almost all constructs is consistent with those reported in 
extant literature. For instance, the CFA is applied to confirm the underlying structure 
among the variables in the analysis of three constructs in the uses of corporate 
reputation and three constructs of brand image strategy.  
 
In summary, the findings of the scale purification suggest two main points. First, when 
a scale is applied to another context, it is necessary to measure the relevance of the 
definition and the operationalisation of the old scale (Sekaran, 1983; Douglas and 
Nijssen, 2003; Srivoravilai and Melewar, 2003, 2005) to achieve the validity of 
substantive inferences (Singh, 1995). A vital question may be whether the same 
construct exists in another context. And even if it exists in another context, it may not 
have the same items (Craig and Douglas, 2000, p.256). 
 
Second, to ensure the applicability of adapted scales, it is important to assess external 
validity in addition to internal criteria (i.e. reliability and validity) (Craig and Douglas, 
2000, p. 257). In this study, qualitative methods have been employed (Groenland, 2002) 
to evaluate the constructs in a Taiwan context and quantitative techniques were used to 
examine factorial similarity (i.e. whether scale items load on the same factors as those 
in original scale) (Singh, 1995).  
 
 
6.4 The Uses of Corporate Reputation: Antecedents of Brand Image 
Strategy 
 
The quantative findings show that six out of ten hypotheses were supported, three were 
partially supported and one was rejected. Therefore, the uses of corporate reputation 
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were proved to be somewhat significantly associated with brand image strategy. 
Moreover, medicine price was found to play a partially negative moderating effect on 
the relationship between the uses of corporate reputation and brand image strategy.  
 
Despite the importance of the theme of the uses of corporate reputation, the construct of 
the uses of corporate reputation is not well defined in the marketing literature. A few 
definitions of the uses of corporate reputation (discussed earlier in Chapter 2), and also 
an analysis of those conceptualizations have been provided (according to Chapter 2, the 
conceptualization of the uses of corporate reputation has been taken from six 
paradigms). Moreover, items of the construct were found in the literature (Dickson and 
Ginter, 1987; Wong and Saunders, 1993). Even there, insufficient empirical research 
has been done on finding out the uses of corporate reputation from the managerial 
perspective, especially in relation to the brand strategy implementation.  This study 
therefore attempted to gain meaningful degrees of understanding of the uses of 
corporate reputation construct by using qualitative interviews. 
 
The findings of the qualitative study were treated as indicative only due to the 
qualitative nature of the study. Furthermore, quantitative research was carried out to 
confirm the results of the qualitative study. The quantitative results, specifically, 
illustrated three aspects of the uses of corporate reputation construct in the context of 
the Taiwanese pharmaceutical industry.  
 
This part of the discussion will start from hypotheses about the impacts of the three 
constructs of the uses of corporate reputation on brand segmentation (H1–H3), which 
will then be followed by hypotheses about the impacts of the uses of corporate 
reputation on brand differentiation (H4–H6) and brand positioning (H7–H9). Then the 
results of the test of moderating the relationship between the uses of corporate 
reputation and brand image strategy (H10) will be explained. Next, the limitations of 
the current study and recommendations are outlined. Finally, implications for future 
research are explored. The first implication focuses on the value creation ability that a 
firm possesses so it becomes a core value to compete with other competitors. 
 
 
 
 
` 
 233 
6.4.1 Effects of the Uses of Corporate Reputation on Brand Segmentation 
 
In this study, two of the uses of corporate reputation have a statistically significant 
relationship with brand segmentation. The relationship between each kind of use of 
corporate reputation (i.e. value creation, strategic resources and corporate 
communication) and brand segmentation is somehow found to be positively related. 
First, the relationship between value creation and brand segmentation has been found to 
be statistically significant. Second, the relationship of strategic resources to brand 
segmentation has been rejected. Last, the relationship between corporate 
communication and brand segmentation was also found to be statistically significant. 
This suggests that, other things being equal, the more a firm concentrates its focus on its 
value creation ability and corporate communication, the easier it will be to build its 
brand segmentation strategy.  
 
In general, a pharmaceutical company that implements brand segmentation strategy 
signals that the firm has solid and strong marketing capabilities. A pharmaceutical 
company that achieves brand segmentation means that to a certain level it can manage 
its company reputation very well. In addition, a pharmaceutical company depends on 
how its sales or marketing managers use their reputation to establish a solid and strong 
image in its customers’ minds (Temporal and Burnett, 1993; Ensign, 1998).  
 
According to Table 5.44, another issue should also be noted. It is managerially and 
theoretically fruitful to understand what type of the uses of corporate reputation has 
more impact on brand segmentation as previously not enough literature has addressed 
this issue. The researcher therefore assessed the relative influence of each dimension of 
the uses of corporate reputation on brand segmentation by comparing their path 
coefficients.   
 
In this case, the path coefficient of value creation (β = 0.398) is only slightly different 
from that of corporate communication (β = 0.406), this indicating the relatively equal 
importance of value creation and corporate communication. This is considered sensible, 
at least in the Taiwanese pharmaceutical context, because value creation demonstrates 
that not only can the company create value for its consumers – by which the consumers 
can evaluate a firm’s R&D ability – but it also shows that if a company can organize a 
good marketing campaign, which will benefit its customers. At the same time, corporate 
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communication depicts the importance of activities and actions by which consumers’ 
impressions of a firm will be further formed. Moreover, a firm’s value cannot be 
perfectly shown if the corporate communication doesn’t do a good job in 
communicating this value to the public. Therefore, a similar weight of importance using 
quantative analysis is considered to be reasonable.  
 
According to the literature and qualitative data results, value creation (the value created 
either for the customer or for the firm) can be divided into four categories: 
functional/instrumental, experiential/hedonic, symbolic/expressive, and cost/sacrifice. 
The current research is based on the firm’s perspective, and thus value creation herein 
pertains to the value created for the firm. 
 
• Cost/sacrifice and symbolic/expressive value 
At present, the top 10 local pharmaceutical companies are listed 
companies, except for TBC. This is because its director has an 
accounting background and is very sensitive to numbers. He wanted 
to build the corporate reputation himself. From 1945, TBC focused 
on the intravenous drip and did well with it. Starting 20 years ago, 
we started to build OLAHOME. It has been going well. Now we are 
going into the healthy food market, signing a contract with 
Carrefour and opening a store inside of Carrefour stores. It is 
TBC’s cosmetics store. And the board chairman is the TBC board 
chairman’s son. Now we are a team helping this business. This is 
how we use our corporate reputation to extend the business. Also, 
we can use corporate reputation to make a leveraged buyout. 
[Manager in company A] 
 
 
• Symbolic/expressive value 
If you can enter the market earlier, even this is not a new thing. 
Usually only foreign-funded enterprises do this, and their R&D are 
not in Taiwan. They usually have several centres, one in New York, 
one in Australia, and one in Asia Pacific, usually in Japan, or 
Singapore. It is because Taiwanese local pharmaceutical companies 
don’t deal with this part. Only foreign-funded company try to enter 
the market in advance. They schedule the top line for the most recent 
ten years, three years, and five years. In every category they try to 
manage the company in several areas, such as CV, heart department, 
and metabolism department etc., which are categorised as aged 
problem. Because the organs function is in decline when people get 
old. [Manager in company A] 
 
• Experience/hedonic value 
Although TBC is not a listed company, it has shareholders. So before 
they make any decision, they have to report to the board of directors, 
let them understand what’s the next step the company is heading to, 
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such as an overall market layout for the next year. However, the 
message the company sends to its customers is very important. It 
relies on the sales people because it has so many similar things. For 
example, for metabolism, almost every company has this medicine 
because so many people have diabetes. It means that each doctor is 
approached by five or six sales people from different companies. So 
why do I use your brand? [Manager in company A] 
 
A pharmaceutical company’s value creation ability can be used as a statement of its 
corporate reputation. It may become known for creating functional value with a high 
standard of product; it may also create a good impression through the use or purchasing 
of its product or its customer service; it may also be known for having the long history 
or having an iconic impression in the industry, or for savings the customer’s money or 
having the lowest cost for its product. The value created for the customers is judged by 
the customers to be helpful in their life. Slowly the customers benefit from the value 
that a firm has created for them, will start to appreciate the company as a reputable one. 
In this way, managers can build with that for segmenting their customers, depending on 
customer needs. 
 
A firm can apply the following activities to improve its segmentation strategy and build 
best practices: First, a firm should strive to enhance its value-chain activity to make it 
consistent with experiential value creation—for example, integrating the medicinal 
material supply with innovation, R&D, manufacturing, and after-sales service. Second, 
the firm should allocate resources to be more consistent with experiential value creation. 
Third, the firm should try to enhance the customers’ self-identity. Fourth, the firm 
should communicate more effectively with shareholders and other stakeholders to shape 
their perceptions about the firm. Fifth, the firm should build customer relationship. 
Sixth, the firm should negotiate with competitors to take advantage of joint resources 
and to ensure its product suits the market better. Seventh, the firm should negotiate with 
the government to affect policy. 
 
However, in practice, recently the National Health Service (NHS) in Taiwan changed its 
medicine price policy. As a result of focusing on cutting the medicine price, 
pharmaceutical companies received little benefit from elaborating their brand. 
Distinguishing a brand either by more functional or experiential value created in their 
products cannot provide a higher benefit, therefore causing fierce price competition. 
The effects on medicine price policy are stated by a manager as follows: 
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“We, the Gentle Pharma., are less than excellent, but more than 
general. This is to boast ourselves. So we can segment the market, 
that you can buy a bit less than excellent, but much cheaper. Maybe 
they will accept us. So we just follow the excellent companies. We 
don’t compete with the cheapest ones. We compete with the 
excellent ones. This is our position of our company or brand you 
can say. But nowadays there’s no difference between each 
company after the NHS set up the price policy. We don’t have the 
price difference for the NHS price. And moreover now the hospitals 
only want the price difference when they bid for the medicine.” 
[Manager in company C] 
 
 
“Now in Taiwan we are trying to carry out the PIC/s (The 
Pharmaceutical Inspection Cooperation Scheme) standard. It 
means we are following the international GMP standard. However, 
they want us to go through the PIC/s standard examination. They 
will send a representative to examine our factory. So we have to 
reach the PIC/s standard if we want to sell our product to Europe 
or England.” [Manager in company C] 
 
A pharmaceutical company can also use its corporate reputation to apply brand 
segmentation. A pharmaceutical company can enhance its corporate reputation by 
making it qualified to the PIC/s. From time to time, the requirement for GMP (Good 
Manufacturing Practice), CGMP (Current Good Manufacturing Practice) and nowadays 
PIC/s makes the new pharmaceutical companies improve their hardware and software. 
Then they are qualified to export their products to advanced countries (i.e. Europe, 
America etc.).  
 
In this specific industry, in this particular environment, the researcher found that the 
result doesn’t support these hypotheses perhaps for the following reasons. That is: 
 
“If I say now I want to sell to China, I will have a different 
corporate reputation with a Chinese company. The corporate 
reputation will create segmentation, as does the price segmentation. 
Now Taiwan can be approved by international markets. Actually 
the Chinese may achieve the US FDA standard and Taiwan can 
also achieve the US FDA. Everyone producing the product can 
achieve the US FDA standard. Actually if we talk about strategy, 
products from everywhere we shall consider as having the same 
quality. We consider that for one company, even if they have 
factories all over the world, the same company product should go 
through the same standards of quality control.” [Manager in 
company D] 
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6.4.2 Effects of the Uses of Corporate Reputation on Brand 
Differentiation 
 
According to Dannenberg and Kleinhans (2004), brand management is becoming the 
central capability for auto makers to differentiate themselves. And value creation 
occupies an important part of the brand management in the vehicle engineering and 
production. Moreover, according to Sheth and Parvatiyar (1995), “in the face of 
competition, marketers realized the benefits of focusing on specific groups of customers 
for whom they could tailor their marketing programs and successfully differentiate 
themselves from their competitors” (Peterson, 1962) by providing different value 
created to their customers. Also according to Lynch and Chernatony (2004), emotional 
brand value development may also cause value creation for their customers that can be 
a means of developing a sustainable differential advantage. 
 
According to Table 5.44, the researcher assessed the relative influence of all types of 
uses of corporate reputation on brand differentiation by comparing their path 
coefficients.  The direct effects of two dimensions of the uses of corporate reputation 
(e.g. value creation and corporate communication) on brand differentiation were found 
to be positive and statistically significant. However, the relationship between strategic 
resource and brand differentiation had to be rejected. This suggests that, given that all 
other factors are equal, the more value creation is employed, and the more corporate 
communication is established by a firm with their customers, the easier it is to build a 
firm’s brand differentiation strategy.  
 
In this case, the path coefficient of value creation (β = 0.253) differs hugely from that of 
corporate communication (β = 0.640). This indicates a higher importance for corporate 
communication than the value creation on the brand differentiation. This is considered 
reasonable in the Taiwanese pharmaceutical context because how a brand is 
differentiated from another depends more on how a firm communicates with its 
stakeholders (e.g. by using advertisements or showing how professional are its sales 
representatives) than on the real value a firm creates for its customers.  
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Moreover, according to the literature and qualitative results of data, several issues were 
raised by the interviewees regarding the uses of corporate reputation on building the 
brand differentiation strategy. For example, the NATURAL-oriented products were 
created as a value added to the brand by company D. And a manager in company F 
suggested doing differentiation from the customer’s side. 
 
“Nowadays there are many things using herbal products; some 
cosmetics are herbal too. They say ‘We don’t use chemical stuff, 
but use herbal products’. So this is included in a firm’s reputation. 
Before, our cosmetics usually added some fragrances, nowadays 
there’s less fragrance in them. Cosmetics actually don’t need any 
fragrance because it just has to protect us. But fragrance is just a 
thing that makes you more comfortable, and is not helpful in 
protecting us. So nowadays people use this kind of strategy that 
emphasizes that the product is more natural – which the added 
fragrance was not since it is distilled from other stuff. Therefore, a 
firm’s reputation creates the brand value and brand differentiation.” 
[Manager in company D] 
 
 
“I strongly agree with this idea. And I would rather hope to create 
differentiation from the customer side. This means we shall apply a 
differentiation strategy for pharmacists and doctors. Because the 
differentiations of medicine, unlike food, are very rigid and 
confined, there is not too much variance for them. If you want to 
create brand differentiation, rather than product differentiation, I 
would suggest creating it from the customer side. And do it 
reversely. It will come out with the same result. Because whether it 
is product differentiation, or customer differentiation, with both 
what you have to influence is the result. Therefore, from the 
customer side to apply brand differentiation, one way of doing it is 
through sales behaviour, and the other one is customer service.” 
[Manager in company F] 
 
 
“As I mentioned before, our success is because of signing the 
contract. Our contract is very flexible, and variable. It aims to let 
the front line people change the contract decision according to the 
customer’s needs. It is not necessary to reach a big amount for us 
to agree to send the product. Because some of the clinics are too 
small they can only order a very small amount of stock – maybe not 
even one thousand in one season. Therefore, in order to cooperate 
with these clients, our contract is flexible and variable. ” [Manager 
in company F] 
 
 
“I think so. However, for brand positioning, communication is 
related to the different ways that the shareholders deal with things. 
All these will influence customer choice.  And the customer’s 
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choice is related to knowledge transferring. In other words, this is 
one kind of customer service. For example, nowadays each month 
we issue a magazine called Yun-Shin medicine information. We 
usually distribute the magazine to doctors, drug store pharmacists 
etc. In this magazine it usually discusses about the topics of 
medical common sense, or clinical experiments from abroad, our 
product conditions etc. Therefore, our corporate reputaion can 
help us find some information, and some communication tool. This 
product provides this kind of service, it has some educational 
position. It is because the professionals don’t really have spare 
time to read other books. However, this magazine has satisfied 
their wish to update their knowledge. Since there is no other 
company doing this, the customers would consider our company to 
have better service quality. Some products have side effects, some 
newly issued drugs that might affect some races but others not etc. 
Such information is needed by doctors. Most people think it’s 
reasonable to spend time to get the most updated information. 
Therefore, it shows our brand positioning has its own value.” 
[Manager in company D] 
 
 
The non-significant coefficient of strategic resources indicates a different view from 
that of marketing research as existing literature generally suggests that the more uses of 
strategic resources for a firm’s reputation, the better a firm can apply their 
differentiation strategy (Yeoh and Roth, 1999; Cornwell et al., 2001; Priem and Butler, 
2001). On the other hand, respondents from follow-up interviews did not fully agree 
with this statistical finding as they showed their mixed comments on the relative 
importance of three dimensions of the uses of corporate reputation. Some interviewees 
put more emphasis on customer service whereas others stressed the importance of 
corporate communication such as knowledge transferring and advertising. For example, 
the quote from the manager in company F (see above) does not support the statistical 
finding, whereas the comments from manager in company D do. These mixed views 
reveal a need for further examination of the relative significance of different types of 
corporate reputation use. Future research on this issue should help researchers and 
practitioners to better understand about how to use a firm’s corporate reputation to 
benefit its differentiation strategy.   
 
A pharmaceutical company can also enhance its branding strategy through other uses of 
corporate reputation, including value creation and corporate communication. Both the 
quantitative and the qualitative data show that when pharmaceutical company managers 
use value creation and corporate communication to implement their brand 
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differentiation strategy (Holsapple and Singh, 2001; Lynch and de Chernatony, 2004; 
Harrington, 2007), they reach their targets more easily. Thus, companies can apply the 
same seven activities as mentioned previously: that is, firms should (1) strive to enhance 
its value-chain activity to make it consistent with experiential value creation, (2) 
allocate resources to be more consistent with experiential value creation, (3) try to 
enhance the customers’ self-identity, (4) communicate more effectively with 
shareholders and other stakeholders to shape their perceptions about the firm, (5) build 
customer relationship, (6) negotiate with competitors to take advantage of joint 
resources and to ensure its product suits the market better, and (7) negotiate with the 
government to affect policy, all to improve their brand differentiation strategy and build 
best practice. Moreover, according to Lynch and de Chernatony (2004) and Harrington 
(2007), firms can implement the strategy in two ways: One is based on emotional 
characteristics, and the other is based on knowledge sharing (Holsapple and Singh, 
2001). 
 
The statistical support of H4 and H6 (value creation and corporate communication is 
positively associated with brand differentiation) is evidence of this claim. Moreover, 
this finding also confirms and expands existing knowledge in other research such as 
corporate communication (Shelby, 1993). For instance, it provides an explanation  as to 
why there is a  relationship between corporate communication and knowledge transfer 
(Von Krog et al., 1997; Van Riel and van Bruggen, 2002). 
 
6.4.3 Effects of the Uses of Corporate Reputation on Brand Positioning 
 
Finally, the relationship between two dimensions of the uses of corporate reputation (e.g. 
value creation and strategic resources) and brand positioning is also found to be 
supported in statistical analysis. Moreover, the relationship between corporate 
communication and brand positioning is found to be partially supported. This suggests 
that, all other things being equal, the more a firm can create value for its customer, and 
the more a firm uses their corporate reputation as a strategic resource, the easier it will 
be to build its brand positioning strategy. 
 
According to Table 5.44, another issue should also be noted. It is managerially and 
theoretically fruitful to understand that the uses of corporate reputation have an impact 
on brand positioning. The researcher assessed the relative influence of all types of uses 
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of corporate reputation on brand differentiation by comparing their path coefficients.  
The direct effects of two dimentions of the uses of corporate reputation (e.g. value 
creation and strategic resources) on brand positioning were found to be positive and 
statistically significant. However, the relationship between corporate communication 
and brand positioning is found to be only partially supported. This suggests that the 
more value creation is employed, and the more strategic resources are applied by a firm 
to their customers, the easier it will be to build a firm’s brand positioning strategy.  
 
In this case, the path coefficient of value creation (β = 0.432) is not very different from 
that of the strategic resources (β = 0.507). This indicates that the use of corporate 
reputation as strategic resource is somehow more important than the use of corporate 
reputation as value creation in brand positioning strategy. This is considered reasonable 
in the Taiwanese pharmaceutical context because using the corporate reputation as a 
strategic resource, for example, to enter the market early, and to obtain large cash 
resources can help a firm to provide its brand with a good image in the consumer’s 
mind. In addition, a firm’s value creation ability can create an image for the consumer’s 
mind. And the managers can use this kind of core competence as an announcement to 
the public that the firm’s R&D is strong so customers can trust it. Such a relationship 
showed that value creation ability enhances brand positioning strategy. This finding 
helps to further explain evidence pertaining to research about value-based theory.  
 
Moreover, according to the literature and qualitative result of data, there are several 
issues raised by the interviewees regarding the uses of corporate reputation in building 
the brand positioning strategy. For example, the products from Taiwan are considered 
as top market products in China. 
 
“In China, our product is sold as a better value than products from 
Europe. Maybe it is because luckily it was a turning point in the 
market condition. Actually some of the European companies, such 
as Bayer, were angry with this. A previous government official had 
heart disease. He was having treatment in the heart department in 
one of the big hospitals in Beijing. They use the Bayer Aspirin. It is 
commonly known that it will cause discomfort in the stomach when 
one takes aspirin. So this old person was feeling uncomfortable in 
the stomach. Afterwards we went to see that doctor, and told the 
doctor that if you take our pill, then your stomach will not get 
uncomfortable. Therefore, this product has the advantage of no 
side effects. Because people with heart disease are usually elders, 
for safety reasons, they use our product. So we changed a little bit 
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from the original product, and added some other ingredients, so it 
has fewer side effects. Under these circumstances, I think in the 
beginning we can ask a higher price, meaning we can position our 
product in a higher market.This product was then taken  off the 
market but brought back again because they say it’s very effective 
medicine and safe. So the market was back for this product. So our 
firm’s corporate reputation signifies that our product is effective 
and safe. It therefore can be positioned as a high priced product. 
And also, it will lead other product…. ” [Manager in company D] 
 
 
“From the product point of view, let me take Yin-Yuan as an 
example. We have three companies, one is Yin-Yuan, another one is 
Yin-Jie and the third one is Yin-An. The positioning strategy for 
each company is clear. Yin-Yuan is targeting everyday products, 
such as headache pain killer, flu and syrup etc. Yin-Yuan has 
everything you want. If you cannot find something in the market, 
just give a phone call to Yin-Yuan see if we have it. The other one 
is Yin-Jie. There are above 50% of its performance comes from 
eye-drops. Eye-drops are Yin-Jie’s competitive product. Therefore, 
now we faced a problem, which is the blind competition from the 
new competitor in this area.…… However, through last year, we 
found that the situation is not that bad. We traced back that the 
reason for this might be an important action that we did, which was 
to sign a contract. This action protected us from the severe 
competition. The other company Yin-An was focusing on injections.” 
[Manager in company F] 
 
 
The positive relationship between strategic resources and brand positioning can be 
explained by the interviewee’s way of locating different resources in each company 
(Bowman and Hurry, 1993). This postulates that a firm can manage its reputation by 
allocating similar resources together and targeting different customers (Turnbull and 
Valla, 1993).  
 
“If I want to make an advertisement, I would have to collect a big 
amount of funds from others. The original company might spend a 
billion pounds of operating fees for a new product to enter the 
market. Maybe I can build my company image or reputation 
through marketing channels in order to advertise or market my 
company. Believe it or not, if you have a distributor, you should 
offer a seminar when you want your new product to enter the 
market. You should position this product and make the consumer 
confident about it. For example, in sales marketing, the 
advertisement may target the consumers…. Or it aims to influence 
customers’ perception of such a marketing strategy. Or they can 
hold a seminar, in order to build up a new product line. However, 
as a product manager, I will have to coordinate this, which is 
called “psychological education” or “confidence education”. 
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Because if others doubt your product and the salesperson is afraid, 
they cannot get a good performance. Therefore for a good 
marketing manager, confidence is very important. It is important to 
believe in his product when selling it. Second, he needs to think the 
product is good too, so that he can answer customer’s questions 
and explain to them. Then you will get good performance. So you 
can market your corporate reputation and brand to your agent, 
your salespeople, and then to the customers. And then use 
advertisements to market to your consumers. This is marketing 
strategy.” [Manager in company B] 
 
 
A firm can undertake activities as best practice to achieve a better brand positioning 
strategy. These activities include (1) improving its value-chain activity to make it 
consistent with experiential value creation, (2) allocating its resources to be more 
consistent with experiential value creation, (3) enhancing the customers’ self-identity, (4) 
entering the market earlier, (5) more efficiently managing the marketing system and (6) 
maintaining customer relationship. These activities give the brand a clearer image, 
provide consumers with a more thorough understanding of the firm and the brand and 
effectively transfer the product or brand information to the consumers.  
 
In summary, this chapter provides comments on the results of the measurement scales 
purification and hypotheses testing. Follow-up interviews have been used as a tool to 
help explain the findings. Both statistical findings and interview results support a 
proposition that a company may be able to apply brand image strategy via knowledge 
transfer and conformity with international manufactory standards (e.g. GMP, cGMP, 
PIC/s… etc.) (Li and Houston, 2001). Moreover, good brand image strategy is 
confirmed to be positively associated with the proper use of a firm’s corporate 
reputation such as value creation and corporate communication. However, some 
comments from interviewees raise questions about the external conditions or 
environmental factors (government policy) which may distort or even suppress the 
relationship found in this study. For instance, it has been noticed that the uses of 
corporate reputation may not lead to brand image strategy setting if price regulation has 
interfered in this relationship. 
 
Finally, the medicine price is found to negatively moderate the relationship between the 
overall uses of corporate reputation and the overall application of brand image strategy 
(H10). According to Table 5.18, a negative overall moderating effect was found in the 
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statistical test. This indicates from the interviews that the medicine price was playing an 
important moderating role, even though there was not enough literature to support this 
view. After the statistical test, it turned out there was not support for each path. 
Therefore this suggests that the medicine price is partially and negatively supported in 
the relationship between the uses of corporate reputation and brand image strategy.   
 
In the next chapter, theoretical, managerial and policy implications will be presented. 
Research limitations will also be noted and other potential research directions will be 
discussed in more detail. 
 
 
6.5 Recommendations 
 
Several decades ago, when the Taiwan economy was growing rapidly, the Taiwanese 
government tried to increase and strengthen the development of small and medium-
sized enterprises. Therefore, the pharmaceutical industry in Taiwan generally comprises 
private, small and medium-sized firms. Moreover, Taiwan’s government now also 
encourages the transformation of economic status and firm development and upgrading 
in such a crowded business environment. For example, many of the Taiwanese 
manufacturers currently applying the original equipment manufacturer (OEM) business 
model are transforming their model to one based on branding.  
 
This study categorised three types of pharmaceutical companies according to the size of 
the firm; size is a key feature to measure the amount of production or transaction of the 
business in the Taiwanese pharmaceutical industry. Therefore, the study used the total 
number of employees, as follows: small (0–49 employees), medium (50–299 employees) 
and large (more than 300 employees). First, compared with smaller firms, larger firms 
tend to have more capital, are more influential and tend to assume a leading role in the 
industry. Therefore, this study recommends that these firms pay more attention to 
corporate social responsibility and the feedback it receives to transform their ‘corporate 
philosophy’ into practice, thus gaining a higher corporate reputation. Moreover, because 
larger firms are more powerful than smaller firms, they are better able to negotiate with 
the government to set new policies to benefit and direct industry rights and interests, 
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thereby also benefiting small and medium-sized firms’ strategy decision. Thus, larger 
firms tend to maintain a leading role in the industry.  
 
Second, medium-sized companies can adjust their value-chain activity and resource 
allocation to be more consistent with experiential value creation (happiness, affection 
and excitement), and thereby enhance their customer identity. These points emphasize 
the role of customers’ experiences and how customers see the firm. The company thus 
should create more experiential value for customers, because within this ‘self-
experience’, customer can learn the companies’ self-identity more easily (who they are 
and what they think they are).  
 
Third, small firms also should improve their value-chain activity and resource allocation 
to align with international standardised processes, thus creating a functional value to the 
customers. After gaining the customers’ basic trust about product quality, these firms 
can begin to build their reputation by creating functional/good-quality products, the 
foundation of the pharmaceutical industry. Moreover, small firms can try to revise 
components of generic medicine to improve the effectiveness of the medicine itself or 
attempt to build their R&D to undertake more underlying functions of a medicine. 
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CHAPTER SEVEN: CONCLUSION 
 
 
7.1 Introduction 
 
This research examines the roles of the uses of corporate reputation (i.e. value creation, 
strategic resources and corporate communication) factors in the process of brand image 
strategy building. It also investigates how medicine price plays a moderating role in the 
relationship of the uses of corporate reputation and brand image strategy in the 
Taiwanese pharmaceutical industry. The study helps fill research gaps mainly by 
providing alternative insights to the uses of corporate reputation on the consequences of 
applications in brand image strategy and by testing theories in a non-western setting to 
increase their external validity. The study employs a hybrid methodology comprising a 
dominant quantitative (i.e. survey) and a less-dominant qualitative (i.e. interview) 
component to develop measurement scales and test hypotheses.  
 
Statistical and qualitative findings generally support the framework proposed in Chapter 
3. According to Figure 5.2, the medicine price is found to be negatively associated with 
brand image strategy and completely moderates the relationship of the uses of corporate 
reputation (as a whole) impact on brand image strategy (as a whole). The uses of 
corporate reputation are also found to be generally positively correlated with brand 
image strategy. The discussion on these findings and follow-up interviews also points 
out that there are limitations but potential for future research. 
 
In this chapter, research contributions in two aspects (theoretical and managerial) will 
be presented. Limitations and future research directions will also be discussed in more 
detail. This chapter will start by discussing the theoretical and managerial implications 
of this research. The limitations of the study will then be reviewed. Finally, future 
research directions on two different levels, theoretical and methodological, will be 
presented.  
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7.2 Research Contributions 
 
7.2.1 Theoretical Implications 
 
This research contributes to existing literature on reputation and other fields in at least 
six ways. First, most studies in corporate reputation literature have concentrated on the 
general concept of corporate reputation theoretically rather than relating it to actual 
practice. This study contributes to existing knowledge by linking the theoretical 
corporate reputation theory with a firm’s strategic usage of it in practice. There is a lack 
of literature investigating the relationship between corporate reputation and branding 
issues. Although a few studies addressing the uses of corporate reputation have already 
been conducted (e.g. Okano et al., 1999; Bickerton, 2000; Michell et al., 2001; Davies 
and Chun, 2002), they have been done without empirical evidence explicating the 
relationships between these constructs. 
 
Second, most studies in strategy and marketing have ignored the corporate literature on 
the uses of corporate reputation that can cause an impact on the corporate and brand 
strategy. This study contributes to existing knowledge by theoretically building the 
constructs with regard to how corporate reputation is practically used in three 
dimensions from six different perspectives. Six different perspectives on uses of 
corporate reputation were collected and then categorized into three dimensions which 
serve as the original concepts in strategic uses of corporate reputation. The concepts 
were then linked to brand image strategies based on three main theories (value-based 
theory, resource-based theory and integrated marketing communication theory). The 
theories are borrowed to explain how to use corporate reputation to build brand image 
strategy. In particular, the relative impacts of three uses of corporate reputation (i.e. 
value creation, strategic resources and corporate communication) on brand image 
strategy (i.e. brand segmentation, brand differentiation and brand positioning) are 
evaluated. 
 
Statistical results show that some hypotheses are accepted, some are partially accepted, 
and a few are rejected. Overall uses of corporate reputation are found to be significant 
when correlated with brand image strategy. The relative explanatory powers of different 
uses of these three constructs (value creation, strategic resources and corporate 
communication) are found to be asymmetrical. These findings of this research indicate 
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that six perspectives of concepts can be used effectively to explain the variation in the 
uses of corporate reputation and its consequences.  
 
Third, this research advances current understanding about a generative process by which 
brand image strategy is formed and applied, with statistical evidence followed by the 
theory building. The current literature (e.g. Okano et al., 1999; Michell et al., 2001; 
Davies and Chun, 2002) has only conceptualized the direct impacts for each construct of 
the uses of corporate reputation on each brand image strategy but none has empirically 
examined these relationships.  
 
Fourth, no previous study has empirically examined the moderating effects involved in 
creating brand image strategy in the pharmaceutical practice. For example, this study 
finds that medicine price negatively moderates the impact of the overall uses of 
corporate reputation on overall brand image strategy.  
 
Fifth, it provides partial evidence to a long-standing debate about how to construct the 
uses of corporate reputation. Some past studies suggest the link of corporate 
communication as one of several dimensions in the uses of corporate reputation. A 
firm’s corporate reputation can be used for corporate communication as it creates 
knowledge transfer, such as the communication of the sales staff to the customer, basic 
medical knowledge education, research outcomes updated, product information or 
effects revealed, and the newest research reported and delivered.  
 
In terms of methodology, the major contribution of this study is twofold. First, this 
research is one of the few that tests reputation-and-branding-building models outside of 
the USA and Europe. Reputation researchers (e.g. Nguyen and Leblanc, 2001; Gardberg 
and Fombrun, 2002; Roberts and Dowling, 2002) have highlighted a global trend in 
reputation management and raised their concerns about the necessity for cross-cultural 
research. Other researchers in general have also been aware of the applicability of their 
theories across nations and have encouraged new studies to establish their external 
validity (e.g. Sekaran, 1981; Boyacigiller and Adler, 1991; Peng et al., 1991). The 
research to some extent responds to those calls for global investigations by testing a 
reputation-building model in Taiwan, a country in Southeast Asia. Examining the model 
there could render additional insights into extant literature because Taiwanese 
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consumers and their cultural backgrounds are substantially different from those of 
western countries (Hsieh and Scammon, 1993; Hsieh and Tsai, 2009). 
 
The findings of the study suggest that the uses of corporate reputation are recognized as 
an important concept in western countries (according to literature, see Chapter 2) as 
well as to Taiwanese companies. Taiwanese show a similar understanding about the 
overall concept to those reported in literature but place more weight on different 
domains. In addition, the model explains well the dimensions and the consequences of 
the uses of corporate reputaiton, indicating that these concepts may be effectively used 
in other management research in other countries as well.  
 
Second, this study verifies, adapts and purifies existing measurement instruments in a 
country which is culturally different from the setting in which these items were first 
developed. For instance, the value creation scale was purified and tested in an attempt to 
fill a gap suggested by recent research (e.g. Sweeney and Soutar, 2001; Ulaga Eggert, 
2003). Similar processes were also completed for other constructs.  
 
According to the findings, all scales generally appear valid in their original content but 
the number of dimensions in purified scales is not the same as those of the original 
scales. For instance, some of the measurement items were dropped because of the 
Cronbach’s α (reliability) scale did not reach 0.7, whereas its original scale comprises 
more items (see Chapters 4 and 5). Future cross-national research could benefit from 
future investigations about essential conditions in which the comparability of scales 
across countries is affected.  
 
Finally, this study also advances existing knowledge in marketing and strategic 
management. From the marketing viewpoint, the study contributes to the literature in 
the corporate reputation construct and another construct for practitioners called the uses 
of corporate reputation (how do firms use their corporate reputation to …). For instance, 
it confirms the findings that a well-reputed firm can create a distinctive position for the 
company in the mind of stakeholders (Fombrun and Shanley, 1990; Gregory, 1991; 
Marconi, 1991; Day, 1994; Fortune, 1995; Fombrun and van Riel, 2004) and enables 
customers to gauge the merits of a product or service, especially when customers are 
faced by vague corporate or product information (Fombrun and Shanley, 1990). 
Moreover, it adds evidence about the impact of advertising on levels of customer 
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attitudes and customer loyalty (Hartwick, 1990; Yoon et al, 1993; Saxton, 1998; 
Campbell, 1999; Nguyen and Leblanc, 2001). In particular, it informs the marketing 
literature about the mechanism through which a well-known firm’s reputation gives 
confidence to its customers about its products and service quality.   
 
From a strategic management perspective, this research shows that the concept of the 
uses of corporate reputation can complement the resource-based view (RBV) in 
explaining how corporate reputation qualifies as a source of intangible assets and 
competitive advantage. To resource-based theorists, corporate reputation is a valuable 
asset because it is considered rare, non-substitutable and not easy to imitate (Barney, 
1986, 2001; Dierickx and Cool, 1986). However, RBV focuses more on the 
characteristics of resource and market to explain firms’ competitive advantage and pays 
less attention to using these advantages to enhance the level of branding strategy by 
implementing an intangible asset to become a strategic resource. Strategy researchers 
have scarcely incorporated social and economic factors into their studies about strategic 
resource accumulation. This research helps bridge such a gap by adding another 
example about how an intangible resource can be acquired within a pharmaceutical 
setting.  
 
7.2.2 Managerial Implications 
 
Current reputation management models have mostly been formulated from economic or 
strategic angles. Often, corporations build their reputation without fully using it. They 
do not link it very well into developing some strategy from it or applying it to practical 
use. Reputation issues are usually been fully aware of and strategies will be applied 
when a firm has to confront reputation damage. Firms are likely to passively manage 
their reputation rather than actively control it and make a full use of it. 
 
This study offers practical guidelines for managers in actively managing the reputation 
of their companies and makes a full use of it from six different perspectives. Three 
dimensions of synthesised constructs of the uses of corporate reputation are 
recommended to be adopted into practical management by their company. For example, 
the findings from this research suggest that firms can develop the firm’s brand 
segmentation strategy by incorporating value creation and the corporate communication 
ability of the firm. Companies that can maintain their operations and apply their brand 
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image strategies effectively may able to regenerate their reputation signal to their 
customers.  
 
For example, given a specific industry, companies may design a set of strategies that 
might be led by a certain level of use of each corporate reputation dimension. These 
image strategies aim to influence the targeted consumer’s mind. They could also take a 
more proactive measure by incorporating their customers into the strategy-making 
structures (i.e. let their customer take part in shaping their strategy) (Hart, 1990).  In 
short, this is similar to the concepts about customer focus in management research. 
 
 
7.3 Limitations and future research 
 
As with all research projects, this study has several limitations. The following section 
elaborates the limitations posed by the research setting, research design and 
measurement issues. 
 
7.3.1 Limitations of the study 
 
The researcher attempted to expand the understanding of the construct of the uses of 
corporate reputation and its consequences for strategy planning. Although the 
endeavour was worthwhile, it was not without its limitations.  
 
Like other studies in marketing and strategy, this research contains some limitations. 
First, for the methodological weaknesses of this study, this study is cross-sectional 
representing static relationships between variables in the framework. By the nature of 
cross-sectional study, the researcher is only allowed to capture the linkage of variables 
over a short span of time (Bordens and Abbott, 2008).  
 
A further limitation is regarding the normality of data and contruct reliability. Even the 
examination of a model analysed by SEM provides strong support for the acceptable 
structure path and measurement weights, but the psychometric properties of 
measurement items were weak in some points. Therefore, some of the measurement 
items were removed during the item purification process. The deletion of these items 
was due to the fact that the items cannot perfectly measure the construct domain. Hence, 
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removing some of the items from the original dimensions limits the generalizability of 
the original constructs. 
 
There is also a limitation regarding the issue of the external validity. This study was 
conducted in a single setting, which provided the researcher with a better control over 
market and environmental anomalies (Conant et al., 1990) and industry effects (Rao, 
1994) but does limit the generalizability of findings. The small and mediun enterprise 
(SME) setting also enabled the researcher to clearly detect the effects of corporate 
factors. However, although the SME in a pharmaceutical context provides many 
opportunities for corporate issues–manager relations that raise strategy issues for firm 
managers (Napier and Smith, 1987; Baysinger and Hoskisson, 1990), the focus of this 
research on the pharmaceutical industry would certainly limit the generalizability of the 
findings to industries other than pharmaceutical industry. In addition, the study focuses 
on only one industry in Taiwan which would be significantly different compared to 
other studies which compare more than two industries in Taiwan – this factor may have 
influenced the survey results. Furthermore, the findings may be limited to the Taiwnese 
context and may not necessarily reflect managers’ brand image strategies in other 
countries. Therefore, there is a need to replicate and extend this study to other contexts.  
 
Moreover, this study has used small-number sample size analysis because the entire 
number of targeted respondents is around 200 people. Also because of the researcher’s 
limited time and resources, firm managers rather than customers of the pharmaceutical 
companies were selected as the targeted respondents. This study only reveals the 
perception of the branding strategy at manager level and cannot be generalized for 
individual customer perception. Also, this study used a non-probability sampling 
method to select the respondents that limits understanding the benefit of the probability 
sampling such as: (1) “the resulting sample is likely to provide a representative cross-
section of the whole” (Denscombe, 2002, p. 12) and (2) “the accuracy and validity of 
the finding from the survey by referencing to the degree of error and/or bias which may 
be present in it as measured by well understood statistical methods” (Baker, 2002, p. 
106). 
 
Finally, this research may also possess a respondent bias towards managers who have 
their own opinions about their own company. However, the selected group of 
respondents was desirable for this study due to two reasons. First, it was the group that 
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could estimate the uses of corporate reputation and brand image strategy of 
pharmaceutical companies more accurately than others could due to their direct 
experience of management and strategy planning. Second, it was one of the most 
accessible groups of respondents, which helped facilitate the survey procedure. 
 
The findings of this research may also suffer from common method bias, which is 
possible when perceptual data for independent (e.g. the uses of corporate reputation 
constructs) and dependent variables (e.g. the brand image strategy constructs) are 
collected from the same source (managers). However, it is hard to avoid one party (as 
managers) from being have biased. Additionally, the researcher further investigated this 
potential problem by following Podsakoff and Organ’s (1986) approach. Harmon’s one-
factor test was performed in a confirmatory manner (e.g. Morgan et al., 2004; Vorhies 
and Morgan, 2005). If the problem exists, CFA should yield a well-fitted one-factor 
model which contains all observed variables. 
 
7.3.2 Directions for Future Research 
 
Having identified the limitations of the study, this section then provides some 
suggestions for future research to extend the current body of knowledge in the literature 
on corporate reputation, corporate strategy and brand strategy.  
 
Four directions for future research can be identified. First, this study focuses on the uses 
of corporate reputation which a company has used for creating brand image strategies. 
In a context of imperfect information, according to some scholars (Weigelt and Camerer, 
1988; Wartick, 1992; Herbig and Milewicz, 1993) customers tend to use corporate 
reptutation to deduce the quality of a particular product or service offered by a company 
or to try to forecast its future action. Based on this logic, a firm manager can use its 
corporate reputation to deploy a strategy that has some level of influence on the 
customer’s perception. 
 
This research has been applied to examine the Taiwanese pharmaceutical industry. 
However, this whole process of theoretical building can be applied to other contexts of 
study such as another industry or another country, for digging indepth regarding the 
branding strategy issue in different contexts.  Future research can be structured in a 
similar way to the theoretical building of this research. It is suggested to go through 
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another qualitative interview process to purify the proposed measurement scales. Some 
different measurement items would be removed during the item purification process 
when examining under a different context. This process is necessary for the researcher 
to perfectly measure the construct domain in a specific context. 
 
This study applied to one industry in one country in far eastern Asia; it would be 
significantly different for other studies which compare more than two industries in 
Taiwan or compare the same (pharmaceutical) industry in more than two countries. 
Future research as a comparative study, possibly with more than two different industries 
or countries is recommended in order to understand this theoretical structure more 
thoroughly. Thus, there is a need to replicate and extend this study to other contexts 
either in other industries or countries.  
 
Extensive studies about the relative influences of different dimensions of the uses of 
corporate reputation on image strategy should also be conducted, which can partly help 
answer the question about whether a firm’s reputation can have an impact on its brand 
image (Bickerton, 2000). Practically, it should also help managers to effectively select 
reputation-building activities, consequently allocate their budgets and build a brand 
image strategy based on a firm’s intangible asset.  
 
Another future direction of this research would be to develop a measurement to measure 
the relationship between this current study and financial performance. The reputation–
performance literature from many areas of study is huge and has been researched for a 
long period of time, showing both positive and negative links between the two. From a 
review of the literature, for example, marketing scholars (Fombrun, 1996; Caruana, 
1997; Srivastava et al., 1997) assert that a good corporate reputation generates good 
returns and affects corporate performance. Accounting scholars affirmed that a firm’s 
corporate reputation enables it to profit from a variety of benefits (Herremans et al., 
1993). At the same time economic scholars (Sabate and Puente, 2003; Sobol and Farrell, 
1988) and management scholars (Deephouse, 1997; Brown, 1997; Roberts and Dowling, 
1997) indicate that a good corporate reputation is used by firms to enhance corporate 
performance and financial performance (Roberts and Dowling, 2002; Kotha et al., 2001; 
McGuire et al., 1990). Therefore, a link of this current study and financial performance 
is suggested for examination in future research. 
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Appendix 1a – Taiwan and Its Pharmaceutical Industry 
 
A1.1 Taiwan at a glance 
 
 
Geography Maximum Length 394 km 
 Maximum Width 144 km  
 Land Area 36,190 sq.km. 
   
Population 23.02 Million*  
 (2.59 Million in Taipei, the Capital city)  
 * Based on July 2010 estimation of US 
Bureau of the Census based on statistics 
from population censuses 
 
   
Religion Buddhist and Taoist 93% 
 Christian 4.5% 
 Others 2.5% 
   
Currency TWD (Approximately 30TWD/US$ or 
48TWD/£) 
 
   
Language Mandarin Chinese  
   
Government Presidential system  
 
President of Taiwan: Ma, Ying-jeou 
 
 
 
 
Econimic  2009 GDP US$ 379.03 Billion 
Indicators 2009 Export US$ 203.67 Billion 
 
2009 Import 174.36 Billion 
 
2009 Intrest Rate (Prime Rate) 
 
 
International Reserve US$ 380.51 Billion 
 
 
 
(Source: German Trade Office Taipei; http://www.taiwan.ahk.de/taiwan/taiwan-at-a-
glance/) 
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Appendix1. Table 1b: Benefits and limitations of alternative approaches for measuring business performance 
Category Label Description Benefits Limitations Key methodological considerations when 
using this approach 
Illustrative studies 
reference 
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1 Financial data from 
secondary sources 
(a) Provides data on 
financial aspects, which may not 
be otherwise available;  
(b) Can be used especially 
in a single/dominant business 
type sample, and in “within-
industry” studies. 
(c) Possibility of 
employing stock market 
indicators of performance. 
(a) Differences in accounting 
policies may limit its use 
for comparison purposes 
(unless stock-market 
indicators are adopted). 
(b) Cannot be meaningfully 
used at strategic business 
unit level due to 
“aggregation” problems. 
(a) Examine the feasibility of using 
stock-market indicators as well as 
the measure of return on value 
added (ROVA) in view of its 
“invariance” across industrial 
contexts, as noted by Hofer (1983) 
(b) Use industry-relative performance 
when multiple industries are 
included in the sample 
(c) Access differences in accounting 
policies when feasible. 
Rumelt (1974) 
 
Montgomery & Singh 
(1984) 
 
Bettis and Hall (1982) 
2 Financial data from 
primary sources 
(a) Provides self-reported 
financial data with fewer 
problems of external 
interpretation and aggregation 
of data; 
(b) Can be used at both 
corporate and strategic business 
unit level of analysis. 
(a) Data is likely to be 
biased;  
(b) Complete data may 
not be available due to 
confidentiality reasons. 
(a) Choose target respondents based on 
specific criteria (position, function, 
etc.). 
(b) Use multiple respondents to 
examine the extent of systematic 
bias as well as minimize 
measurement error. 
Dess and Robinson (1984) 
 
(PIMS-based studies’ use 
of ROI measure) 
3 Operational data from 
secondary sources 
(a) Provides performance 
data when financial data either 
may not be available or may be 
inappropriate. 
(a) Problems of data 
availability on various 
indicators to develop the 
requisite measures; 
(b) Some operational data 
may be industry-specific and 
may not lend itself to multi-
industry studies; 
(c) Relationship to 
financial performance not 
known. 
(a) Use industry as the reference point 
for developing measures; 
(b) Attempt to define concepts such as 
market-share, efficiency, etc., as 
consistently as possible across 
industries. 
 
 
 
-market-share data in 
Schendel and Patton 
(1978) 
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4 Operational data from 
primary sources 
(a) Provides some basis to 
include considerations of 
performance in the research 
design; 
(b) Less likely to be 
influenced by reasons of 
confidentiality, sensitivity, etc. 
(c) Data is likely to be 
biased; 
(d) Relationship to 
financial performance not 
known. 
(a) Choose target respondents based on 
specific criteria (position, function, etc.) 
(b) Use multiple respondents to 
examine the extent of systematic bias as well 
as to minimize measurement error. 
 
 
 
 
-market-share data in 
PIMS-based studies 
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A Financial data from 
both primary and 
secondary sources 
(a) Provides scope for 
assessing convergent validity to 
enhance the “quality” of 
measurement. 
 
 
 
(a) Compatible data from 
two different data 
sources may not be 
readily available; 
(b) Cannot be meaning-
fully done when 
research studies are 
designed at the 
strategic business unit 
level due to problems 
of obtaining 
secondary data; 
(c) Operational aspects of 
performance are not 
covered. 
(a) Check for definitional consistency;  
(b) Identify reasons for non-
convergence, if observed and 
reconceptualize the concept if 
necessary; 
(c) Examine 
substitutability/interchangability of 
one measure for the other; 
(d) Use industry referent measures in 
multi-industry studies; 
 
(e) Evaluate the feasibility of using 
stock-market measures or ROVA. 
Venkatraman and 
Ramanujam (1985) 
B Business performance 
viewed in terms of 
both financial and 
operational indicators, 
with data from 
secondary sources. 
(a) Provides a more 
comprehensive 
operationalization of business; 
(b) Enables one to 
examine the relationship 
between financial and 
operational aspects of 
performance. 
(c) Inability to validate 
operationalizations across 
different data sources; 
(d) Cannot be 
meaningfully used at a 
strategic business unit level of 
analysis. 
(a) Define financial and operational 
indicators in industry-relative 
terms; 
(b) Assess differences in accounting 
policies; 
(c) Address the dimensionality issue 
both theoretically and empirically. 
 
 
 
Schendel and Patton 
(1978) 
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C Operational data from 
both primary and 
secondary sources 
(a) Provides scope for 
assessing convergent validity of 
operationalization using two 
different methods. 
 
(b) Data availability may 
prove to be a key limitation; 
(c) Financial aspects of 
performance are not 
considered, and the 
relationships between financial 
and operational indicators are 
not known. 
(a) Check for definitional consistency; 
(b) Identify reasons for 
nonconvergence, if observed; 
(c) Examine 
substitutability/interchangeability 
of operationalizations. 
 
 
D Business performance 
viewed in terms of 
both financial and 
operational indicators, 
with data from primary 
sources 
(a) Provides a more 
comprehensive 
operationalization of business 
performance; 
(b) Enables one to examine the 
relationship between financial 
and operational aspect of 
performance; 
(c) Can also be adopted at the 
strategic business unit level. 
 
(a) Inability to validate 
operationalizations across 
different data sources. 
(a) Choose target respondents based on 
specific criteria; 
(b) Define indicators in industry-relative 
terms; 
(c) Address the dimensionality issue both 
theoretically and empirically; 
(d) Use multiple respondents to examine 
systematic bias due to position, level, etc., as 
well as minimize measurement error. 
Burgeois (1980) 
Gupta and Govindarajan 
(1984) 
Woo and Willard (1983) 
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E Financial data from 
secondary sources and 
operational data from 
primary sources 
(a) Provides a scheme to enlarge 
the conceptualization of 
business performance, when 
financial data may not be 
forthcoming due to reasons of 
confidentiality. 
(a) Limited use at a strategic 
business unit level of analysis. 
 
(a) Limited use at a strategic business unit 
level of analysis. 
 
F Operational data from 
secondary sources and 
financial data from 
primary sources 
 
Unlikely option since if financial data are available through 
primary sources, it is equally likely that operational data also may 
be available from the same sources. 
  
a  Although in an isolated study (Venkatraman and Ramanujam, 1985), positive and statistically significant association between perceptual (primary) and secondary data on three performance 
indices were observed, the possibility of bias cannot be completely ruled out, and should be specifically tested in each study.  
b All the PIMS-based strategy studies are not separately listed. For a review see Ramanujam and Venkatraman (1984). 
Source: Adapted from Venkatraman and Ramanujam (1986) 
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Appendix 1. List of Journals in the Literature Search 
 
 
Following is the list of journals included in the literature search as part of the 
measurement scale development process: 
 
(1) Academy of Management Journal  
(2) Academy of Management Review 
(3) Corporate Reputation Review 
(4) European Journal of Marketing 
(5) European Management Journal 
(6) Harvard Business Review 
(7) Journal of the Academy of Marketing Science 
(8) Journal of Advertising 
(9) Journal of Business and Industrial Marketing 
(10) Journal of Business Ethics  
(11) Journal of Business Research 
(12) Journal of Consumer Research 
(13) Journal of General Management 
(14) Journal of International Business Studies  
(15) Journal of Management 
(16) Journal of Management Studies 
(17) Journal of Marketing 
(18) Journal of Marketing Management 
(19) Journal of Marketing Research 
(20) Journal of Public Relations Research 
(21) Management Science 
(22) Strategic Management Journal 
(23)The Marketing Review 
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Appendix 2. Face-to-face semi-structured interview participant consent form 
 
 
Application of the uses of corporate reputation on brand image 
strategy 
 
 
Marketing Department  
Brunel Business School PhD Study 
Brunel University 
 
 
This interview is being conducted on behalf of the Brunel Business School led by Brunel University. 
Please read the separate information sheet for a description of the aim and purpose of this research. 
 
This study aims to determine the three uses of corporate reputation dimensions and its application on 
the establishment of an image strategy. This semi-structured interview allows a fairly open 
conversational framework. A number of questions were designed ahead of time to guide the 
conversation. However, during the interview, both the interviewer and the interviewee have the 
flexibility to steer the conversation to achieve the purpose of this study. It is open to discuss about 
various details in order to present the main ideas that may not be discussed by using a formal, closed 
question set. You have been chosen randomly from company managers in the Taiwanese 
pharmaceutical industry to participate in the study.  
 
An audio recording may be required by the researcher to aid subsequent data analysis. If so, you will be 
informed at the beginning of the interview. All records of the interview, including the notes, audio file 
and transcripts (if produced), will be kept secure and at all times personal data will be treated in ways 
that are consistent with the data protection principles set out in the UK Data Protection Act 1998. 
 
The interview will take approximately one hour to complete. You may withdraw from the interview at 
any time and any data already recorded will be discarded if you choose. 
If you have any questions or comments regarding this interview, please contact: 
 
Chen Chu Chen 
Brunel Business School, Brunel University 
01895 266386 
Chen.chu.chen@brunel.ac.uk 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
□ I agree to take part in this interview. 
□ I confirm that I have read the associated information sheet and understand the intent   
      and purpose of this research. 
□ I agree that data captured by this interview can be shared amongst the academia which  
      engage and support projects to conduct further analysis*, and 
□ I agree that anonymised extracts from the interview transcript may be used in   
      documents intended for public dissemination.* 
 
Name:  ______________________________________  
Email:  ______________________________________ 
Signature: ___________________________________ 
Date:  _______________________________________ 
* Ticking these agreement statements is optional. 
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Title:  ______________________________________________________________ 
 
Interviewer: ______________________________________________________________ 
• Position: ________________________________________________________ 
 
• Personal responsibilities:   General manager   Marketing manager   Sales Manager   Public 
relations manager 
 
• How long have you been with the company? ______ years and ______ months 
 
• How many staff are there in your company?  _________________________ 
 
 
Name of company: ________________________________________________ 
 
Date: ___________________________________________________________ 
 
Introduction: My name is Chen-Chu Chen and I am currently a Doctoral student at Brunel Business 
School, Brunel University, Uxbridge, UK.  
The research title of this study is: The use of corporate reputation in the development of brand image 
strategy and its effects on brand market shares in the Taiwanese pharmaceutical industry. The aim of 
this study is to investigate the uses of corporate reputation. It explores the factors of the uses of 
corporate reputation that influence a manager’s strategy decisions and whether the uses of a firm’s 
corporate reputation can be applied to making a firm’s brand image strategy. This research examines 
the main effectiveness of a firm’s reputation as a device for developing a firm’s brand image strategy 
by managers. The brand image strategy is based on competitive positioning, product differentiation and 
segment development. 
The purpose of this study is to build a firm’s brand image in order to provide managers with guidelines 
on the uses of a firm’s reputation to implement their brand image strategy effectively. Therefore, it 
studies the three main dimensions of the uses of corporate reputation that influence brand image 
strategy setting at a corporate level. 
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Qualitative interview questions – part 1. Research conceptual framework and content of the interview questions 
Research conceptual framework (with items for each construct) 
 
Resource: Developed by the author 
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Research questions, hypotheses and qualitative questions (English version)  
RQ: How do (Taiwanese pharmaceutical) companies use their corporate reputation to develop brand image strategy? 
   
*RQ: Key research question  
SRQ1.   Can a firm’s corporate reputation have an impact on its product’s market segment development? 
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of a 
product’s segment development? 
Can you suggest the characteristics of value creation which tend to encourage the setting of a product’s segment development? And why do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create a product’s segment development. What value creation 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so? 
The items for value creation are suggested as follows (please see List 1) 
The items for segment development are suggested as follows (please see List 4) 
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of a 
product’s segment development? 
Can you suggest the characteristics of strategic resources which tend to encourage the setting of brand segmentation and positioning strategy? And why do you 
suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create brand segmentation and positioning strategy. What strategic 
resource characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so? 
The items for strategic resource are suggested as follows (please see List 2). 
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting 
in terms of a product’s market segment development? 
Can you suggest the characteristics of corporate communication which tend to encourage the setting of brand segmentation and positioning strategy? And why 
do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create brand segmentation and positioning strategy. What 
communication characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so? 
The items for corporate communication are suggested as follows (please see List 3). 
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SRQ2.  Can a firm’s corporate reputation have an impact on its product differentiation? 
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of its product 
differentiation? 
Can you suggest the characteristics of value creation which tend to encourage the setting of its product differentiation? And why do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation. What value creation 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest in more? And why do you think so? 
The items for value creation are suggested as follows (please see List 1). 
The items for product differentiation are suggested as follows (please see List 5). 
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of its 
product differentiation? 
Can you suggest the characteristics of strategic resources which tend to encourage the setting of your product differentiation? And why do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation. What strategic resource 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so? 
The items for strategic resource are suggested as follows (please see List 2). 
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting 
in terms of its product differentiation? 
Can you suggest the characteristics of corporate communication which tend to encourage the setting of your product differentiation? And why do you suggest 
this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your product differentiation, what communication 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you suggest this? 
The items for corporate communication are suggested as follows (please see List 3). 
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SRQ3.  Can a firm’s corporate reputation have an impact on a brand’s competitive position? 
Do you think a firm’s corporate reputation, which is used to create value, has a positive impact on a firm’s brand image strategy in terms of the 
brand’s competitive position? 
Can you suggest the characteristics of value creation which tend to encourage the setting of your brand positioning strategy? And why do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand’s positioning strategy. What value creation 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so? 
The items for value creation are suggested as follows (please see List 1). 
The items for product differentiation are suggested as follows (please see List 6). 
Do you think a firm’s corporate reputation, which is used as a strategic resource, has a positive impact on a firm’s brand image strategy in terms of a 
brand’s competitive position? 
Can you suggest the characteristics of strategic resources which tend to encourage the setting of your brand positioning strategy? And why do you suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand positioning strategy. What strategic resource 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you think so? 
The items for strategic resource are suggested as follows (please see List 2). 
Do you think a firm’s corporate reputation, which is used to communicate with its stakeholders, has a positive impact on a firm’s brand image setting 
in terms of its product differentiation? 
Can you suggest the characteristics of corporate communication which tend to encourage the setting of your brand positioning strategy? And why do you 
suggest this?   
As a brand manager, you are responsible for controlling the quality of a brand in the firm to create your brand positioning strategy, what communication 
characteristics (of the uses of corporate reputation) would you pay more attention to or would like to invest more? And why do you suggest this? 
The items for corporate communication are suggested as follows (please see List 3). 
Source: Developed by the author 
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Qualitative interview questions – part 2. Items of each construct  
List 1. Items for the uses of corporate reputation – value creation (Wong and Saunders, 1993) 
Function/Instrumental Value 
 Compete by creating useful products. 
 Compete by creating correct/accurate attributes 
 Compete by appropriate performances. 
 Compete by appropriate outcomes. 
 Value-chain activity/resource allocation consistent with functional value creation. 
 
Experiential/Hedonic Value 
 Compete by creating sensory value or appealing to the senses. 
 Compete by creating appropriate emotions (fun, pleasure, excitement, relaxation, etc.) 
 Compete by facilitating social relationships (bonds, attachments, togetherness) 
 Compete by creating epistemic value (knowledge, novelty, fantasy). 
 Compete by creating epistemic value (knowledge, novelty, fantasy). 
 Value-chain activity/resource allocation consistent with experiential value creation. 
 
Symbolic/Expressive Value 
 Compete by enhancing self-identity, self-concept, self-worth. 
 Compete by creating personal meaning. 
 Compete by facilitating self-expression. 
 
Cost/Sacrifice Value 
 Compete by offering economic value (low prices, value in use, life costs). 
 Compete by minimizing psychological investment of customers (ease of use, ease of doing business, simplicity, availability, accessibility). 
 Compete by minizing personal investment of customers (time, effort, energy). 
 Compete by minimizing customer risk (personal, technological, strategic). 
 Value-chain activity/resource allocation consistent with symbolic value creation. 
 
List 2. Items for the uses of corporate reputation  – strategic resource (Wong and Saunders, 1993) 
 Product differentiation 
 Segmentation and positioning 
 Efficient sales and marketing 
 Advanced R&D 
 Early to market 
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 Large cash resources 
 
List 3. Items for the uses of corporate reputation – corporate communication (Johar and Sirgy, 1989; Hooley et al., 2004; Ogilvy, 1963; Sirgy, 1989; Reeves, 1961; 
Madhavaram et al., 2005; Vargo and Lusch, 2004; Dickson and Ginter, 1987; Peltier and Schribrowsky, 1997; Nandan, 2005; Flint, 2004) 
• Shape the perception of shareholders and stakeholders  
• Influence consumer choices  
•  Build a relationship between the firm and the customers  
•  It is used as a signal to customers 
•  To influence consumer choices 
 
List 4. Items for brand image strategy – segment development (Dickson and Ginter, 1987) 
 This brand has one particular form of demand function modification 
 This brand requires product differentiation in exitence or as a complementary strategy 
 This brand may entail change in ideal point location 
 This brand may entail change in importance attached to a physical or nonphysical product 
 
List 5. Items for brand image strategy – product differentiation (Dickson and Ginter, 1987) 
 This brand is created perceptual differently by usage experience, word of mouth, and promotion 
 This brand is actually created differently by product characteristics 
 This brand maybe directed at entire market or at one (or more segments) 
 This brand may utilize either physical or non-physical product characteristics 
 
List 6. Items for brand image strategy – competitive position (Wong and Saunders, 1993) 
 Very superior quality 
 Superior quality 
 Better product performance 
 Higher advertising 
 Long distribution chain 
 Service much better 
 Fulfils basic need 
• Upmarket 
Source: Adapted from previous literature as stated 
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Appendix 3 Questionnaire (First version, developed directly from literature) 
 
The uses of corporate reputation scale 
 
For each of the following statements, please indicate the response that most closely describes your organization. 
 
Strongly 
disagree  
1 
Moderately 
disagree 
2 
Neither agree 
nor disagree 3 
Moderately 
agree 
4 
Strongly agree 
5 
 
Value creation  
   __________________  01.  Our firm’s corporate reputation promises good quality products and service to customers. 
   __________________  02.  The corporate reputation of our firm helps to reduce transaction costs.  
   __________________  03. Our firm competes by creating useful products. 
   __________________  04. Our firm competes by creating the correct product attributes for its targeted customers. 
   __________________  05. Our firm competes by appropriate performances. 
   __________________  06. Our firm competes by appropriate outcomes. 
   __________________  07. Our firm’s value-chain activity is consistent with functional value creation. 
   __________________  08. Our firm’s resource allocation is consistent with functional value creation. 
   __________________  09. Our firm competes by appealing to the senses. 
   __________________  10. Our firm competes by creating appropriate emotions (fun, pleasure, excitement, relaxation, etc.) 
   __________________  11. Our firm competes by facilitating social relationships (bonds, attachments, and togetherness). 
   __________________  12. Our firm competes by creating epistemic value (knowledge, novelty, fantasy). 
   __________________  13. Our firm’s value-chain activity is consistent with experiential value creation. 
   __________________  14. Our firm’s resource allocation is consistent with experiential value creation. 
   __________________  15. Our firm competes by enhancing its customers’ self-identity. 
   __________________  16. Our firm competes by enhancing its customers’ self-concept. 
   __________________  17. Our firm competes by enhancing its customers’ self-worth. 
   __________________  18. Our firm competes by creating personal meaning. 
   __________________  19. Our firm competes by facilitating self-expression. 
   __________________  20. Our firm competes by offering economic value (low prices, value in use, life costs). 
   __________________  21. Our firm competes by simplifying the purchasing process for its consumers (ease of use, ease of doing business, simplicity, 
availability, accessibility). 
   __________________  22. Our firm compete by enabling ease of use of its products (time, effort, energy). 
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   __________________  23. Our firm competes by minimising customer risk (personal, technological, strategic).  
   __________________  24. Our firm’s value-chain activity is consistent with symbolic value creation. 
   __________________  25. Our firm’s resource allocation is consistent with symbolic value creation. 
 
Strategic value or resource 
 
   __________________  01.  In our organisation, corporate reputation serves as a competitive advantage. 
   __________________  02.  Our firm’s corporate reputation sends a strong signal to its customers. 
   __________________  03. Our firm’s corporate reputation implies efficient sales and marketing.  
   __________________  04. Our firm’s corporate reputation implies its advanced R&D. 
   __________________  05. Our firm’s corporate reputation implies that we are able to enter markets early. 
  
Corporate communication  
   __________________  01.  Our firm’s corporate reputation shapes the perceptions of shareholders and other stakeholders. 
   __________________  02.  Our firm’s corporate reputation builds a relationship between the firm and its customers. 
   __________________  03.  Our firm’s corporate reputation influences consumer choices. 
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Brand image strategy scale 
 
For each of the following statements, please indicate the response that most closely describes your organisation. 
 
Strongly 
disagree  
1 
Moderately 
disagree 
2 
Neither agree 
nor disagree 3 
Moderately 
agree 
4 
Strongly agree 
5 
 
Competitive position   
   ___________________  1. Our firm’s corporate brand positioning strategy signifies high quality to its customers.  
   ___________________  2. Our firm’s corporate brand positioning strategy signifies better product performance to its customers. 
   ___________________  3. Our firm’s corporate brand positioning strategy is to achieve a higher frequency of advertising. 
   ___________________  4. Our firm’s corporate brand positioning strategy involves a long distribution chain.  
   ___________________  5. Our firm’s corporate brand positioning strategy is to provide a much better service to its customers.   
   ___________________  6. Our firm’s corporate brand positioning strategy tries to fulfil the basic needs of our customers. 
   ___________________  7. Our firm’s corporate brand positioning strategy tries to target upmarket audiences. 
  
Product differentiation  
   ___________________  1. How our corporate brand is perceived varies according to whether consumers have experienced our products. 
   ___________________  2. How our corporate brand is perceived varies by word of mouth. 
   ___________________  3. How our corporate brand is perceived varies by promotion. 
   ___________________  4. Our corporate brand is actually created differently by product characteristics. 
   ___________________  5. Our corporate branding maybe directed at different market segments. 
   ___________________  6. Our corporate brand may utilise physical product characteristics. 
   ___________________  7. Our corporate brand may utilise non-physical product characteristics. 
  
Segment development  
   ___________________  1. Our corporate brand strategy has one particular form of demand function modification. 
   ___________________  2. Our corporate brand strategy requires product differentiation. 
   ___________________  3. Our corporate brand strategy requires changes in point distribution location. 
   ___________________  4. Our corporate brand strategy requires changes in importance attached to a non-physical product. 
   ___________________  5. Our corporate brand strategy requires changes in importance attached to a physical product. 
______________________________________________________________________________________________________________________________________ 
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Appendix 4. Questionnaire (A revised version after qualitative interview):  
 
 
 
 
Value creation items: 
     
 
1. Our firm’s corporate reputation promises good quality products and service to 
customers. 
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. The corporate reputation of our firm helps to reduce transaction costs.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our firm competes by creating useful products.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our firm competes by creating the correct product attributes for its targeted 
customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our firm competes by providing good financial performances.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our firm competes by providing product with appropriate outcomes.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our firm’s value-chain activity is consistent with functional value creation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
8. Our firm’s resource allocation is consistent with functional value creation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
9. Our firm’s products compete by appealing to the senses.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
10. Our firm competes by creating appropriate emotions (e.g. fun, pleasure, excitement, 
relaxation, etc.)  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
11. Our firm competes by facilitating social relationships (e.g. bonds, attachments and 
togetherness).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
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12. Our firm competes by creating epistemic value (e.g. knowledge and novelty).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
13. Our firm’s value-chain activity is consistent with experiential value creation (e.g. 
happiness, affection and excitement...).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
14. Our firm’s resource allocation is consistent with experiential value creation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
15. Our firm competes by enhancing its customers’ self-identity.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
16. Our firm competes by enhancing its customers’ self-concept (or self-image).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
17. Our firm competes by enhancing its customers’ self-worth.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
18. Our firm competes by facilitating self-expression.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
19. Our firm competes by offering economic value (low prices, value in use, life costs).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
20. Our firm competes by simplifying the purchasing process for its consumers (ease of 
use, ease of doing business, simplicity, availability of purchasing, accessibility).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
21. Our firm competes by enabling ease of use of its products (time, effort, energy).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
22. Our firm competes by minimizing customer risk (personal, technological, strategic).
  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
23. Our firm’s value-chain activity is consistent with symbolic value creation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
24. Our firm’s resource allocation is consistent with symbolic value creation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
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Strategic resources items: 
     
 
1. In our organization, corporate reputation serves as a competitive advantage.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. Our firm’s corporate reputation sends a strong signal to its customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our firm’s corporate reputation implies efficient sales and marketing.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our firm’s corporate reputation implies it has advanced R&D.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our firm’s corporate reputation implies that we are able to enter markets early.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our firm’s corporate reputation gains the firm more opportunity for strategic alliance 
or business cooperation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our firm’s corporate reputation is enhancing the prices by validating them in 
published clinical reports.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
8. Our firm’s corporate reputation enables the firm to enter the market easier.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
9. Our firm’s corporate reputation gains more customers for the firm.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
10. Our firm’s corporate reputation makes the marketing system work more efficiently.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
11. Our firm’s corporate reputation makes it easier for us to find a downstream reseller.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
12. Our firm’s corporate reputation can enhance our firm’s sales force.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
13. Our firm’s corporate reputation helps the new product to enter the market.  
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1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
14. Our firm’s corporate reputation helps the strategic link with complementary 
products.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
 
 
 
Corporate communication items:  
 
 
1. Our firm’s corporate reputation shapes the perceptions of shareholders and other 
stakeholders.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. Our firm’s corporate reputation builds a relationship between the firm and its 
customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our firm’s corporate reputation influences consumer choices.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our firm’s corporate reputation is based on the experience of the sales people.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our firm’s corporate reputation is based on the sales ability of the sales people.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our firm’s corporate reputation is based on the firm's awareness of social 
responsibility.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our firm’s corporate reputation can be used for all types of negotiations with our 
customers, competitors or the government.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
8. Our firm’s corporate reputation helps internal communication (the communication 
between our firm and our staffs).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
9. Our firm’s corporate reputation helps external communication (the communication 
between our firm and our customers).  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
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Brand positioning items:  
     
 
1. Our firm’s corporate brand positioning strategy signifies high quality to its customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. Our firm’s corporate brand positioning strategy signifies better product performance 
for its customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our firm’s corporate brand positioning strategy is to achieve a higher frequency of 
advertising.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our firm’s corporate brand positioning strategy involves a long distribution chain.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our firm’s corporate brand positioning strategy is to provide a much better service to 
its customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our firm’s corporate brand positioning strategy tries to fulfil the basic needs of our 
customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our firm’s corporate brand positioning strategy tries to target upmarket audiences.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
 
 
 
Brand differentiation items:  
 
 
1. Our corporate brand is perceived differently according to whether consumers have 
experienced our products.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. Our corporate brand is perceived differently by word of mouth.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our corporate brand is perceived differently by promotion.  
 
1 2 3 4 5 
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Disagree □ □ □ □ □ Agree 
 
4. Our corporate brand is actually created differently by product characteristics.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our corporate branding may be directed at different market segments.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our corporate brand may utilize physical product characteristics.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our corporate brand may utilize non-physical product characteristics.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
8. Our firm’s corporate brand positioning strategy is based on advanced R&D which 
leads the needs of the targeted market.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
 
 
 
Brand segmentation items:  
 
 
1. Our corporate brand strategy has one particular form of demand function 
modification.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. Our corporate brand strategy requires product differentiation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. Our corporate brand strategy requires changes in point distribution location.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our corporate brand strategy requires changes in importance attached to a 
nonphysical product.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our corporate brand strategy requires changes in importance attached to a physical 
product.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our corporate brand strategy is decided by the needs of the customers to decide the 
product differentiation.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
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7. Our corporate brand strategy is based on different channels of distribution.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
 
 
 
Medicine price items: 
     
 
1. A medicine with a higher price shows a higher quality of product to its customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
2. A medicine with a higher price shows a better image of the company it belongs to.
  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
3. A medicine with a higher price usually captures the value that is generated in the 
product.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
4. Our firm customizes price by value that is perceived by our customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
5. Our firm customizes price by distinguishing customers who pursue high values and 
customers with strict budgets.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
6. Our firm customizes price by offering coupons, regional prices, limited consumption 
or negotiatory prices to a specific group of customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
7. Our firm customizes price according to the characteristics of the customers.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
8. Our firms customize price according to the trading characteristics.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
9. Our firm pays considerable attention to effective publicity and communication while 
operating bulk buying/discounts.  
 
1 2 3 4 5 
 
Disagree □ □ □ □ □ Agree 
 
 
 
 
 
Thank you very much for your co-operation
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Appendix 5. Survey respondents background information 
1. Company 
History: 
2. Turnover 
(Million 
Pounds): 3. Service Type (Multiple): 
4. Size 
(People): 5. Department: 6. Position: 
7. Years of 
experience in 
the company: 
11–30 years Between 1 and 3  
A trader company (Trade Asian 
company products) 0–49  
Marketing 
department 
Department 
manager 
More than 25 
years 
11–30 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
31–50 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  Sales department Board chairman 
More than 25 
years 
31–50 years Above 10  
Taiwanese local company 
(Manufacture+Sell) 50–99  
Management 
department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  
Management 
department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  Sales department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Under 1  
A trader company (Trade Asian 
company products) 0–49  
Management 
department General manager 
More than 25 
years 
11–30 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  Sales department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Under 1  
Taiwanese local company 
(Manufacture+Sell) 0–49  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
11–30 years 
Between 1 and 3 
millions 
A trader company (Trade European 
company products) 
50–99  
Management 
department Board chairman 
More than 25 
years 
Taiwanese local company 
(Manufacture+Sell) 
31–50 years Above 10  
A trader company (Trade American 
company products) 
50–99  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
11–30 years Between 1 and 3  
A trader company (Trade American 
company products) 0–49  
Management 
department 
Department 
manager 
Between 2 to 5 
years 
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A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
11–30 years Above 10  
A trader company (Trade European 
company products) 
over 300  
Marketing 
department 
Department 
manager 
Between 2 to 5 
years 
A trader company (Trade Asian 
company products) 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Under 1  
A trader company (Trade Asian 
company products) 0–49  
Management 
department General manager 
Between 6 to 14 
years 
Less than 10 
years Under 1  
A trader company (Trade Asian 
company products) 
0–49  Sales department 
Department 
manager Less than 1 year 
Taiwanese local company 
(Manufacture+Sell) 
Less than 10 
years Between 1 and 3 
A trader company (Trade Asian 
company products) 0–49  Sales department General manager 
Between 6 to 14 
years 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Management 
department General manager 
More than 25 
years 
31–50 years Between 3 and 10 
A trader company (Trade European 
company products) 50–99  Sales department 
Department 
manager 
Between 15 to 24 
years 
31–50 years Above 10  
Taiwanese local company 
(Manufacture+Sell) 100 – 299  Sales department 
Department 
manager Less than 1 year 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Marketing 
department General manager 
More than 25 
years 
11–30 years Between 1 and 3  
A trader company (Trade Asian 
company products) 0–49  
Management 
department General manager 
Between 15 to 24 
years 
11–30 years Between 1 and 3  
A trader company (Trade American 
company products) 50–99  Sales department 
Department 
manager 
Between 6 to 14 
years 
31–50 years Between 1 and 3 
A trader company (Trade American 
company products) 
50–99  
Management 
department 
Department 
manager Less than 1 year 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Above 10  A trader company (Trade American 0–49  Management Department Between 15 to 24 
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company products) department manager years 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) over 300  
Marketing 
department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Between 1 and 3  
A trader company (Trade Asian 
company products) 
0–49  
Marketing 
department 
Department 
manager 
More than 25 
years 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Between 1 and 3  
Taiwanese local company 
(Manufacture+Sell) 50–99  
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
51–80 years Above 10  
A trader company (Trade American 
company products) 
over 300  Sales department 
Department 
manager 
Between 2 to 5 
years 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Above 10  
A trader company (Trade American 
company products) 
0–49  Sales department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Between 1 and 3  
A trader company (Trade European 
company products) 50–99  
Marketing 
department 
Department 
manager 
Between 2 to 5 
years 
11–30 years Between 1 and 3 
A trader company (Trade Asian 
company products) 50–99  Sales department 
Department 
manager 
Between 6 to 14 
years 
11–30 years Between 1 and 3  
A trader company (Trade European 
company products) 
50–99  
Management 
department 
Department 
manager 
More than 25 
years 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Above 10  
A foreign owned company (Asian 
company) (Manufacture+Sell) 
100 – 299  Sales department 
Department 
manager 
Between 15 to 24 
years 
A trader company (Trade European 
company products) 
31–50 years Above 10  
A foreign owned company (American 
company) (Manufacture+Sell) over 300 
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
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11–30 years Between 1 and 3  
A trader company (Trade American 
company products) 
0–49  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
11–30 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Management 
department 
Department 
manager 
More than 25 
years 
51–80 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
51–80 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
11–30 years Between 3 and 10 
A trader company (Trade Asian 
company products) 
100 – 299  
Management 
department 
Department 
manager 
Between 2 to 5 
years 
Taiwanese local company 
(Manufacture+Sell) 
Over 81 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Management 
department General manager 
Between 15 to 24 
years 
31–50 years Under 1000  
Taiwanese local company 
(Manufacture+Sell) 0–49  Sales department Board chairman 
More than 25 
years 
11–30 years Under 1000  
Taiwanese local company 
(Manufacture+Sell) 0–49  
Management 
department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Under 1000  
A trader company (Trade Asian 
company products) 0–49  
Management 
department General manager 
More than 25 
years 
11–30 years Under 1000  
Taiwanese local company 
(Manufacture+Sell) 0–49  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
31–50 years Above 10  
A trader company (Trade American 
company products) 
50–99  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
11–30 years Above 10  
A trader company (Trade European 
company products) 
over 300  
Marketing 
department 
Department 
manager 
Between 2 to 5 
years A trader company (Trade Asian 
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company products) 
Taiwanese local company 
(Manufacture+Sell) 
Less than 10 
years Under 1  
A trader company (Trade Asian 
company products) 
0–49  Sales department 
Department 
manager Less than 1 year 
Taiwanese local company 
(Manufacture+Sell) 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Management 
department General manager 
More than 25 
years 
31–50 years Between 3 and 10 
A trader company (Trade European 
company products) 50–99  Sales department 
Department 
manager 
Between 15 to 24 
years 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Marketing 
department General manager 
More than 25 
years 
11–30 years 
Between 1 and 3 
million 
A trader company (Trade American 
company products) 50–99  Sales department 
Department 
manager 
Between 6 to 14 
years 
11–30 years Above 10  
A trader company (Trade American 
company products) 0–49  
Management 
department 
Department 
manager 
Between 15 to 24 
years 
31–50 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) over 300  
Marketing 
department 
Department 
manager 
Between 15 to 24 
years 
11–30 years Between 1 and 3  
Taiwanese local company 
(Manufacture+Sell) 50–99  
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
51–80 years Above 10  
A trader company (Trade American 
company products) 
 over 300  Sales department 
Department 
manager 
Between 2 to 5 
years 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Above 10  
A trader company (Trade American 
company products) 
0–49  Sales department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
Taiwanese local company 
(Manufacture+Sell) 
11–30 years Between 1 and 3  
A trader company (Trade Asian 
company products) 50–99  Sales department 
Department 
manager 
Between 6 to 14 
years 
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11–30 years Above 10  
A foreign owned company (Asian 
company) (Manufacture+Sell) 
100 – 299  Sales department 
Department 
manager 
Between 15 to 24 
years 
A trader company (Trade European 
company products) 
11–30 years Between 1 and 3  
A trader company (Trade American 
company products) 
0–49  
Management 
department 
Department 
manager 
Between 6 to 14 
years 
A trader company (Trade European 
company products) 
A trader company (Trade Asian 
company products) 
51–80 years Between 3 and 10 
Taiwanese local company 
(Manufacture+Sell) 100 – 299  
Marketing 
department 
Department 
manager 
Between 6 to 14 
years 
11–30 years Between 3 and 10 
A trader company (Trade Asian 
company products) 
100 – 299  
Management 
department 
Department 
manager 
Between 2 to 5 
years 
Taiwanese local company 
(Manufacture+Sell) 
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Appendix 6. List of overall company profile in Taiwanese pharmaceutical industry 
Company Email Address Tel. No. (+886=0) Fax No. (+886=0) 
Address 
area code Website 
Koda Pharmaceutical Co. Ltd.  koda@koda.com.tw  (03)4696105 (03)4691447 324 www.koda.com.tw  
Yuan Chou Chemical & Pharmaceutical 
Co., Ltd. a2256666@ms71.hinet.net (049)2253190 (049)2255-330 540 www.yuanchou.com.tw  
Fu Tan Pharmaceutical Co.,Ltd.  a481069@yahoo.com.tw  
(04)8884138, 
(04)8884139 (04)888-3608 521   
Chen Ta Pharmaceutical Co.,Ltd.  a7211111@ms24.hinet.net (06)5721102 (06)572-6535 721   
Nysco Co., Ltd. accounting@nysco.net  (02)29017321 (02)2908-5268 242 www.nysco.net 
Chun Da Co., Ltd. adm@paolyta.com.tw (03)5983150 (02)27413511 303   
Aerolead International Ltd. aled@aerolead.com.tw (03)4839606 (02)2876-5845 328   
Taiwan Shionogi & Co.,Ltd alice@shionogi.com.tw (02)24512466-7 (02)2536-2326 206   
San You Biotech & Pharmaceutical Co., 
Ltd. allcare@sun-you.com.tw  (06)6353338 (06)6353656 731 www.sun-you.com.tw  
AND Pharmaceutical & Chemical Industry 
Co Ltd. and.lin@msa.hinet.net (04)7621135 (04)763-1369 500   
Kuang Nan Pharmaceutical Co., Ltd. angus@iloveyou-bio.com  
(03)9382954, 
(03)9383235 (03)9386-916 260 www.iloveyou-bio.com  
ARICH Enterprise Co., Ltd. arich@ms7.hinet.net (02)25057295 (02)25047665 104 www.arich.com.tw  
Astar Chemical & Pharmaceutical Co Ltd. astarnet@ms25.hinet.net (03)5591158-9 (03)559-0028 304   
Kuo Chang Pharmaceutical Co., Ltd. biomist@anet.net.tw (06)2613165-7 (06)261-6296 702 www.gcnkh.com  
Caleb Pharmaceuticals, Inc. caleb@caleb-pharm.com  (03)579-5858 (03)579-5656 300 www.caleb-pharm.com 
China Biological & Chemical Co Ltd.  cbc.pharmal@msa.hinet.net (02)26235507 (02)8631-0200 251 www.cbcl.com.tw 
Chunghwa Chemical Synthesis & Biotech 
Co., Ltd. ccsb@ccsb.com.tw  (02)8684-3318 (02)8684-3202 238 www.ccsb.com.tw  
Chu Chen Ind. Co., Ltd. cctmj@kingcar.com.tw (07)6967156 (02)2368-8128 821 www.kingcar.com.tw  
Century Chem. & Pharm.Co.,Ltd.  century.ct115@msa.hinet.net (02)24967112 (02)2496-8307 224 www.century115.com 
Chang An Chemical Industries Co.,Ltd. chanan66@ms23.hinet.net (04)7695126 (04)769-5120 506   
Chin Ang Pharmaceutical Co.,Ltd.  changmp@ch-angmp.com.tw  (05)2216025-6 (05)221-8833 621 www.ch-angmp.com.tw  
Cheng Fong Chemical Co., Ltd. cheng.fong@msa.hinet.net (03)3868383 (02)2966-9575 337 www.cf-chemical.com.tw 
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Chien Min Pharmaceutical Co., Ltd. chenmin.chenmin@msa.hinet.net (04)23500663 (04)2350-5329 407   
Chia Shin Pharmaceutical Co Ltd. chiashin2@yahoo.com.tw (05)2354872-3 (05)2358496 600   
Chin Teng Pharmaceutical Industrial 
Co.,Ltd.  chinteng@ms12.hinet.net (04)26812468 (04)2681-6878 437 www.chinteng.com.tw 
Chiu Jern Chem. & Pharm. Co., Ltd.  chiu.jern@msa.hinet.net (02)26211111-2 (02)2623-5324 251   
Overseas Chinese Pharmaceutical Co., 
Ltd. chwovc@yahoo.com.tw  (02)22866217 (02)22874228 241   
Chung Mei Pharmaceutical Co Ltd. cmnet001@ms21.hinet.net (04)7524161 (04)761-3986 500 www.chungmei.com.tw 
Sheng Foong Co., Ltd. company@shengfoong.com.tw  (03)9905900 (02)2769-8785 270 www.shengfoong.com.tw 
Chung Tai Sing Chemical Industry Co., 
Ltd. cts@crocoil.com.tw  (03)5387135 (03)5387-539 300 www.crocoil.com.tw  
The Curie Chem & Pharm 
Manufacturing Co Ltd. curie.cr@msa.hinet.net 
(02)26214538, 
(02)26231666, 
(02)26256365 (02)2623-1249 251   
Shun Hwa Pharmaceutical Co., Ltd. d3565@ms34.hinet.net (02)26711597 (02)2307-9171 237   
Daw Jih Pharmacy Works Co Ltd.  dauge@ms2.hinet.net (08)7070705 (08)707-0606 913 www.dauge.com.tw  
Danver Chemical & Pharmaceutical Co 
Ltd.  dcpclee@seed.net.tw (03)3869200 (03)386-9202 337   
Delta Synthetic Co., Ltd. deltayc@ms25.hinet.net (02)22685604 (02)2268-0895 236   
Factor PharmaceuticalCo.,Ltd.  dfe688@ms23.hinet.net (07)7038748 (07)7022558 831   
Everest Pahrm. Industrial Co., Ltd. everestm@ms38.hinet.net (05)2218686 (05)221-3383 621   
Forever Chemical Co., Ltd. fcco1999@yahoo.com.tw (03)3862421 
(02)8861-3292,2882-
9663 337 www.forever-chem.com.tw 
Ya Sian Biotech Co., Ltd. felix@eusol-biotech.com.tw (02)22994836 (02)22996026 248   
Fisherman Pharmaceutical Co Ltd. fisher.mar@msa.hinet.net 
(07)3417718, 
(07)3416396 (07)341-8266 813 www.fisher-man.com.tw 
Eisai Taiwan Inc. fmchang@eisai.com.tw  (06)6985180 (02)2531-0063 720 www.eisai.com.tw 
Fuh Teng PharmaceuticalCo.,Ltd. fu.tain@msa.hinet.net (04)7989696 (04)798-0796 509   
Fung Song Pharm .Biotechnology .Co ., 
Ltd. fung.song@msa.hinet.net (06)6987396 (06)6990039 720   
Fu Yuan Chem. & Pharm. Co., Ltd. fuyuan17303@seed.net.tw (02)24972872 (02)2433-2079 224   
Genuine Chemical gcpc2030@ms37.hinet.net (03)4524382 (03)462-7749 320   
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Pharmaceutical Co., Ltd.  
Gentle Pharmaceutical Co., Ltd.  gen11101@ms36.hinet.net (05)5911101-2 (05)591-1103 631   
New Bellus Entierprises Co., Ltd. gkimail@tpts5.seed.net.tw (03)4572121 (02)2393-7001 320 www.grapeking.com.tw  
Hansen Pharmaceutical Co., Ltd. han.sheng88@msa.hinet.net 
(08)7226222, 
(08)8000381~2 (08)8000383 900   
Hui Chun Tang Pharmaceutical Works Co 
Ltd.  hctpharm@ms65.hinet.net (03)4775185 (02)2999-1911 327 www.hctpharm.com.tw 
Health Chemical Pharmaceutical Co Ltd. healthcgmp@yahoo.com.tw  (04)26811733 (04)26818462 437   
Tainan Peng Lai Enterprise Co. Ltd. helen106@ms13.hinet.net (06)2673036 (06)2673-084 701   
Heng An Pharmaceutical 
Industrial Co.,Ltd. hengan23593019@yahoo.com.tw  
(04)23593019, 
(04)23593222 (04)2359-0120 407   
Hwa Kuo Pharmacy Co., Ltd.  hk23rd36th@yahoo.com.tw (04)23592993 (04)2359-3841 408   
Hui Kwang Chemical Co.,Ltd.  hkc@huikwang.com  (06)5702181 (06)5700065 721 www.huikwang.com 
Hong Shing Pharmaceutical Co., Ltd. hong.shingf@msa.hinet.net (03)4521818 (02)2708-8800 320 www.hongshing.com.tw 
Unifarma Co., Ltd. hongchusis@yahoo.com.tw  (04)7356825  (04)736-1180 500   
Taiwan Dersan Pharmaceutical Co. Ltd  hsien.ju@msa.hinet.net (05)2209897 (05)220-9685 621   
Syngen Biotech Co., Ltd. huang.adam@syngen.com.tw  (06)6323588 (06)6361964 730 www.syngen.com.tw  
Hwang's Pharmaceutical Co Ltd.  hwangs.ltd@msa.hinet.net (05)5971197 (02)2771-2573 630 www.hwangs.com.tw 
Hsin Wan Jen Chem.&Pharm.Co.,Ltd.  hwj@greenoil.com.tw  (04)25269105 (04)2524-2570 42049 www.greenoil.com.tw 
Union Chem & Pharm Co Ltd. ict.union@msa.hinet.net (02)22833001-3 (02)2281-7044 247   
Formosa Laboratories Inc. info@formosalab.com (03)3240895 (03)324-0923 338 www.formosalab.com 
Taiwan Biotech Co Ltd.  info@mail.sintong.com  (03)3612131 (03)367-0029 330 www.sintong.com 
Sinphar Pharmaceutical Co., Ltd. info@sinphar.com (03)9581101-5 
(03)9583040, 
(02)27699918 269 www.sinphar.com 
Jen Chang Sheng Chem.& Pharm.Co.,Ltd.  jcsc.jcsc@msa.hinet.net (04)7354976-7 (04)735-4978 508   
Jen Sheng Pharmaceutical Co., Ltd jena@jensheng.com (04)23592345 (04)2359-1997 407 http://www.jensheng.com 
Center Laboratories, Inc. jessie@centerlab.com.tw  (03)5981829 (02)2545-3562 303 www.centerlab.com.tw  
Jilly Pharmaceutical Co., Ltd. jilly.gmp@gmail.com (04)8223141-3 (04)823-4162 512   
Jinup Enterprise Co. Ltd.  jinup@ms37.hinet.net 
(05)2262395, 
(05)2262769 (05)226-8393 621   
Johnson Chem. Pharm. Works Ltd.  johnson.twjcp@msa.hinet.net (02)22878405 (02)2971-2579 241   
Jeou Song Chemical Enterprise Co.,Ltd.  jschem@ms39.hinet.net (04)7695106-7 (04)769-5108 504   
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Taiwan Three Mast 
Pharmaceuticl Co., Ltd. kamtamt@seed.net.tw (06)2042345 (06)2637414 710 www.3mast.com.tw  
Taiwan Veterans Pharmaceutical Co Ltd.  kate_wu@taiwanvpc.com.tw  (03)4651190 (03)465-7381 320 www.taiwanvpc.com.tw 
Everlight Chemical Industrial Corp.  kingdavid@ecic.com.tw (03)4838088 (02)27031386 328 www.ecic.com  
Kink Laboratories Co Ltd.  kink@ms29.hinet.net (04)22263921 (04)2223-3041 411   
Chirogate International Inc. kirogate@ms63.hinet.net (03)4963808 (03)4963800 32657 www.chirogate.com  
Kojar Pharmaceutical Ind Co Ltd.  kojar.c9388@msa.hinet.net (04)26815051-3 (04)26816198 437 www.kojar.com.tw 
Tien Liang Biotech Co., Ltd. ktl.chan@msa.hinet.net  (03)4696792 (02)2647-5179 324   
Panion&BF Biotech, INC. leesufen@pbf.com.tw  (03)4697159 (02)26558318 324   
Li Ta Pharmacy Co Ltd.  lita.wang@msa.hinet.net (04)26872345 (04)2686-8381 437   
Tolin Pharmaceutical Industries Co.,Ltd. long_jacyyang@yahoo.com.tw  
(04)25364377, 
(04)25363677 (04)2536-1020 427 http://www.tolya.com.tw  
Long Der Pharmaceutical Co.,Ltd. longder@seed.net.tw (07)6220909 (07)622-6461 828   
Lotus Pharmaceutical Co Ltd.  lotus@lotuspharm.com (049)2250411 
(02)27782798, 
(02)27115262 540 www.lotuspharm.com.tw 
Long Shin Biotech & Pharmaceutical Co., 
Ltd. ls928@aptg.net  (06)7220666 (06)722-9548 722 www.lsbiopharma.com  
Meider Pharmaceutical Co Ltd.  meider.drugs@msa.hinet.net (03)4723567 (03)521-4179 326   
Mey See Pharmaceutical Co Ltd.  mey.see@msa.hinet.net (07)3711234 (07)3736359 814 www.meysee.com.tw  
SCI Pharmtech,Inc. 
michele.seah@sci-
pharmtech.com.tw  (03)3543133 (03)354-3137 33856 www.sci-pharmtech.com.tw  
Ming Ta Chemistry Pharmacy Co., Ltd. mingta52@ms45.hinet.net (04)26870115-7 (04)2687-0118 438   
Min Ton Pharmaceutical Co., Ltd. mintong@ms6.tisnet.net.tw (04)23590107 (04)2359-4256 408   
Tong Yang Pharmaceutical Co., Ltd. msa@ms8.hinet.net (06)6987661 (06)698-7663 720 www.tong-yang.com.tw  
Mingtai Chemical Co., Ltd. mtchem@ms24.hinet.net (03)3682295 (02)2721-6326 334 www.mingtai.com 
Mu Tsu Pharmaceutical Chemical Co Ltd. mtpc.komt@msa.hinet.net 
(04)8330229, 
(04)8321229 (04)833-7702 510   
Nan Tu Chemical Pharmaceutical Co.,Ltd.  nan.tu@msa.hinet.net (06)7260339 (06)726-1128 722   
Chung His Chemical Plant, Ltd.  nancylee@chunghsi.com.tw (03)5772551-2 (02)2351-2884 300 www.chunghsi.com.tw  
Newai Chemical Industries Ltd. newai.company@msa.hinet.net 
(05)5571111, 
(05)5571405 (06)274-5456 640 www.newai.com.tw  
New Chemical International 
Enterprise Co. Ltd.  newchem@giga.net.tw 
(06)6550550,  
(06)6550551 (06)655-0552 737 www.newchem.com.tw  
  
 326
Nang Kuang Pharmaceutical Co., Ltd. nkcp@ms15.hinet.net (06)5984121-6 (06)597-2033 712 www.nangkuang.com.tw  
Oasis Chemical IndustriesCo.,Ltd.  oasis@ms65.hinet.net (02)27671288 (02)2762-3883 105   
Sage Biotechnology Co., LTD. onpylu@ms52.hinet.net (02)24978076 (02)2321-5861 224   
Tung Chou Chemical & Pharmaceutical 
Co., Ltd. orichem@ms41.hinet.net (02)22815252 (02)2281-8282 247 www.oriental.com.tw 
Panbiotic Laboratories panbio@ksts.seed.net.tw (07)7317861 (07)731-6002 833 www.panbiotic.com.tw  
You Zhi Bao Biopharmaceuticals Co., Ltd. Passalip@Yahoo.com.tw (06)6525757 (06)6373177 730   
Bei Chin International Inc. peijin@ms6.hinet.net (02)27089462 (02)26486748 106   
Pfoshen Pharmaceutical Co Ltd.  ph.119@yahoo.com.tw  (04)7223923 (04)723-2498 500   
Timing-Life Medical, Inc  ppin0214@yahoo.com.tw  (07)3715106 (07)372-1182 814   
Prince Pharmaceutical Co., Ltd. prince30@ms14.hinet.net (03)5981438  (02)2988-5137 303   
Hua Shin Chemical Pharmaceutical 
Works Co.,Ltd. propr2@hspg.com.tw (04)8832121 (04)883-0916 522 www.hspg.com.tw  
San Yo Pharmaceutical Industrial Co., Ltd. qcwen2007@hokia.com.tw (07)7871266 (07)224-3456 831   
Taiwan Yang Sheng Pharmaceutical 
Ind. Co.,Ltd.  r2681132@ms43.hinet.net (08)7524112 (08)753-9476 900   
Root Chemical Pharmacy Co Ltd. rootph.com@msa.hinet.net (04)26882666-7 (04)2688-2667 437   
Royal Chemical & Pharmaceutical Co Ltd. rp7310@ms23.hinet.net (07)7310537 (07)731-0538 833   
Synmax Biochemical Co., Ltd.  sales@synmax.com.tw (03)4863160 (02)23820559 327 www.synmax.com.tw 
De Licacy Garment Co., Ltd. san.hord@msa.hinet.net (04)25322867 (04)2532-8821 420 www.1pco.com.tw  
San Nang Chemical Co.,Ltd.  sannan168@yahoo.com.tw  (04)7692668-9 (04)769-0306 504   
Shou Chan Industrial Co.,Ltd.  sc254221@ms14.hinet.net (049)2254221-3 (049)2254-617 540   
SuChiang Chemical & 
Pharmaceutical Co., Ltd. sccpcl@ms38.hinet.net (02)25618026 (02)2542-2497 104   
Sheng Chang Pharmaceufical Co.,Ltd sctechli@gmail.com  (03)4909682 (02)23011269 320 www.herb.com.tw  
Shyh Dar Pharmaceuticl 
Industrial Co., Ltd. sdpi@shyhdar.com  (04)23593862 (04)2359-3966 407 http://www.shyhdar.com 
Sen Tai Pharmaceutical Co Ltd.  sentai.tw@msa.hinet.net (06)6529887-9 (06)652-9884 730   
Ming Hwa Drug Co., Ltd.  service.minghwa@msa.hinet,net (02)24978397 (02)2497-8398 224   
Pei Li Pharmaceutical Industrial Co Ltd.  service@peili.com.tw (04)23592576 (04)2359-0992 407 www.peili.com.tw 
Synpac-Kingdom Pharmaceutical Co Ltd.  service@sking.com.tw  (02)22605490 (02)25816608 236 www.sking.com.tw 
TTY Biopharm Co., Ltd. service@tty.com.tw  (03)4522160 (02)27180648 320 www.tty.com.tw  
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Seven Star Pharm Co., Ltd. sevensta@seed.net.tw (02)22685871 (02)2268-1706 236 www.sevenstarpharm.com.tw 
Shinlon Pharmaceutical Industrial Co Ltd.  shinlon.pharm@msa.hinet.net (06)2705711-2 (06)270-4821 717   
Shunjan Pharmaceutical Co., Ltd. shunjan.gmp@msa.hinet.net (049)2251668 (049)2251-279 540 www.shunjan.com.tw 
 Siu Guan Chem. Ind. Co., Ltd. siuguan@ms66.hinet.net (05)2360636-9 (05)2865232 600   
Shinlin Sinseng Pharmaceutical Co Ltd.  ss.pharm@msa.hinet.net (03)4703248 (03)470-2646 325   
Sun Laboratories Co., Ltd. sunlab@ms35.hinet.net (02)28914125-8 (02)2894-0576 112   
Swiss Pharmaceutical Co.,Ltd. swiss404@ms1.hinet.net (06)2326853 (06)211-0728 710 www.swisspharm-fac.com.tw 
San Yueh Chemical Corporation.  sycp@ms24.hinet.net (05)2219068 (05)221-1063 621   
Syn-Tech Chem. & Pharm.Co., Ltd. syntech@msl.hinet.net (06)6362121-3 (06)635-1165 730 www.syn-tech.com.tw 
Ta Fong Pharmaceutical Co Ltd.  tafong2@giga.net.tw (04)7138165 (04)7138178 500 http://www.tfp.com.tw  
Tah-An Chemical & Pharmaceutical Co., 
Ltd. tah.an@msa.hinet.net 
(06)2030503、
(06)2328797 (06)2377750 710   
Tai Ho Tang Pharmaceutical Co., Ltd. taiho.tang@msa.hinet.net (06)2633911-3 (06)264-7293 702 www.taihotang.com.tw  
Taisho Pharmaceutical (Taiwan) Co., Ltd. taisho.tw@msa.hinet.net (03)5982624-5 (02)2559-6496 303 www.twtaisho.com.tw 
Tai Yu Chemical & Pharmaceutical Co 
Ltd.  taiyu.act@msa.hinet.net (03)5826655 (03)582-2389 310 www.tai-yu.com.tw 
Daiichi Sankyo ProPharma Co., Ltd. tds1002@ms27.hinet.net (03)4580802 (02)87862569 324   
TehSeng Pharmaceutical Mfg. Co., Ltd. teh.seng@msa.hinet.net (06)2311636 (06)2334596 710 www.tehseng.com 
Tai Fu Pharmaceutical Co., Ltd. tffuji@ms47.hinet.net (03)3865117 (03)386-5118 337   
Tian I Pharmaceutical Co.,Ltd. tian.yi@msa.hinet.net (06)6985978-9 (06)698-6662 720 www.tian-i.com.tw 
Tien Chen Pharmaceutical Co., Ltd. tien3502@ms64.hinet.net (06)7941788 (06)794-3519 725   
Taiwan Patron Chemical & 
Pharmaceutical Co Ltd. tpc6216126@seed.net.tw (07)6216126 (07)622-0930 820   
Chen Ho Pharmaceutical Co.,Ltd.  tracy@chenho.com.tw  (06)6529311-3 (06)652-8563 730 www.chenho.com.tw 
InnoPharmax, Inc.  tring7477@innopharmax.com (02)87977607 (02)87975627 114 http://www.innopharmax.com 
Taiwan Tanabe Seiyaku Co Ltd.  ttanabep@ms38.hinet.net (03)5983655 (02)2753-4789 303 www.tanabe.com.tw  
Tung Fa Pharmaceutical Co., Ltd. tungfa01@ms23.hinet.net (08)7530177 (08)753-6017 900   
Orient Europharma Co Ltd.  ty_plant@oep.com.tw (03)3614102 (02)2702-4324 330 www.oep.com.tw 
U Chu Pharmaceutical Co., Ltd. ucp210@ucpharm.com.tw  
(03)4773411, 
(03)4775177-8 (03)4777121 327 www.ucpharm.com.tw  
U-Liang Pharmaceutical Co., Ltd. uliang@ms27.hinet.net (03)4523183 (03)452-3964 320   
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Tian Machinery Technologies Co., Ltd. vicky11251983@yahoo.com.tw  (02)29421916 (02)2941-0742 231   
Shiteh Organic Pharmaceutical Co Ltd.  vivian@healthcare.com.tw  (02)29811451 (02)2298-1565 241 www.shiteh.com.tw  
Synmosa Biopharma Corp. 
wayne3001@mail.synmosa.com.t
w (03)5983500  (03)598-1390 303 www.synmosa.com.tw  
WEIDAR CHEM. & PHARM. CO., LTD.  
wd830121@ms8.hinet.net/judych
ang@weidar.com.tw 
(04)23593847, 
(04)23593852 (04)2359-3336 408 www.weidar.com.tw 
Chiuann Feng Tarng 
Pharmaceutical Co.,Ltd.  webmaster@ox-brand.com (03)4737996 (03)4737995 328 www.ox-brand.com 
Chi Sheng Chemical Corporation wen@csop.com.tw (03)5983811 (03)598-2855 303   
GenMont Biotech Inc. william@genmont.com.tw  (06)5052151 (06)5052152 741 www.genmant.com.tw 
Genovate Biotechnbology Co., Ltd. williechiang@genovate-bio.com  (03)5982221 (03)5982804 303 www.genovate-bio.com 
Winston Medical Supply Co Ltd.  winstons@ms11.hinet.net (06)2533124-6 (06)2538590 710   
Wan-Kuo Pharmaceuticals Co., Ltd. wkp@wkp.com.tw (06)3310999 (06)2919723 701   
Washington Pharmaceutical Co., Ltd. wp3711651@yahoo.com.tw (07)3711651 (07)3714801 814   
Wu-Fu Laboratories Co.,Ltd wufu.lab@msa.hinet.net 
(03)9901470, 
(03)9902489 (03)9902-487 270   
China Chemical & Pharmaceutical Co., 
Ltd. y.n.sun@ccpc.com.tw (03)5599866 (02)2361-5143 304 www.ccpc.com.tw 
Ying Yuan Chemical & 
Pharmaceutical Co Ltd.  y2654883@ms17.hinet.net (06)2654883 (06)264-3511 702 www.ying-yuan.com.tw  
Sheng Chung Chun Tang Pharmaceutical 
Industrial Co., Ltd. ycheng2@herbalmed.com.tw  (06)2325155 (06)233-5076 710 www.shengchun.com 
Souriree Biotech Pharmaceutical Co Ltd. ye@souriree.com.tw (02)26726032 (02)25216124 237   
Y F Chemical Corp. yfc@yfchem.com.tw  (02)22021112 (02)2204-1116 242 www.yfchem.com.tw  
Yung Sine Pharmaceutical Co Ltd.  ys3688@ms15.hinet.net (03)3688321-4 (03)368-6507 334   
Yung Shin Pharm Ind. Co., Ltd. ysp@yungshingroup.com  (04)26815181 (04)26869418 437 www.yungshingroup.com  
Yung Zip Chemical Co.,Ltd. yspgyzc@yungshingroup.com (04)26811344 (04)2682-1007 437 www.yungzip.com 
Yusheng Pharmaceutical Co., Ltd. yspharm@ms14.hinet.net (04)23593968 (04)2359-0924 40850 www.yusheng.com.tw  
Yih Sheng Tang Pharmaceutical Co., Ltd.  ystc430@ms38.hinet.net (03)5983406 (02)2311-8928 303   
Chung I PharmaceuticalCo.,Ltd. yuenuo.biotec@seed.net.tw  (06)2662163 (06)366-1057 717   
Savior Lifetec Co., Ltd. sales@saviorlifetec.com.tw  (037)580100 (037)580200 350 http://champlee.myweb.hinet.net 
 
